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resumo 
 
A espécie mediterrânica Cynara cardunculus L. é reconhecida na medicina 
tradicional, pelos seus efeitos hepatoprotetor e colerético. A biomassa de C. 
cardunculus L. var. altilis (DC), ou cardo cultivado, poderá ser explorada não 
só para a produção de energia e fibras de pasta de papel, mas também para a 
extração de compostos bioativos. A caracterização química dos componentes 
extratáveis, nomeadamente os compostos terpénicos e fenólicos, poderá 
valorizar a plantação de cardo cultivado, dadas as suas atividades 
antioxidante, antitumoral e antimicrobiana. 
Neste estudo, a composição química das frações lipofílica e fenólica de C. 
cardunculus L. var. altilis (DC), cultivado no sul de Portugal (região do Baixo 
Alentejo), foi caracterizada em detalhe, com vista à valorização integral da sua 
biomassa. A atividade biológica dos extratos de cardo cultivado foi avaliada em 
termos de efeitos antioxidante, antiproliferativa em células humanas tumorais, 
e antibacteriano. 
A análise química dos compostos lipofílicos foi realizada por cromatografia em 
fase gasosa acoplada à espectrometria de massa (GC-MS). Identificaram-se 
65 compostos lipofílicos, dos quais 1 lactona sesquiterpénica e 4 triterpenos 
pentacíclicos foram descritos, pela primeira vez, como componentes do cardo 
cultivado, tais como: desacilcinaropicrina, acetatos de β- e α-amirina, acetato 
de lupenilo e acetato de ψ-taraxasterilo. As lactonas sesquiterpénicas foram a 
principal família de compostos lipofílicos das folhas (≈94,5 g/kg), 
maioritariamente representadas pela cinaropicrina (≈87,4 g/kg). Os triterpenos 
pentacíclicos foram também detetados, em teores consideravelmente 
elevados, nas restantes partes do cardo cultivado, em especial nos floretos 
(≈27,5 g/kg). O acetato de taraxasterilo foi o triterpeno pentacíclico maioritário 
(≈8,9 g/kg nos floretos). 
Para a análise química dos compostos fenólicos foi utilizada a cromatografia 
líquida de alta resolução acoplada à espectrometria de massa (HPLC-MS). 
Entre os 28 compostos fenólicos identificados, o erioditiol hexósido foi descrito 
pela primeira vez como componente de C. cardunculus L., e 6 como 
componentes do cardo cultivado, nomeadamente ácido 1,4-di-O-cafeoilquínico, 
naringenina 7-O-glucósido, naringenina rutinósido, naringenina, luteolina acetil-
hexósido e apigenina acetil-hexósido. A concentração mais alta de compostos 
fenólicos identificados foi observada nos floretos (≈12,6 g/kg). A parte externa 
dos caules continha o maior teor em ácidos hidroxicinâmicos (≈10,3 g/kg), e os 
floretos apresentaram o maior teor em flavonoides (≈10,3 g/kg). 
A atividade antioxidante da fração fenólica foi examinada face ao radical livre 
2,2-difenil-1-picril-hidrazilo (DPPH). Os extratos da parte externa do caule, e 
dos recetáculos e brácteas demonstraram o maior efeito antioxidante, face ao 
DPPH (IC50 de 34,35 µg/mL e 35,25 µg/mL, respetivamente). (cont.) 
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A atividade antioxidante face ao DPPH foi correlacionada linearmente com a 
concentração total de ácidos hidroxicinâmicos (r = -0.990).  
A atividade antiproliferativa in vitro dos extratos lipofílicos e fenólicos de cardo 
cultivado foi avaliada numa linha de células tumorais humanas de cancro da 
mama de fenótipo triplo-negativo (MDA-MB-231), um dos tipos de cancro 
humano mais refratários às terapêuticas convencionais. Após 48 h de 
exposição, o efeito inibitório do extrato lipofílico das folhas (IC50 = 10,39 µg/mL) 
foi superior ao do extrato lipofílico dos floretos (IC50 = 315,22 µg/mL), sobre a 
viabilidade celular de MDA-MB-231. O composto puro da cinaropicrina, 
representativo do composto maioritário identificado no extrato lipofílico das 
folhas, também inibiu a proliferação das células MDA-MB-231 (IC50 = 17,86 
µM). As células MDA-MB-231 foram muito mais resistentes, ao tratamento de 
48 h, com os extratos fenólicos da parte externa dos caules (IC50 = 3341,20 
µg/mL) e dos floretos (IC50 > 4500 µg/mL), e também com o composto puro do 
ácido 1,5-di-O-cafeoilquínico (IC50 = 1741,69 µM). 
As células MDA-MB-231 foram expostas, durante 48 h, às respetivas 
concentrações de IC50 do extrato lipofílico das folhas e do composto puro da 
cinaropicrina, de modo a perceber a sua capacidade em modelar respostas 
celulares, e consequentemente potenciais vias de sinalização importantes para 
o decréscimo da viabilidade celular. O extrato lipofílico das folhas aumentou a 
atividade enzimática da caspase-3, ao contrário do composto puro da 
cinaropicrina. Além disso, o extrato lipofílico das folhas e o composto puro da 
cinaropicrina causaram paragem do ciclo celular na fase G2, possivelmente 
através do aumento da expressão proteica de p21
Waf1/Cip1
 e da acumulação das 
proteínas fosfo-Tyr15-CDK1 e ciclina B1. Os efeitos inibitórios do extrato 
lipofílico das folhas e do composto puro da cinaropicrina, contra a proliferação 
das células MDA-MB-231, poderão também estar relacionados com a 
diminuição da expressão proteica da fosfo-Ser473-Akt. 
A atividade antibacteriana dos extratos lipofílicos e fenólicos de cardo cultivado 
foi avaliada, pela primeira vez, sobre duas bactérias multirresistentes, tais 
como a bactéria Gram-negativa Pseudomonas aeruginosa PAO1 e a bactéria 
Gram-positiva Staphylococcus aureus resistente à meticilina (MRSA), duas das 
principais bactérias responsáveis pelas infeções associadas aos cuidados de 
saúde. Para tal, determinaram-se as concentrações inibitórias mínimas (MIC). 
Os extratos lipofílicos e fenólicos dos floretos não revelaram atividade 
antibacteriana contra P. aeruginosa PAO1 e MRSA (MIC > 2048 µg/mL). O 
extrato lipofílico das folhas não inibiu o crescimento de P. aeruginosa PAO1, 
mas o composto puro da cinaropicrina foi ligeiramente ativo (CIM = 2048 
µg/mL). O extrato lipofílico das folhas e o padrão puro da cinaropicrina 
bloquearam o crescimento de MRSA (MIC de 1024 e 256 µg/mL, 
respetivamente). 
O conhecimento científico revelado nesta tese, quer do ponto de vista químico, 
quer do ponto de vista biológico, contribui para a valorização da biomassa de 
C. cardunculus L. var. altilis (DC). O cardo cultivado tem potencial para ser 
explorado como fonte de compostos bioativos, em conciliação com outras vias 
de valorização, e a produção de queijos tradicionais portugueses. 
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abstract 
 
The Mediterranean species Cynara cardunculus L. is recognized in the 
traditional medicine, for their hepatoprotective and choleretic effects. Biomass 
of C. cardunculus L. var. altilis (DC), or cultivated cardoon, may be explored not 
only for the production of energy and pulp fibers, but also for the extraction of 
bioactive compounds. The chemical characterization of extractable 
components, namely terpenic and phenolic compounds, may valorize the 
cultivated cardoon plantation, due to their antioxidant, antitumoral and 
antimicrobial activities. 
In this study, the chemical composition of lipophilic and phenolic fractions of C. 
cardunculus L. var. altilis (DC), cultivated in the south of Portugal (Baixo 
Alentejo region) was characterized in detail, intending the integral valorization 
of its biomass. The biological activity of cultivated cardoon extracts was 
evaluated in terms of antioxidant, human tumor cell antiproliferative and 
antibacterial effects. 
Gas chromatography-mass spectrometry (GC-MS) was used for the chemical 
analysis of lipophilic compounds. Sixty-five lipophilic compounds were 
identified, from which 1 sesquiterpene lactone and 4 pentacyclic triterpenes 
were described, for the first time, as cultivated cardoon components, such as: 
deacylcynaropicrin, acetates of β- and α-amyrin, lupenyl acetate and ψ-
taraxasteryl acetate. Sesquiterpene lactones were the major family of lipophilic 
components of leaves (≈94.5 g/kg), mostly represented by cynaropicrin (≈87.4 
g/kg). Pentacyclic triterpenes were also detected, in considerably high 
contents, in the remaining parts of cultivated cardoon, especially in the florets 
(≈27.5 g/kg). Taraxasteryl acetate was the main pentacyclic triterpene (≈8.9 
g/kg in florets). 
High pressure liquid chromatography-mass spectrometry (HPLC-MS) was 
utilized for the chemical analysis of phenolic compounds. Among the identified 
28 phenolic compounds, eriodictyol hexoside was reported for the first time as 
C. cardunculus L. component, and 6 as cultivated cardoon components, 
namely 1,4-di-O-caffeoylquinic acid, naringenin 7-O-glucoside, naringenin 
rutinoside, naringenin, luteolin acetylhexoside and apigenin acetylhexoside. 
The highest content of the identified phenolic compounds was observed in the 
florets (≈12.6 g/kg). Stalks outer part contained the highest hydroxycinnamic 
acids abundance (≈10.3 g/kg), and florets presented the highest flavonoids 
content (≈10.3 g/kg). 
The antioxidant activity of phenolic fraction was examined through 2,2-
diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay. Stalks outer 
part, and receptacles and bracts extracts demonstrated the highest antioxidant 
effect on DPPH (IC50 of 34.35 µg/mL and 35.25 µg/mL, respectively). (cont.) 
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The DPPH scavenging effect was linearly correlated with the total contents of 
hydroxycinnamic acids (r = -0.990). 
The in vitro antiproliferative activity of cultivated cardoon lipophilic and phenolic 
extracts was evaluated on a human tumor cells line of triple-negative breast 
cancer (MDA-MB-231), one of the most refractory human cancers to 
conventional therapeutics. After 48 h of exposition, leaves lipophilic extract 
showed higher inhibitory effect (IC50 = 10.39 µg/mL) than florets lipophilic 
extract (IC50 = 315.22 µg/mL), upon MDA-MB-231 cellular viability. Pure 
compound of cynaropicrin, representative of the main compound identified in 
leaves lipophilic extract, also prevented the cell proliferation of MDA-MB-231 
(IC50 = 17.86 µM). MDA-MB-231 cells were much more resistant to the 48 h- 
treatment with phenolic extracts of stalks outer part (IC50 = 3341.20 µg/mL) and 
florets (IC50 > 4500 µg/mL), and also with the pure compound of 1,5-di-O-
caffeoylquinic acid (IC50 = 1741.69 µM). 
MDA-MB-231 cells were exposed, for 48 h, to the respective IC50 
concentrations of leaves lipophilic extract and pure compound of cynaropicrin, 
in order to understand their ability in modelling cellular responses, and 
consequently important potentially signaling pathways for the cellular viability 
decrease. Leaves lipophilic extract increased the caspase-3 enzymatic activity, 
contrarily to pure compound of cynaropicrin. Additionally, leaves lipophilic 
extract and pure compound of cynaropicrin caused G2 cell cycle arrest, 
possibly by upregulating the p21
Waf1/Cip1
 and the accumulation of phospho-
Tyr15-CDK1 and cyclin B1. The inhibitory effects of leaves lipophilic extract and 
cynaropicrin pure compound, against the MDA-MB-231 cell proliferation, may 
also be related to the downregulation of phospho-Ser473-Akt. 
The antibacterial activity of cultivated cardoon lipophilic and phenolic extracts 
was assessed, for the first time, on two multidrug-resistant bacteria, such as 
the Gram-negative Pseudomonas aeruginosa PAO1 and the Gram-positive 
methicillin-resistant Staphylococcus aureus (MRSA), two of the main bacteria 
responsible for health care-associated infections. Accordingly, the minimum 
inhibitory concentrations (MIC) were determined. Lipophilic and phenolic 
extracts of florets did not have antibacterial activity on P. aeruginosa PAO1 and 
MRSA (MIC > 2048 µg/mL). Leaves lipophilic extract did not prevent the P. 
aeruginosa PAO1 growth, but pure compound of cynaropicrin was slightly 
active (MIC = 2048 µg/mL). Leaves lipophilic extract and pure compound of 
cynaropicrin blocked MRSA growth (MIC of 1024 and 256 µg/mL, respectively). 
The scientific knowledge revealed in this thesis, either by the chemical 
viewpoint, or by the biological viewpoint, contributes for the valorization of C. 
cardunculus L. var. altilis (DC) biomass. Cultivated cardoon has potential to be 
exploited as source of bioactive compounds, in conciliation with other 
valorization pathways, and Portuguese traditional cheeses manufacturing. 
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1. The context 
1.1 Natural products within the pharmaceutical field 
The empiric use of medicinal plants is as old as humanity’s history. The interest of 
pharmaceutical industry for the natural products field was boosted by the isolation of morphine 
from Papaver somnifera, in 1804, by Friedrich Serturner. Due to its analgesic action, morphine 
started to be commercialized in 1827 by Heinrich Merck, long before the creation of the 
modern Food and Drug Administration (FDA) in 1938.
1
 
In the 1930-1970s, natural-based derivatives represented more than 50% of the total 
annually FDA-approved new molecular entities (NMEs). Nevertheless, there was a decrease 
of natural-based NMEs percentage, with FDA approval, to ≈30% in the 1990s, which was 
ascribed to a higher production of synthetic compounds “libraries”.1 Due to a “crisis” in finding 
new active principles, pharmaceutical industry has been turning to the research of natural 
compounds, in an effort to synthesize novel, biologically active, “natural product-like” 
molecules, owing to: (i) chemical diversity; (ii) “privileged structures”, resulting from selected 
evolution to bind to biological macromolecules; and (iii) pleiotropic mechanisms of action.
1–3
 In 
this manner, the natural-based drugs fraction, in the 2000s, increased to 38% of the annually 
FDA-approved NMEs, and it reached more than 20% in 2011-2013.
1
 
Between 1935 and 2013, a huge search for anticancer and antibacterial drugs 
contributed to respectively 13% and 20% of the total natural-based NMEs approved by FDA.
1
 
Secondary metabolites of plants origin have been a source of natural-based NMEs, approved 
by FDA, accounting for 25%, in the same period. Among natural-based NMEs, 16% and 2% 
corresponded to plant-based NMEs for the therapeutic of cancer and bacterial infections, 
respectively.
1
 
There has been a growing interest in the consumption of herbal products, as a 
complementary approach to the treatment with synthetic drugs, to manage in a gentler way, 
some of the dominant chronic diseases in the 21
st
 century, namely cardiovascular diseases, 
cancer, diabetes and mental disorders.
4
 The scientific knowledge, about the chemical 
composition and physiological effects of herbal products, has contributed to enhance their 
effectiveness and safe usage.
5
 Veregen, an aqueous extract of green tea leaves containing 
catechins, was the first botanical prescription drug approved by FDA, in 2006. The FDA-
approval of Veregen represents an important step in the botanical drug development.
6
 
 
1.2 Biorefinery concept 
The term biorefinery was recently redefined within the project Biorefinery Euroview: 
“Biorefineries could be described as integrated bio-based industries using a variety of 
technologies to make products such as chemicals, biofuels, food and feed ingredients, 
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biomaterials, fibers, heat and power, aiming at maximizing the added value along the three 
pillars of sustainability (Environment, Economy and Society)”.7 Nowadays, the production of 
chemicals, including pharmaceuticals, materials and energy, are highly dependent on non-
renewable fossil fuels, implicating serious global issues, namely climate change, petroleum 
depletion, energy and food supply, biodiversity, etc.
8,9
 For reducing production costs and 
environmental negative impact, the pharmaceutical industry should integrate alternative raw 
materials, based on renewable resources as plant biomass, which perfectly fulfills the 
biorefinery concept. Additionally, the application of clean processes with reduced solvent 
consumption, lower energy input, renewable catalysts, and mild conditions for reaction and 
separation should also be considered.
8
 
 
1.3 Industrial perspectives for Cynara cardunculus L. 
Cynara cardunculus L. is a Mediterannean species, englobing three varieties, namely 
var. sylvestris (Lamk) (wild cardoon), var. scolymus (L.) (globe artichoke) and var. altilis (DC) 
(cultivated cardoon). Growing conditions of cultivated cardoon fit well with the clay soils and 
hot summers of the Mediterranean countries. Cultivated cardoon plantation is, until now, 
located in Spain, Italy, France, Greece,
10,11
 and south of Portugal.
12
 Experimental plantations 
of cultivated cardoon could afford a biomass productivity from 7.5 t dw/ha (Beja, Portugal)
12
 to 
33.4 t dw/ha (Tebas, Greece),
11
 after the second growing season. Wild cardoon naturally 
develops in the Mediterranean basin countries and Macaronesia (Madeira and Canary 
Islands), while the artichoke cultivar is spread worldwide.
10
 
Cultivated cardoon is much appreciated in regional dishes in Spain, Italy and France,
13
 
due to its fleshy stems and leaf petioles. Traditionally, capitula of wild cardoon and cultivated 
cardoon are used for producing several traditional ewe’s cheeses, namely “Serra da Estrela”, 
“Serpa”, “Nisa” and “Évora” in Portugal,14,15 and “La Serena” and “Guía” in Spain.14 
Furthermore, infusions of C. cardunculus L. leaves have been known in the folk medicine, 
given their hepatoprotective
16
 and choleretic actions,
17
 mainly ascribed to phenolic 
compounds, such as caffeoylquinic acids (e.g., cynarin)
16
 and luteolin derivatives (e.g., luteolin 
7-O-glucoside and luteolin).
17
 Besides the traditional uses, various prospective industrial 
applications have also been considered for cultivated cardoon, owing to its high contents of 
cellulose and hemicelluloses,
11,18–21
 as follows: pulp fibers production,
11,18
 solid biofuel,
19
 
biogas
20
 and bioethanol production.
21
 Moreover, cultivated cardoon seed oil has shown to be 
adequate for the biodiesel production.
11
 
Several reports have shown valuable biological properties of artichoke extracts, 
namely rat serum-triglycerides elevation inhibition,
22
 antioxidant,
23
 anti-inflammatory,
24
 
antitumoral
24,25
 and antimicrobial.
26
 These have been associated with the secondary 
metabolites composition, namely sesquiterpene lactones
22
 (e.g. cynaropicrin), pentacyclic 
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triterpenes
24
 (e.g. taraxasterol) and hydroxycinnamic acids (e.g. 5-O-caffeoylquinic acid).
23,25,26
 
Few studies have also revealed some of those biological activities, in what concerns to 
extracts of both wild and cultivated varieties of cardoon, namely antioxidant
27,28
 and 
antitumoral,
27
 mainly attributed to phenolic compounds. 
Taking in account the increasing interest on the production of cultivated cardoon in the 
Mediterranean countries,
12,11,27,29
 a detailed chemical characterization of the bioactive 
extractable components is still missing. This would open several possibilities for the 
valorization of cultivated cardoon biomass, integrated in a sustainable biorefinery concept,
30
 
through the extraction of added-value bioactive compounds, conciliated with the 
manufacturing of Iberian traditional ewe’s cheeses, as well as with the energy production. 
 
2. Objectives and outline of the thesis 
The detailed chemical characterization of extractable compounds from C. cardunculus 
L. var. altilis (DC), as well as evaluation of their associated biological properties, would 
contribute for the valorization of its plantation. Some reports evidenced antioxidant
27,28
 and 
antitumoral
27
 effects of cultivated cardoon hydroalcoholic extracts, being mainly attributed to 
phenolic compounds. Nevertheless, it was not carried out a complete study describing, in 
detail, the chemical composition and the biological activity of different extractable classes of 
cultivated cardoon, principally regarding the lipophilic fraction. Moreover, no study reported, so 
far, the inhibitory functions of the lipophilic components of cultivated cardoon in important 
signaling pathways, in what concerns to tumor cells proliferation. Finally, at the current 
knowledge, no study has demonstrated the antibacterial activity of different extractable 
fractions of cultivated cardoon against multidrug-resistant (MDR) bacteria. 
In this context, several objectives were traced for this thesis: 
 to determine the chemical composition of lipophilic and phenolic-rich fractions of stalks 
(outer and inner parts), capitula (receptacles, bracts and florets) and leaves of C. cardunculus 
L. var. altilis (DC), by employing respectively gas chromatography-mass spectrometry and 
high performance liquid chromatography-mass spectrometry; 
 to evaluate the antioxidant activity of cultivated cardoon phenolic-rich extracts, through an 
in vitro scavenging assay; 
 to assess the in vitro inhibitory effects of lipophilic and phenolic-rich fractions of cultivated 
cardoon, as well as pure compounds regarding the most abundant identified compounds, on 
the cellular viability of MDA-MB-231, a human triple-negative breast cancer (TNBC) cell line; 
 to study the suppressive actions of lipophilic and phenolic-rich extracts of cultivated 
cardoon, on two MDR bacteria, namely Pseudomonas aeruginosa and methicillin-resistant 
Staphylococcus aureus (MRSA). 
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The present thesis is thus organized in eight chapters. 
In Part A, introduction and objectives of the thesis are indicated in the Chapter I. 
Chapter II is also included in Part A, which reviews the most relevant literature data about the 
chemical composition of C. cardunculus L. varieties, with more emphasis on extractable 
compounds, and the biological activity of their derived extracts and pure compounds, namely 
antioxidant, antitumoral and antibacterial properties. 
The Part B is devoted to the chemical characterization of C. cardunculus L. var. altilis 
(DC). 
Chapter III highlights the identification and quantification of lipophilic compounds in 
stalks (outer and inner parts), capitula (receptacles, bracts and florets) and leaves of C. 
cardunculus L. var. altilis (DC), by applying gas chromatography-mass spectrometry. Nuclear 
magnetic resonance spectroscopic techniques were also applied for the chemical identification 
of some specific compunds. 
Chapter IV addresses the identification and quantification of phenolic compounds in 
the several morphological parts of C. cardunculus L. var. altilis (DC), by utilizing high-
performance liquid chromatography-ultraviolet detection-mass spectrometry. 
The Part C is focused on the evaluation of biological activity of lipophilic and phenolic-
rich extracts derived from C. cardunculus L. var. altilis (DC). 
Chapter V describes the antioxidant activity of cultivated cardoon phenolic-rich 
extracts, by assessing the in vitro scavenging effect on 2,2-diphenyl-1-picrylhydrazyl free 
radicals. 
Chapter VI presents the inhibitory effects of cultivated cardoon lipophilic and phenolic- 
rich extracts, as well as of pure compounds, on TNBC MDA-MB-231 cellular viability. 
Moreover, downstream mechanisms involved in the cellular inhibition of the most potent 
extract(s) and pure compound(s) were further evaluated, in terms of other cellular assays. 
Furthermore, the molecular signaling pathways were investigated in what concerns to cell 
cycle regulation and Akt pathway. 
Chapter VII comprehends the antibacterial activity of cultivated cardoon lipophilic and 
phenolic-rich extracts on the growth of two MDR bacteria, namely Gram-negative P. 
aeruginosa and Gram-positive MRSA. 
 Finally, Part D comprises the most relevant conclusions obtained in this thesis, as well 
as suggestions for future work (Chapter VIII). 
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1. General considerations about Cynara cardunculus L. 
1.1 Morphological characteristics 
Cynara cardunculus L. belongs to the Asteraceae family,
1,2
 being subclassified in three 
varieties (Figure 1): sylvestris (Lamk) Fiori (wild cardoon), scolymus (L.) Fiori (globe artichoke) 
and altilis DC (cultivated cardoon). 
 
 
Figure 1: Illustrations of plants belonging to the three C. cardunculus L. varieties: (A) sylvestris (Lamk) 
(wild cardoon); (B) scolymus (L.) Fiori (artichoke); (C) altilis DC (cultivated cardoon). 
 
Wild cardoon (Figure 1A) has a characteristic rosette of large leaves and branched 
stalks, with violet-blue capitula, all with long spines.
2,3
 Several cytogenetic and isozyme 
studies
4–7
 suggested that wild cardoon is the ancestor of both artichoke and cultivated 
cardoon, showing completely different morphological characteristics, as a result of agricultural 
selection criteria. Contrary to wild cardoon, C. cardunculus L. cultivated forms do not have any 
spines in stalks, capitula and leaves.
3,4,8
 Artichoke (Figure 1B) was domesticated through the 
enlargement of capitula (immature inflorescences), displaying bracts notched at the tip. 
Cultivated cardoon (Figure 1C) was developed for the enlargement of the main leaf rib,
2
 
showing a globous violet-blue capitula with bracts tapering to a stout point.
3,9,10
 
 
1.2 Geographical distribution 
Wild cardoon is native from west and central parts of the Mediterranean basin (north 
and south Portugal, south Spain (Andalusia)), and it is spread over Macaronesia (Madeira and 
Canary Islands), North Africa, Cyprus and Turkey. This feral type is also a colonizer in Mexico, 
California, Argentina and Australia.
2,3
 Regarding artichoke, its production is disseminated for 
all over the world, bringing an important economic impact, specially in Italy, Spain, France and 
Turkey. This crop is also produced in North Africa (Egypt, Morocco and Tunisia) and near East 
(Israel, Lebanon, Syrian and United Arab Republic). Apart from Mediterranean countries, 
artichoke is also cultivated in United States of America (California), South America (Argentina, 
Brazil, Chile and Peru) and China.
3,4,8,11
 Finally, the production of cultivated cardoon is, until 
now, restricted to Spain, Italy, France, Greece
3,9,12
 and south of Portugal.
13,14
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1.3 Life cycle 
Cultivated and wild varieties of cardoon are herbaceous perennial plants (10-15 years) 
that grow under the xerothermic conditions of Mediterranean summers, marked by high 
temperatures and water stress. These plants have a robust root system (5 m in depth), which 
contributes greatly for their resistance to water-limited conditions, and for their regrowth of 
aboveground part after the summer.
12,15
 
Figure 2 illustrates the main stages of life cycle of cultivated cardoon and wild cardoon, 
under the Mediterranean climatic conditions, namely cool humid winters and dry summers.
16
 
 
 
Figure 2: Illustrations of the main life cycle steps of cardoon (cultivated and wild varieties): (A) 
cotyledons emergence; (B) leaf rosette state; (C) first buds; (D) corymb group; (E) macroscopic view of 
floret: st, stigma; pt, petals; ft, floral tube; p, pappus; ov, ovary; (F) blossoming phase; (G) general 
perspective of adult wild cardoon; (H) senescence phase; (I) longitudinal cut of the capitulum at harvest 
time: br, bract; p, pappus; ha, hairs; ac, achene; re, receptacle; (J) first leaves burst in the beginning of 
the second cycle (adapted from 
16–18
). 
 
The first growth cycle of cardoon plants begins with the seed germination in early 
autumn (September-October). The two first fresh cotyledons then emerge through the soil 
surface (Figure 2A), followed by the growing of leaves in a rosette arrangement (November) 
(Figure 2B). Cardoon plants hold in the rosette stage during winter and early spring. Stalk 
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starts to elongate in April-May, whereas buds are already formed, though initially surrounded 
by green leaves (Figure 2C). The normal plant development goes on with the formation of 
higher branches (new buds) and elongation of older ones (enlarged buds), giving rise to a 
corymb group (Figure 2D). The inflorescence is formed by the capitulum (head), in which the 
florets (flowers) are located on a flattened surface (receptacle), surrounded by an ovoid-
globose involucre with bracts. Mature florets (Figure 2E) have lilac petals and a calyx modified 
into a pappus, required for seed (achene) dispersal. Inflorescence emergence usually starts in 
the end of April, followed by the flowering (blossoming) (Figure 2F) in June. An adult plant can 
reach a height of 3 m (Figure 2G) and spread over an area of 1.5 m in diameter.
12
 The plant 
senescence (Figure 2H) begins in mid-July and continues during August, with the dryness of 
stalks and leaves, as well as the opening and dryness of the heads (Figure 2I), and further 
seed dispersal. The underground part enters in dormancy (Figure 2J), until a new cycle begins 
with the leaf burst in the early autumn.
12,15,16,19
 
 
1.4 Traditional and industrial applications 
1.4.1 Traditional uses 
Artichoke capitula make part of the Mediterranean diet since the 15
th
 century.
20
 
Artichoke capitula are worldwide consumed as vegetables, either in fresh, frozen or canned 
form.
3,4,11
 The artichoke leaf extract is also used to prepare the popular bitter liqueur “Cynar”.2 
Fleshy inner stalks and leaf petioles of cultivated cardoon are collected in late autumn-
early winter, and submitted to a blanching process before cooking, i.e. they are wrapped with 
straw to be buried underground for three weeks, in order to intensify their flavor and 
tenderness.
21
 This “delicacy” is much appreciated in regional soups and stews in Spain, Italy, 
France.
3,9,10,21
 
Traditionally, wild cardoon capitula have been used for centuries, in the Iberian 
Peninsula, for the manufacturing of valuable ewe’s cheeses,3 such as “Serra da Estrela”, 
“Serpa”, “Nisa” and “Évora” in Portugal,11,22 and “La Serena” and “Guía” in Spain.11 The 
clotting activity of wild cardoon stigmas and styles extracts results from the high abundance of 
aspartic proteinases, namely cardosins A, B,
18,23
 E, F, G and H.
24
 
Artichoke and wild cardoon leaves infusions have been used since the 4
th
 century 
B.C.,
25
 owing to their healthy benefices, in protecting liver
26
 and stimulating bile flow from the 
gallbladder (choleretic action).
25,27–29
 Artichoke leaves and seeds extracts are also consumed 
to protect towards atherosclerosis, arterial hypertension and hyperuricemia.
2,30
 Wild cardoon 
leaves are also popular in folk medicine, given their cardiotonic, antihemorrhodial, and 
antidiabetic actions.
31
 Many of these physiological effects are related to the secondary 
metabolites composition, mainly terpenic and phenolic compounds, as it will be further 
discussed in this chapter. 
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1.4.2 Industrial applications 
Cultivated cardoon experimental plantations have been implemented, under several 
European research and development projects, in some Mediterranean countries, such as 
Spain, Greece and Italy.
12
 Depending on the edapho-climatic conditions, the annual biomass 
yield of cultivated cardoon could reach, at maximum, 33.4 t dw/ha in Greece, after the second 
growing season.
12
 Ierna, et al.
32
 also demonstrated that plantations of cultivated cardoon, in 
Italy, gave rise to higher biomass yields (24.8-31.0 t dw/ha) compared to the one of wild 
cardoon (8.9-19.4 t dw/ha), after the second growing season. A cultivated cardoon field was 
also implemented in the south of Portugal, producing about 7.5 t dw/ha, after the second 
growing season, which is a value considerably lower than the previous cultivated cardoon 
samples. This may be associated with, on the one hand, the soil and climatic conditions, 
particularly the rainfall periodicity, and, on the other hand, the biomass estimation procedure.
13
 
Recently, Lourenço et al.
14
 described that a plantation of cultivated cardoon in Spain could 
yield, at maximum, 2804.7 g dw/plant; capitula, stalks and leaves represented 49.2%, 31.4% 
and 19.4%, respectively. 
The lignocellulosic fraction of cultivated cardoon may be used as a solid biofuel,
12
 as 
well as for the production of biogas
33
 and bioethanol,
34
 being a potential alternative to fossil 
materials in European countries. Stalks and capitula of cultivated cardoon may be also used to 
produce pulp fibers.
12,15,17
 Moreover, the fatty acid composition of seed oil has revealed to be 
suitable for the production of biodiesel.
12,35
 
Artichoke extracts make part of commercial dietary juices and capsules for the 
treatment of digestion perturbations, being related with the bioactive extractives composition, 
as explained bellow.
36–38
 Finally, leaf rosettes of cultivated cardoon can be a good substitute 
for green forage during wintertime.
12
 
 
2. General chemical composition of C. cardunculus L. 
The proximate and elemental analyzes, as well as the heat value of cultivated cardoon 
biomass are listed in Table 1. C. cardunculus L. var. altilis (DC) biomass has high volatile 
matter content (73%), which is adequate to a good regulation of combustion or gasification 
processes in large-scale.
39
 However, some environmental questions may occur, due the 
emission of nitrogen oxides during combustion, due to the relatively high nitrogen levels 
(1.5%). The study of Angelini, et al.
39
 also indicated that the calorific value of cultivated 
cardoon was 14.9 MJ/kg. Moreover, Fernández, et al.
12
 highlighted that the calorific values, in 
the different morphological parts of cultivated cardoon, can vary between 15.3 MJ/kg (basal 
leaves) and 23.3 MJ/kg (seeds). Recently, Lourenço, et al.
14
 noticed a calorific value of 17.6 
MJ/kg for cultivated cardoon stalks. 
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Table 1: Proximate analysis, elemental analysis and heat value of cultivated cardoon.
39
 
Proximate analysis (% dw) Cultivated cardoon 
Moisture 10 
Volatile matter 73 
Fixed carbon 13.1 
Ash 13.1 
Elemental analysis (% dw)  
C 39 
H 6.6 
N 1.5 
S 0.2 
O 52.7 
Cl 18.7 
Calorific value (MJ/kg) 14.9 
 
2.1 Monosaccharides 
Table 2 depicts the monosaccharides composition of several morphological parts from 
cultivated cardoon. Glucose is the major monosaccharide of cultivated cardoon biomass, 
ranging from 36.3% dw in stalks33 to 48.9% dw in capitula hairs.17 Moreover, glucose 
represented the most abundant of the monosaccharides of cultivated cardoon (64.9-67.33% 
dw, regarding to the total monosaccharides content).34,40 Xylose was also found in cultivated 
cardoon, at considerable contents (Table 2), varying between 16.3% in stalks33 and 29.2% dw 
in capitula pappi.17 
 
Table 2: Monosaccharides composition of cultivated cardoon. 
Cultivated 
cardoon 
Monosaccharide content (% dw) 
Source 
Glucose Galactose Mannose Rhamnose Xylose Arabinose 
Stalks 
65.5 
(I)
 1.4 
(I)
 3.7 
(I)
 0.9 
(I)
 26.0 
(I)
 2.5 
(I)
 
15
 
67.33 
(I)
 1.74 
(I)
 1.42 
(I)
 0.96 
(I)
 27.07 
(I)
 1.48 
(I)
 
40
 
36.3 1.4 1.4 0.6 16.3 1.3 
33
 
Stalks and 
leaves 
64.9 
(I)
 2.5 
(I)
 1.8 
(I)
 1.1 
(I)
 27.0 
(I)
 2.7 
(I)
 
34
 
Capitula 
hairs 
48.9 0.8 1.0 ‒ 24.4 0.9 
17
 
Capitula 
pappi 
40.5 1.4 1.0 0.7 29.2 1.7 
(I) 
Percent of total monosaccharides content. 
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Figure 3 elucidates the chemical structures of the most common monosaccharides 
found in cultivated cardoon biomass. 
 
 
Figure 3: Structures of the most common monosaccharides in cultivated cardoon. 
 
2.2 Polysaccharides 
Polysaccharides are constituted by a large number of monosaccharide units, ranging 
from hundreds to thousands, connected by glycosidic bonds. These macromolecules are 
used, in plants, as energy storage forms or as structural materials.
41
 Various works17,33,34,40 
have studied the polysaccharide composition of cultivated cardoon, as summarized in Table 3. 
 
Table 3: Polysaccharide composition of cultivated cardoon. 
Cultivated cardoon 
Polysaccharides (% dw) 
Source 
Cellulose α-Cellulose Hemicellulose 
Stalks 
‒ 39.28 30.59 40 
‒ 36.3 16.3 33 
Stalks and leaves 41.9 ‒ 12.8 34 
Capitula hairs ‒ 55.2 ‒ 17 
Capitula pappi ‒ 46.8 ‒ 
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Cellulose (Figure 4) consists of a homopolysaccharide composed by D-glucose units, 
linked to each other via β-1,4-glucosidic bonds,41 and it is the most important structural 
polysaccharide in plants.
41
 Stalks and leaves of cultivated cardoon (Table 3) exhibited 41.9% 
dw of cellulose.
34
 More specifically, α-cellulose was detected in considerably high amounts in 
cultivated cardoon stalks (Table 3), ranging from 36.3 to 39.28% dw,
33,40
 and even at higher 
levels in capitula hairs and pappi, accounting for 55.2 and 46.8% dw, respectively.
17 
 
 
Figure 4: Structure of cellulose. 
 
Hemicellulose comprises different heteropolysaccharides, formed by various 
monosaccharide units linked through β-1,4- and, occasionally, β-1,3-glycosidic bonds: D-
xylose, D-mannose, D-galactose, D-glucose and L-arabinose (Figure 3), 4-O-methyl-
glucuronic, D-galacturonic and D-glucuronic acids.
42
 Depending on the predominant 
monosaccharide units, hemicelluloses can be separated in xylans, mannans, β-glucans and 
xyloglucans. Hemicelluloses are found associated with cellulose in the cell walls of higher 
plants.
43
 Studies of Shatalov and Pereira,
40
 and Oliveira, et al.
33
 demonstrated that 
hemicellulose content of cultivated cardoon stalks can vary from 16.3 to 30.59% dw (Table 3). 
Nevertheless, Fernandes, et al.
34
 indicated lower hemicellulose contents (12.8% dw in stalks 
and leaves of cultivated cardoon). 
Among the hemicelluloses present in stalks, capitula and leaves of cultivated cardoon, 
the majority were probably xylans, based on the high xylose concentration.33,34,40 Mannans and 
galactanans are also thought to be part of cultivated cardoon biomass,33,34,40 owing to the 
detection of mannose and galactose (Table 2). 
Inulin (Figure 5) is a linear polysaccharide, constituted by β-(2→1) linked 
fructofuranosyl units, with a terminal glucose residue. Being a reserve carbohydrate in 
Asteraceae plants, inulin is retained in roots of wild cardoon, artichoke and cultivated cardoon, 
at considerably high contents, accounting for 71.5%, 50.8% and 71.8% dw, respectively.
44
 
This is an important polysaccharide for the C. cardunculus L. development, since the rapid 
growth of aerial organs, and the subsequent sprouting of buds, demand high amounts of 
energy.
44
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Figure 5: Structure of inulin. 
 
2.3 Lignin 
 Lignin is characterized by an amorphous crosslinked and highly irregular 
macromolecular structure. Lignins can be considered as resulting from the polymerization of 
hydroxycinnamyl alcohol monomers, with different structures depending on the plant type.
45
 
The most important monomers are 4-hydroxycinnamyl alcohol (p-coumaryl alcohol), coniferyl 
alcohol and sinapyl alcohol
46
 (Figure 6). Lignin carries an import strength function in the plant 
cell wall, as a matrix for cellulose microfibrils. 
 
 
Figure 6: Structures of the most common hydroxycinnamyl alcohol monomers detected in lignin. 
 
 Table 4 indicates the lignin composition of stalks, capitula and leaves of cultivated 
cardoon. Low lignin content was observed in whole stalks (17.0-19.8% dw).
15,33
 More 
specifically, low lignin abundances were detected in the outer (13.6% dw) and in the inner 
Chapter II – Bibliographic review 
 
23 
(20.3% dw) parts of stalks
15
 (Table 4). Hairs and pappi of capitula also presented low lignin 
proportions (10.6% dw and 17.8% dw, respectively).
17
 In all morphological parts, the greatest 
part of lignin was acid-insoluble, ranging from 6.9% dw in capitula hairs
17
 to 18.8% dw in stalks 
inner part.
15
 
 
Table 4: Lignin composition of cultivated cardoon. 
Cultivated cardoon 
Lignin content (% dw) 
Source 
Total Klason (acid-insoluble) Acid soluble 
Stalks 
17.0 15.0 1.8 
15
 
‒ 15.46 ‒ 40 
19.8 ‒ ‒ 33 
Stalks outer part 13.6 11.3 2.3 
15
 
Stalks inner part 20.3 18.8 1.5 
Stalks and leaves ‒ 14.9 ‒ 34 
Capitula hairs 10.6 6.9 3.7 
17
 
Capitula pappi 17.8 14.0 3.7 
 
 Lourenço, et al.
14
 have recently revealed the structure of lignin pyrolysis products, 
derived from stalks outer and inner parts of cultivated cardoon. This group justified that 
syringyl-units, including sinapyl alcohol (Figure 6), represented the major lignin component, 
being mostly retained in the inner part of stalks (64% of total lignin), compared to the outer 
part (53% of total lignin). Guaiacyl-units, like coniferyl alcohol (Figure 6), were mainly found in 
the stalks outer part (40% of total lignin), relatively to the inner part (29% of total lignin). 
Lourenço, et al.
14
 also reported minor amounts of hydroxyphenyl-units (7% dw of total lignin in 
both parts), e.g. 4-hydroxycinnamyl alcohol (Figure 6). In this manner, outer and inner parts of 
stalks showed high syringyl-units/guaiacyl-units ratios (1.3 and 2.1, respectively), which 
means that the lignin of both components of cultivated cardoon stalks may have a more open 
matrix, being easier to remove it during the production of pulp fibers.
14
 
 
3. Extractives composition of C. cardunculus L. 
Extractives are the nonstructural components of plants, which can be removed with 
organic solvents and water.
47
 These compounds are mainly present in plant cell lumens, albeit 
they may also be found in cell walls.
48
 Most of the plant extractives are secondary 
metabolites.
47
 Certain classes of secondary metabolites can be restricted to a particular 
taxonomic group (species, genus, family, or closely related group of families).
49
 For example, 
sesquiterpene lactones are mostly exclusive from Asteraceae plants.
50
 
Chapter II – Bibliographic review 
 
24 
Plants biosynthesize secondary metabolites with specific tasks for their survival, 
namely: (i) chemical defense against microorganisms, insects and herbivores, and even other 
plants (allelochemicals); (ii) attraction of animals for pollination and seed dispersal; and (iii) 
chemical adaptations to environmental stresses, for instance ultraviolet electromagnetic 
radiation, evaporation and cold.
49,51
 Although frequently present in small amounts, secondary 
metabolites have shown to be highly valuable products, being commercially used as, for 
instance, pharmaceuticals, flavors, fragrances and pesticides.
49
 
 According to their biosynthesis pathways (Figure 7), plant secondary metabolites can 
be classified in three main groups: terpenes, phenolic compounds and alkaloids.
52,53
 Terpenes 
are biosynthesized from dimethylallyl pyrophosphate and isopentenyl pyrophosphate. Sterols 
are also afforded by this pathway.
46,54
 Phenolic compounds are derived from the shikimic acid 
pathway or the malonate/acetate pathway. Finally, alkaloids are mainly generated within the 
amino acids pathway.
46,49,52
 Other plant compounds can be assigned as primary or secondary 
metabolites. For example, in the case of fatty acids and glucosides, the largest part is better 
described as primary metabolites, whilst some of them are extremely rare, being referred as 
secondary metabolites.
46
 As indicated in the Figure 7, fatty acids are formed in the acetate 
pathway.
46
 
 
 
Figure 7: Secondary metabolism pathways for the biosynthesis of terpenes, phenolic compounds and 
alkaloids. Abbreviations: PEP, phosphoenolpyruvate; E4P, D-erythrose 4-phosphate; CoA, coenzyme A 
(adapted from 
46,49,55
). 
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Table 5 outlines the extractives yields from stalks, capitula and leaves of cultivated 
cardoon
15,17,34,40
 and wild cardoon,
56
 by using organic solvents of different polarities, and 
water. 
 
Table 5: Extractives yield (% dw) of stalks, capitula and leaves of cultivated and wild varieties of 
cardoon, by using organic solvents and water. 
Cardoon 
Extractives yield (% dw) 
Hexane Cyclohexane DCM Acetone MeOH EtOH Water Source 
Cultivated cardoon         
Stalks (whole) ‒ 1.7 ‒ ‒ ‒ 7.2 5.7 15 
Stalks (whole) ‒ ‒ 0.41 ‒ ‒ 3.25 3.70 40 
Stalks outer part ‒ 1.6 ‒ ‒ ‒ 5.4 6.8 15 
Stalks inner part ‒ 1.4 ‒ ‒ ‒ 6.4 5.1  
Stalks and leaves ‒ ‒ ‒ 1.4 ‒ ‒ ‒ 34 
Capitula hairs ‒ ‒ 0.5 ‒ ‒ 2.8 2.1 17 
Capitula pappi ‒ ‒ 0.8 ‒ ‒ 3.9 1.2 
Wild cardoon         
Stalks 2.24 ‒ 0.91 0.5 14.20 ‒ ‒ 56 
Leaves 2.77 ‒ 4.44 3.15 5.77 ‒ ‒  
Abbreviations: DCM, dicholoromethane; EtOH, ethanol; MeOH, methanol. 
 
Extractives yields (Table 5), obtained from cultivated cardoon stalks, were higher with 
ethanol (3.25-7.2% dw)
15,40
 and water (3.70-6.8% dw)
15,40
 than with non-polar organic 
solvents, such as cyclohexane (1.4-1.7% dw)
15
 and dichloromethane (0.41% dw).
40
 The 
extractives yields of cultivated cardoon capitula parts (Table 5) were also higher with ethanol 
and water, compared to those with dichloromethane.
17
 These results may be associated with 
the extraction of more polar components, such as carbohydrates and phenolic compounds. 
Regarding to wild cardoon, Kammoun, et al.
56
 highlighted much higher extractives yield of 
stalks with methanol (14.20% dw) than those obtained with less polar organic solvents, like 
hexane, dichloromethane and acetone. The extractives yields of wild cardoon leaves were 
similar between each other, being also higher with methanol (5.77% dw).
56
 
The chemical composition of C. cardunculus L. varieties, in terms of lipophilic 
extractives, namely fatty acids, syn-alkane-6,8-diols, terpenes and sterols, as well as of 
phenolic compounds, will be discussed in detail. 
 
3.1 Fatty acids 
Fatty acids are biosynthesized through the acetate pathway. These plant metabolites 
are linear chains, formed by an even number of carbon atoms, ranging from 4 to 30, albeit the 
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commonest have 16 or 18 carbon atoms. Odd-chain fatty acids can arise either through the 
incorporation of other biosynthesis starting unit (e.g. propionic acid), or by loss of one carbon 
from an even-numbered fatty acid. Fatty acids can be classified as saturated, 
monounsaturated or polyunsaturated, depending on the number of double bonds. Among the 
unsaturated fatty acids, the Z-isomers are the most commonly present in plants.
46
 
Fatty acids are mainly found esterified with glycerol, forming triglycerides, as in the 
case of vegetal oils, being an important energy reserve of seeds.
46
 Maccarone, et al.
57
 referred 
that the seed oil yields corresponded to 21.80-24.25% for wild cardoon, 23.50-24.55% for 
artichoke and 24.6-26.6% for cultivated cardoon. They also observed that the seed oils from 
C. cardunculus L. varieties presented 9Z,12Z-octadeca-9,12-dienoic acid (linoleic acid) (Figure 
8), followed by 9Z-octadec-9-enoic acid (oleic acid) (Figure 8), either in the free or in the 
esterified form. Moreover, hexadecanoic acid (palmitic acid) and octadecanoic acid (stearic 
acid) (Figure 8) were the main saturated fatty acids found. Unsaturated fatty acids were 
prevalent over the saturated ones, in C. cardunculus L. seed oils.
57
 Moreover, Curt, et al
19
 also 
detected odd-numbered fatty acids, namely heptadecanoic and heptadecenoic acids, in 
cultivated cardoon seed oil (20.6-32.47% oil yield). 
Farag, et al.
58
 discovered 9Z,12Z,15Z-octadeca-9,12,15-trienoic acid (linolenic acid) in 
artichoke leaves, in addition to isomers of hydroxyoctadecadienoic, hydroxyoctadecatrienoic, 
dihydroxyoctadecadienoic, dihydroxyoctadecatrienoic acids. 
 
 
Figure 8: Structure of the most common fatty acids in seed oil of the three varieties of C. cardunculus L. 
 
3.2 syn-alkane-6,8-diols 
Akihisa, et al.
59
 isolated ten syn-alkane-6,8-diols from capitula of cardoon, without 
referring the variety, namely syn(R,S and/or S,R)-C23-, C25-, C27-C33, and C35-alkane-6,8-
diols. The odd chain syn-alkane-6,8-diols were clearly prevalent in the non-saponifiable lipid 
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fraction of methanol extract (91.3%). Later, Ukiya, et al.
60
 indicated the 6S,8R-stereochemistry 
of C27- and C29-alkane-6,8-diols (Figure 9). 
 
 
Figure 9: Structures of two syn-alkane-6,8-diols isolated from cardoon capitula. 
 
3.3 Terpenes 
Terpenes can be considered as isoprene (2-methylbuta-1,3-diene) units-based 
structures, albeit their biosynthetic precursors are isopentenyl pyrophosphate and dimethylallyl 
pyrophosphate.
46
 The number of isoprene units defines the different terpenic classes, such as: 
hemiterpenes (1 unit), monoterpenes (2 units), sesquiterpenes (3 units), diterpenes (4 units), 
sesterterpenes (5 units), triterpenes (6 units) and tetraterpenes (8 units) and polyterpenes (> 8 
units).
46
 Mono-, di-, tetraterpenes and some sesquiterpenes are biosynthesized through the 1-
deoxy-D-xylulose 5-phosphate pathway, whereas the most of the sesquiterpenes and 
triterpenes are produced in the mevalonate pathway.
61
 
Regarding isoprene structure (Figure 10), the isopropylene moiety is considered as the 
“head”, while the ethylene moiety as the “tail”. The isoprene units are bonded with each other 
from “head-to-tail” in mono-, sesqui-, di- and sesterterpenes, and from “tail-to-tail” in the center 
of tri- and tetraterpenes.
54 
 
 
Figure 10: Structure of isoprene. 
 
A great diversity of mono-, sesqui- and triterpenes were identified in the three varieties 
of C. cardunculus L., as next explained. 
 
3.3.1 Monoterpenes 
The biosynthetic precursor of monoterpenes (C10) is the geranyl pyrophosphate which 
is originated by the combination of isopentenyl pyrophosphate and dimethylallyl 
pyrophosphate.
46
 Monoterpenes are generally present in essential oils, which can be 
selectively removed from plants by hydrodistillation. 
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Four monoterpenes were found in the artichoke volatile oil, namely linalool, linalool 
oxide C, α-terpineol62 and limonene63 (Figure 11). 
 
 
Figure 11: Structures of monoterpenes identified in artichoke volatile oil. 
 
3.3.2 Sesquiterpenes 
The farnesyl pyrophosphate is the direct precursor of sesquiterpenes (C15), resulting 
from the addition of isopentenyl pyrophosphate to geranyl pyrophosphate. 
Three sesquiterpene hydrocarbons were found in the artichoke volatile oil: β-selinene, 
caryophyllene and α-humulene (Figure 12).62,63 Other members of this family were also 
detected in the artichoke volatile oil, namely β-elemene, α-cedrene and longifolene.63 
 
 
Figure 12: Structures of sesquiterpene hydrocarbons identified in artichoke volatile oil. 
 
Sesquiterpene lactones are a specific class of sesquiterpenes, containing a lactone 
ring. This sesquiterpenic subclass can be organized in four main groups, according to their 
carbon-cyclic skeleton: (i) germacranolides (ten-membered ring); (ii) eudesmanolides and 
eremophilanolides (six/six-bicyclic compounds); (iii) guaianolides and pseudoguaianolides (all 
five/seven-bicyclic compounds)
50
 and (iv) elemanolides (six-membered ring).
64
 
The bitter taste of artichoke has been attributed to four guaianolides, namely 
dehydrocynaropicrin, cynaratriol, grosheimin and cynaropicrin
36,65
 (Figure 13). These 
compounds were already isolated from capitula
66
 and leaves
36,65–69
 of artichoke. 
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Figure 13: Structures of sesquiterpene lactones that contribute for the artichoke bitter taste. 
 
Cynaropicrin (Figure 13) is regarded as the main artichoke bitter principle, accounting 
for 80% of the total bitter artichoke taste.
36
 This guaianolide is quite important to the 
organoleptic characteristics of the fresh artichoke capitula, as well as to the preparation of 
bitter liqueurs from artichoke leaf.
65
 Schneider and Thiele
70
 quantified the bitter principle, 
represented as cynaropicrin in artichoke leaves (<0.5-4.5% dw). Moreover, this group realized 
that the bitter principle in leaves achieved two maxima during the vegetative period, namely in 
early summer (July), and the in September until October.
70
 Analyzing the distribution of 
cynaropicrin in the all morphological parts of artichoke, Eljounaidi, et al.
71
 recently observed 
that this compound was mainly retained in leaves, at the mature stage (6 weeks old), 
accounting for 9.6 mg/g dw. They also noticed that the content of this compound decreased in 
the receptacles up to 8-fold, during the capitula development, until they reached the 
commercial stage (0.05 mg/g dw). This probably resulted from the domestication of 
artichoke.
72
 Traces were registered in stalks and roots, while cynaropicrin was absent in 
external bracts.
71
 Furthermore, Fritsche, et al.
36
 noticed that the cynaropicrin content varied 
from <0.06 to 22.6 mg/g in commercial artichoke leaves extracts, available in the European 
market. In addition to cynaropicrin, 8-deoxy-11,13-dihydroxygrosheimin and grosheimin were 
also discovered in the commercial artichoke leaves extracts.
36
 Several other sesquiterpene 
lactones, isolated from capitula
66,68,73
 and leaves
36,65–68,74,75
 of artichoke, are given in Table 6. 
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Table 6: Sesquiterpene lactones isolated from the three varieties of C. cardunculus L. 
Sesquiterpene lactones WC Artichoke CC 
Aguerin A  c, l
66
  
Aguerin B l
76
 c, l
66
  
Cynarascoloside A  l
68
  
Cynarascoloside B  l
68
  
Cynarascoloside C  c,
66
 l
58,66,68
  
Cynaropicrin l
76
 c,
66
 l
65–69
  
Cynaratriol  c, l
66
  
Cynarinin A  c, l
66
  
Cynarinin B  c, l
66
  
Cynaroside A  c
73
  
Deacylcynaropicrin  
77
  
Dehydrocynaropicrin  c, l
66
  
Dehydromelitensin l
76
   
11β,13-Dihydrodesacylcynaropicrin-8-β-D-glucoside  l
68
 c
73
 
11,13-Dihydroxi-8-desoxigrosheimin l
76
   
11-H-13-Methylsulfonylgrosheimin (grosulfeimin)  l
74
  
8α-Acetoxyzaluzanin C l76   
8-Deoxy-11,13-dihydroxygrosheimin  l
74
  
8-Deoxy-11-hydroxy-13-chlorogrosheimin  l
74
  
8-Epigrosheimin  l
74
  
Grosheimin l
76
 c,
66
 l
65–68
  
3β,8α,11β,13-Tetrahydroxy-10(14)-guaien-1α,4β,5α,6βH-6α,12-olide  l75  
Abbreviations: A, artichoke; c, capitula; CC, cultivated cardoon; l, leaves; WC, wild cardoon. 
 
Súchy, et al.
69
 earlier isolated cynaropicrin from cardoon, though without referring the 
variety. Besides cynaropicrin, Rial, et al.
76
 isolated five guaianolides, including aguerin B 
(Figure 14), and an elemanolide named as dehydromelitensin (Figure 14) from wild cardoon 
leaves (Table 6). Moreover, Shimizu and colleagues
73
 isolated 11β,13-
dihydrodesacylcynaropicrin-8-β-D-glucoside (Table 6) from cultivated cardoon capitula. 
 
 
Figure 14: Structures of sesquiterpene lactones isolated from wild cardoon leaves and cultivated 
cardoon capitula. Abbreviation: Glc, glucosyl. 
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3.3.3 Triterpenes 
Squalene, the biosynthetic intermediary of triterpenes (C30), is constituted by two 
farnesane units bonded in the tail-to-tail manner.
54
 Then, squalene is oxidized to 2,3-
oxidosqualene. When the cyclization of 2,3-oxidosqualene occurs in the chair-chair-chair-boat 
conformation, the precursor of cyclic triterpenes, known as dammarenyl cation, is formed.
46,78
 
Dammarenyl cation can lead to the formation of a diversity of tetracyclic and pentacyclic 
triterpenic cations, direct precursors of tetracyclic (6-6-6-5) and pentacyclic (6-6-6-6-5 or 6-6-
6-6-6) triterpenes, respectively.
46,79
 The backbone structures of pentacyclic triterpenes 
comprise baccharanes, lupanes, oleananes, taraxastanes and ursanes.
54
  
Table 7 describes the pentacyclic triterpenes isolated from capitula
80
 and leaves
67,81
 of 
artichoke. 
 
Table 7: Pentacyclic triterpenes isolated from artichoke. 
Triterpenes Artichoke 
α-Amyrin c80 
α-Amyrin acetate c80 
β-Amyrin c80 
β-Amyrin acetate c80 
Lupeol l
67
 
Ψ-Taraxasterol c,80,81 l81 
Taraxasterol c,
80,81
 l
81
 
Ψ-Taraxasteryl acetate c80 
Taraxasteryl acetate c
80
 
Abbreviations: c, capitula; l, leaves. 
 
Two ursanes (α-amyrin and its acetate derivative), two oleananes (β-amyrin (Figure 
15) and its acetate derivative), one lupane (lupeol) and four taraxastanes (ψ-taraxasterol and 
taraxasterol (Figure 15), and their acetate derivates) were isolated from artichoke capitula
80,81
 
and leaves (Table 7).
81
 Lupeol was also isolated from artichoke leaves.
67 
 
 
Figure 15: Structures of pentacyclic triterpenes isolated from capitula and leaves of artichoke. 
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The pentacyclic triterpenic composition, regarding to wild or cultivated variety, has 
been less explored. Grancai, et al.82 isolated taraxasterol (Figure 15) and its acetate derivative 
from roots of cardoon, although without citing the variety. Moreover, Akihisa, et al.
83
 also 
indicated the isolation of five pentacyclic triterpenes from cardoon capitula (without explaining 
the variety wild or cultivated), namely: α- and β-amyrin, lupeol, ψ-taraxasterol (Figure 15) and 
taraxasterol. 
 
3.4 Sterols 
The protosteryl cation, resulting from the cyclization of 2,3-squalene oxide in a chair-
boat-chair-boat conformation, is the biosynthetic precursor of sterols.
46
 
Table 8 lists the sterols detected in the three varieties of C. cardunculus L. 
 
Table 8: Sterols identified in several morphological parts of C. cardunculus L. varieties. 
Sterols Wild cardoon Artichoke Cultivated cardoon 
β-Sitosterol s57 c,81 s57 s57 
Campesterol s
57
 s
57
 s
57
 
Δ7-Stigmastenol s57 s57 s57 
Stigmasterol s
57
 s
57
 s
57
 
24-Methylenecycloartanol  c
83
  
Abbreviations: c, capitula; s, seed oil. 
 
Maccarone, et al.
57
 identified three stigmastanes, namely β-sitosterol, stigmasterol 
(Figure 16) and Δ7-stigmastenol, and a campestane, known as campesterol, in the seed oil of 
the three varieties of C. cardunculus L. (Table 8). Furthermore, a cycloartane, named as 24-
methylenecycloartanol (Figure 16), was isolated from cultivated cardoon capitula.
57 
 
 
Figure 16: Structures of sterols identified in the three varieties of C. cardunculus L. 
 
A study of Grancai, et al.
82
 indicated the isolation of β-sitosterol, sitosteryl-3β-acetate 
and sitosteryl-3β-D-glucoside from roots and inner bracts of cardoon, but with no specification 
regarding to either wild or cultivated variety. 
Chapter II – Bibliographic review 
 
33 
3.5 Phenolic compounds 
Phenolic compounds are constituted by one or various aromatic rings, containing one 
or more hydroxyl substituents. Phenolic compounds can be classified according to basic 
phenolic skeleton: 
(i) simple phenols and benzoquinones (C6); 
(ii) phenolic acids (C6‒C1); 
(iii) phenylacetic acids (C6‒C2); 
(iv) phenylpropenes, cinnamic acid, hydroxycinnamic acids, coumarins and chromones  
(C6‒C3); 
(v) naphtoquinones (C6‒C4); 
(vi) xanthones (C6‒C1‒C6); 
(vii) stilbenes and anthraquinones (C6‒C2‒C6); 
(viii) flavonoids (C6‒C3‒C6); 
(ix) lignans ((C6‒C3)2); 
(x) biflavonoids ((C6‒C3‒C6)2); 
(xi) tannins (polymers). 
 
Several subgroups of phenolic compounds have been elucidated in the three C. 
cardunculus L. varieties, as shown in this chapter. 
 
3.5.1 Phenolic acids 
Phenolic acids are phenolic compounds characterized by having one carboxylic group. 
Two phenolic acids, namely protocatechuic and gallic acids (Figure 17), were identified in 
artichoke industrial wastes (bracts, receptacles and floral stems).
84
 Vanillic and syringic acids 
(Figure 17) were also found in wild cardoon leaves.
85
 
 
 
Figure 17: Structures of phenolic acids identified in artichoke by-products and wild cardoon. 
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3.5.2 Cinnamic and hydroxycinnamic acids, and coumarins 
E-cinnamic acid was detected by Falleh, et al.
85
 in wild cardoon leaves. 
Hydroxycinnamic acids are hydroxyl derivatives of cinnamic acid. These compounds were 
commonly found in C. cardunculus L. Two hydroxycinnamic acids, known as p-coumaric and 
ferulic acids (Figure 18 and Table 9), were identified in wild cardoon leaves,
85
 as well as in 
capitula of artichoke
86
 and cultivated cardoon.
87
 Another hydroxycinnamic acid, caffeic acid 
(Figure 18 and Table 9), was commonly identified in leaves
88–90
 and outer bracts of capitula
88
 
of artichoke. Industrial by-products of artichoke also contained caffeic acid.
84,91
 
 
 
Figure 18: Structures of hydroxycinnamic acids identified in the C. cardunculus L. varieties. 
 
  
Table 9: Hydroxycinnamic acids identified in several morphological parts of C. cardunculus L. varieties. 
Hydroxycinnamic acids Wild cardoon Artichoke Cultivated cardoon 
Caffeic acid  c,
88
 l,
88–90
 bp
84,91
  
Ferulic acid l
85
 r, b
87
 r, b
87
 
Ferulic acid glucoside isomer  bp
84
  
Feruloylquinic acid isomer  l, bp
37
  
3-O-Feruloylquinic acid  l
58
  
p-Coumaric acid l
85
 c,
86
 r, b
87
 r, b
87
 
p-Coumaric acid glucoside isomer  c,
86
 bp
84
  
Sinapic acid l
85
   
Monocaffeoylquinic acids    
1-O-Caffeoylquinic acid (pseudochlorogenic acid) l
9
 fs,
92,93
 c,
38,94,95
 r,
93,95–97
 b,
93,95,97
 l,
58,89,92,98
 ds, bp
38
 l
9
 
3-O-Caffeoylquinic acid (neochlorogenic acid) fs, l
92,99
 fs,
92,93
 c,
38,94,95
 r,
93,95,96
 b,
93,95
 l,
37,58,89,90,92
 ds,
36–38
 bp
38
 fs, l
92
 
4-O-Caffeoylquinic acid (cryptochlorogenic acid) l
99
 fs,
93
 c,
38,94,95
 r, b,
93,95
 l,
58,89,90
 ds,
36,38
 bp
91
  
5-O-Caffeoylquinic acid (chlorogenic acid) fs,
92
 r, b,
87
 l
9,92,99
 fs,
92,93
 c,
38,94,95,98
 r,
87,95–97
 b,
87,93,95,97
 l,
37,58,89,90,92,98,100
 ds,
36–38
 bp
38,84,91
 fs,
92
 l
9,92
 
Caffeoylquinic acid diglycoside isomer  l
37
  
Dicaffeoylquinic acids    
1,3-Di-O-caffeoylquinic acid (cynarin) l
99
 fs,
93
 c,
38,94,95,98,101
 r, b,
87,93,95
 l,
37,58,98,100
 j,
36–38
 bp
38
 r, b
87
 
1,4-Di-O-caffeoylquinic acid  bp
91
  
1,5-Di-O-caffeoylquinic acid fs,
92
 c,
102
 l
92,99
 fs,
92,93
 c,
38,94,95,102
 r, b,
93,95,97
 l,
37,58,90,92
 ds,
37
 bp,
38,91
 ds
38
 fs
92
 
3,4-Di-O-caffeoylquinic acid  fs,
93
 c,
38,94
 r, b,
93
 l,
37,90
 ds, bp
38
  
3,5-Di-O-caffeoylquinic acid  fs,
92,93
 c,
38,94,101
 r, b,
93
 l,
37,90,100
 ds,
37,38
 bp
38,91
  
4,5-Di-O-caffeoylquinic acid  fs,
93
 c,
38,94,101
 r,
93,97
 b,
97
 l,
37,90,100
 ds,
38
 bp
38,91
  
1,3-Di-O-caffeoylquinic acid hexoside isomer  l
37
  
Dicaffeoylsuccinoylquinic acids    
Dicaffeoylsuccinoylquinic acid isomers fs,
92
 l
9
 fs
92
 fs,
92
 l
9
 
Dicaffeoyldisuccinoylquinic acid isomer l
9
   
Abbreviations: b, bracts; bp, by-products; c, capitula; ds, dietary supplements; fs, floral stems; j, juice; l, leaves; r, receptacles. 
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3.5.2.1 Caffeoylquinic acids 
Caffeic acid can be found esterified with quinic acid, originating caffeoylquinic acids 
(Table 9 and Figure 19). 
 
 
Figure 19: Structures of the main caffeoylquinic acids identified in C. cardunculus L. 
 
Monocaffeoylquinic acids, namely 1-, 3-, 4- and 5-O-caffeoylquinic acids (Table 9), are 
commonly present in leaves,
37,89,90,92,98,100
 floral stems
92,93
 and capitula of artichoke,
38,94–
96,98,102
 more specifically in receptacles, external, intermediate and internal bracts.
87,93,95–97
 
These compounds were also detected in commercially available dietary supplements (e.g. 
juices from capitula and capsules containing leaves extract),
36–38
 as well as in industrial by-
products of artichoke.
38,84,91
 According to several studies on the quantitative 
monocaffeoylquinic acid composition of artichoke,
38,92,94–96,102
 5-O-caffeoylquinic acid (Table 9) 
was the most common compound of this subclass, accounting for 13.3 mg/g dw in the floral 
stems.
92
 Regarding the two varieties of cardoon, 5-O-caffeoylquinic acid also given as the 
most abundant monocaffeoylquinic acid in floral stems
92
 and leaves,
9,92
 reaching 21.91 and 
26.11 g/kg dw in leaves of respectively wild and cultivated types.
9
 
Six dicaffeoylquinic acids, namely 1,3-; 1,4-; 1,5-; 3,4-; 3,5- and 4,5-di-O-caffeoylquinic 
acids (Table 9), were identified in floral stems,
92,93
 leaves,
37,90,92,98,100
 and 
capitula
38,94,95,98,101,102
 of artichoke. These compounds were also detected in the constitutive 
parts of capitula, such as receptacles, outer, intermediate and inner bracts.
87,93,95,97
 
Furthermore, dicaffeoylquinic acids were also detected in commercial dietary supplements,
36–
38
 as well as in artichoke industrial residues.
38,91
 The 1,5-di-O-caffeoylquinic acid (Table 9) was 
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the most abundant compound of this subclass in the studied morphological parts of 
artichoke,
37,92,93,95,97
 achieving about 28.8 g/kg dw in capitula.
95
 In what concerns to cardoon 
varieties, 1,5-di-O-caffeoylquinic acid was found in floral stems of cultivated cardoon,
92
 as well 
as in floral stems,
92
 capitula
102
 and leaves
92,99
 of wild cardoon. This compound accounted for 
13.3 g/kg dw and 6.2 g/kg dw in floral stems of wild cardoon and cultivated cardoon, 
respectively.
92
 
Gouveia, et al.
37
 also discovered glucosylated derivatives of caffeoylquinic acids in 
artichoke leaves, namely 1,3-di-O-caffeoylquinic acid hexoside and a caffeoylquinic acid 
diglycoside isomer (Table 9). 
Dicaffeoylsuccinoylquinic acids are dicaffeoylquinic acids that present one or more 
succinoyl moieties esterified with quinic acid. An isomer (Table 9) was identified in the floral 
stems of artichoke.
92
 Furthermore, two dicaffeoylsuccinoylquinic acid isomers were also 
detected in floral stems
92
 and leaves
9
 of both cardoon types. Only one 
dicaffeoyldisuccinoylquinic acid isomer was detected in wild cardoon leaves.
9
 
 
3.5.2.2 Coumarins 
Coumarins are hydroxycinnamic acid lactone derivatives, constituted by fused 
benzene and α-pyrone rings.46,103 Sánchez-Rabaneda, et al.84 reported esculin (Figure 20) in 
artichoke by-products.
84
 Moreover, Grancai, et al.
104
 isolated scopoletin and its glucosylated 
form, i.e. scopolin (Figure 20), from capitula involucral bracts of cardoon, albeit they did not 
refer the variety. 
 
 
Figure 20: Structures of coumarins identified in C. cardunculus L. plants. Abbreviation: Glc, glucosyl. 
 
3.5.3 Flavonoids 
Flavonoids derive from a cinnamoyl-CoA starting unit and a chain extension with three 
molecules of malonyl-CoA.
46
 These compounds are constituted by two aromatic rings joined 
through a three carbon chain (C6-C3-C6). The central propane chain may form a closed pyran 
ring with one of the two aromatic rings. These compounds can be organized in several 
subclasses, based on the oxidation state of the central pyran ring, as follows (Figure 21): 
chalcones, aurones, flavanones, flavanonols, flavones, flavonols, isoflavones, flavan-3-ols and 
anthocyanidins.
105
 Mono-, di-, tri- and tetrasaccharide units are frequently attached to the 
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flavonoid nucleus. Aromatic and aliphatic acids, prenyl, methylenedioxyl, isoprenyl, methyl, 
methoxyl, hydroxyl or sulfate groups are often part of flavonoid chemical structure.
105 
 
 
Figure 21: Backbone structures of the flavonoid subclasses commonly found in the plant kingdom. 
 
3.5.3.1 Flavanones 
Several studies
38,84,86,93,94,98
 investigated the presence of flavanones in capitula, 
commercial products and industrial residues of artichoke, as depicted in Table 10. 
 
Table 10: Flavanones identified in artichoke morphological parts. 
Flavanones Artichoke 
Naringenin fs,
93
 c,
94
 r, b,
93
 bp
84
 
Naringenin 7-O-glucoside (prunin) fs,
93
 c,
38,94
 r, b,
93
 j,
38
 bp
38,84
 
Naringenin 7-O-neohesperidoside (naringin) bp
84
 
Naringenin 7-O-rutinoside (narirutin) c,
38,86,94,98
 j, bp
38
 
Eriodictyol glucuronide isomer bp
84
 
Abbreviations: b, bracts; bp, by-products; c, capitula; fs, floral stems; j, juice; r, roots. 
 
Naringenin and two glycosylated forms, namely naringenin 7-O-glucoside and 7-O-
rutinoside (Figure 22), were found in capitula
38,86,94,98
 and their constitutive parts, such as 
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receptacles, outer and inner bracts
93
 (Table 10). Naringenin 7-O-glucoside was the most 
abundant naringenin derivative, accounting for 106.8 mg/kg dw in artichoke receptacles.
93
 
Naringenin 7-O-neohesperidose (Figure 22) was only detected in the artichoke by-products.
84 
 
 
Figure 22: Structures of naringenin and derivatives identified in artichoke. Abbreviations: Glc, glucosyl; 
Rha, rhamnosyl. 
 
An eriodictyol glucuronide isomer was discovered in artichoke by-products (Table 10 
and Figure 23).
84
 
 
 
Figure 23: Structure of eriodictyol 7-O-glucuronide. 
 
3.5.3.2 Flavones 
Flavones, such as apigenin, chrysoeriol and luteolin and their derivatives, were 
identified in wild cardoon, artichoke and cultivated cardoon, as explained in Table 11. 
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Table 11: Flavones identified in several morphological parts of C. cardunculus L. plants. 
Flavones WC Artichoke CC 
Apigenin derivatives    
Apigenin fs,
92
, c,
102,106
 
l
9,85,92
 
fs,
92,97
 c,
102
 r, b,
87,95–97
 l,
58,92
 bp
84
 fs,
92
 c,
102
 l
9,92
 
Apigenin 7-O-acetylglucoside  c
86
  
Apigenin 7-O-glucoside l
92,99
 fs,
97
 c,
38,94,95
 r, b,
93,95–97
 l,
58,92,100
 
d
37
 
l
92
 
Apigenin 7-O-glucuronide l
9,92
 fs,
92,97
 c,
38,94,95,102
 r, b,
93,95–97
 l,
107
 
ds
37
 bp
84
 
c,
102
 l
9,92
 
Apigenin 7-O-malonylglucoside 
isomer 
fs, l
92
 fs,
92,97
 c,
102
 r, b,
96,97
 l
92
 fs,
92
 c,
102
 l
92
 
Apigenin 7-O-rutinoside (isohoifolin) c,
102,106
 l
9,92
 c,
38,94,95,98
 r,
93
 b,
93,95–97
 l,
92,100
 bp
84
 c,
102
 l
9,92
 
Chrysoeriol  bp
84
  
Luteolin derivatives    
Luteolin c,
102,106
 l
9,92
 fs,
92,97
 c,
95,102,107
 r, b,
87,95–97
 
l,
90,92,107
 bp
84
 
fs,
92
 r, b,
87
 l
9,92
 
Luteolin 7-O-acetylglucoside  ds
37
  
Luteolin 7-O-galactoside  bp
84
  
Luteolin 7-O-glucuronide l
9,92
 c,
38,94,95,102
 r, b,
93,95–97
 l,
37,92,107
 
ds,
37
 bp 
84
 
fs,
92
 l
9,92
 
Luteolin 7-O-glucoside (cynaroside) fs,
92
 l
9,92,99
 fs,
92,97
 c,
38,94,95,102
 r, b,
93,95–97
 
l,
58,90,92,98,100,107
 ds
36
 bp
84
 
fs,
92
 l
9,92
 
Luteolin 7-O-malonylglucoside l
9
 fs,
97
 l
107
 l
9
 
Luteolin 7-O-malonylglucoside isomer fs
92
 l
92
  
Luteolin 7-O-neohesperidoside  bp
84
  
Luteolin 7-O-rhamnoside  bp
84
  
Luteolin 7-O-rutinoside (scolymoside) fs,
92
 l
9,92
 fs,
92,97
 c,
94,95,102
 r, b,
93,95–97
 
l,
58,92,98,100,107
 bp
84
 
l
9
 
Abbreviations: b, bracts; bp, by-products; c, capitula; CC, cultivated cardoon; ds, dietary supplements; 
fs, floral stems; l, leaves; r, receptacles; WC, wild cardoon. 
 
Apigenin and several glycosylated derivatives, namely apigenin 7-O-glucoside, 7-O-
glucuronide and 7-O-rutinoside (Figure 24), and an apigenin malonylglucoside isomer, were 
identified in the floral stems,
92,97
 capitula,
38,94,95,98,102
 receptacles and bracts,
87,93,95–97
 and 
leaves
92,100,107
 of artichoke (Table 11). With the exception of apigenin malonylglucoside 
isomer, all of these apigenin derivatives were also found in dietary supplements,
37
 as well as 
in industrial by-products of artichoke.
84
 These compounds were mainly concentrated in 
capitula of artichoke,
38,93,94,96,97,102,107
 with apigenin glucuronide as the most abundant one, 
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achieving ≈6.2 g/kg dw in receptacles.93 Regarding to cardoon, apigenin and its derivatives 
were also present in floral stem, capitula and leaves of wild9,85,92,99,102,106 and cultivated 
types9,92,102 (Table 11). Furthermore, Mucaji, et al.
108
 isolated apigenin 7-O-methylglucuronide 
(Figure 24) from cardoon capitula, without citing which was the variety. Apigenin 7-O-
glucuronide was shown as the most common apigenin derivative in both cardoon 
varieties,
9,92,102
 reaching about 10.59 g/kg dw in leaves of wild cardoon
9
 and ≈7.0 g/kg dw in 
capitula of cultivated cardoon.
102
 
 
 
Figure 24: Structures of apigenin and derivatives identified in C. cardunculus L. varieties. Abbreviations: 
GlcAc, acetylglucosyl; Glc, glucosyl; GlcMetUA, methylglucuronyl; GlcUA, glucuronyl; Rha, rhamnosyl. 
 
Luteolin 7-O-glucoside, 7-O-glucuronide, 7-O-rutinoside, 7-O-malonylglucoside and 
luteolin (Figure 25) were identified in the floral stems,
92,97
 capitula
38,86,90,92–98,100,102,107
 and 
leaves
37,90,92,93,95–98,100,107
 of artichoke (Table 11). Luteolin 7-O-glucoside and 7-O-glucuronide 
were also found in dietary supplements of artichoke.
36,37
 Furthermore, luteolin 7-O-
galactoside, 7-O-rhamnoside and 7-O-neohesperidoside (Figure 25) were detected in 
industrial artichoke by-products.
84
 Luteolin 7-O-glucuronide displayed the highest abundance 
among luteolin derivatives of artichoke,
38,92–97,102,107
 achieving about ~1.6 g/kg dw in 
receptacles.
93
 In what concerns to cardoon, luteolin 7-O-glucoside, 7-O-glucuronide, 7-O-
rutinoside and 7-O-malonylglucoside, and luteolin were detected in the floral stems,
92
 
capitula
87,102
 and leaves
9,92
 of wild9,92,99,102,106 and cultivated cardoon9,87,92 (Table 11). According 
to quantitative analysis,
9,92,102
 luteolin 7-O-malonylglucoside was the most common luteolin 
derivative in leaves of cultivated cardoon and wild cardoon, approximately at 22.98 and 8.05 
g/kg dw, respectively.
9
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Figure 25: Structures of luteolin and its glycosyl derivatives identified in the three varieties of C. 
cardunculus L. Abbreviations: Gal, galactosyl; Glc, glucosyl; GlcUA, glucuronyl; MalGlc, 
malonylglucosyl; Rha, rhamnosyl. 
 
Chrysoeriol (Table 11 and Figure 26) is another flavone identified in artichoke by-
products.
84
 
 
 
Figure 26: Structure of chrysoeriol identified in artichoke industrial residues. 
 
3.5.3.3 Flavonols 
Table 12 highlights the flavonols identified in artichoke, namely quercetin and its 
derivatives. Quercetin and several glycosylated forms, namely quercetin 3-O-arabinoside, 3-
O-galactoside, 3-O-glucoside, 3-O-rhamnoside, 3-O-rutinoside and 7-O-neohesperidoside 
(Figure 27), were detected in artichoke capitula
86
 and dietary supplements,
37
 as well as in 
industrial by-products.
84
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Table 12: Flavonols identified in artichoke. 
Flavonoids Artichoke 
Quercetin bp
84
 
Quercetin 3-O-arabinoside (avicularin) bp
84
 
Quercetin 3-O-galactoside (hyperoside) bp
84
 
Quercetin-3-O-glucoside (isoquercitrin) bp
84
 
Quercetin 3-O-rhamnoside (quercitrin) bp
84
 
Quercetin 3-O-rutinoside (rutin) c,
86
 j,
37
 bp
84
 
Quercetin 7-O-neohesperidoside ds
37
 
Abbreviations: bp, by-products; c, capitula; ds, dietary 
supplements; j, juice. 
 
 
Figure 27: Structures of quercetin and derivatives identified in artichoke. Abbreviations: Ara, arabinosyl; 
Gal, galactosyl; Glc, glucosyl; Rha, rhamnosyl. 
 
3.5.3.4 Other flavonoid subclasses 
Phloretin 2-O-glucoside and epicatechin are, so far, the unique chalcone and flavan-3-
ol, respectively, identified in C. cardunculus L. (Figure 28). Epicatechin was found in wild 
cardoon leaves,
85
 whereas phloretin 2-O-glucoside was detected in artichoke by-products.
84
 A 
biflavonoid, named as amentoflavone (Figure 28), was also present in wild cardoon leaves.
85
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Figure 28: Other subclasses of flavonoids identified in C. cardunculus L. Abbreviation: Glc, glucosyl. 
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4. Extraction and chemical analysis of plants extractives 
4.1 Extraction methods 
The extraction process is an important step for the analysis of plants extractable 
compounds. The solubility of a compound in the extraction solvent is one of the key 
parameters of extraction process, which may be predicted with the knowledge of polarity.
109
 
Moreover, the transport of a compound from the plant matrix to the solvent is another 
important extraction parameter. The mass transfer implies solvent penetration into the matrix 
and removal of target compounds from the adsorbed sites, which is controlled by partition 
coefficient, particle size and matrix structure.
110
 Another important aspect is related with the 
fact that, in several cases, target compounds are not freely available, and interacts with other 
matrix components, namely proteins, carbohydrates and lipids. Therefore, it will be necessary 
to provide enough energy to break the intermolecular interactions between target compounds 
and matrix components for a successful extraction.
109
 
The extraction method should be selected regarding the plant matrix to be processed 
and the target compounds to be analyzed. Exhaustive extraction methods are preferentially 
chosen for the analytical assessment of plants phytochemical profiles, since they virtually 
enable the complete removal of target compounds from the matrix. Soxhlet extraction and 
solid-liquid extraction are regarded as exhaustive extraction methods. The exhaustive 
extraction of plants secondary metabolites can comprise multiple consecutive steps, involving 
different extractions methods and/or solvents.
109
 Our group have demonstrated the usefulness 
of sequential extraction for analyzing different families of extractable compounds in plant 
matrices, namely lipophilic and phenolic compounds.
111,112
 
 
4.1.1 Soxhlet extraction 
The Soxhlet extraction is a general and well-established technique, which has been 
used for the extraction of plants secondary metabolites,
109
 for instance fatty acids, sterols and 
pentacyclic triterpenes.
113–115
 
The Soxhlet extractor system (Figure 29) is constituted by a condenser, a thimble 
holder (Soxhlet) and a round-bottomed flask. The ground material plant is placed in a porous 
cellulose filter thimble. The thimble is located in a glass thimble holder (Soxhlet), which is 
above the round-bottomed flask and below the condenser. The solvent is placed in the round-
bottom flask and heated to its boiling point. The solvent vapor goes through the side tube of 
Soxhlet, reaching the condenser where it condenses and drips into the thimble holder. When 
the condensed solvent fills the thimble holder and reaches the top of the siphon of the return 
tube, it is drained back into the flask through the siphon, carrying the extractable compounds 
into the solvent reservoir bellow. At this point the extraction thimble does not contain any 
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solvent. The first cycle of the extraction was thus performed. This cycle repeats many times for 
a predetermined time period. In the solvent flask, the extractable compounds are separated 
from extraction solvent by distillation, since they have lower volatility than the solvent. In this 
manner, the plant sample is always extracted with fresh solvent in each cycle.
109,110
 
 
 
Figure 29: Soxhlet apparatus (adapted from 
110
). 
 
Despite its simplicity and the inexpensive extraction apparatus, some disadvantages 
have been pointed out, namely the long extraction time (6-48 h), and the possibility of 
degradation of thermolabile compounds, due to the extraction temperature corresponds to the 
extraction solvent boiling point, for a long time.
109,110
 
The Soxhlet method was used to estimate the seed oil percentage of C. cardunculus 
L. var. altilis (DC), using ethyl ether as extraction solvent.
19
 
 
4.1.2 Solid-liquid extraction 
In the solid-liquid extraction, powdered plant material is placed in contact with the 
solvent, for many hours or even days, allowing transfer of target compounds from the plant 
matrix to the solvent. Mechanical stirring and centrifugation are generally included in this 
method, in order to increase mass transfer. This process is commonly performed under room 
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temperature, but high temperatures can also be applied to promote the extraction efficiency. 
Nonetheless, the use of high temperatures should be avoided in what regards to the extraction 
of thermolabile compounds. This technique has been commonly used for the extraction of 
plants phenolic compounds.
116,117
 
Several studies have used the solid-liquid extraction for the removal of phenolic 
compounds from C. cardunculus L., with organic solvents or mixtures (e.g. methanol and 
acetone/ethanol/methanol (70:15:15)); hydroalcoholic solutions (e.g., 70% ethanol, adjusted to 
pH 3.2 and 60-70% methanol); and water. Mechanic stirring, followed by centrifugation was 
also applied, under low (4 ºC), room or boiling temperatures.
9,38,85,92,99
 
 
4.2 Analytical techniques 
Components of complex plant extracts have been mainly analyzed by gas 
chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography-
mass spectrometry (HPLC-MS). After compounds separation by chromatographic techniques, 
like GC or HPLC, mass spectrometry provides relevant compound information, namely 
molecular weight and fragmentation patterns fundamental to establish the chemical structure. 
Chemical structure of each compound can be established either by comparing mass spectrum 
with those of pure compounds and library data, or by interpreting the fragmentation 
pathways.
118
 
When the mass spectroscopic data are not enough to unambiguously identify a 
compound, it is necessary to isolate it through preparative chromatographic techniques, such 
as adsorption chromatography or thin layer chromatography (TLC), for identification by nuclear 
magnetic resonance (NMR) spectroscopy, or other spectroscopic techniques (e.g. X-ray). 
Some sesquiterpene lactones,
68
 pentacyclic triterpenes
83
 and phenolic compounds
67,68
 
were isolated from C. cardunculus L. varieties and identified by various NMR spectroscopic 
techniques, namely 
1
H and 
13
C NMR, Distortionless Enhancement Polarization Transfer 
(DEPT) and two-dimension NMR, such as COrrelated SpectroscopY (COSY), Heteronuclear 
Multiple Quantum Coherence (HMQC), Heteronuclear Multiple Bond Coherence (HMBC) and 
Nuclear Overhauser Effect SpectroscopY (NOESY). 
In GC-MS and HPLC-MS systems (Figure 30), compounds are separated in the 
chromatographic columns and transferred to mass spectrometers. Each eluted compound is 
ionized to gas-phase ionic species, in the ionization source. The excess energy transferred 
during ionization causes fragmentation of those ionic species to product ions. All ions are 
thereafter separated by their mass-to-charge ratio (m/z) values in the mass analyzer. The type 
of mass analyzer will decide the type and quality of experimental data obtained regarding to 
mass accuracy, mass resolution and sensitivity.
119
 Finally, the ion current is measured and 
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amplified in electron multiplier or array detectors. The generated quantity of electrical current 
will depend on the abundance of ions hitting the detector.
119
 
 
 
Figure 30: Basic components of chromatographic equipment coupled to mass spectrometer (adapted 
from 
120
). 
 
Table 13 lists the most used devices of GC-MS and HPLC-MS systems in the 
chemical analysis of plant volatile hydrocarbons and phenolic compounds, respectively. 
 
Table 13: GC-MS and HPLC-MS systems most used in analysis of volatile lipophilic and phenolic 
compounds, respectively.
118,121,122
 
 GC-MS HPLC-MS 
Chromatographic 
column 
 Capillary fused-silica Reversed phase octadecyl silica 
(C-18) 
Interface  Direct coupling interface Fast atom bombardment 
Electrospray ionization 
Atmospheric pressure chemical 
ionization 
Mass spectrometer Ionization source Electron ionization 
Chemical ionization 
Analyzer Quadrupole 
Ion trap 
Time of flight 
Triple quadrupole 
Ion trap 
Time of flight 
Triple quadrupole-ion trap 
Triple quadrupole-time of flight 
Ion trap-time of flight 
 
4.2.1 Gas chromatography-mass spectrometry 
GC application for the separation of extractives is restricted to volatile and thermally 
stable compounds.
123
 Preliminary derivatization reactions are often needed to transform an 
analyte in a volatile derivative to be eluted from the GC column. Derivatization will render 
highly polar compounds to be volatile, in a way they can be eluted without thermal 
decomposition, at temperatures that often can reach up to 300 ºC. Compounds, exhibiting thiol 
(-SH), hydroxyl (-OH), amine (-NH) and carboxylic (-COOH) groups, have a tendency to form 
hydrogen bonds which may affect their volatility, interaction with column packing materials and 
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thermal stability. Silylation is one of the most prevalent derivatization methods. This reaction 
relies on the substitution of active hydrogens in those functional groups by trimethylsilyl 
substituents, lowering the analyte polarity and hydrogen bonding. N,O-
bis(trimethylsilyl)trifluoroacetamide is mainly used in the silylation reaction. The addition of 
trimethylchlorosilane catalyzes reactions of hindered functional groups, in secondary alcohols 
and amines. The silylated derivatives are more volatile and more stable, providing narrow and 
symmetrical chromatographic peaks.
124
 
The stationary phase is a film chemically bonded to the inner wall of a capillary fused-
silica column. GC columns with 0.25-0.33 μm film thickness are suitable for the separation of 
higher-boiling and heat-sensitive compounds, whereas thicker stationary phases (1 μm film 
thickness) for low-boiling compounds. The nonpolar GC stationary phases, like those 
constituted by dimethylpolysiloxane (DB-1 or equivalent) and 5% phenyl and 95% 
dimethylpolysiloxane (DB-5 or equivalent), are the most commonly recommended in the 
separation of lipophilic compounds, providing adequate peak resolution. GC capillary columns 
with 30-60 m of length are typically used. Shorter columns (5-15 m length) are advantageous 
for thermally labile and higher-boiling compounds. The internal diameter of the most used GC 
capillary columns varies between 0.25 and 0.53 mm. 
The sample is transferred from a heated injector, where it rapidly volatilizes, through 
the heated column by the carrier gas (helium in the case of GC-MS system). Compounds are 
selectively retarded by the stationary phase, being eluted according to their boiling 
temperature and polarity.
123
 Then, at the end of the column, compounds reach the mass 
spectrometer. 
The major problem of GC-MS, when it was developed, consisted of the incompatibility 
of GC carrier gas high pressure, caused by the high flow rate (e.g. 25 mL/min or more), with 
the high vacuum required in the mass spectrometer system (10
-5
-10
-8
 Torr in MS analyzer).
125
 
This issue was solved with the development of suitable interfaces (e.g., split system, jet 
concentrator, helium diffuser)
125
 which are able to diminish the flow rate by removing the 
carrier gas before it reaches the ionization source.
120
 With the emergence of capillary GC 
columns, the interface does not exist in the GC-MS, since the mass spectrometer pumping 
system can handle the low flow rate from the column (1-2 mL/min).
120,123
 In this way, the 
column exit is directly connected to the mass ionization source via a vacuum-tight 
flange.
120,123,125
 This device must be heated above the maximum temperature of the column 
for the sample, in a way that any compound does not condense before entering into ionization 
source.
123
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Electron ionization (EI) (Figure 31) is the ionization technique most commonly used in 
the identification of volatile extractives by GC-MS. For instance, it was applied in the GC-MS 
analysis of sesquiterpenes present in artichoke volatile oil.
62,63
 
 
 
Figure 31: Scheme of EI source (adapted from 
126
). 
 
In EI, electrons are emitted from a heated metal filament (cathode, e.g. tungsten) and 
accelerated by 70 eV towards the anode.
120
 Those electrons collide with the gaseous 
molecules of the analyzed sample, and they may transfer enough energy to remove outer 
shell electrons, giving rise to an additional free electron and a positive radical molecular ion 
([M]
+. ) (Equation (1)). Since the electron beam energy is high, molecular ions often fragment 
into product ions and neutral fragments (Equation (2)).
123,126
 EI mass spectra thus display 
many product ions, and molecular ion is often absent.
127
 
 
M + e
‒
  [M]
+.  + 2e
‒
 (1) 
[M]
+.   [A]
+
 + B
•
 (2) 
 
Quadrupole (Figure 32) is the mass analyzer more frequently installed in the mass 
spectrometer coupled to GC. It is constituted by four parallel cylindrical metal rods, arranged 
specifically in a square. A positive direct current (dc) voltage is applied to one pair of opposing 
rods, whereas the other pair receives a negative dc voltage. Superimposed radiofrequency (rf) 
voltages are also applied to each pair of rods.
128
 The consequent dynamic electric field acts as 
a filter in that it only allows ions of a given m/z (“resonant ions”) to pass down the gap between 
Chapter II – Bibliographic review 
 
51 
the four rods, for a certain rf/dc ratio. Ions of different m/z values (non resonance ions) have 
unstable trajectories, and will collide with the rods and become neutralized. Mass-to-charge 
scanning is accomplished by varying the rf or dc voltages, while keeping rf/dc ratio constant 
the rf/dc ratio, to obtain the mass spectrum over the required m/z range.
119,128 
 
 
Figure 32: Scheme of a quadrupole (adapted from 
119
). 
 
4.2.2 High-performance liquid chromatography-mass spectrometry 
In high-performance liquid chromatography (HPLC), the stationary phase is a liquid 
film covalently bound to silica particles within a stainless steel column, and the mobile phase is 
a liquid (e.g. organic solvents or water/organic solvent mixtures). Compounds are separated 
according to their affinity to the stationary or mobile phases. In reversed-phase 
chromatography, the stationary phase is nonpolar and the mobile phase is polar. In this 
manner, the more polar compounds are the first to be eluted from the column, while the less 
polar compounds are retained longer in the column. At the column end, compounds reach the 
detector, being ultraviolet-visible spectrophotometers and diode array detectors (DAD) the 
most common. DAD has been important for the identification of analyte phenolic subclass, 
since the UV-Vis spectrum is specific for each other.
129
 HPLC-UV was applied in the 
quantification of hydroxycinnamic acids and flavonoids detected in C. cardunculus 
L.
9,38,85,87,89,92,97,99,102
 
HPLC-UV-MS has revealed to be a powerful in the identification of phenolic 
compounds. Phenolic compounds of wild cardoon,
9,92,102
 artichoke,
38,84,88,89,94,96,102,107
 and 
cultivated cardoon
9,92,102
 have been analyzed by HPLC-UV-MS. The separation of phenolic 
compounds, by HPLC, is generally performed in an octadecyl (C18) bonded silica column 
(100-250 mm in length and 2.1-4.6 mm in internal diameter). Growing attention has been 
given to the sub-2 μm particles HPLC columns, known as ultra-HPLC (UHPLC) columns, since 
these increase the optimum mobile phase velocity, supporting higher flow rates, maintaining 
high chromatographic efficiency, to decrease analysis time.
130
 Farag, et al.
58
 used UHPLC-UV-
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MS to detect 50 secondary metabolites of artichoke leaves within 13 minutes, compared to the 
50-90 minutes earlier required.
38,87,93
 The UHPLC columns have been operated at 
temperatures higher than room temperature (50-70 ºC), in the analysis of plant phenolic 
compounds.
131,132
 The use of HPLC columns at higher temperatures decreases the mobile 
phase viscosity and increases the solute diffusivity, which allows the use of higher mobile 
linear velocity, leading thereby to faster analyses.
133
 
The mobile phase used for the phenolic compounds analysis, through reversed-phase 
HPLC, is generally constituted by water and less polar organic solvents (e.g. acetonitrile or 
methanol). Acetic, formic or phosphoric acids are often added to the mobile phase.
121,134
 
Coupling HPLC to MS initially was not straightforward, because the normal operating 
conditions of mass spectrometer are diametrically opposed to those used in HPLC, such as 
high vacuum, high temperature, gas-phase operation and low flow rates.
135
 The currently used 
ionization sources, like thermospray and electrospray, have solved this issue, working as 
introduction systems to the mass spectrometer.
125
 
 Electrospray ionization (ESI) (Figure 33) has been the most utilized ionization 
technique in the identification of phenolic compounds in C. cardunculus L. varieties, by HPLC-
MS.
9,38,84,88,89,92,94,96,102,107 
 
Figure 33: Scheme of electrospray ionization process (positive ion mode) (adapted from 
136
). 
 
Within an ESI source, a continuous stream of sample solution is passed through a 
stainless steel or quartz silica capillary tube. A strong electric field is obtained by applying a 
potential difference of 3-6 kV between the capillary and the counter-electrode.
126
 The counter 
electrode may be a heated capillary (Figure 33) which drives ions to the mass spectrometer.
136
 
This field causes a charge accumulation at the liquid surface, at the end of the capillary. which 
will break to form highly charged droplets.
126
 When the pressure of the accumulated charges 
is higher than the surface tension, the shape of the droplet assumes a conical shape, known 
as Taylor cone. The Taylor cone originates a fine jet, which is divided in tiny, highly charged 
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droplets. As the solvent evaporation occurs, the droplet size continuously diminishes, until it 
reaches the point that the surface tension can no longer sustain the charge, known as the 
Rayleigh limit. At this point, a Coulombic explosion occurs and the droplet is ripped apart, 
producing smaller droplets. These small, highly charged droplets will continue to lose solvent, 
and when the electric field on their surface becomes large enough, desorption of ions from the 
surface occurs.
119,126
 Since ions may be clustered with solvent molecules and other additives, 
they are subjected to a thermal declustering or “clean-up” stage at a heated capillary. Often, a 
countercurrent flow of an inert gas (e.g. nitrogen) is used to minimize the entry of solvent 
vapor into the vacuum region (Figure 33). An electric potential difference is applied between 
the heated capillary exit and the skimmer originates a second clean-up of ions, through 
collisional activation.
136
 
The dominating signals result from the so-called “quasi-molecular” ions, such as: (i) 
protonated or sodiated ions, i.e. [M+H]
+
 or [M+Na]
+
; (ii) clusters, e.g. [2M+H]
+
, [3M+Na]
+
 or 
[M+H+solvent]
+
, (iii) multiple charged molecules as [M+2H]
2+
 or (iv) deprotonated or adduct 
ions, i.e. [M-H]
-
, [M+Cl]
-
 and [M+HCOO]
-
. This is a very soft method of ionization as very little 
residual energy is retained by the analyte upon ionization, resulting in low fragmentation.
119,137
 
For the detection of positive ions, electrons have to be provided from the capillary to the 
circuit, which will occur through oxidation of molecules in the solution at the capillary tip. For 
negative ions, electrons have to be consumed through reduction. 
 Triple quadrupole (QqQ) (Figure 34) has been the commonest MS analyzer used to 
identify phenolic compounds in C. cardunculus L. plants, by HPLC-MS.
9,38,84,88,92,96,102,107
 
Successive ion fragmentations (MS/MS) can be produced in QqQ analyzer. The first 
quadrupole (Q1) separates and selects the precursor ion of a specific m/z. Then, the ion is 
transferred to a collision cell (q), namely a quadrupole, hexapole or octapole, which operates 
in rf-only mode.
126,138
 At the collision cell, the ion suffers a collision induced dissociation (CID), 
a process by which the translational energy of the ion accelerated towards a neutral target 
species (or “collision gas”, such as argon, helium or nitrogen) is partitioned in internal energy, 
with the consequent decomposition in product ions.
139
 Finally, in the last quadrupole (Q2), the 
product ions coming from CID are separated and directed to the detector.
138 
 
 
Figure 34: Scheme of triple quadrupole (adapted from 
121
). 
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Ion trap (Figure 35) is a three-dimensional analogue of the quadrupole mass analyzer, 
containing a central ring electrode between two identical end-capped electrodes, with a 
hyperbolic geometry. One of the end-cap electrodes has a small aperture which allows ion 
injection into the analyzer from an external source. The other end-cap electrode has several 
perforations for the ejection of ions towards the detector.
120
 This analyzer is named as trap, 
because it enables ions to be trapped in an electric field by applying an rf voltage to the ring 
electrode.
119
 The mass separation is achieved by storing the ions in the trapping space (1-30 
ms), and by manipulating their motion in time, under an oscillating electric field.
119,120
 Mass 
spectrum of trapped ions is obtained by the mass-selective axial ejection. The increase of rf 
voltage destabilizes the trajectories of ions, and ejects them sequentially from the ion-trap 
region, through the end cap electrode.
119
 Ion trap is particularly adequate for multi-step mass 
spectrometry without additional mass analyzers, because ions are stored and fragmented by 
CID in the same device. CID is accomplished by applying an excitation waveform which 
accelerates and then decelerates the ions, in the presence of a collision gas (e.g. helium). 
Slow and multiple collisions of ions lead to highly efficient and low energy CID.
122
 CID is 
performed after ejecting all ions from the trap except the selected precursor, which is 
energized to originate product ions (Figure 35). Then, a specific product ion can be selected, 
trapped and collided with the helium gas to give rise product ions for another mass 
spectrum.
138
 Fragmentation of ions can be repeated in a sequential manner, allowing to obtain 
valuable structural information. This type of analyzer was used in the identification of phenolic 
compounds in artichoke.
93,94
 
 
 
Figure 35: Scheme of ion trap (adapted from 
119
). 
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5. Phytotherapy 
The use of herbal teas, poultices and powders for relieving illness is as old as the 
humanity’s history. The phytotherapy term was firstly used by Henri Leclerc (1870-1955) for 
the study of herbal drugs in the treatment of human diseases, regarding their effectiveness 
and limitation.
140
 The scientific knowledge on phytotherapy is currently one of the fastest 
growing areas of biomedical research, given the molecular biology advancements in the last 
years. Actually, the number of publications related to the biological activity assessment of 
medicinal plants increased more than four times in the last decade (2004-2014) (Figure 36). 
 
 
Figure 36: Number of publications in the last decade (2004-2014) with the keywords in topics 
search “medicinal plant” and “activity” of Web of Science (2015 May). 
 
The wide use of medicinal plants in developing countries, namely in African countries, 
is frequently associated with its accessibility and affordability, specially in rural areas where 
people have hardly access to allopathic health care.
141
 On the other hand, the consumption of 
herbal products is becoming more common in developed countries, for several reasons: (i) the 
preference for natural therapies towards chemical products; (ii) the concern relatively to the 
undesirable side effects of synthetic medicines; (iii) the preference for preventive medicine, as 
a consequence of population ageing, and (iv) the scientific evidence supporting efficacy and 
safety of herbal products.
142
 
Phytotherapeutic agents can be seen as an alternative or complementary treatment to 
conventional medicines against various chronic diseases, such as cardiovascular diseases, 
cancer, diabetes and mental disorders. More than 100 million of Europeans are nowadays 
users of traditional and complementary medicine (TCM), with 20% preferring health care 
including medicinal plant products.
143
 In addition to European countries, there is a great TCM 
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consumption in Asiatic and North American countries.
142,143
 In fact, relevant policy issues have 
been implemented for the appropriate usage of TCM.
143
 
After a stagnation in the development of new molecular entities (NMEs) during the last 
years, the pharmaceutical industry is more and more dedicated in the search for new NMEs, 
among the secondary metabolites.
144
 These compounds display “privileged” chemical 
structures, since they bind naturally to biological macromolecules and exhibit pleiotropic 
mechanisms of action.
144–148
 The drug discovery process has been estimated to take around 
10 years.
144
 Figure 37 shows the main steps for the development of NMEs based on plant 
secondary compounds. 
 
 
Figure 37: Drug development process, derived from plant secondary metabolites (adapted from 
149–151
). 
Abbreviations: cDNA, complementary DNA; FTIR, Fourier transformed infrared; mRNA, messenger 
RNA; UV-Vis, ultraviolet-visible spectroscopy. 
 
After the botanical identification of the medicinal plant, the drug development process 
(Figure 37) is initiated with the extracts preparation and their chemical characterization 
through GC-MS and HPLC-MS analysis.
152
 These plant extracts are then submitted to the 
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evaluation of a diversity of biological activities, including: (i) antioxidant activity; (ii) in vitro 
animal cell cultures assays, through genomics, transcriptomics and metabolomics-based 
approaches (iii) antimicrobial action; and (iv) in vivo assays (e.g. rodent and non-rodent 
mammals).
147,150
 
The biologically active plant extracts are sequentially fractionated, through 
chromatographic techniques, namely thin layer chromatography, solid-phase extraction and 
advanced high-performance liquid chromatographic technique.
153
 Each fraction is also 
subjected to biological activity tests, in order to isolate the most promising bioactive 
compound. This process is known as bioactivity-guided fractionation.
150
 The chemical 
structure of the lead compound is elucidated through spectroscopic methods, such as: (i) 
ultraviolet-violet spectroscopy; (ii) mass spectrometry; (iii) Fourier transformed infrared 
spectroscopy; (iv) one and two dimensional proton (
1
H) and carbon (
13
C) NMR spectroscopic 
techniques.
153
 
The following step of the drug development consists of tentatively synthesizing the 
lead compound. The lead optimization also comprehends the synthesis of lead derivatives, 
lying on combinatorial chemistry, in order to understand the structure-activity relationship.
149
 
Either the large-scale isolation, or the synthesis of drug candidates is needed for the clinical 
and toxicological trials, centered in the future therapeutic application.
150
 
 
6. Biological activity of C. cardunculus L. extracts 
C. cardunculus L. leaves infusions are quite utilized in the traditional medicine of 
Europe and North Africa, due to their hepatoprotective and anticholestatic effects.
30,154
 These 
biological effects have been related with the phenolic composition, namely hydroxycinnamic 
acids and flavonoids.
26,29
 Adzet, et al.
26
 observed that cynarin and luteolin 7-O-glucoside 
prevented, in a dose-dependent manner, the carbon tetrachloride-induced leakage of both 
aspartic and alanine transaminases. Moreover, Saénz Rodriguez, et al.
29
 also demonstrated 
that a commercial artichoke leaves aqueous extract, containing 1.5% caffeoylquinic acids and 
0.5% flavonoids, increased the bile flow and bile acids excretion in Wistar rats (100-400 
mg/kg). 
Table 14 lists some of the studied biological activities of artichoke and wild cardoon 
extracts, and their relationship with the secondary metabolites composition. 
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Table 14: Some of C. cardunculus L. extracts biological activities, and relationship with the chemical 
composition. 
C. cardunculus L. 
extracts 
Biological activity 
Main responsible secondary 
metabolites 
Source 
Artichoke leaves Inhibition of olive oil-induced 
triglycerides elevation in rat serum 
Cynaropicrin, aguerin B, 
grosheimin, luteolin 7-O-
glucoside and 7-O-rutinoside 
68
 
Cholesterol biosynthesis inhibition Luteolin and luteolin 7-O- 
glucoside 
155
 
Nitric oxide increased production 
and eNOS activity up-regulation 
156
 
Wild cardoon eNOS activity induction Luteolin 7-O-glucoside 
157
 
Vasomotion recuperation in rats Luteolin and apigenin 
158
 
Abbreviations: eNOS, endothelial nitric oxide synthase. 
 
Shimoda, et al.
68
 noted that artichoke leaves methanol extract inhibited the serum 
triglycerides elevation in olive oil-loaded mice (Table 14), with cynaropicrin as the most 
effective agent, followed by grosheimin and aguerin B. This research group proposed that the 
oxygen functional group, as well as the exo-methylene moiety in the α-methylene-γ-
butyrolactone ring were essential for the anti-hyperlipidemic activity of guaianolides.
68
 
Moreover, Gebhardt
155
 showed that a commercial artichoke leaves aqueous extract blocked 
the cholesterol biosynthesis in primary cultured rat hepatocytes, probably due to luteolin and 
luteolin 7-O-glucoside (Table 14). 
Three studies indicated the cardiovascular properties of artichoke and wild cardoon 
extracts
156–158
 (Table 14). Li, et al.
156
 found that a commercial artichoke leaves aqueous 
extract (10.10% of caffeoylquinic acids and 2.17% of flavonoids), and its ethyl acetate/n-
butanol (2:1) fraction (26.30% of caffeoylquinic acids and 13.29% of flavonoids), induced 
endothelial nitric-oxide synthase (eNOS) protein expression. They also proved that luteolin 7-
O-glucoside and luteolin, known to be present in commercial artichoke leaves extract, 
increased the eNOS mRNA expression.
156
 A wild cardoon 90% ethanol extract (1 µM gallic 
acid equivalents (GAE)) was also demonstrated to induce the eNOS activity, in primary 
porcine aortic endothelial cells, after 16 h.
157
 Moreover, Rossoni, et al.
158
 demonstrated that a 
water-soluble extract of wild cardoon, containing luteolin and apigenin, could restore proper 
vasomotion, in aged rats, to a similar degree of young animals. 
Artichoke capitula are worldwide consumed as a vegetable, specially in the 
Mediterranean countries. Several epidemiological studies have correlated the Mediterranean 
diet with a lower incidence of coronary heart diseases and cancer.
159–161
 These health benefits 
can be associated with the high intake of fish, olive oil, fruit and vegetables, which have 
revealed to be sources of -3 fatty acids, phytosterols and phenolic compounds. 
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Phenolic compounds are well-known by their antioxidant activity. Several studies have 
tried to understand the mechanism of action of phenolic compounds on tumor cell models, 
through their effects on the antioxidant-prooxidant balance.
162,163
 Plant lipophilic components 
have also shown antiproliferative effects on human tumor cell lines, for instance sesquiterpene 
lactones
50
 and pentacyclic triterpenes.
79
 
The antioxidant and the antitumoral effects of C. cardunculus L. extracts have been 
vastly assayed in the last years. Seeking for natural antibiotics, the antimicrobial action of C. 
cardunculus L. extracts have also been approached. These three important biological activities 
of C. cardunculus L. extracts and their relationship with the secondary metabolites 
composition will be exposed, as it follows. 
 
6.1 Antioxidant activity 
Oxidative stress is caused by disruption in the balance between production of free 
radicals and antioxidant defense mechanisms. Several reactive oxygen species (ROS) and 
reactive nitrogen species (Figure 38) can cause oxidative damage to lipids, proteins and 
nucleic acids, promoting membrane destruction, enzyme inactivation and DNA breakage.
41,164
 
These oxidative damages are allied to the initiation and progression of degenerative diseases, 
namely inflammation, cancer, ageing and cardiovascular diseases.
165
 
 
 
Figure 38: Structures of common reactive oxygen species and reactive nitrogen species. 
 
Making part of medicinal plants, spices, fruit and vegetables, antioxidants may aid to 
protect the human body against the ROS injuries. The antioxidant concept was defined as 
“any substance that, when present at low concentrations compared to those of an oxidizable 
substrate, significantly delays or prevents oxidation of that substrate”. Antioxidants may act 
either by inhibiting free radicals formation, or by directly scavenging free radicals. Moreover, 
antioxidants might raise the levels of endogenous antioxidant defenses, for instance by 
upregulating expression of the genes encoding superoxide dismutase, catalase or glutathione 
peroxidase.
166
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Several studies have devoted to the antioxidant potential of C. cardunculus L. 
phenolic-containing extracts and their components, by using in vitro and in vivo assays. 
 
6.1.1 In vitro assays 
Several in vitro methods have been utilized to investigate the antioxidant activity of C. 
cardunculus L. extracts and their phenolic constituents, based on hydrogen atom transfer 
(HAT) and single electron transfer (SET) assays, as well as on the ROS scavenging effect. 
 
6.1.1.1 Hydrogen atom transfer assays 
 HAT-based methods determine the ability of an antioxidant to quench free radicals, by 
giving one hydrogen atom, based on the Equation (3): 
 
X
·
 + AH  XH + A
·
 (3) 
 
Oxidation of low-density lipoprotein (LDL) is a HAT-based method that can be applied 
for evaluating the antioxidant effect in a more physiologically relevant system. This antioxidant 
test involves the LDL oxidation induced by Cu(II) ions or 2,2´-azobis(2-
amidinopropane)dihydrochloride, giving rise to lipid peroxides. Lipid peroxides can be 
monitored by detecting conjugated dienes (max = 234 nm),
167
 or by quantifying their 
decomposition products, like malonaldehyde (MDA), through the thiobarbituric acid method.
88
 
Brown, et al.
168
 demonstrated that a commercial artichoke leaves aqueous extract was 
able to delay Cu
2+
-induced LDL oxidation, in a concentration-dependent way (1-20 µg/mL). 
The major phenolic compound of this extract, luteolin 7-O-glucoside, also prevented the LDL 
oxidation, probably by chelating Cu
2+
 ions.
168
 Coinu, et al.
88
 noted that ethanol and ethyl 
acetate extracts, derived from artichoke outer bracts and leaves, strongly decreased the 
production of LDL diene conjugates, though no correlation with the total contents of phenolic 
compounds, caffeoylquinic acids or flavonoids was pointed out. With the exception of apigenin 
7-O-glucoside, the main identified phenolic compounds in artichoke extracts inhibited Cu
2+
-
induced LDL peroxidation, as follows: caffeic acid > 5-O-caffeoylquinic acid > luteolin 7-O-
glucoside > 1,5-di-O-caffeoylquinic acid > luteolin.
88
 
Pistón, et al.
164
 approached the scavenging effect of artichoke leaves extracts against 
peroxyl (ROO
·) radicals, by using the oxygen radical absorbance capacity (ORAC) assay. 
This assay evaluates whether a test compound is able to transfer a hydrogen atom to ROO
·
 
radicals, which reflects a classical radical chain breaking antioxidant effect.
167
 The ROO
·
 
radicals may be prepared by thermodecomposition of α,α´-azodiisobutyramidine.164 Then, the 
antioxidant potential is evaluated by monitoring the fluorescence decay resulting from the 
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ROO
·
-induced oxidation of fluorescein (3´,6´-dihydroxyspiroisobenzofuran-13H,9´,9H-xanthen-
3-one) (Equation (4), Figure 39).
164,167
 In the presence of an antioxidant, the fluorescein decay 
is retarded (Equation (5)). The reaction is monitored at 485 nm (excitation)/525 nm (emission) 
for fluorescence variations, during reaction time.
169
 The antioxidant effect is determined 
through the integrated areas under the fluorescence decay curves (AUC) [AUCsample – AUCno 
sample].
167 
 
 
(4) 
(5) 
Figure 39: Peroxyl radical scavenging effect of a test antioxidant, by using the oxygen radical 
absorbance capacity (adapted from 
167
). 
 
Using the ORAC method, Pistón, et al.
164
 observed that an artichoke leaves infusion, 
containing 108 mg/g extract of identified phenolic compounds, was more active in inhibiting 
the fluorescein oxidation by ROO
·
 radicals, comparatively to the aqueous (decoction) and 
ethanol/water (70:30) extracts (63 and 73 mg/g extract of identified phenolic compounds, 
respectively). 
 
6.1.1.2 Single electron transfer assays 
 SET-based methods are related with the ability of an antioxidant (A) to transfer one 
electron to reduce metals (Equation (6)) and radicals (Equations (7)-(9)): 
M(III) + AH  AH
+
 + M(II) (6) 
X
·
 + AH
 
 X
‒
 + AH
·+
 (7) 
AH
·+   
 A
·
 + H3O
+
 (8) 
X
‒
 + H3O
+
  XH + H2O (9) 
 
Phenolic compounds have shown reducing ability, which can depend on the 
hydroxylation degree and the extent of double bond conjugation.
170
 Two SET-based assays 
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were applied in the assessment of C. cardunculus L. extracts reducing power, namely Ferric 
Reducing Antioxidant Power (FRAP)
92
 and reducing power.
171
 
FRAP consists of the donation of an electron by the antioxidant to reduce bis(2,4,6-
tris(2-pyridyl)-s-triazine)iron (III) to bis(2,4,6-tris(2-pyridyl)-s-triazine)iron (II) (Equation (10)) 
which is monitored at 595 nm (Figure 40).
167
 This assay was primarily created to measure the 
reducing power of antioxidants in plasma, but currently it is also used to study the antioxidant 
effect of plant extracts.
170
 This method may predict the free radical scavenging action of 
phenolic compounds.
167
 In this manner, Pandino, et al.
92
 observed that the FRAP of 70% 
methanol extracts, derived from C. cardunculus L. floral stem and leaves, was linearly and 
positively correlated with hydroxycinnamic acids (r = 0.95) and luteolin derivatives contents (r 
= 0.97), respectively. 
 
 
(10) 
Figure 40: Redox reactions involved in the ferric reducing antioxidant power assay (adapted from 
167
). 
 
The reducing power assay is based on the capacity of an antioxidant to reduce the 
ferricyanide ion ([Fe(CN)6]
3-
) to [Fe(CN6)]
4-
 ion (Equation (11)). Then, the [Fe(CN6)]
4-
 ion reacts 
with ferric ion (Fe(III)), generating Fe[Fe(CN)6]
-
 (Equation (12)). In this method, the 
Fe[Fe(CN)6]
-
 is monitored at 700 nm, by measuring the absorbance of Prussian blue salt 
(KFe[Fe(CN)6]).
172 
 
[Fe(CN)6]
3-
 + A  [Fe(CN)6]
4-
 + oxidized A (11) 
[Fe(CN)6]
4-
 + Fe
3+ 
  Fe[Fe(CN)6]
-
 (12) 
 
Using this method, our group
171
 tested the reducing power of methanol aqueos 
extracts, derived from stalks, capitula and leaves of wild and cultivated cardoon. Nonetheless, 
this research group observed a weak linear correlation between the reducing power and the 
total phenolic contents (r = -0.553).
171
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6.1.1.3 Hydrogen atom transfer and single electron transfer assays 
The scavenging effect assays of 2,2´-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS
.+
) and 2,2-diphenyl-1-picrylhydrazyl (DPPH
·
) (Figure 41) are usually classified as SET 
reactions. However, both synthetic organic radicals may be neutralized either by direct 
reduction via electron transfer (SET), or by radical quenching via hydrogen atom transfer 
(HAT).
167
 
 
Figure 41: Structures of 2,2´-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS
·+
), and 2,2-
diphenyl-1-picrylhydrazyl (DPPH
·
) free radicals. 
 
The ABTS
·+
 scavenging effect is monitored through the decrease of ABTS
·+ 
radical 
absorbance at 415 or 734 nm, in the presence of the tested compound. The ABTS
·+
 radical is 
previously formed through the ABTS oxidation induced by ROO
·
 radicals or other oxidants. A 
compound can reduce ABTS
·+ 
radical if it has a redox potential lower than that of 
ABTS
·+/ABTS (Ɛº = 0.68 V). The inhibitory concentration at 50% (IC50) of the tested 
compound, regarding to ABTS
·+
 scavenging effect, is usually expressed as Trolox equivalent 
antioxidant capacity (TEAC).
167
 Llorach, et al.91 described the scavenging effect of methanol 
and aqueous extracts, derived from artichoke by-products towards ABTS
·+
 radicals, observing 
a weak linear correlation between TEAC and total phenolic contents (r = 0.78). Betancor-
Fernández, et al.
173
 approached the ABTS
·+
 scavenging effect of four fractions of different 
polarities (acetone/water (75:25), methanol/water (70:30), ethanol and water), derived from 
commercial artichoke leaves extract. This group noted that TEAC of artichoke fractions was 
linearly correlated with the total phenolic contents (r = 0.973).
173
 
The DPPH assay consists of monitoring the decay of DPPH radicals absorbance (max 
= 515-517 nm), while the antioxidant neutralizes the DPPH free radicals to DPPH-H. This is 
one of the most used tests to evaluate the antioxidant capacity of plant phenolic-containing 
extracts.
167
 Phenolic compounds can react with DPPH radicals through mechanisms of HAT 
(Equation (13))
174
 or SET (Equations (14)-(16)).
175
 According to Foti, et al.,
174
 the transference 
of an electron from the phenoxide anion (ArO
-
) to DPPH
·
 free radicals is prevalent in polar 
solvents, like methanol and ethanol, and HAT path is a marginal reaction. 
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HAT DPPH
·
 + AH  DPPH-H + A
·
 (13) 
SET ArOH  ArO
-
 + H
+
 (14) 
ArO
-
 + DPPH
·
  ArO
·
 + DPPH
-
 (15) 
DPPH
-
 + H
+
  DPPH-H (16) 
 
The steric accessibility is also important in the DPPH scavenging effect, since small 
molecules that have better access to the radical site have higher apparent antioxidant effect in 
this test. Moreover, DPPH is a stable nitrogen radical that is not similar to the highly reactive 
ROO
·
 radicals involved in lipid peroxidation. Many antioxidants that react quickly with ROO
·
 
radicals may react slowly or even do not react with DPPH due to steric inaccessibility.
167
 
Wang, et al.
98
 assayed the DPPH scavenging effect of seven phenolic compounds, 
isolated from artichoke capitula and leaves, reporting the following antioxidant capacity order: 
1,3-di-O-caffeoylquinic acid > luteolin 7-O-rutinoside ≈ luteolin 7-O-glucoside > 1-O-
caffeoylquinic acid ≈ 5-O-caffeoylquinic acid > naringenin 7-O-rutinoside > apigenin 7-O-
rutinoside. The two caffeoyl moieties may actually contribute for the antioxidant ability of 1,3-
di-O-caffeoylquinic acid. It was proposed that caffeic acid neutralizes DPPH free radicals, 
through the formation of o- or p-quinones,
175
 with resonance stabilization across the aromatic 
ring connected with the highly conjugated side chain CH=CH-COOH (Figure 42).
176,177
 
 
 
Figure 42: Resonance structures of caffeic acid radical. 
 
Wang, et al.
98
 also noticed that luteolin 7-O-rutinoside and 7-O-glucoside represented 
the more active flavonoids, isolated from artichoke capitula and leaves, in neutralizing the 
DPPH free radicals. This can be related with the fact that the luteolin aglycone has two of the 
three essential structural characteristics for the maximum scavenging effect: (i) the presence 
of 3´,4´-dihydroxystructure in the B-ring and (ii) the presence of a 2,3-double bound in 
conjugation with the 4-oxo group in the heterocycle, allowing for conjugation between A- and 
B-rings. The third structural condition is associated with the presence of 3- and 5-hydroxyl 
groups in the A ring, together with a 4-oxo function in A and C rings.
170
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Table 15 summarizes the antioxidant action of C. cardunculus L. extracts assessed 
through the DPPH radicals scavenging assay. 
 
Table 15: DPPH scavenging effect of C. cardunculus L. extracts, and its correlation with the phenolic 
composition. 
C. cardunculus L. extracts Correlation with phenolic compounds Source 
Artichoke By-products Linear correlation with total phenolic content (r = -0.98) 
91
 
Capitula, leaves Linear correlation with the total phenolic content (r = -0.96) 
98
 
Artichoke 
and wild 
cardoon 
Stalks, seeds Linear correlation with total phenolic content (r = -0.832) 
and condensed tannins content (r = -0.915). 
178
 
Wild 
cardoon 
Capitula, leaves, 
seeds 
Linear correlation with total phenolic content (r = -0.93), 
total flavonoid content (r = -0.98) and condensed tannins 
content (r = -0.96) 
85
 
Wild and 
cultivated 
cardoon 
Stalks, capitula, 
leaves 
Weak linear correlation with total phenolic contents (r = -
0.716) 
171
 
 
Both reports of Llorach, et al.
91
 and Wang, et al.
98
 (Table 15) indicated that the 
antioxidant activities of methanol extracts,
91,98
 derived from industrial wastes (floral stems and 
capitula),
91
 capitula and leaves of artichoke,
98
 was linearly correlated with the total phenolic 
contents, by employing the DPPH assay. Furthermore, Falleh, et al.
85
 and Soumaya, et al.
178
 
(Table 15) referenced that the DPPH scavenging effects of methanol extracts from wild 
cardoon and artichoke were linearly correlated with the total phenolic, total flavonoid and 
condensed tannins contents.
85,178
 Kukic, et al.
10
 studied the DPPH scavenging effect of a 96% 
ethanol extract of capitula wild cardoon, as well as four derived-fractions, namely chloroform, 
ethyl acetate, butanol and water. They observed that the DPPH scavenging effect of artichoke 
fractions was dependent on the total phenolic contents, being the ethyl acetate the strongest 
(0.203 mg GAE/mg extract). Our research group
171
 published data regarding to the DPPH 
scavenging effect of methanol aqueous extracts from stalks, capitula and leaves of wild and 
cultivated cardoon, collected at the flowering and senescence stages. The antioxidant power 
of these extracts were weakly linearly correlated with the total phenolic contents.
171
 
 
6.1.1.4 Scavenging effect of reactive oxygen species 
Some works have examined the scavenging effect of C. cardunculus L. extracts on 
several ROS, namely superoxide radical anion (O2
·‒
), hydroxyl radical (HO
·
), singlet oxygen 
(
1
O2) and hydrogen peroxide (H2O2).
165,179
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Non-cellular systems-based assays 
Three reports
85,99,164
 showed the scavenging effect of C. cardunculus L. extracts upon 
several ROS, such as O2
·‒
, HO
·
 and 
1
O2. Table 16 depicts several assays used to evaluate 
ROS scavenging effect of artichoke and wild cardoon extracts. 
 
Table 16: ROS scavenging assays used for assessing the C. cardunculus L. extracts antioxidant effect. 
ROS C. cardunculus L. extracts Assay Source 
O2
·‒
 Artichoke Leaves infusion PMS/NADH/O2 
164
 
Wild cardoon Leaves infusion PMS/NADH/O2 and X/XO 
99
 
Leaves methanol extract PMS/NADH/O2 
85
 
HO
·
 Wild cardoon Leaves infusion Fe(III)-EDTA/ascorbic acid 
99
 
1
O2 Artichoke Leaves infusion, decoction and 
ethanol/water (70:30) extract 
Dihydrorhodamine 123 
oxidation 
164
 
Abbreviations: NADH, nicotinamide adenine dinucleotide in the reduced form; PMS, phenazine 
methosulfate; X/XO, xanthine/xanthine oxidase system. 
 
The superoxide anion radical is the first ROS generated from the reduction of oxygen, 
during mitochondrial electron transport. Due to its solubility properties, O2
·‒
 causes 
considerable damages to membrane phospholipid components.
41
 Pistón, et al.
164
 evaluated 
the O2
·‒
 scavenging effect of artichoke leaves extracts, applying a non-enzymatic system 
constituted by a mixture of phenazine methosulfate (PMS) and nicotinamide adenine 
dinucleotide (NADH). This mixture, in the presence of oxygen, generates O2
·‒
 through the 
univalent oxidation of PMS. Thereafter, O2
·‒
 is monitored through reduction of nitroblue 
tetrazolium to a formazan product which is quantified by UV-Vis spectroscopy (max = 560 
nm).
180
 Pistón, et al.
164
 observed that artichoke leaves infusion was the most effective to 
scavenge O2
·‒
 radical anions, which was associated with higher concentrations of phenolic 
compounds and chlorogenic acid. Falleh, et al.
85
 observed weak linear correlations between 
the O2
·‒
 scavenging effect of wild cardoon methanol extracts, and the contents of phenolic 
compounds (r = -0.81), condensed tannins (r = -0.75) and flavonoids (r = -0.68).
85
 Besides the 
PMS/NADH/O2 assay, Valentão, et al.
99
 also examined the O2
·‒
 scavenging effect of wild 
cardoon leaves infusion, through the xanthine/xanthine oxidase (X/XO) system. Different IC50 
values were obtained with PMS/NADH/O2 (145.2 µg/mL) and X/XO systems (35.0 µg/mL), 
being justified with the higher O2
·‒
 level, generated by the former system.
99
 
The HO
·
 radical is one of the strongest oxidizing agents, which reacts with 
polyunsaturated fatty acids, giving rise to ROO
·
 radicals and, consequently, initiating lipid 
peroxidation.
164
 Valentão, et al.
99
 observed that wild cardoon leaves infusion exhibited HO
· 
scavenging ability, in a dose-dependent way (3.1-800 µg/mL). The HO
·
 radical was generated 
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by H2O2 reaction with Fe (II) (Fenton reaction), in the presence of EDTA and ascorbic acid.
99
 
EDTA was added to the mixture, in order to prevent Fe(II) chelation by the test antioxidant, 
while ascorbic acid was added to act as pro-oxidant through reduction of Fe(III) to Fe(II), and 
therefore to generate a constant flux of HO
·
 radicals, in the presence of excess H2O2.
181
 These 
radicals were reacted with 2-deoxy-D-ribose, forming MDA which was further quantified 
spectrophotometrically after its reaction with thiobarbituric acid (λmax = 532 nm).
99
 
 Singlet oxygen is a highly excited state, resulting from sufficient energy, absorbed by 
dioxygen (O2), to shift an unpaired electron to a higher orbital. It is more reactive than HO
·
 
radicals.
41
 Pistón, et al.
164
 observed the scavenging effect of three artichoke leaves extracts 
against 
1
O2, through a fluorescence method based on the 
1
O2 induced-oxidation of 
dihydrorhodamine 123 to the fluorescent rhodamine 123 (λexcitation = 485 nm and λemission = 528 
nm
182
). Among artichoke leaves extracts, Pistón, et al.
164
 referred that ethanol/water (70:30) 
extract (73 mg/g of identified phenolic compounds) was the most active extract in preventing 
the oxidation of dihydrorhodamine 123 induced by 
1
O2. 
 
Cellular systems-based assays 
Some researchers have studied the in vitro inhibition action of artichoke extracts, upon 
ROS production in animal cell cultures assays. Pérez-García, et al.
183
 noticed that a 
commercial artichoke leaves aqueous extract (1.5% caffeoylquinic acids and 0.7% flavonoids) 
reduced, in a dose-dependent way (0.001-100 µg/mL), the ROS production in human 
leukocytes, stimulated by H2O2 and N-formylmethyl-leucyl-phenylalanine. It was indicated that 
the antioxidant power of artichoke leaves extract could be related with the phenolic 
composition.
183
 Moreover, Gebhardt
184
 also described that a commercial artichoke leaves 
aqueous extract (5 and 500 µg/mL), as well as chlorogenic acid and cynarin, inhibited the 
MDA retention originated by the tert-butylhydroperoxide (t-BHP) stimulated lipid peroxidation, 
in rat hepatocytes. In fact, the antioxidant effect of this artichoke extract was higher than that 
of chlorogenic acid plus cynarin mixture (2-fold).
184
 Gebhardt
184
 further observed that artichoke 
leaves extract (0.5-1000 µg/mL) inhibited the GSH loss in t-BHP stimulated rat hepatocytes, 
principally when the cells were pretreated with diethylmaleate, a GSH depleting compound. 
Similarly, Miccadei, et al.
185
 demonstrated that artichoke capitula extract (1 mM chlorogenic 
acid equivalents (CAE)) treatment prevented the GSH loss, as well as the MDA accumulation 
in H2O2-stimulated rat hepatocytes. 
 Our group
171
 reported the protective effect of methanol aqueous extracts from stalks, 
capitula and leaves of cultivated cardoon on the H2O2 injury on the Saccharomyces cerevisiae 
proliferation. It was verified that cultivated cardoon extracts could prevent the H2O2 cytotoxicity 
on Saccharomyces cerevisiae, at 25 µg/mL GAE, being comparable to the synthetic 
antioxidant 2-tert-butyl-4-methoxyphenol (25 µg/mL).
171
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6.1.2 In vivo assays 
Living organisms developed antioxidant defense mechanisms to protect themselves 
towards the oxidative stress, namely enzymatic systems, such as superoxide dismutase, 
catalase and glutathione peroxidase.
166
 At the current knowledge, only one report
186
 examined 
the physiological effect of artichoke capitula methanol/water (50:50) extract on the rat 
antioxidant status, after 3 weeks of intake. Jiménez-Escrib, et al.
186
 explained that the 
phenolic-containing extract of artichoke capitula did not significantly change the radical 
scavenging effect in the plasma, but it increased the GSH peroxidase activity in erythrocytes. 
Jiménez-Escrib, et al.
186
 also suggested that either flavones or hydroxicinnamic acids probably 
contributed for the antioxidant effect of artichoke capitula extract. 
 
6.2 Antitumoral activity 
The development of cancer is incited by the increased proliferation of tumor cells, 
which reflects a breakdown in the balance between de novo cell replication and the 
programmed cell death.
187,188
 Several environmental factors have been implicated in the 
etiology of this disease, as follows: (i) chemical carcinogens, as those found in tobacco smoke 
(e.g. benzo(a)pyrene, dimethylnitrosamine, and nickel compounds); (ii) physical carcinogens, 
such as UV radiation and asbestos; and (iii) infection by pathogenic bacteria and viruses, 
namely Helicobacter pylori, human papilloma virus and human hepatitis B and C virus.
189
 They 
alter the function of key cellular regulatory proteins in two ways, namely through: (i) the 
formation of DNA adducts, and subsequent somatic mutations, changing the protein structure 
and function; (ii) errors that affect DNA methylation pattern in the promoter region of certain 
genes, affecting mRNA level and protein expression. The cellular transformations, stimulated 
by environmental factors, also depend on the germline mutations of each individual which 
determine the relative risk to cancer predisposition.
189
 
Cancer is originated by alterations in critical regulatory genes that control cell 
proliferation, differentiation and survival, like proto-oncogenes, oncogenes and tumor 
suppressor genes.
187
 Proto-oncogenes are important cellular regulatory genes, in many cases 
encoding proteins implicated in signal transduction pathways, controlling normal cell 
proliferation (e.g., src, ras, and raf). The oncogenes are abnormally expressed or mutated 
forms of the respective proto-oncogenes. The progressive acquisition of activating mutations 
in oncogenes drives to abnormal cell proliferation and tumor development.
187,188
 Besides this, 
the inactivation of tumor suppressor genes is also responsible for tumor development. Tumor 
suppressor genes usually act to inhibit cell proliferation and tumor development. In many 
tumors, these genes are lost or inactivated and, consequently, the negative regulators of cell 
proliferation are downregulated, contributing to the abnormal tumor cells regulation.
187
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Mutations of tumor suppressor genes are generally inherited and contribute to familial 
cancers.
188
 
The carcinogenesis is indeed a complex multistep process, comprehending mutation 
and selection in favor to the transformed cells, with increasing ability for proliferation, survival, 
invasion and metastasis.
187
 This process comprises three major steps, namely: (i) initiation, (ii) 
promotion and (iii) progression. Initiation results from genetic alterations, leading to abnormal 
cell proliferation. During the promotion step, abnormal cells replicate and may generate a 
focus of preneoplastic cells.
190
 Primary tumor is formed as preneoplastic cells grow.
191
 In the 
progression step, additional mutations allow the gradual conversion of premalignant cells to 
neoplastic ones, with higher invasiveness and metastatic potential.
187
 Nutrients and oxygen 
needs of primary tumor will cause segregation of angiogenic inducers to the extracellular 
medium, being a stimulus for cell growth and angiogenesis, progressing with the formation of 
secondary tumors at distant locals, known as metastases.
187,190
 
Chemoprevention includes the administration of natural and/or synthetic compounds 
during the initiation, promotion and progression steps of carcinogenesis.
192
 Plant secondary 
metabolites have shown to be promising chemopreventive agents, due to: (i) reduced toxicity; 
(ii) desired range of efficacy; and (iii) ability to influence simultaneously multiple signaling 
pathways.
193
 
Cancer chemopreventive compounds can be separated in two main groups: (i) 
blocking agents, which inhibit the mutagenic initiation, and (ii) suppressing agents, which stops 
the promotion or progression of lesions that have already been established.
189
 At the 
promotion phase, the suppressing agents can induce cell cycle arrest or apoptosis, since 
these can inhibit or slow down cell division, restoring the balance between cell proliferation 
and death. At the progression step, chemopreventive agents should prevent malignant cells 
tumors to migrate, to invade, to stimulate angiogenesis and to decrease the route of 
metastasis formation.
190
 
Several groups have studied, in the last decade, the antitumoral potential of C. 
cardunculus L. extracts, as well of isolated terpenic and phenolic components, by using in vitro 
and in vivo assays, as indicated in this chapter. 
 
6.2.1 In vitro assays 
Two works revealed the antiangiogenic
171
 and antimigratory
194
 potential of C. 
cardunculus L. phenolic extracts. Our group
171
 reported the antiangiogenic potential of a 
cultivated cardoon leaves methanol aqueous extract, based in the assessment of 
intersegmental vessels number, in a transgenic zebrafish model (Tg(fli1:EGFP)), observing 
the decreasing number of intersegmental vessels as response of the increased cultivated 
cardoon leaves methanol extract concentration (0.15-30 mg/mL). The antiangiogenic effect of 
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cultivated cardoon leaves methanol extract showed an IC50 of 10.05 mg/mL. Mileo, et al.
194
 
indicated that 24 h and 48 h-treatments with artichoke capitula methanol extract (200 µM CAE) 
diminished greatly the MDA-MB-231 cell invasion ability, almost 2-fold compared to control 
cells. 
The majority of the studies
171,185,194–197
 approached the antiproliferative potential of C. 
cardunculus L. phenolic-containing extracts, against human tumor cell lines of leukemia,
195
 
hepatocellular carcinoma (HCC)
185,196,197
 and triple-negative breast cancer (TNBC).
171,194
 
Nadova, et al.
195
 investigated the antiproliferative effect of an ethyl acetate fraction 
(21.26% of caffeoylquinic acids and 3.25% of flavonoids), derived from artichoke capitula 
ethanol extract, on human promyelocytic leukemia HL-60 cell line (Figure 43A). This fraction 
prevented the HL-60 cell growth, in a dose-dependent manner (500-2500 µg/mL), during 24 
h.
195
 
 
 
Figure 43: Representative photographs of (A) HL-60, (B) HepG2 and (C) MDA-MB-231 cell lines 
(Source: American Type Cell Culture
198
). 
 
Miccadei, et al.
185
 studied the antiproliferative action of an artichoke capitula methanol 
extract, presenting hydroxycinnamic acids and flavonoids, against the HCC HepG2 cell line 
(Figure 43B). They reported the ability of this extract to decrease the HepG2 cellular viability, 
in a dose- (400-1200 µM CAE) and time- (24, 48 and 72 h) dependent ways. Furthermore, 
Menghini, et al.
196
 proved that an artichoke leaves phenolic-containing extract (13.3% of 
caffeoylquinic acids) prevented the HepG2 cell growth, for 48 h, in a dose-dependent manner 
(75 and 100 µg/mL). The 48 h-treatment of an artichoke leaves infusion (20.82 mg GAE/g) 
also inhibited the HepG2 cellular viability (IC50 = 52.06 µg/mL).
197
 
Mileo, et al.
194
 noted that an artichoke capitula methanol extract, mainly constituted by 
caffeoylquinic acids, reduced the TNBC MDA-MB-231 cellular viability (Figure 43C), for 24 h, 
in a dose-dependent manner (200-800 µM CAE). TNBC is defined as absence of estrogen 
(ER) and progesterone (PR) receptors and lacking overexpression of human epidermal growth 
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factor receptor type 2 (HER2).
199
 Moreover, Mileo, et al.
194
 observed that increasing 
concentrations of artichoke phenolic-containing extract decreased the cellular viability of other 
cell lines of human BC, namely T47D (ER positive), MCF-7 (ER positive) and BT549 (ER 
negative). At the same concentration range, this artichoke phenolic-containing extract did not 
have impact on the cellular viability of MCF-10A, an immortalized human breast epithelium cell 
line. 
Our group
171
 also studied the inhibitory effects of methanol aqueous extracts, derived 
from leaves and capitula of wild and cultivated varieties of cardoon on MDA-MB-231 cell 
growth, during 48 h. Cultivated cardoon leaves methanol extract was the most effective (IC50 = 
259.4 µg/mL).
171
 
Three independent research works
185,194,195
 have given insights relatively to the 
regulating role of artichoke phenolic-containing extracts, upon cell cycle and apoptosis 
signaling pathways in HL-60,
195
 HepG2 cell lines
185
 and MDA-MB-231
194
 (Table 17). 
 
Table 17: Effects of artichoke capitula phenolic-containing extracts on cell cycle and apoptosis signaling 
pathways, in human tumor cell lines. 
Artichoke extracts Human tumor cell line Cell cycle 
(I)
 Apoptosis 
(I)
 Source 
Hydroxycinnamic acids 
and flavonoids 
Promyelocytic leukemia 
HL-60 cells 
G0/G1 cell 
cycle arrest 
↑: cytochrome-c; 
active caspases-9 and 
-3; ↓PARP-1 
195
 
Caffeoylquinic acids, 
luteolin and apigenin 
glycosides 
HCC HepG2 cells  ↑ cleaved caspase-3 185 
TNBC MDA-MB-231 
cells 
↑p21 ↑: caspases-9 and -8; 
Bax; ↓Bcl-2 
194
 
(I) The arrow indicates increase (↑) or decrease (↓) in protein expression level, relatively to control. 
Abbreviations: HCC, hepatocellular carcinoma; PARP, poly(ADP-ribose) polymerase; TNBC, triple-
negative breast cancer. 
 
6.2.1.1 Effects on cell cycle 
Cell cycle embraces the DNA replication and segregation of replicated chromosomes 
to two separate cells. This process occurs during two main consecutive steps (Figure 44): (i) 
interphase, which comprehends G1, S and G2 phases; and (ii) mitosis, which includes 
prophase, metaphase, anaphase and telophase. DNA replication takes place in the S phase. 
The S phase is preceded by G1 phase, during which the cell is prepared for DNA synthesis, 
and followed by the G2 phase, during which the cell growth continues and proteins are 
synthesized for mitosis. In the presence of extracellular growth factors, animal cell passes 
through a decision point, in late G1, known as restriction point, and enter into S phase.
187,200
 
Once it passed through the restriction point, the cell no longer needs mitogenic stimuli to 
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undergo cell division.
187,201
 Accordingly, cells can not pass the restriction point in the absence 
of growth factors, entering thus into the quiescent step G0 phase. At G0, cells remain 
metabolically active, although they cease growth and have reduced protein synthesis 
rates.
187,200
 Cells can exit from G0 and reenter into cell cycle, towards growth factor 
stimulation.
187
 
 
 
Figure 44: Mammalian cell cycle phases and CDK/cyclin complexes. Abbreviations: CDK, cyclin-
dependent kinase; Cyc, cyclin; G1, G1 cell cycle phase; G2, G2 cell cycle phase; RP, restriction point 
and S, S cell cycle phase (adapted from 
187,201
). 
 
Cell cycle regulation is dependent on several cell cycle checkpoints, which prevent the 
cell entry into the next step, until the events of preceding step have been finished. These 
checkpoints “recognize” unreplicated or damaged DNA, resulting in cell cycle arrest to activate 
DNA replication or repair and, in some cases, programmed cell death.
187,200
 Cell cycle 
checkpoints at G1, S and G2 phases are regulated by a family of serine/threonine protein 
kinases, denominated as cyclin-dependent kinases (CDK) (Figure 44). Four CDKs are active 
during the cell cycle, specifically: (i) CDK4, CDK6 and CDK2 in G1; (ii) CDK2 in S; (iii) CDK1 in 
G2 phase and mitosis.
187,200
 These are activated by binding with the respective cyclins (Figure 
44), as explained herein: (i) cyclin D can bind to CDK4 and to CDK6; CDK4,6/cyclin D 
complexes are essential in G1 phase for the progression through the restriction point; (ii) 
cyclin E associates to CDK2, for regulating G1/S transition; (iii) cyclin A connects to CDK2 
during progression throughout S phase; iv) cyclin A links to CDK1 for S/G2 transition; v) cyclin 
B binds to CDK1 for passage from G2 to mitosis.
201
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The CDK kinase activity is regulated by at least four mechanisms:
187
 (i) formation of 
CDK/cyclin complexes, depending on the cyclin synthesis and degradation; (ii) activating 
phosphorylation of a conserved CDK threonine (Thr) residue around position 160, which is 
catalyzed by the CDK-activating kinase (CAK) (CDK7/cyclin H complex); (iii) inhibitory 
phosphorylation of tyrosine (Tyr)-15 and Thr14 residues; iv) binding of CDK inhibitors (CKI).
187
 
Two CKI families regulate the different CDK/cyclin complexes (Figure 45), namely Ink4 
(p15
INK4b
, p16
INK4a
, p18
INK4c
, p19
INK4d
) and Cip/Kip (p21
Waf1, Cip1
 (referred hereafter as p21), 
p27
Cip2
 and p57
Kip2
) families. The Ink4 specifically inactivates G1 phase CDKs (CDK4 and 6), 
because they generate stable complexes with those CDKs, before cyclin D binding.
200
 The 
Cip/Kip family bind to complexes of CDK2, 4 and 6 with cyclins A, D and E, throughout G1 and 
S phases.
187,200
 Additionally, p21 can inhibit the kinase activity of CDK1/cyclin B complexes.
202
 
 
 
Figure 45: The inhibitor families of G1, S and G2 CDKs.
187,200,202
 
 
When DNA is damaged, two protein kinases are activated, known as ataxia-
telangiectasia-mutated (ATM), and ataxia and rad3 related (ATR). Active ATR and ATM then 
phosphorylate and activate the downstream kinases Chk1 and Chk2, respectively. Chk1 and 
Chk2, in turn, phosphorylate cell cycle checkpoint proteins, leading to cell cycle arrest at G1, S 
and G2 phases.
187
 
The cell cycle arrest at G1 checkpoint is mediated by the transcription factor p53 
(Figure 46). ATM phosphorylates and stabilizes p53, resulting in a rapid protein level increase. 
p53 upregulates p21 expression which inhibits CDK4,6/cyclin D complexes, leading to cell 
cycle blockage.
187,200
 When p53 loses its function, the G1 arrest is inhibited. Therefore, the 
damaged DNA is replicated and passed into daughter cells instead of being repaired. This 
inheritance of damaged DNA results in an increment of mutations frequency and cellular 
genome instability, which ultimately contributes to carcinogenesis.
187
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Figure 46: Main mechanisms of cell cycle arrest at G1, S and G2 phases.
187,201–203
 
 
If DNA is damaged in the S phase (Figure 46), active Chk1 and Chk2 protein kinases 
will phosphorylate Cdc25A. Cdc25A is responsible for the dephosphorylation and activation of 
CDK2/cyclin E and CDK2/cyclin A complexes. Cdc25A phosphorylation causes its rapid 
degradation, originating cell cycle arrest at S phase.
187
 
The CDK1/cyclin B1 complex, also recognized as mitosis promoting factor (MPF), has 
a critical function in the cell cycle transition from G2 phase to mitosis. Cyclin B1 protein level 
increases during S phase, accumulating and forming complexes with CDK1 (MPF) at S and 
G2 phases.
187
 In cycling cells, MPF is kept inactive, during S and G2 phases, by inhibitory 
phosphorylations of CDK1 at Thr-161, Tyr-15 and Thr-14. The phosphorylations of Tyr-15 and 
Thr-14 are mediated by the protein kinases Wee1/Mik1 and Myt1, respectively. The prophase 
onset correlates with the Cdc25 mediated-dephosphorylation of CDK1 at Thr-14 and Tyr-15.
202
 
Towards damaged DNA, G2 cell cycle arrest can be mediated by Chk1 and Chk2 which 
phosphorylate Cdc25 members, preventing the MPF activation (Figure 46).
187,202
 Other 
pathway was suggested to support the MPF inactivation, implying p53-dependent p21 
upregulation (Figure 46).
202
 On one hand, p21 can inhibit the MPF activation, by interfering 
with CDK1 phosphorylation mediated by CAK;
202,203
 on the other hand, p21 can block the 
CDK1 dephosphorylation mediated by Cdc25 phosphatase.
202
 
In what concerns the effect of C. cardunculus L. extracts on cell cycle regulation, 
Nadova, et al.
195
 observed that the 24 h-treatment of human leukemia HL-60 cells, with an 
artichoke capitula ethyl acetate fraction, blocked the cell cycle at G0/G1 phases (Table 17, 
page 71), in a dose-dependent manner (500-2500 µg/mL). Other study reported the action of 
an artichoke capitula methanol extract (200-800 µM CAE), upon p53 and p21 proteins 
regulation in MDA-MB-231 cells, for 24 h (Table 17, page 71).
194
 Mileo, et al.
194
 referenced 
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that this extract upregulated p21 in MDA-MB-231 cells, specially at lower concentrations (200 
and 400 µM CAE), being stronger than the known cytostatic paclitaxel (1 µM). Nevertheless, 
p53 protein levels were practically unaffected at the tested artichoke extract concentrations, 
relatively to control cells.
194
 They suggested that the antiproliferative effect of artichoke 
phenolic-containing extract, on MDA-MB-231 cells, could be related to cell cycle regulation.
194
 
 
6.2.1.2 Effects on apoptosis 
Apoptosis is considered as an important mode of “programmed” cell death, i.e. a 
genetically cell “discard”. This comprises a cascade of molecular events, which occurs as a 
homeostatic mechanism to maintain cell populations in tissues. There are two main pathways 
(Figure 47): (i) the extrinsic or death receptor pathway (“type I”), and (ii) the intrinsic or 
mitochondrial pathway (“type II”).204 These pathways converge to the execution pathway which 
is started with the caspase-3 cleavage, originating DNA fragmentation, degradation of 
cytoskeletal and nuclear proteins, cross-linking of proteins, formation of apoptotic bodies, 
expression of ligands for phagocytic cell receptors and, ultimately, uptake of phagocytic 
cells.
204 
 
 
Figure 47: Extrinsic and intrinsic pathways of apoptosis (adapted from 
205,206
). Abbreviations: CAD, 
caspase-activated DNase; DISC, death-inducing signaling complex; MOMP, mitochondrial outer 
membrane permeabilization. 
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The extrinsic pathway (Figure 47) involves binding of death ligand to the 
corresponding death receptors, members of the tumor necrosis factor (TNF) receptor gene 
superfamily. TNF receptor family members have a cytoplasmic “death domain” critical for 
transmitting the death signal, from the cell surface to the intracellular signaling pathways. 
Once death ligand is bonded to the death receptor, the death-inducing signaling complex 
(DISC) is triggered to be formed, resulting in autocatalytic activation of initiators procaspases-
8 and -10.
204
 Active caspases-8 and -10 at DISC cleave directly the effector procaspases-3 
and -7. Therefore, active caspases-3 and -7 cleave cytokeratins, nuclear lamins and the 
inhibitor of caspase-activated DNase.
206
 Caspase Activated DNAse activation then causes 
chromosomal DNA degradation and chromatin condensation.
204 
The intrinsic pathway (Figure 47) does not involve receptor-mediated stimuli, but it 
implicates instead stimuli that promote mitochondrial-mediated intracellular signals. Pro-
apoptosis positive signals comprehends several factors, such as radiation, toxins, hypoxia, 
hyperthermia, viral infections and free radicals.
204
 All of these stimuli induce the formation of 
pores in the mitochondrial membrane, causing mitochondrial outer membrane 
permeabilization (MOMP), and loss of the mitochondrial transmembrane potential. Bcl-2 
protein family members regulate the mitochondrial pore formation, which can be classified in 
four groups, as follows: (i) “effectors” Bax and Bak, whose oligomerization creates pores; (ii) 
“inhibitors” of Bax and Bak association, namely Bcl-2, Mcl1 and BclxL; (iii) “activators” of Bax 
and Bak, e.g. Bid and Bim; and iv) “sensitizers”, such as Bad, Bik, and Noxa which antagonize 
the antiapoptotic Bcl-2-like proteins. Initiator caspases-8 and -10, activated at the DISC, 
cleave Bid to tBid, which leads to conformational changes and oligomerization of Bax and Bak. 
Bax and Bak oligomers thereafter originate mitochondrial outer membrane pores, as well as 
promote cytoplasmic translocation of critical apoptosis regulators, such as cytochrome c and 
Smac/DIABLO which are usually in the mitochondrial intermembrane space.
206
 Once in the 
cytosol, cytochrome c binds and activates Apaf-1 and procaspase-9, forming the apoptosome. 
Caspase-9 activates effector procaspases-3 and -7.
204
 However, XIAP associates to the 
catalytic pocket of active effector caspases-3 and -7, thereby inhibiting their protease activity 
and promoting their ubiquitin-dependent degradation. Binding of Smac/DIABLO to XIAP 
relieves this inhibition, allowing full activation of effector caspases and consequently cell 
death. 
Some reports
185,194,195
 have examined the apopotic action of artichoke phenolic-
containing extracts in three human tumor cell lines. Nadova, et al.
195
 noticed that the 24 h-
treatment of human leukemia HL-60 cells, with the artichoke capitula ethyl acetate fraction, 
caused apoptosis (Table 17, page 71), probably through the extrinsic pathway. This artichoke 
extract induced, in a dose-dependent manner (1250-2500 µg/mL), the cytochrome-c release, 
as well as caspases-9/-3 activation and protein expression decrease of poly(ADP-ribose) 
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polymerase (PARP), the caspase-3 substrate.
195
 Internucleosomal DNA fragmentation was 
also detected in HL-60 cells, after 24 h-treatment with artichoke capitula ethyl acetate fraction 
at 2500 µg/mL.
195
 
Miccadei, et al.
185
 observed that 24 h-treatment of HepG2 cells with artichoke capitula 
methanol extract (400-1200 µM CAE) increased, in a dose-dependent manner, the apoptotic 
cell population, to a maximum of 64.5%. This extract, at 1200 µM CAE, caused 3.1-fold higher 
apoptotic cell percentage than 1200 µM 5-O-caffeoylquinic acid.185 Another evidence of 
apoptotic action was shown through an higher protein expression of cleaved executioner 
caspase-3 in HepG2 cells (Table 17, page 71), compared to control, after 24 h of exposition 
with artichoke methanol extract, at 400 and 800 µM CAE.
185
 
Mileo, et al.
194
 analyzed several apoptotic molecular targets in MDA-MB-231 cells, 
after 24 h-treatment with artichoke capitula methanol extract (200-800 µM CAE). This extract 
increased the apoptotic cell population percentage, relatively to control cell population, 
reaching 45% at 400 µM.194 They proposed that artichoke capitula methanol extract could 
induce apoptosis, on one hand, through the extrinsic pathway, due to increased protein 
expression of caspase-8, relatively to control cells. On the other hand, the intrinsic pathway of 
apoptosis could also be boosted (Table 17, page 71), since the artichoke capitula methanol 
extract upregulated the apoptosis effector Bax and downregulated the inhibitor Bcl-2, as well 
as increased the caspase-9 protein level. Additionally, the 24 h-incubation of MDA-MB-231 
cells with artichoke capitula methanol extract, at 200 µM CAE, caused a drop in mitochondrial 
membrane potential.
194 
 
6.2.2 In vivo assays 
Yasukawa, et al.
80
 studied the inhibitory effect of an artichoke capitula methanol 
extract against the formation of mouse skin tumor. The tumor formation was induced by 7,12-
dimethylbenz[a]anthracene (DMBA) and promoted by 12-O-tetradecanoylphorbol-13-acetate 
(TPA)
80
 (Figure 48). It was noted that the topical application of artichoke capitula extract (1 
mg), during 2 weeks, delayed the occurrence of the first skin tumor, as well as decreased the 
average number of tumors per mice (73%).
80
 Yasukawa, et al.
80
 also referred a 27% reduction 
in the number of tumor-bearing mice, after 20 weeks of tumor promotion with DMBA plus TPA 
and artichoke extract treatment. They suggested that the antitumoral potential of artichoke 
capitula extract could be ascribed to pentacyclic triterpenes, such as taraxasterol, ψ-
taraxasterol, α- and β-amyrin and their acetate derivatives.80 Indeed, Yasukawa, et al.207 had 
earlier proven that the application of taraxasterol (2 µmol) in mouse skin markedly decreased 
the tumor-bearing mice number (73%), and the number of mouse skin papillomas (86%), 
during the 20 weeks of tumor promotion with DMBA plus TPA. By using the same two-step 
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carcinogenesis mouse skin model, Takasaki, et al.
208
 noted that the topical application of 
taraxasteryl acetate (85 nmol) was much weaker than taraxasterol (85 nmol) to inhibit mouse 
skin tumor formation, after 20 weeks, being comparable to positive control. 
 
 
Figure 48: Structures of 7,12-dimethylbenz[a]anthracene (DMBA, inducer) and 12-O-
tetradecanoylphorbol-13-acetate (TPA, promotor) used in the mouse skin two-stage carcinogenesis 
assay. 
 
6.3 Antimicrobial activity 
The antimicrobial effects of artichoke leaves
100
 and wild cardoon capitula extracts
10
 were 
studied, in what regards to antifungal and antibacterial actions. 
 
6.3.1 Antifungal activity 
Few groups reported the antifungal action of C. cardunculus L. and their main phenolic 
compounds.
10,100
 
Zhu, et al.
100
 found that 5-O-caffeoylquinic acid was the most active phenolic 
compound, isolated from artichoke leaves, in inhibiting growth of four yeasts, namely Candida 
albicans, C. lusitaniae, Saccharomyces cerevisiae and S. carlsbergensis, within the range 50-
200 µg/mL of minimum inhibitory concentration (MIC) values. Moreover, luteolin 7-O-glucoside 
demonstrated the highest inhibitory action on growth of four molds, namely Aspergillus niger, 
Penicillium oxalicum, Mucor mucedo and Cladosporium cucumerinum, with MIC of 50 
µg/mL.
100
 
 Kukic, et al.
10
 investigated the antifungal effect of wild cardoon capitula 96% ethanol 
extract, and derived-fractions (chloroform, ethyl acetate, butanol and water) against the growth 
of eight fungi, namely Aspergillus niger, A. ochraceus, A. flavus, Penicillium ochrochloron, P. 
funiculosum, Trichoderma viride, Fusarium tricinctum and Alternaria alternate. Ethyl acetate 
fraction, containing the highest total phenolic content (0.203 mg GAE/mg extract), evidenced 
to be the most active in preventing growth of those fungi, within ranges 1000-1500 µg/mL of 
Chapter II – Bibliographic review 
 
79 
MIC and Minimum Fungicidal Concentration (MFC) values. Nonetheless, wild cardoon capitula 
96% ethanol extract, and derived-fractions were weaker than miconazole (ranges 0.2-2.0 
µg/mL and 1.0-5.0 µg/mL of MICs and MFCs, respectively). It was noted that luteolin 
presented the highest antifungal action, among the isolated compounds from wild cardoon 
capitula (ranges 30-100 µg/mL and 50-100 µg/mL of MICs and MFCs, respectively). However, 
the inhibitory actions of luteolin against the tested fungi were weaker compared to 
miconazole.
10
 
 
6.3.2 Antibacterial activity 
Bacteria are classified in two groups, namely Gram-negative and Gram-positive 
(Figure 49). Gram-negative bacteria have a complex outer membrane covering the thin 
peptidoglycan cell wall, while the outer membrane is absent in Gram-positive bacteria.
209
 
 
 
Figure 49: Morphological aspect of Gram-negative and Gram-positive bacteria (adapted from 
209
). 
 
Nowadays, pharmaceutical companies are urgently searching for new antibacterial 
drugs, principally due to occurrence and spread of multidrug-resistant (MDR) bacteria which 
has resulted by misuse and, consequently, effectiveness loss of antibiotics. Through an 
initiative of the European Centre for Disease Prevention and Control and the Centers for 
Disease Control and Prevention, a group of international experts proposed a definition for 
MDR bacteria, as non-susceptible “to at least one agent in three or more antimicrobial 
categories”.210 MDR bacteria represent a serious burden to public health worldwide, 
contributing for an increased risk of morbidity and mortality.
211
 It is estimated that MDR 
bacterial infections can cause 25000 deaths per year in Europe.
212
 MDR bacteria are often the 
main responsible for the health care-associated infections, formerly known as “nosocomial” or 
“hospital” infections. Examples of MDR bacteria are the Gram-negative Escherichia coli, 
Klebsiella pneumonia (Figure 50A), Acinetobacter species and Pseudomonas aeruginosa 
(Figure 50B), as well as the Gram-positive Enterococcus faecalis (Figure 50C), E. faecium, 
Streptococcus pneumonia and Staphylococcus aureus (Figure 50D).
212
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Figure 50: Representative scanning electron microscopy photographs of the Gram-negative (A) 
Klebsiella pneumonia, (B) Pseudomonas aeruginosa, and the Gram-positive (C) Enterococcus faecalis 
and (D) Staphylococcus aureus (Source: Centers for Disease Control and Prevention
213
). 
 
Zhu, et al.
100
 assessed the antibacterial activity of phenolic compounds isolated from 
artichoke leaves, namely caffeoylquinic acids, apigenin and luteolin glycosides. Among these 
compounds, they noticed that 4,5-di-O-caffeoylquinic acid and luteolin 7-O-glucoside were the 
most active phenolic compounds, with Minimum Inhibitory Concentration (MIC) of 50 µg/mL, 
on growth of Micrococcus luteus and S. aureus, respectively. Nevertheless, the antibacterial 
effects of these compounds were less active than ampicillin, streptomycin and kanamycin 
sulfate (range 5-40 µg/mL of MICs).
100
 
Kukić, et al.10 investigated the antibacterial of wild cardoon capitula 96% ethanol 
extract, and fractions (chloroform, ethyl acetate, n-butanol and water), by determining the MIC 
and the Minimum Bactericidal Concentration (MBC) values (Table 18). The ethyl acetate 
fraction, presenting 20.3% of GAE, was the most active in preventing growth of the tested 
bacteria, with MIC values of 1000-1500 µg/mL and MBC values of 1500-2000 µg/mL. 
Nevertheless, wild cardoon capitula 96% ethanol extract and fractions were less potent than 
streptomycin (range 0.5-1.0 µg/mL of MICs and MBCs).
10
 Moreover, it was shown that luteolin 
was the most active antibacterial compound isolated from wild cardoon capitula, among 
sterols, triterpenic saponins and phenolic compounds, with MIC values of 50-100 µg/mL and 
MBC values of 50-100 µg/mL. However, this compound was weaker than streptomycin (MIC 
and MBC values of 0.5-1.0 µg/mL).
10
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Table 18: Minimum inhibitory and bactericidal concentrations (MICs and MBCs) of wild cardoon capitula 
96% ethanol extract, and fractions (chloroform, ethyl acetate, n-butanol and water).
10
 
Bacteria MIC (µg/mL) MBC (µg/mL) 
Gram-negative   
Escherichia coli 1000-1500 1500-2000 
Salmonella typhimurium 1500-2000 2000-2500 
Gram-positive   
Bacillus subtilis 1000-2000 1000-2500 
Staphylococcus aureus 1500 2000 
Staphylococcus epidermidis 1500 2000 
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Abstract 
Lipophilic extracts of Cynara cardunculus L. var. altilis (DC) from the south of Portugal 
(Baixo Alentejo) were studied by gas chromatography-mass spectrometry which allowed the 
analysis of 65 components. Thirty three compounds were here identified and quantified, for 
the first time, as C. cardunculus L. components: 6 aromatic compounds, 9 fatty acids, 2 
hydroxyfatty acids, 8 long chain aliphatic alcohols, 4 sterols, 1 pentacyclic triterpene and 3 
other compounds (inositol, 2,3-dihydroxypropyl hexadecanoate, E-squalene). Four triterpenyl 
fatty acid esters were also identified for the first time. In addition to these compounds, 2 
aromatic compounds, 2 fatty acids, 1 sesquiterpene lactone and 3 pentacyclic triterpenes were 
reported, for the first time, as cultivated cardoon components, namely vanillic and syringic 
acids, (9Z)-hexadec-9-enoic (15) and tetracosanoic acids, deacylcynaropicrin, and acetates of 
β- and α-amyrin and ψ-taraxasteryl acetate. Sesquiterpene lactones and pentacyclic 
triterpenes were the major lipophilic families, accounting for respectively ≈94.5 g/kg dw in 
leaves and ≈27.5 g/kg dw in florets. Cynaropicrin was the most abundant sesquiterpene 
lactone, while taraxasteryl acetate was the main pentacyclic triterpene. Fatty acids and sterols, 
mainly represented by respectively hexadecanoic acid and β-sitosterol, were present at lower 
amounts, accounting for ≈3.7 g/kg dw in leaves and ≈1.4 g/kg dw in florets. Long chain 
aliphatic alcohols and aromatic compounds were detected at low abundances. 
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1. Introduction 
Cynara cardunculus L. (Asteraceae) is a Mediterranean plant species that includes 
three varieties, namely var. sylvestris (Lamk) Fiori (wild cardoon), var. scolymus (L.) Fiori 
(globe artichoke) and var. altilis (DC) (cultivated cardoon).
1
 The wild cardoon grows 
spontaneously in clay soils in the Mediterranean basin and Macaronesia (Madeira and Canary 
Islands).
2
 Several lines of evidence have shown that wild cardoon is the ancestor of both 
cultivated forms, characterized by different morphological traits, due to agricultural selection.
3
 
Globe artichoke is cultivated all over the world for its edible immature large capitula, with high 
economic importance in Italy, Spain, France and Turkey.
2
 Cultivated cardoon has been 
explored for its fleshy stems and leaf petioles. These are generally collected in late autumn-
early winter and submitted to a blanching process before cooking. This “delicacy” is much 
appreciated in regional dishes in Spain, Italy, France.
4
 Another traditional application, in the 
Iberian Peninsula, involves the use of wild cardoon capitula as source of aspartic proteinases 
(cardosins A and B) for milk clotting during sheep cheeses manufacturing.
5
 Furthermore, both 
artichoke and wild cardoon leaves extracts have been used since ancient times in folk 
medicine for the hepatobiliary system regulation,
6,7
 due to their recognized hepatoprotective,
8
 
hypocholesterolemic,
9
 choleretic and anti-cholestatic
10
 actions. 
Several industrial applications have been considered for cultivated cardoon biomass, 
namely for pulp production,
11–13
 power generation
11,14
 and domestic heating.
15
 Moreover, the 
cultivated cardoon oil seed is suitable for biodiesel production.
11,16,17
 Thus, cultivated cardoon 
has been regarded as a multipurpose perennial crop for a sustainable economic development 
in south European countries, well adapted to the Mediterranean climatic and soil conditions 
and with high biomass productivities (in the range 15.2-24.2 t/ha).
11,18
 
Besides the lignocellulosic fraction, cardoon plantation can be further valorized through 
the exploitation of high value extractable compounds, addressing the key goal of the 
biorefinary concept which is based on the integrated use of all the fractions of any biomass 
resource.
19
 The valorization of any plant biomass requires the detailed knowledge of its 
chemical composition, the establishment of relationships with traditional applications and the 
search for new applications. Regarding the dietary and nutraceutical applications, several 
studies have been focused on the relationship between phenolic composition and biological 
activity of C. cardunculus L. extracts, specifically antioxidant
20
 and anti-tumor activities.
21,22
 So 
far, few studies have been devoted to the study of the lipophilic composition of globe 
artichoke, for example the isolation of sesquiterpene lactones from the leaves
23
 and 
pentacyclic triterpenes from the capitula.
24
 However, less attention has been devoted to the 
lipophilic fraction of C. cardunculus L. var. altilis (DC),
 
beyond the fatty acids composition of 
seed oil.
25
 Finally, the isolation of pentacyclic triterpenes and sterols from cardoon has already 
been reported,
26
 with no differentiation between wild and cultivated cardoon varieties. 
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Therefore, considering the growing interest in the exploitation of cultivated cardoon as a 
biomass resource in the south of Portugal, and the lack of detailed information on the 
extractives composition, it is given here a detailed chemical characterization of the lipophilic 
fractions of different morphological parts of C. cardunculus L. var. altilis (DC) by gas 
chromatography-mass spectrometry (GC-MS) analysis. 
 
2. Materials and Methods 
2.1 Chemicals 
Dichloromethane (p.a. ≥99% purity), methanol (p.a., ≥99.8% purity) and light petroleum 
(p.a., ≥99% purity) were supplied by Fischer Scientific (Pittsburgh, Pennsylvania, USA). Ethyl 
acetate (p.a., ≥99.8% purity) was purchased from Carlo Erba Reagents (Val de Reuil, France). 
Hydrochloric acid (HCl) (p.a., ≥37%) was purchased from Fluka Chemie (Madrid, Spain). 
Potassium hydroxide (KOH) (p.a., ≥88% purity), N,O-bis(trimethylsilyl)trifluroacetamide (99% 
purity), trimethylchlorosilane (99% purity), hexadecane (99% purity), hexadecanoic acid (≥99% 
purity), nonadeca-1-nol (99% purity), vanillin (99% purity), cholesterol (99% purity), lupeol 
(≥94% purity), deuterated chloroform (CDCl3) (99.8% D), tetramethylsilane (≥ 99.9% purity) 
and acetyl chloride (p.a. ≥99% purity) were obtained from Sigma Chemicals Co. (Madrid, 
Spain). Silica gel grade 60 for column chromatography (63-200 μm of particle size) and for thin 
layer chromatography (5-40 μm of particle size) were purchased from Merck (Darmstadt, 
Germany). Pyridine (p.a., ≥99.5% purity) was purchased from Panreac (Castellar del Vallès, 
Spain). Cynaropicrin (≥97.5% purity) and β-amyrin (≥98.5% purity) were obtained from 
Extrasynthese (Genay Cedex, France). Taraxasteryl acetate (≥99.2% purity) was purchased 
from AvaChem Scientific (San Antonio, Texas, USA). 
 
2.2 Samples preparation 
C. cardunculus L. var. altilis (DC) was collected during the flowering stage, in June 
2010 at the Experimental Center of Agriculture School of the Instituto Politécnico de Beja, 
southern Portugal. Plants were separated into stalks, capitula and leaves, and preserved at -
20 ºC until analysis. Before extraction, samples were freeze-dried. Then the stalks were 
separated into outer and inner parts and capitula into receptacles, bracts and florets. 
 
2.3 Extraction 
All plant fractions were ground to a granulometry of 40-60 mesh prior to extraction. 
Each sample (6 g of dry weight) was Soxhlet extracted with dichloromethane (150 mL) for 7 h. 
Dichloromethane was chosen because it is a fairly specific solvent for lipophilic extractives.
27
 
The solvent was evaporated to dryness at low-pressure. The dried extracts were weighted, 
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and the results are expressed as percentages of dry biomass material (w/w, %). Two extracts 
were prepared for each morphological part of cultivated cardoon.  
 
2.4 Alkaline hydrolysis 
About 20 mg of each extract was dissolved in 10 mL of 1 M KOH in 10% aqueous 
methanol. The mixture was heated at 100 ºC, under nitrogen atmosphere, for 1 h. The reaction 
mixture was cooled, acidified with 1 M aqueous HCl to pH ≈ 2, and then extracted three times 
with dichloromethane and the solvent was evaporated to dryness.
27
 The alkaline hydrolysis 
reaction was performed to indirectly detect esterified compounds, e.g. triglycerides, steryl 
esters, among others. 
 
2.5 GC-MS analysis 
Before GC-MS analysis, nearly 20 mg of each dried sample was converted into 
trimethylsilyl derivatives.
27
 Each sample was dissolved in 250 μL of pyridine containing 1 mg of 
hexadecane (internal standard), and compounds with hydroxyl and carboxyl groups were 
converted into trimethylsilyl (TMS) ethers and esters, respectively, by adding 250 μL of N,O-
bis(trimethylsilyl)trifluoroacetamide and 50 μL of trimethylchlorosilane. The mixture was 
maintained at 70 ºC for 30 min. 
GC-MS analyses were performed using a Trace gas chromatograph (2000 series) 
equipped with a Thermo Scientific DSQ II mass spectrometer (Waltham, Massachusetts, 
USA). Separation of compounds was carried out in a DB-1 J&W capillary column (30 m x 0.32 
mm inner diameter, 0.25 μm film thickness) using helium as the carrier gas (35 cm s-1). The 
chromatographic conditions were as follows: initial temperature, 80 ºC for 5 min; temperature 
rate of 4 ºC min
-1
 up to 260 ºC; 2 ºC min
-1
 up to 285 ºC which was maintained for 8 min; 
injector temperature, 250 ºC; transfer-line temperature, 290 ºC; split ratio, 1:33. The mass 
spectrometer was operated in the electron ionization (EI) mode with the energy of 70 eV and 
data collected at a rate of 1 scan s
-1
 over a range of m/z 33-700. The ionization source was 
kept at 250 ºC.
28
 
To detect the presence of esterified structures, dichloromethane extracts were also 
analyzed in a short DB-1 J&W capillary column (15 m x 0.32 mm inner diameter, 0.25 μm film 
thickness); the chromatographic conditions were as follows: initial temperature, 100 ºC for 3 
min; temperature gradient, 5 ºC min
-1
; final temperature, 340 ºC for 12 min; injector 
temperature, 290 ºC; transfer-line temperature, 290 ºC; and split ratio, 1:33.
27
 
Chromatographic peaks were identified by comparing their mass spectra with the 
equipment mass spectral library (Wiley-NIST Mass Spectral Library), literature data and, when 
needed, by injection of standards. In some cases, identification was also confirmed based on 
characteristic retention times (RTs) under the described experimental conditions.
27–29
 For 
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quantitative analysis, GC-MS was calibrated with pure reference compounds, representative 
of the major lipophilic extractive components (namely hexadecanoic acid, nonadecan-1-ol, 
vanillin, cynaropicrin, lupeol and cholesterol) relative to hexadecane (the internal standard). 
The respective response factors were calculated as the average of four GC-MS runs. 
For each morphological part of cultivated cardoon, two extracts were analyzed before 
alkaline hydrolysis, and another two after alkaline hydrolysis. Each extract was injected in 
duplicate. Results represent the mean value for each morphological part (less than 5% 
variation between injections of the same extract and between extracts of the same 
morphological part). The compound contents were expressed as milligram per kilogram of dry 
weight of plant biomass. 
 
2.6 Nuclear magnetic resonance experiments 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance 300 
spectrometer (Wissembourg, France) (300.13 and 75.47 MHz, for 
1
H and 
13
C, respectively), 
using chloroform-d as the solvent and tetramethylsilane as the internal reference. Unequivocal 
1
H and 
13
C assignments were made with the aid of unidimensional distortionless enhancement 
polarization transfer (DEPT) and bidimensional, namely COSY (
1
H/
1
H), HSQC (
1
H/
13
C) and 
HMBC (
1
H/
13
C) experiments. The low-pass J-filter portion of the HMBC experiment was 
optimized for an average of one-bond heteronuclear coupling of 145 Hz; the delay for 
evolution of long-range couplings was optimized for 7 and 2 Hz. 
 
2.7 Isolation and characterization of cynaropicrin and grosheimin from leaves 
extract 
About 50 g of cultivated cardoon leaves was Soxhlet extracted with dichloromethane 
(750 mL) for 7 h to afford 7.5 g of crude extract. About 1 g of dried extract was dissolved in 
dichloromethane, subjected to column chromatography on silica gel, and continuously eluted 
with a gradient of ethyl acetate in light petroleum, collecting 50 mL of each fraction: fractions 
F1 and F2 were collected with 10% ethyl acetate, fractions F3 and F4 with 20%, fractions F5 
and F6 with 40%, fractions F7 and F8 with 50% and fractions F9-F11 with 100%. An aliquot of 
each fraction was submitted to derivatization and analyzed by GC-MS. Fractions F10 and F11, 
accounting for 363.7 mg, presented higher relative abundances of cynaropicrin and 
grosheimin which were separated from each other, as explained thereafter. 
 
2.7.1 Isolation of cynaropicrin 
About 312.4 mg of F10 and F11 combined fractions were dissolved in dichloromethane 
and further fractionated by column chromatography on silica gel eluting with 50% ethyl acetate 
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in light petroleum to collect five fractions, F1a to F5a (50 mL each). The column was then 
eluted with 60% ethyl acetate in light petroleum to collect the fractions F6a and F7a (50 mL 
each) and F8a-F11a (25 mL each). The fraction F11a yielded 10 mg of cynaropicrin (Figure 1) 
that was identified by comparing its NMR and EI-MS data with literature data.
30 
 
 
Figure 1: Structure of cynaropicrin. 
 
EI-MS (70 eV) m/z (relative intensity, %): 346 [M]+.  (2), 262 (18), 245 [M‒C4H5O3]
+
 (7), 244 
[M‒C4H6O3]
+
 (48), 226 (27), 216 (21), 198 (31), 148 (33), 91 (47), 85 (100). 
1
H NMR (300.13 MHz, CDCl3): δ = 1.67 (1H, ddd, J = 5.2, 7.9, 15.9 Hz, 2α-CH2CHOH), 2.18 
(1H, dt, J = 6.2, 13.2 Hz, 2β-CH2CHOH), 2.34 (1H, dd, J = 3.5, 14.6 Hz, 9α-CH2COC(=O)), 
2.65 (1H, dd, J = 3.5, 14.6 Hz, 9β-CH2COC(=O)), 2.79 (1H, dd, J = 8.9, 10.8 Hz, 5-
CHCHOC(=O)), 2.92 (1H, dt, J = 5.2, 10.8, Hz, 1-CHC=CH2), 3.14 (1H, tt, J = 3.2, 10.0 Hz, 7-
CHC=CH2), 4.20 (1H, dd, J = 8.9, 10.0 Hz, 6-CHOC(=O)), 4.32 (2H, s, 4´-CH2OH), 4.50 (1H, 
tt, J = 1.8, 7.9 Hz, 3-CHOH), 4.89 (1H, d, J = 1.4 Hz, 14a-CH2=C), 5.08 (2H, m, 8-CHOC(=O) 
and 14b-CH2=C), 5.31 (1H, t, J = 1.8 Hz, 15a-CH2=C), 5.44 (1H, t, J = 1.8 Hz, 15b-CH2=C), 
5.57 (1H, d, J = 3.2 Hz, 13a-CH2=C), 5.90 (1H, q, J = 1.1 Hz, 3´a-CH2=C), 6.16 (1H, d, J = 3.2 
Hz, 13b-CH2=C), 6.27 ppm (1H, d, J = 1.1 Hz, 3´b-CH2=C). 
13
C NMR (75.47 MHz, CDCl3): δ = 37.0 (9-CH2COC(=O)), 39.0 (2-CH2CHOH), 45.3 (1-
CHC=CH2), 47.6 (7-CHCOC(=O)), 51.4 (5-CHCOC(=O)), 62.3 (4´-CH2OH), 73.7 (3-CHOH), 
74.3 (8-CHOC(=O)), 78.4 (6-CHOC(=O)), 113.6 (15-CH2=C), 118.2 (14-CH2=C), 122.7 (13-
CH2=C), 127.8 (3´-CH2=C), 137.3 (11-C=CH2), 139.2 (2´-C=CH2), 141.7 (10-C=CH2), 152.2 (4-
C=CH2), 165.3 (1´-C(=O)O), 169.0 ppm (12-C(=O)O). 
 
2.7.2 Isolation of grosheimin 
About 51.3 mg of the F10 and F11 combined fractions were dissolved in 
dichloromethane and applied to thin layer chromatography plates (TLC), which were eluted 
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with dichloromethane/methanol (95:5). A main spot was observed at Rf = 0.31 and isolated 
from TLC plates, yielding 7 mg of pure grosheimin (Figure 2) which was identified by 
comparing EI-MS data with the equipment mass spectral library. 
 
 
Figure 2: Structure of grosheimin. 
 
EI-MS (70 eV) of grosheimin, m/z (relative intensity, %): 262 [M]+.  (13), 244 (88), 166 (35), 165 
(47), 137 (63), 136 (87), 93 (47), 91 (49), 69 (100), 68 (26), 67 (30), 41 (9). 
 
2.8 Lupenyl acetate preparation 
Lupenyl acetate (Figure 3) was prepared by acetylation of lupeol with acetyl chloride in 
pyridine at room temperature for 12 h.
31
 The reaction product was analyzed by GC-MS, and 
the identification confirmed by comparing its EI-MS data with literature data.
32 
 
 
Figure 3: Structure of lupenyl acetate. 
 
EI-MS (70 eV) of lupenyl acetate, m/z (relative intensity, %): 468 [M]
+.  (18), 453 [M-CH3]
+
 (11), 
408 [M-CH3COOH]
+
 (6), 249 [M-C16H27]
+
 (13), 218 [M-C16H26O2]
+
 (30), 204 [M-C17H28O2]
+
 (32), 
203 [204-H]
+
 (40), 189 [M-C18H31O2, 249-CH3COOH]
+
 (100). 
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2.9 Statistical analysis 
The quantitative analysis results were analyzed using the MIXED procedure option of 
SAS (SAS Institute Inc., Cary, North Carolina, USA), considering morphological parts of 
cultivated cardoon and extracts as fixed and random effects, respectively. Where differences 
existed, the source of the differences at p < 0.05 of significance level was identified by all 
pairwise multiple comparison procedure. The Tukey’s test was used for pairwise comparisons. 
 
3. Results and Discussion 
3.1 Dichloromethane extractives yield 
Dichloromethane extractives yields of C. cardunculus L. var. altilis (DC) morphological 
parts (Table 1) varied between 1.0 and 2.0% (w/w) for stalks parts, and 3.3 and 4.5% (w/w) for 
capitula parts, reaching at maximum 17.3% (w/w) for leaves. The extractives yields of outer 
and inner parts of stalks are in good agreement with the previously reported results (0.75-
0.98%),
12
 while the yield shown here for leaves is considerably higher than the previously 
published values (4% (w/w)).
33
 
 
Table 1: Extractives yields with dichloromethane (%, w/w) for the different morphological parts of C. 
cardunculus L. var. altilis (DC). 
Morphological parts of Cynara cardunculus L. var. altilis (DC) Extractives yield (% w/w) 
Stalks 
Outer part 1.0 ± 0.1 
Inner part 2.0 ± 0.1 
Capitula 
Receptacles and bracts 3.3 ± 0.2 
Florets 4.5 ± 0.8 
Leaves  17.3 ± 0.5 
Results represent the mean estimated from two extracts. 
 
3.2 GC-MS analysis of C. cardunculus L. var. altilis (DC) dichloromethane extracts 
GC-MS allowed the identification of 65 compounds in dichloromethane extracts of C. 
cardunculus L. var. altilis (DC), before and after alkaline hydrolysis (Figure 4). The identified 
compounds in cultivated cardoon dichloromethane extracts were grouped into six chemical 
classes, namely aromatic compounds, fatty acids, long chain aliphatic alcohols, sesquiterpene 
lactones, pentacyclic triterpenes and sterols. 
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Figure 4: GC-MS chromatograms (DB-1 30 m column) of the trimethylsilyl derivatized dichloromethane 
extract of stalks outer part from C. cardunculus L. var. altilis (DC), before (BH) and after (AH) alkaline 
hydrolysis. Chromatographic peak numbers are those indicated in the Table 2. Abbreviation: IS, internal 
standard. 
 
In Table 2, the retention time of the 65 compounds, identified in the C. cardunculus L. 
var. altilis (DC) dichloromethane extracts, are indicated. Among these, 33 and 41 were 
described here for the first time as C. cardunculus L. and cultivated cardoon components, 
respectively. With the exception of sesquiterpene lactones, the compounds detected in the 
studied extracts were identified by comparing the EI-MS fragmentation of the respective TMS 
derivatives with literature data and, in some cases, with the injection of standards, as 
explained along this chapter. Sesquiterpene lactones were identified through the EI-MS data, 
obtained before the TMS derivatization, since there is no publication regarding the EI-MS data 
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of the corresponding TMS ethers. In addition to these data, the NMR spectroscopic analysis 
was also employed to identify cynaropicrin. 
 
Table 2: Retention time (RT) of the compounds identified in the dichloromethane extracts of C. 
cardunculus L. var. altilis (DC) by GC-MS analysis. 
No. 
RT 
(min) 
Compound 
Presence in C. 
cardunculus L. 
1 10.29 Benzoic acid RFCC 
2 15.27 2-Hydroxyheptanoic acid RFCC 
3 19.07 Vanillin RFCC 
4 23.75 Syringaldehyde RFCC 
5 24.02 2,6-Dimethoxyhydroquinone RFCC 
6 24.29 2-Hydroxyundecanoic acid RFCC 
7 26.14 Vanillic acid WC
34
 
8 27.75 3-Vanillylpropanol RFCC 
9 28.54 Tetradecanoic acid (myristic acid) WC,
25
 CC
17
 
10 29.35 Vanillylpropanoic acid RFCC 
11 29.44 Syringic acid WC
34
 
12 29.96 Z-Ferulic acid Art, CC
35
 
13 30.94 Pentadecanoic acid RFCC 
14 31.46 Hexadecan-1-ol RFCC 
15 32.50 (9Z)-Hexadec-9-enoic acid (palmitoleic acid) WC
25
 
16 32.61 (9E)-Hexadec-9-enoic acid RFCC 
17 33.02 Inositol RFCC 
18 33.22 Hexadecanoic acid (palmitic acid) WC, Art,
25
 CC
17,25
 
19 33.81 E-Ferulic acid Art, CC
35
 
20 35.19 (9Z)-Octadec-9-en-1-ol RFCC 
21 35.41 Heptadecanoic acid CC
17
 
22 35.89 Octadecan-1-ol RFCC 
23 36.64 (9Z,12Z)-Octadeca-9,12-dienoic acid (linoleic acid) WC, Art,
25
 CC
17,25
 
24 36.70 (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid (linolenic acid) WC,
25
 CC
17
 
25 36.84 (9Z)-Octadec-9-enoic acid (oleic acid) WC,
25
 Art,
25
 CC
17,25
 
26 37.00 (9E)-Octadec-9-enoic acid RFCC 
27 37.54 Octadecanoic acid (stearic acid) WC,
25
 Art,
25
 CC
17,25
  
28 39.53 Nonadecanoic acid RFCC 
29 39.91 Grosheimin Art,
6,23,36–38
 C
39
 
30 40.03 Eicosan-1-ol RFCC-AH 
31 41.50 Eicosanoic acid (arachidic acid) WC,
25
 CC
17
 
32 41.75 Deacylcynaropicrin Art
40
 
33 43.40 Heneicosanoic acid RFCC 
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No. 
RT 
(min) 
Compound 
Presence in C. 
cardunculus L. 
34 43.87 Docosan-1-ol RFCC 
35 45.00 2,3-Dihydroxypropyl hexadecanoate RFCC 
36 45.21 Docosanoic acid (behenic acid) WC,
25
 CC
17
 
37 46.99 Tricosanoic acid RFCC 
38 47.44 Tetracosan-1-ol RFCC 
39 48.55 E-Squalene RFCC 
40 48.69 Tetracosanoic acid (lignoceric acid) WC
25
 
41 49.73 Cynaropicrin Art,
6,23,36–38,41
 C
41
 
42 50.50 Pentacosanoic acid RFCC-AH 
43 50.79 Hexacosan-1-ol RFCC 
44 52.19 Hexacosanoic acid RFCC 
45 53.62 Cholesterol RFCC 
46 54.11 α-Tocopherol WC, Art, CC25 
47 54.45 Octocosan-1-ol RFCC 
48 54.88 Scopolin C
42
 
49 55.45 24-Methylenecholesterol RFCC 
50 55.61 Campesterol WC, Art, CC
25
 
51 56.01 Octacosanoic acid RFCC 
52 56.24 Stigmasterol WC, Art, CC
25
 
53 57.30 β-Amyrin Art,24 C43 
54 57.42 β-Sitosterol WC,25 Art, CC25 
55 57.62 β-Sitostanol RFCC 
56 57.78 Δ5-Avenasterol RFCC 
57 57.91 α-Amyrin Art,24 C43 
58 58.16 Lupeol Art,
38
 C
43
 
59 58.55 β-Amyrin acetate Art24 
60 59.38 α-Amyrin acetate Art24 
61 59.43 Lupenyl acetate RFCC 
62 59.70 ψ-Taraxasterol Art,24 C43 
63 59.88 Taraxasterol Art,
24
 C
26,43
 
64 61.12 ψ-Taraxasteryl acetate Art24 
65 61.31 Taraxasteryl acetate Art,
24
 C
26
 
Abbreviations: Art, artichoke; CC, cultivated cardoon; C, cardoon without reference in literature 
regarding the variety; RFCC, referenced for the first time as C. cardunculus L. component; RFCC-AH, 
referenced for the first time as C. cardunculus L. component, after alkaline hydrolysis; WC, wild cardoon. 
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3.2.1 Aromatic compounds 
Eleven aromatic compounds were identified in the cultivated cardoon dichloromethane 
extracts (Table 2 and Figure 5). 
 
 
Figure 5: Aromatic compounds identified in the C. cardunculus L. var. altilis (DC) dichloromethane 
extracts. Abbreviation: Glc, glucosyl. 
 
Six aromatic compounds were referenced for the first time as C. cardunculus L. 
components (Table 2 and Figure 5), namely benzoic acid (1), vanillin (3), syringaldehyde (4), 
2,6-dimethoxyhydroquinone (5), 3-vanillylpropanol (8) and vanillylpropanoic acid (10). In 
addition to these, 2 aromatic compounds were here referred, for the first time, as cultivated 
cardoon extractives, such as vanillic (7) and syringic (11) acids. These compounds had 
previously been identified in the wild cardoon.
34
 Scopolin was earlier isolated from cardoon, 
but without citing the variety.
42
 
Aromatic compounds were identified by comparing the EI-MS data of the respective 
TMS derivatives with those of the equipment mass spectral library and with published 
data.
27,28,44
 The EI mass spectra of the aromatic TMS derivatives were characterized by 
intense peaks, in what respects to the molecular ion [M]+.  as well as to product ions arising 
from losses of a methyl radical from TMS group (-15 Da), CHO from alkylic aldehydes (-29 Da) 
and HCHO from methoxyphenyl derivatives (-30 Da).
44
 Figure 6 illustrates the EI mass 
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spectrum of the syringaldehyde TMS ether, with the indication of the molecular ion and the 
main mass fragmentation product ions. 
 
 
Figure 6: EI mass spectrum and the main fragmentation product ions of the syringaldehyde (4) 
trimethylsilyl ether derivative. 
 
Table 3 summarizes the EI-MS data of the aromatic compounds identified in the 
cultivated cardoon dichloromethane extracts. 
 
  
Table 3: EI mass spectroscopic data of the trimethylsilyl (TMS) derivatives of the aromatic compounds identified in C. cardunculus L. var. altilis (DC) 
dichloromethane extracts. 
No. Aromatic compound TMS derivative 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Identification 
1 Benzoic acid 194 194 [M]+.  (4), 179 [M-CH3]
+
 (100), 135 (40), 105 [M-(CH3)3SiO]
+
 (53), 77 (48), 75 
[(CH3)2SiOH]
+
 (26), 73 [(CH3)3Si]
+
 (24) 
28
 
3 Vanillin 224 224 [M]+.  (28), 209 [M-CH3]
+
 (50), 195 [M-CHO]
+
 (17) 194 [M-HCHO]
+
 (100), 163 (7), 
135 (3) [M-(CH3)3SiO]
+
, 93 (13), 79 (14), 75 (40), 73 (25) 
Co 
4 Syringaldehyde 254 254 [M]+.  (25), 239 [M-CH3]
+
 (42), 225 [M-CHO]
+
 (16), 224 [M-HCHO]
+
 (100), 209 (4), 
194 [M-2HCHO]
+
 (2), 165 [M-(CH3)3SiO]
+
 (2), 75 (3), 73 (10) 
28,44
 
5 2,6-Dimethoxyhydroquinone 314 314 [M]+.  (50), 299 [M-CH3]
+
 (10), 284 [M-HCHO]
+
 (100), 254 [M-2HCHO]
+
 (8), 195 (2), 
75 (28), 73 (55) 
27,44
 
7 Vanillic acid 312 312 [M]+.  (50), 297 [M-CH3]
+
 (100), 282 [M-HCHO]
+
 (33), 267 (75), 253 (45), 223 (46), 
193 (19), 165 (13), 126 (23), 75 (56), 73 (54) 
28,44
 
8 3-Vanillylpropanol 326 326 [M]+.  (34), 311 [M-CH3]
+
 (16), 296 [M-HCHO]
+
 (3), 236 (16), 221 (15), 206 (100), 
179 (26), 148 (10), 75 (19), 73 (33) 
27
 
10 Vanillylpropanoic acid 340 340 [M]+.  (55), 325 [M-CH3]
+
 (28), 310 [M-HCHO]
+
 (25), 222 (21), 209 (100), 192 (44), 
179 (30), 149 (9), 89 (6), 75 (81), 73 (62) 
Wiley-NIST 
MS Library 
11 Syringic acid 342 342 [M]+.  (58), 327 [M-CH3]
+
 (100), 312 [M-HCHO]
+
 (66), 297 (67), 283 (23), 253 (38), 
223 (15), 149 (17), 141 (23), 75 (25), 73 (41) 
27,28,44
 
12 Z-Ferulic acid 338 338 [M]+.  (100), 323 [M-CH3]
+
 (63), 308 [M-HCHO]
+
 (59), 293 (59), 249 (72), 219 (26), 
191 (16), 75 (53), 73 (65), 45 (9) 
27,44
 
19 E-Ferulic acid 338 338 [M]+.  (100), 323 [M-CH3]
+
 (64), 308 [M-HCHO]
+
 (62), 293 (49), 279 (13), 249 (56), 
219 (21), 191 (10), 75 (13), 73 (35) 
27,44
 
48 Scopolin 642 450 [C6H5O((CH3)3SiO)4]
+
 (3), 361 (72), 331 (6), 319 (8), 271 (19), 264 (47), 243 (15), 
217 (74), 191 [C10H7O4]
+
 (16), 147 (36), 129 (19), 103 [(CH3)3SiOCH2]
+
 (12), 75 (14), 
73 (100) 
Wiley-NIST 
MS Library 
Abbreviation: Co, co-injection of authentic standard. 
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3.2.2 Fatty acids 
Twenty fatty acids were detected in the C. cardunculus L. var. altilis (DC) 
dichloromethane extracts, where 14 were saturated (9, 13, 18, 21, 27, 28, 31, 33, 36, 37, 40, 
42, 44, 51) and 6 were unsaturated (15, 16, 23-26). Among these, 9 were identified for the first 
time in C. cardunculus L., namely pentadecanoic acid (13), (9E)-hexadec-9-enoic acid (16), 
(9E)-octadec-9-enoic acid (26) (Figure 7), nonadecanoic acid (28), heneicosanoic acid (33), 
tricosanoic acid (37), hexacosanoic acid (44), octacosanoic acid (51) and pentacosanoic acid 
(42); the last one after alkaline hydrolysis. In addition to these compounds, (9Z)-hexadec-9-
enoic (15) and tetracosanoic (40) acids were identified here for the first time as cultivated 
cardoon components. Additionally, two 2-hydroxy fatty acids, namely 2-hydroxyheptanoic acid 
(2) and 2-hydroxyundecanoic acid (6) (Figure 7), were identified in this study, for the first time, 
as C. cardunculus L. components. 
 
 
Figure 7: Structures of some of the fatty acids and hydroxyfatty acids identified in the C. cardunculus L. 
var. altilis (DC) dichloromethane extracts. 
 
Fatty and hydroxyfatty acids were identified based on the EI-MS data of the 
corresponding TMS esters, as outlined in Table 4. 
  
Table 4: EI mass spectroscopic data of the fatty acid trimethylsilyl (TMS) esters identified in the C. cardunculus L. var. altilis (DC) dichloromethane extracts. 
No. Fatty acid TMS ester 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Identification 
2 2-Hydroxyheptanoic acid 290 275 [M-CH3]
+
 (4), 173 [M-COOSi(CH3)3]
+
 (100), 147 (66), 103 (17), 93 (40), 75 
[(CH3)2SiOH]
+
 (68), 73 [(CH3)3Si]
+
 (81) 
Wiley-NIST 
MS Library 
6 2-Hydroxyundecanoic acid 346 229 [M-COOSi(CH3)3]
+
 (67), 147 (24), 117 (5), 97 (100), 75 (7), 73 (22) Wiley-NIST 
MS Library 
9 Tetradecanoic acid 300 300 [M]
+.  (2), 285 [M-CH3]
+
 (83), 145 (16), 132 (25), 129 (41), 117 (84), 75 
(87), 73 (100) 
27–29
 
13 Pentadecanoic acid 314 314 [M]
+.  (5), 299 [M-CH3]
+
 (100), 145 (24), 132 (27), 129 (41), 117 (86), 75 
(67), 73 (83) 
27,28
 
15 (9Z)-Hexadec-9-enoic acid 326 326 [M]
+.  (3), 311 [M-CH3]
+
 (27), 145 (14), 132 (6), 129 (48), 117 (100), 95 
(28), 75 (95), 73 (73) 
Wiley-NIST 
MS Library 
16 (9E)-Hexadec-9-enoic acid 326 326 [M]
+.  (4), 311 (88), 145 (27), 132 (11), 129 (59), 117 (71), 95 (29), 75 
(100), 73 (95) 
Wiley-NIST 
MS Library 
18 Hexadecanoic acid 328 328 [M]
+.  (4), 313 [M-CH3]
+
 (100), 145 (25), 132 (27), 129 (40), 117 (88), 75 
(43), 73 (60) 
Co 
21 Heptadecanoic acid 342 342 [M]
+.  (5), 327 [M-CH3]
+
 (97), 145 (33), 132 (38), 129 (51), 117 (100), 75 
(67), 73 (91) 
27–29
 
23 (9Z,12Z)-Octadeca-9,12-dienoic acid 352 352 [M]
+.  (3), 337 [M-CH3]
+
 (100), 145 (12), 132 (4), 129 (44), 117 (34), 95 
(43), 75 (86), 73 (86) 
Wiley-NIST 
MS Library 
24 (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid 350 350 [M]
+.  (4), 335 [M-CH3]
+
 (33), 173 (12), 163 (11), 149 (22), 145 (16), 132 
(5), 129 (40), 117 (27), 108 (32), 95 (62), 79 (100), 75 (95), 73 (87) 
Wiley-NIST 
MS Library 
25 (9Z)-Octadec-9-enoic acid 354 354 [M]
+.  (4), 339 [M-CH3]
+
 (92), 264 (12), 222 (14), 199 (13), 185 (12), 145 
(35), 132 (14), 129 (90), 117 (95), 96 (33), 81 (32), 75 (93), 73 (100) 
29
 
26 (9E)-Octadec-9-enoic acid 354 354 [M]
+.  (3), 339 (77), 264 (9), 222 (11), 199 (11), 185 (12), 145 (31), 132 
(14), 129 (75), 117 (74), 96 (28), 81 (30), 75 (98), 73 (100) 
29
 
27 Octadecanoic acid 356 356 [M]
+.  (6), 341 [M-CH3]
+
 (86), 145 (39), 132 (38), 129 (58), 117 (100), 75 
(77), 73 (94) 
27–29
 
  
No. Fatty acid TMS ester 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Identification 
28 Nonadecanoic acid 370 370 [M]
+.  (4), 355 [M-CH3]
+
 (62), 145 (26), 132 (25), 129 (29), 117 (63), 75 
(100), 73 (59) 
28
 
31 Eicosanoic acid 384 384 [M]
+.  (9), 369 [M-CH3]
+
 (100), 145 (35), 132 (33), 129 (40), 117 (84), 75 
(45), 73 (60) 
27–29
 
33 Heneicosanoic acid 398 398 [M]
+.  (2), 383 [M-CH3]
+
 (100), 145 (41), 132 (39), 129 (44), 117 (88), 75 
(69), 73 (80) 
27–29
 
36 Docosanoic acid 412 412 [M]
+.  (12), 397 [M-CH3]
+
  (100), 145 (45), 132 (41), 129 (48), 117 (98), 75 
(42), 73 (69) 
27–29
 
37 Tricosanoic acid 426 426 [M]
+.  (3), 411 [M-CH3]
+
 (92), 145 (44), 132 (46), 129 (55), 117 (100), 75 
(56), 73 (69) 
27–29
 
40 Tetracosanoic acid 440 440 [M]
+.  (13), 425 [M-CH3]
+
  (89), 145 (50), 132 (47), 129 (53), 117 (100), 75 
(49), 73 (71) 
27–29
 
42 Pentacosanoic acid 454 454 [M]
+.  (10), 439 [M-CH3]
+
  (70), 145 (41), 132 (42), 129 (48), 117 (71), 75 
(81), 73 (100) 
27–29
 
44 Hexacosanoic acid 468 468 [M]
+.  (2), 453 [M-CH3]
+
  (85), 145 (59), 135 (48), 129 (53), 117 (100), 75 
(58), 73 (92) 
27–29
 
51 Octacosanoic acid 496 496 [M]
+.  (15), 481 [M-CH3]
+
  (66), 145 (52), 132 (36), 129 (50), 117 (81), 75 
(56), 73 (100) 
28,29
 
Abbreviation: Co, Co-injection of authentic standard. 
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Figure 8 demonstrates the EI mass spectrum of the hexadecanoic acid (18) TMS 
ester. A low relative abundance peak was found at m/z 328 (I), corresponding to the molecular 
ion. The base peak of this EI mass spectrum was detected at m/z 313 (II), due to the loss of a 
methyl radical (-15 Da) from the TMS group. This product ion is useful in assigning the 
molecular weight of the TMS fatty acid ester, since the molecular ion peak can be sometimes 
absent in the EI mass spectra.
45
 Four characteristic product ions regarding the EI 
fragmentation of fatty acid TMS esters were observed at m/z 145 (III), 132 (V), 129 (IV) and 
117 (VI). The product ions at m/z 145 (III) and 129 (IV) resulted from 1,3-hydrogen transfer 
(m/z 145), followed by loss of methane (m/z 129).
45
 The other two product ions at m/z 132 (V) 
and 117 (VI) resulted from McLafferty rearrangement (m/z 132), and successive loss of a 
methyl radical (m/z 117).
45
 Additionally, two high relative abundant peaks, namely at m/z 73 
[(CH3)3Si]
+
 and m/z 75 [(CH3)2SiOH]
+
, were also demonstrated in the EI mass spectrum of 
hexadecanoic acid (18) TMS ester
45
 (Figure 8). 
 
 
Figure 8: EI mass spectrum and the main fragmentation product ions of hexadecanoic acid (18) 
trimethylsilyl ester. 
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Two 2-hydroxyfatty acids (2 and 6) were identified in the cultivated cardoon 
dichloromethane extracts (Table 4). In the EI mass spectra of the respective TMS derivatives, 
the molecular ions were absent. It was common to find a highly abundant product ion 
originated by the loss of COOTMS group (-117 Da) from the molecular ion. 
 
3.2.3 Long chain aliphatic alcohols 
Eight long chain aliphatic alcohols (14, 20, 22, 30, 34, 38, 43 and 47) (Figure 9) were 
identified in dichloromethane extracts of C. cardunculus L. var. altilis (DC). These compounds 
were described, for the first time, as C. cardunculus L. components, although eicosan-1-ol (30) 
was only noticed after alkaline hydrolysis. 
 
 
Figure 9: Structures of some of the long chain aliphatic alcohols identified in the C. cardunculus L. var. 
altilis (DC) dichloromethane extracts. 
 
The EI-MS data was essential to identify the long chain aliphatic alcohols in the 
cultivated cardoon dichloromethane extracts (Table 5), in addition to the retention time for 
comparison with the literature data.
27–29
 
 
Table 5: EI mass spectroscopic data of long chain aliphatic alcohol trimethylsilyl (TMS) ethers identified 
in the C. cardunculus L. var. altilis (DC) dichloromethane extracts. 
No. 
Long chain aliphatic 
alcohol TMS ether 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Identification 
14 Hexadecan-1-ol 314 314 (1), 299 [M-CH3]
+
 (100), 103 
[CH2OSi(CH3)3]
+
 (16), 89 [(CH3)3SiO]
+
 (14), 
75 (65), 73 (42) 
27,29
 
20 (9Z)-Octadec-9-en-1-ol 340 340 (5), 325 [M-CH3]
+
 (21), 103 (16), 89 (11), 
75 (100), 73 (46) 
27,29
 
22 Octadecan-1-ol 342 327 [M-CH3]
+
 (100), 103 (11), 89 (8), 75 (30), 
73 (14) 
27,29
 
30 Eicosan-1-ol 370 355 [M-CH3]
+
 (100), 103 (14), 89 (9), 75 (88), 
73 (84) 
Wiley-NIST 
MS Library 
34 Docosan-1-ol 398 383 [M-CH3]
+
 (100), 103 (15), 89 (8), 75 (58), 
73 (68) 
27,29
 
38 Tetracosan-1-ol 426 411 [M-CH3]
+
 (100), 103 (9), 89 (5), 75 (26), 
73 (13) 
29
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No. 
Long chain aliphatic 
alcohol TMS ether 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
a
 
Identification 
43 Hexacosan-1-ol 454 439 [M-CH3]
+
 (100), 103 (14), 89 (6), 75 (36), 
73 (32) 
28,29
 
47 Octocosan-1-ol 482 467 [M-CH3]
+
 (100), 103 (15), 89 (8), 75 (42), 
73 (23) 
27–29
 
 
Figure 10 reveals the EI mass spectrum of hexacosan-1-ol (43) TMS ether derivative. 
The molecular of this compound (m/z 454) was absent in the EI mass spectrum. The 
molecular ions of TMS ether derivatives of these compounds are generally absent, or denoted 
by a low intense peak.
46
 The base peak was observed at m/z 439 (I), due to the loss of a 
methyl radical from the TMS group. The base peak is very important for determining the 
molecular weight of the long chain aliphatic alcohol TMS derivative. Two characteristic product 
ions were registered at m/z 103 (II) and 89 (III).
46
 The former was afforded by C1-C2 bond 
cleavage (m/z 103), whereas the latter resulted from the bond cleavage between C1 and 
oxygen, and transition of a methyl radical from the TMS group to the oxygen (m/z 89).
46
 The 
characteristic product ions at m/z 75 and m/z 73 were also detected with relative high 
abundance, as earlier explained.
46
 
 
 
Figure 10: EI mass spectrum and the main fragmentation product ions of hexacosan-1-ol (43) 
trimethylsilyl ether. 
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3.2.4 Sesquiterpene lactones 
Three guaianolide sesquiterpene lactones (Table 2 and Figure 11) were identified in C. 
cardunculus L. var. altilis (DC) dichloromethane extracts, namely grosheimin (29), 
deacycynaropicrin (32) and cynaropicrin (41). These compounds were previously isolated from 
artichoke.
23,36–38,41
 Cynaropicrin
41
 and grosheimin
39
 were also isolated from cardoon, although 
without referring the wild or cultivated variety. In this manner, deacycynaropicrin (32) was 
identified for the first time as C. cardunculus L. var. altilis (DC) component. 
 
 
Figure 11: Structures of guaianolide sesquiterpene lactones identified in the C. cardunculus L. var. altilis 
(DC) dichloromethane extracts. 
 
Grosheimin (29) and deacylcynaropicrin (32) were identified by comparing the 
respective EI-MS data with the equipment mass spectral library and literature data.
30
 The 
identification of cynaropicrin (41) was based on the EI-MS and, principally, NMR spectroscopic 
data, as explained bellow in this chapter. The EI-MS data of the guaianolide TMS ethers, 
regarding the three guaianolides identified in cultivated cardoon dichloromethane extracts, 
were reported here for the first time (Table 6). 
 
Table 6: EI mass spectroscopic data of the guaianolide sesquiterpene lactone trimethylsilyl (TMS) 
derivatives identified in C. cardunculus L. var. altilis (DC). 
No. 
Guaianolide sesquiterpene 
lactone TMS derivative 
[𝐌]
+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
29 Grosheimin 334 334 [M]+.  (3), 319 [M-CH3]
+
 (9), 291 (5), 263 (3), 244 (7), 
237 (100), 197 (20), 169 (22), 141 (14), 91 (9), 75 
[(CH3)2SiOH]
+
 (17), 73 [(CH3)3Si]
+
 (63) 
32 Deacylcynaropicrin 406 406 [M]+.  (15), 388 [M-CH3]
+
 (3), 316 (8), 295 (9), 273 (7), 
219 (14), 197 (53), 181 (20), 168 (30), 141 (13), 129 (7), 
91 (8), 75 [(CH3)2SiOH]
+
 (27), 73 [(CH3)3Si]
+
 (100) 
41 Cynaropicrin 490 490 [M]+.  (13), 462 (7), 391 (10), 317 (28), 316 [M‒
(CH3)3SiOCH2CCH2CO2H]
+
 (83), 301 (14), 273 (15), 227 
(74), 168 (77), 103 (14), 91 (19), 75 [(CH3)2SiOH]
+
 (37), 
73 [(CH3)3Si]
+
 (100) 
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The EI mass spectrum of cynaropicrin TMS diether (Table 6 and Figure 12) displayed 
the molecular ion at m/z 490, as well as an intense peak at m/z 316 ([M-
(CH3)3SiOCH2CCH2CO2H]
+
) which was yielded by the loss of the trimethylsilylated ester 
moiety, through McLafferty rearrangement and inductive cleavage.
6
 Additionally, the base 
peak was observed at m/z 73 corresponding to the TMS ion ([(CH3)3Si]
+
), a characteristic EI 
product ion of trimethylsilylated derivatives. 
 
 
Figure 12: EI mass spectrum and the main fragmentation product ions of the cynaropicrin (41) 
trimethylsilyl (TMS) diether. 
 
The NMR spectroscopic analysis showed to be decisive for the identification of 
cynaropicrin, because the EI-MS data of its TMS diether derivative was not previously 
indicated in the literature. 
 
3.2.4.1 Chemical identification of cynaropicrin by NMR spectroscopy 
The identification of cynaropicrin was confirmed by NMR spectroscopic analysis. The 
1
H and 
13
C NMR spectra showed respectively 24 and 19 resonances, namely in the saturated 
(ranges of δH 1.67‒2.92 ppm and δC 37.0-51.4 ppm) and in the alkene regions (ranges of δH 
5.08‒6.27 ppm and δC 113.6-152.2 ppm). According to the DEPT analysis, the resonances 
were ascribed to 7 secondary, 6 tertiary and 6 quaternary carbons. 
In the 
1
H NMR spectrum, two resonances were assigned to H-4´ (δ 4.32 ppm) and H-3 
(δ 4.50 ppm) (Figure 13), corresponding to protons near to alcohol groups, and other two to H-
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6 (δ 4.20 ppm) and H-8 plus 14 (δ 5.08 ppm), relatively to protons near to ester groups, but the 
resonance at H-8 was overlapped with the one at H-14. In the 
13
C NMR spectrum, four 
resonances were ascribed to carbons bonded to oxygen atoms (Figure 13), more specifically 
two carbons bonded to alcohol groups, at C-4´ (δ 62.3 ppm) and C-3 (δ 73.7 ppm), and two 
carbons bonded to ester groups, at C-8 (δ 74.3 ppm) and C-6 (δ 78.4 ppm). Two resonances 
detected in the 
13
C NMR spectrum were assigned to the carbonyls of the ester groups, namely 
at C-1´ (δ 165.3 ppm) and C-12 (δ 169.0 ppm). 
 
 
Figure 13: Chemical shifts of relevant 
1
H (blue) and 
13
C (orange) NMR data (ppm) of cynaropicrin. 
 
Table 7 indicates the COSY, HSQC and HMBC correlations for cynaropicrin. The two-
dimension NMR techniques allowed to identify four methylene groups (C=CH2), namely at C-
13 (δ 122.7 ppm) C-14 (δ 118.2 ppm), C-15 (δ 113.6 ppm) and C-3´ (δ 127.8 ppm) 
resonances. 
 
Table 7: COSY, HSQC and HMBC correlations for cynaropicrin. 
Position COSY HSQC HMBC 
1 H-2α, H-2β, H-5 C-1 C-5, C-6, C-10 
2α H-1, H-2β, H-3 C-2 C-1, C-3, C-10 
2β H-1, H-2α, H-3 C-2 C-5, C-3, C-4 
3 H-2α, H-2β, H-15a, H-15b C-3  
5 H-1, H-6, H-15a C-5 C-4, C-6 
6 H-5, H-7 C-6 C-4, C-8 
7 H-6, H-8+14b, H-13a, H-13b C-7 C-6, C-11 
8 + 14b H-9α, H-9β, H-7, H-14a C-8, C-14 C-9, C-7, C-1, C-10, C-11 
9α H-9β, H-8+14b C-9 C-1, C-7, C-8, C-10, C-14 
9β H-9α, H-8+14b C-9 C-1, C-7, C-8, C-14, C-10 
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Position COSY HSQC HMBC 
13a H-7 C-13 C-7 
13b H-7 C-13 C-7, C-11, C-12 
14a  C-14 C-1, C-9 
15a H-3, H-5 C-15 C-3, C-5 
15b H-3 C-15 C-3, C-4, C-5 
3´a H-4´, H-3´b C-3´ C-1´, C-4´ 
3´b H-4´, H-3´a C-3´ C-1´, C-2´, C-4´ 
4´ H-3´a, H-3´b C-4´ C-1´, C-2´, C-3´ 
 
Figure 14 indicates the COSY and HMBC correlations that endorsed the identification 
of the methylene group at C-13 (C=CH2). According to the HSQC spectrum, two doublets 
noted at δ 5.57 (H-13a) and 6.16 ppm (H-13b) correlate with the secondary carbon (DEPT) 
signal at δ 122.7 ppm (C-13). In the COSY spectrum, both H-13a and H-13b correlate with a 
resonance at δH 3.14 ppm. In the HSQC spectrum, the proton resonance at δ 3.14 ppm 
correlates with the tertiary carbon (DEPT) at δ 47.6 ppm which was assigned to C-7. Both 
protons at C-13 couple with the proton at C-7 (Figure 14). Moreover, the HMBC spectrum 
indicated that H-13b correlates with the C-7 and with two quaternary carbons (DEPT) at δ 
137.3 and 169.0 ppm, attributed to C-11 and C-12 (HSQC), respectively (Figure 14). The 
HMBC spectrum also displayed that H-13a correlates with C-7; nevertheless H-13a should 
also correlates with C-11 and C-12, which it was not noticed in the HMBC spectrum, in the 
experimental conditions covered. 
 
 
Figure 14: Relevant COSY (left) and HMBC (right) correlations of cynaropicrin, with the chemical shifts 
of 
1
H (blue) and 
13
C (orange) NMR spectroscopic data (ppm). 
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3.2.5 Sterols 
Seven sterols were identified in the C. cardunculus L. var. altilis (DC) dichloromethane 
extracts (Table 2 and Figure 15): a stanol, named as β-sitostanol (55), and six Δ5-stenols, 
namely cholesterol (45), 24-methylenecholesterol (49), campesterol (50), stigmasterol (52), β-
sitosterol (54) and Δ5-avenasterol (56). These sterols can be grouped into four subclasses, 
namely cholestane (45), ergostane (49), campestane (50) and stigmastane (52, 54-56). In the 
present work, cholesterol (45), 24-methylenecholesterol (49), β-sitostanol (55) and Δ5-
avenasterol (56) were reported for the first time as C. cardunculus L. components. 
Campesterol (50), stigmasterol (52) and β-sitosterol (54) were previously reported in the seed 
oil composition of the three varieties from C. cardunculus L.
25 
 
 
Figure 15: Structures of sterols identified in the C. cardunculus L. var. altilis (DC) dichloromethane 
extracts. 
 
The identification of sterols in C. cardunculus L. var. altilis (DC) dichloromethane 
extracts was approached by comparing the EI-MS data, elution order and retention time of the 
corresponding TMS ethers with the literature data.
27–29,47–50
 Table 8 lists the EI-MS data of the 
TMS ethers of the identified sterols. 
  
Table 8: EI mass spectroscopic data of sterol trimethylsilyl ethers identified in the C. cardunculus L. var. altilis (DC) dichloromethane extracts. 
No. Sterol TMS ether [M]+.  (m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Identification 
45 Cholesterol 458 458 [M]+.  (23), 443 [M-CH3]
+
 (10), 368 [M-TMSOH]
+
 (55), 353 [M-TMSOH-CH3]
+
 (35), 329 [M-129]
+
 
(68), 281 (55), 255 [M-SC-TMSOH]
+
 (26), 247 [M-TMSOH-(A+B)]
+
 (190), 213 [M--SC-D-TMSOH]
+
 
(15), 129 [M-329]
+
 (89), 75 [(CH3)2SiOH]
+
 (77), 73 (100) [TMS]
+
 
Co 
49 24-Methylenecholesterol 470 470 [M]+.  (3), 455 [M-CH3]
+
 (9), 386 [M-SCβ]
+
 (36), 380 [M-TMSOH]
+
 (21), 365 [M-TMSOH-CH3]
+
 (18), 
341 [M-129]
+
 (38), 296 (25), 259 [M-TMSOH-(A+B)]
+
 (9), 255 [M-SC-TMSOH]
+
 (16), 213 [M-SC-D-
TMSOH]
+
 (17), 129 [M-341]
+
 (100), 75 (66), 73 (91) 
47
 
50 Campesterol 472 472 [M]+.  (32), 457 [M-CH3]
+
 (12), 382 [M-TMSOH]
+
 (87), 367 [M-TMSOH-CH3]
+
 (46), 343 [M-129]
+
 
(95), 303 [M-SC-D]
+
 (1), 261 [M-TMSOH-(A+B)]
+
 (18), 255 [M-TMSOH-SC]
+
 (25), 213 [M-SC-D-
TMSOH]
+
 (17), 129 [M-343]
+
 (100), 75 (40), 73 (55) 
27,28,48,50
 
52 Stigmasterol 484 484 [M]+.  (23), 469 [M-CH3]
+
 (5), 394 [M-TMSOH]
+
 (34), 379 [M-TMSOH-CH3]
+
 (15), 355 [M-129]
+
 
(16), 303 [M-SC-D]
+
 (1), 273 [M-TMSOH-(A+B)]
+
 (2), 255 [M-TMSOH-SC]
+
 (53), 213 [M-271]
+
 (17), 
159 (28), 129 [M-355]
+
 (70), 83 (100), 75 (25), 73 (34) 
28,48,50
 
54 β-Sitosterol 486 486 [M]+.  (26), 471 [M-CH3]
+
 (10), 396 [M-TMSOH]
+
 (78), 381 [M-TMSOH-CH3]
+
 (41), 357 [M-129]
+
 
(86), 303 [M-SC-D]
+
 (6), 275 [M-TMSOH-(A+B)]
+
 (15), 255 [M-TMSOH-SC]
+
 (24), 213 [M-SC-D-
TMSOH]
+
 (16), 129 [M-357]
+
 (100), 75 (34), 73 (42) 
28,29,48,50
 
55 β-Sitostanol 488 488 [M]+.  (20), 473 [M-CH3]
+
 (37), 431 (14), 398 [M-TMSOH]
+
 (19), 383 [M-TMSOH-CH3]
+
 (35), 357 
(34), 305 [M-SC-D]
+
 (18), 257 [M-SC-TMSOH]
+
 (12), 230 [M-SC-C16-C17-TMSOH]
+
 (15), 215 [M-
SC-D-TMSOH]
+
 (99.5), 144 [M-344]
+
 (11), 145 [M-344-H]
+
 (36), 147 (46), 129 [M-359]
+
 (57), 75 
(100), 73 (79) 
48–50
 
56 Δ5-Avenasterol 484 484 [M]+.  (8), 469 [M-CH3]
+
 (6), 394 [M-TMSOH]
+
 (11), 379 [M-TMSOH-CH3]
+
 (9), 386 [M-SCβ]
+
 (100), 
355 [M-129]
+
 (10), 303 [M-SC-D]
+
 (3), 296 (77), 281 (81), 273 [M-TMSOH-(A+B)]
+
 (5), 257 (39), 255 
[M-TMSOH-SC]
+
 (28), 213 [M-SC-D-TMSOH]
+
 (23), 159 (34), 129 [M-355]
+
 (93), 83 (26), 75 (49), 73 
(68) 
48,50
 
Abbreviations: Co, Co-injection of authentic standard; SC, loss of side chain; SCβ, loss of side chain in the β-position of the double bond; A, loss of A-ring; B, loss 
of B-ring; D, loss of D-ring; TMSOH, trimethylsilanol. 
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3.2.5.1 Stanols 
Figure 16 illustrates the EI mass spectrum and the main fragmentation product ions of 
the β-sitostanol (55) TMS ether derivative. 
 
 
Figure 16: EI mass spectrum and the main fragmentation product ions of β-sitostanol (55) trimethylsilyl 
(TMS) ether. *Contamination. 
 
The EI mass spectrum of β-sitostanol TMS ether (Figure 16) exhibited an intense peak 
at m/z 488 (I), corresponding to the molecular ion. The base peak was detected at m/z 215 
(X), due to the loss of trimethylsilanol (-90 Da) from the ion at m/z 305 (VII). Three product 
ions at m/z 305 (VII), 257 (VI) and 230 (VIII) were yielded by the loss of the side chain, 
together with: (i) the loss of C15-C17, for m/z 305; (ii) the trimethylsilanol loss, for m/z 257 and 
(iii) the C16-C17 loss, followed by the trimethylsilanol loss for m/z 230. The C1-C10 and C3-
C4 bonds cleavages originated the product ion at m/z 129 (II), whereas the C1-C10 and C4-
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C5 bonds cleavages gave rise to the product ion at m/z 145 (III) (with hydrogen atom 
transfer).
49
 
 
3.2.5.2 Δ5-Sterols 
Figure 17 indicates the EI mass spectrum of the β-sitosterol (54) TMS ether derivative, 
as well as the main fragmentation product ions. 
 
Figure 17: EI mass spectrum and the main fragmentation product ions of β-sitosterol (54) trimethylsilyl 
(TMS) ether derivative. 
 
The molecular ion of the β-sitosterol (54) TMS ether was observed in the EI mass 
spectrum (Figure 17) like an intense peak at m/z 486 (I). The loss of a methyl radical (-15 Da) 
from the TMS substituent of the molecular ion afforded the product ion at m/z 471 (III).
51
 The 
pair of product ions observed by m/z 129 (VI, base peak) and m/z 357 (VII) ([M-129]
+
) derived 
from the C1-C10 and C3-C4 bonds cleavages, being characteristic of the EI fragmentation of 
TMS derivatives of Δ5-sterols.49,50 Other intense peak was noticed at m/z 396 (IX), which was 
yielded by the loss of the trimethylsilanol from the molecular ion.
50–52
 Moreover, the product 
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ion at m/z 275 (X) resulted from the loss of the A and B-rings, through the retro-Diels-Alder 
reaction on the B ring of the ion at m/z 396 (IX).
50
 A product ion at m/z 213 (IV) was formed by 
the loss of the side chain and the D-ring (C15-C17) (m/z 303), followed by the loss of the 
trimethylsilanol (-90 Da).
52
 This product ion is usually found in the EI mass spectra of sterol 
monoenes.
52
 An intense peak was also observed at m/z 255 (II), due to the loss of side chain, 
followed by the loss of trimethylsilanol.
50
 
Regarding the EI mass spectra of Δ5-sterols with unsaturated side chains, it is also 
possible to recognize product ions formed by the cleavage of the side chain in the beta-
position to the double bond.
50
 The EI fragmentation of 24-methylenecholesterol (49) TMS 
ether (Table 8) generated an abundant product ion at m/z 386, due to the loss of 2,3-
dimethylbutene (-84 Da). Following the same trend, the base peak of EI mass spectrum of Δ5-
avenasterol (56) TMS ether derivative was detected at m/z 386, arising from the loss of 3,4-
dimethylpent-2-ene (-98 Da). 
 
3.2.6 Pentacyclic triterpenes 
Ten pentacyclic triterpenes were identified in the C. cardunculus L. var. altilis (DC) 
dichloromethane extracts (Table 2 and Figure 18): β-amyrin (53), α-amyrin (57), lupeol (58), β-
amyrin acetate (59), α-amyrin acetate (60), lupenyl acetate (61), ψ-taraxasterol (62), 
taraxasterol (63), ψ-taraxasteryl acetate (64) and taraxasteryl acetate (65). These can be 
grouped into four classes, namely oleananes (53 and 59), ursanes (57 and 60), lupanes (58 
and 61) and taraxastanes (62-65). 
 
 
Figure 18: Structures of pentacyclic triterpenes identified in the C. cardunculus L. var. altilis (DC) 
dichloromethane extracts. 
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Lupenyl acetate (61) was cited here for the first time as C. cardunculus L. component. 
The remaining pentacyclic triterpenes were described in artichoke.
24,38
 Some pentacyclic 
triterpenes (53, 57, 58, 62, 63, 65) were also found in cardoon,
26,43
 although without citing the 
cultivated or wild variety. In this manner, the acetates of β-amyrin (59) and α-amyrin (60) and 
ψ-taraxasteryl acetate (64) were identified here for the first time as C. cardunculus L. var. 
altilis (DC) components. 
Pentacyclic triterpenes were identified by comparing the EI-MS data of the 
corresponding TMS derivatives (Table 9) with the literature and, in some cases, with the 
injection of standards, under the same experimental conditions, as explained bellow. 
 
Table 9: EI mass spectroscopic data of the pentacyclic triterpene trimethylsilyl ethers identified in the C. 
cardunculus L. var. altilis (DC) dichloromethane extracts. 
No. 
Pentacyclic 
triterpene TMS 
derivative 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Id. 
53 β-Amyrin 498 498 [M]+.  (1), 483 [M-CH3]
+
 (1), 408 [M-TMSOH]
+
 (1), 393 
[M-TMSOH-CH3]
+
 (2), 279 [M-(D+E)]
+
 (3), 218 [M-(A+B)]
+
 
(100), 205 [M-(A+B+C11)]
+
 (2), 203 [M-(A+B+C28)]
+
 (45), 
75 [(CH3)2SiOH]
+
 (6), 73 [(CH3)3Si]
+
 (9) 
Co 
57 α-Amyrin 498 498 [M]+.  (3), 483 (1), 408 (1), 393 (2), 279 (5), 218 (100), 
205 (2), 203 (21), 75 (8), 73 (13) 
53
 
58 Lupeol 498 498 [M]
+.  (16), 483 [M-CH3]
+
 (7), 456 [M-(C20+C29+C30)]
+
 
(1), 408 [M-TMSOH]
+
 (8), 279 [M-(C+D+E)]
+
 (15), 218 [M-
(A+B)]
+
 (31), 203 [218-CH3]
+
 (54), 190 [279-TMSO]
+
 (63), 
189 [M-(C+D+E)]
+
 (100), 175 [279-CH3-TMSOH]
+
 (32), 161 
[175-CH2]
+
 (29), 135 [203-C5H8]
+
 (47), 75 (45), 73 (52) 
Co 
59 β-Amyrin acetate 468 468 [M]+.  (2), 453 [M-CH3]
+
 (1), 408 [M-CH3CO2H]
+
 (1), 249 
[M-(C+D+E)]
+
 (1), 218 [M-(A+B)]
+
 (100), 203 [218-CH3]
+
 
(57), 189 [218-(C11+C28), 249-CH3CO2H]
+
 (19) 
32
 
60 α-Amyrin acetate 468 468 [M]+.  (4) 453 (2), 408 (2), 249 (2), 218 (100), 203 (24), 
189 (28) 
32
 
61 Lupenyl acetate 468 468 [M]+.  (18), 453 [M‒CH3]
+
 (11), 408 [M‒CH3CO2H]
+
 (6), 
249 [M‒(C+D+E)]+ (13), 218 [M‒(A+B)]+ (30), 204 [M‒
(A+B+C)]
+
 (32), 203 [204‒H]+ (40), 189 [M‒(A+B+C), 249‒
CH3CO2H]
+
 (100) 
Co 
62 ψ-Taraxasterol 498 498 [M]
+.  (6), 483 [M-CH3]
+
 (2), 408 [M-TMSOH]
+
 (12), 279 
[M-(C+D+E)]
+
 (5), 218 [M-(A+B)]
+
 (10), 203 [218-CH3]
+
 
(16), 190 [279-TMSO]
+
 (30), 189 [M-(A+B+C)]
+
 (100), 175 
[279-CH3-TMSOH]
+
 (19), 161 [175-CH2]
+
 (15), 135 (27), 75 
(14), 73 (23) 
54,55
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No. 
Pentacyclic 
triterpene TMS 
derivative 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Id. 
63 Taraxasterol 498 498 [M]
+.  (8), 483 (3), 456 (<1), 408 (8), 279 (8), 218 (9), 
203 (21), 190 (49), 189 (100), 175 (21), 161 (18), 135 (28), 
75 (22), 73 (34) 
54,55
 
64 ψ-Taraxasteryl 
acetate 
468 468 [M]+.  (10), 453 [M-CH3]
+
 (1), 408 [M-CH3COOH]
+
 (9), 
393 [M-CH3-CH3COOH]
+
 (6), 249 [M‒C16H27]
+ 
(8), 218 [M-
C16H26O2]
+ 
(3), 205 [M-C17H29O2]
+
 (6), 204 [M-C17H28O2]
+
 
(10), 203 [218-CH3]
+
 (12), 190 [205-CH3]
+
 (27), 189 [249-
CH3COOH, 204-CH3]
+
 (100) 
56
 
65 Taraxasteryl 
acetate 
468 468 [M]+.  (10), 453 (1), 408 (8), 393 (1), 249 (11), 218 (8), 
205 (15), 204 (17), 203 (20), 190 (37), 189 (100) 
Co 
Abbreviations: A, loss of A-ring; B, loss of B-ring; C, loss of C-ring; Co, Co-injection of authentic 
standard; Id., identification; TMSOH, trimethylsilanol. 
 
3.2.6.1 Oleananes and ursanes 
β-amyrin (53) and α-amyrin (57) (Figure 18) were identified by comparing the EI-MS 
fragmentation of their TMS derivatives
53
 (Table 9), retention time
29
 and elution order
57
 with the 
literature data. The EI mass spectra of both β- and α-amyrin TMS ethers, with the molecular 
ion at m/z 498, revealed a product ion at m/z 218 (base peak), due to the cleavage of C9-C11 
and C8-C14 bonds, containing the D and E rings. An intense peak was also detected at m/z 
203 which was generated by the loss of A and B rings and methyl radical (-15 Da) at C28. 
Other characteristic product ions were found at m/z 408 (loss of TMSOH (-90 Da)), 393 (loss 
of TMSOH and a methyl radical), 279 (loss of D and E rings) and 205 (loss of A and B rings 
and C11).
53
 
β-amyrin acetate (59) and α-amyrin acetate (60) (Figure 18) were identified in the 
cultivated cardoon dichloromethane extracts, through the EI mass data
32
 (Table 9), retention 
time
29
 and elution order.
57
 The EI mass spectra of both β- and α-amyrin acetate derivatives 
(molecular ion at m/z 468) displayed the base peak at m/z 218 whose product ion contained 
the D and E rings, resulting from C9-C11 and C8-C14 bonds cleavages.
32
 A low intense 
fragmentation peak was observed at m/z 189, which may be assigned to two product ions, 
afforded by: (i) the loss of a C2H5 unit from the product ion at m/z 218, and (ii) the loss of the 
acetate group from the product ion at m/z 249, containing the A and B rings.
32
 
 
3.2.6.2 Lupanes 
The EI mass spectrum of the lupeol (58) TMS ether (Table 9 and Figure 19) displayed 
the molecular ion at m/z 498 (I), and the base peak at m/z 189 (VI) which contained the D and 
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E rings, after C12-C13 and C8-C14 bonds cleavages.
58
 The loss of the propenyl moiety from 
molecular ion yielded a product ion at m/z 456 (II). Two product ions were formed due to the 
cleavage of C9-C11 and C8-C14 bonds, namely at m/z 279 (IV), containing the A and B rings, 
and at m/z 218 (V), presenting the D and E rings. An intense peak was noted at m/z 161 (VII), 
whose product ion was due to the loss of CH2 from the ion at m/z 175 (VIII). Cleavages of the 
C18-C19 and C21-C22 bonds in the ion at m/z 203 (IX) gave origin to the product ion at m/z 
135 (X).
58
 The identification of lupeol was further confirmed with the injection of the standard 
compound. 
 
 
Figure 19: EI mass spectrum and the main fragmentation product ions of lupeol (58) trimethylsilyl (TMS) 
ether. 
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The EI-MS spectrum of lupenyl acetate (61) (Table 9 and Figure 20) exhibited the 
molecular ion at m/z 468 (I) and the base peak at m/z 189 (III). The base peak may represent 
two product ions with m/z 189 (III), such as: (i) a product ion containing the D and E rings, 
caused by cleavages of C8-C14 and C12-C13 bonds; and (ii) a product ion containing the A 
and B rings, due to the loss of an acetate from the product ion at m/z 249 (VII).
32
 The product 
ion at m/z 249 resulted from the C9-C11 and C13-C14 bonds cleavages.
32
 Two intense peaks 
were also noticed in the EI mass spectrum of lupenyl acetate, namely at m/z 204 (V) and 218 
(VI): the first was yielded by C11-C12 and C8-C14 bonds cleavages, while the latter was 
afforded by C9-C11 and C8-14 bonds cleavages. Other characteristic product ion was 
observed at m/z 408 (II), due to the loss of an acetate fragment (-60 Da). The identification of 
lupenyl acetate was further confirmed with the injection of a sample previously prepared in this 
work. 
 
 
Figure 20: EI mass spectrum and the main fragmentation product ions of lupenyl acetate (61). 
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3.2.6.3 Taraxastanes 
Both ψ-taraxasterol (62) and taraxasterol (63) TMS ethers presented similar 
fragmentation profiles to the one of lupeol (58) TMS ether. Figure 21 highlights the EI mass 
spectrum and the main fragmentation product ions of taraxasterol TMS ether. The EI mass 
spectra of ψ-taraxasterol and taraxasterol TMS ethers demonstrated the molecular ion at m/z 
498 (I) and the base peak at m/z 189 (III) (Table 9 and Figure 21).
55
 The main product ions 
were generated by C8-C14 and C9-C11 bonds cleavages, containing either the A and B rings 
(IV, V, VI and VII) or the D and E rings (VIII and IX) (Figure 21).
58
 The unambiguous 
identification of ψ-taraxasterol and taraxasterol was complemented by comparing the elution 
order of their TMS ethers with the literature data.
54,57,59
 
 
 
Figure 21: EI mass spectrum and the main fragmentation product ions of taraxasterol (62) trimethylsilyl 
(TMS) ether. 
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The EI mass spectra of ψ-taraxasteryl acetate (64) and taraxasteryl acetate (65) were 
similar to the one of lupenyl acetate (61). Figure 22 indicates the EI mass spectrum and the 
main fragmentation product ions of taraxasteryl acetate. The EI ionization of taraxasteryl 
acetate yielded the molecular ion at m/z 468 (I), as well as two ion products at m/z 249 (II) and 
at m/z 218 (VII) due to the cleavage of C8-C14 and C9-C11 bonds (Table 9 and Figure 22). 
The former product ion (m/z 249) contained the A and B rings, whereas the last one (m/z 218) 
enclosed the D and E rings and part of C ring. Additionally, the base peak was detected at m/z 
189 (IV) which was afforded by the loss of acetate (-60 Da) from the ion at m/z 249 (II).
32,56
 
Other characteristic product ions were detected at m/z 204 (V), owing to C8-C14 and C11-C12 
bonds cleavages.
32
 The identification of taraxasteryl acetate was further confirmed by injection 
of the standard compound, in the same experimental conditions. In the case of ψ-taraxasteryl 
acetate, its identification was based on the similar EI-MS mass and the elution order relatively 
to taraxasteryl acetate.
57
 
 
 
Figure 22: EI mass spectrum and the main fragmentation product ions of taraxasteryl acetate (65). 
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3.2.6.4 Triterpenyl fatty acid esters 
The presence of triterpenyl fatty acid esters in C. cardunculus L. was reported in this 
work for the first time. These compounds were detected in the derivatized dichloromethane 
extracts of C. cardunculus L. var. altilis (DC), by using a short lenght GC column (15 m). 
Figure 23 illustrates the GC-MS chromatogram of the derivatized dicloromethane extract of 
stalks outer part from cultivated cardoon, obtained under these conditions. 
 
 
Figure 23: GC-MS chromatogram obtained with a short column (DB-1 15 m) of the derivatized 
dichloromethane extract of stalks outer part from C. cardunculus L. var. altilis (DC), before alkaline 
hydrolysis. Abbreviations: AC, aromatic compounds; FA, fatty acids; PT, pentacyclic triterpenes; ST, 
sterols; STE, steryl esters. 
 
Four triterpenyl fatty acid esters were identified in the cultivated cardoon 
dichloromethane extracts, by comparing their EI mass data with those earlier described in the 
literature
60
 (Table 10). 
The EI-MS of the peak at RT = 44.39 min (Table 10) showed the molecular ion at m/z 
664 and two characteristic product ions at m/z 409 and m/z 408, owing the loss of 
hexadecanoic acid, through either direct cleavage of the ester bond, or the 1,5 H-transfer 
rearrangement, respectively.
60
 Furthermore, two characteristic product ions were observed, 
due to the EI fragmentation of β-amyryl ion, namely at m/z 218 (base peak) and at m/z 189.32 
Comparing EI-MS data and elution order with those reported in the literature data, this 
compound was tentatively assigned as β-amyryl hexadecanoate.60 
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Table 10: EI mass spectroscopic data of the triterpenyl fatty acid esters identified in the C. cardunculus 
L. var. altilis (DC) dichloromethane extracts. 
RT 
(min) 
Triterpenyl fatty acid 
esters 
[M]+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Id. 
44.39 β-Amyryl hexadecanoate 664 664 [M]+.  (<1), 649 [M-CH3]
+
 (<1), 409                 
[M-CH3(CH2)14CO2]
+
 (1), 408 [M-CH3(CH2)14CO2H]
+
 
(<1), 218 [408-(A+B)]
+
 (100), 203 [218-C28]
+
 (39), 
189 [218-(C11+C28)]
+
 (16) 
32,60
 
45.50 Taraxastarane 
hexadecanoate derivative 
664 664 [M]+.  (2), 649 [M-CH3]
+
 (<1), 409                   
[M-CH3(CH2)14CO2]
+
 (3), 408 [M-CH3(CH2)14CO2H]
+
 
(7), 218 [408-(A+B)]
+
 (7), 204 [408-(A+B+C11)]
+
 
(9), 203 [218-C28]
+
 (13), 189 [204-C28]
+
 (100) 
56,60
 
A, loss of A-ring; B, loss of B-ring; C11, loss of C11; C28, loss of C28; Id., identification. 
 
The chromatographic peak at RT = 44.78 min seems to result from the co-elution of 
two triterpenyl hexadecanoates. Their EI-MS spectra displayed the molecular ion at m/z 664 
and characteristic product ions at m/z 649 [M-CH3]
+
 and 409 [M-CH3(CH2)14COO]
+
. However, 
two fragmentation peaks at m/z 189 and 218 with 100% relative abundance were observed; 
these are generally the base peaks of distinct triterpenic classes, namely lupanes and 
ursanes. Considering the pentacyclic triterpenols identified here, this peak could be attributed 
to lupenyl hexadecanoate (for m/z 189) and α-amyryl hexadecanoate (for m/z 218).61 Despite 
the base peaks of taraxasterol, ψ-taraxasterol and lupeol EI mass spectra being found at m/z 
189, it is not probable that taraxasteryl or ψ-taraxasteryl hexadecanoate (or a mixture) were 
co-eluting with α-amyryl hexadecanoate, since it is known that taraxasteryl hexadecanoate 
elutes after α-amyryl hexadecanoate.62 
Figure 24 illustrates the main fragmentation product ions of the compound observed at 
RT = 45.50 min (Table 10). Its molecular ion was assigned at m/z 664. Moreover, 
characteristic product ions of a triterpenyl hexadecanoate were detected at m/z 649 ([M-CH3]
+
) 
and at m/z 408 ([M-CH3(CH2)14COOH]
+
). Other product ions were noticed at m/z 218, 204 and 
189 (base peak), arising from the EI fragmentation of the taraxastanediene ion (m/z 408).
56,60
 
Furthermore, this compound eluted after α-amyryl hexadecanoate. Therefore, it is most likely 
that this peak corresponds to taraxasteryl hexadecanoate or ψ-taraxasteryl hexadecanoate, or 
a mixture of both. 
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Figure 24: The main fragmentation product ions of taraxasteryl hexadecanoate. 
 
 
3.2.7 Other compounds 
Besides the above families, other compounds were identified in dichloromethane 
extracts of C. cardunculus L. var. altilis (DC), namely inositol (17), 2,3-dihydroxypropyl 
hexadecanoate (35), E-squalene (39) and α-tocopherol (46) (Figure 25). With the exception of 
α-tocopherol,25 these compounds were detected here for the first time as C. cardunculus L. 
components. 
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Figure 25: Structures of inositol (17), 2,3-dihydroxypropyl hexadecanoate (35), E-squalene (39) and α-
tocopherol (46). 
 
The identification of compounds 17, 35, 39 and 46 was performed by comparing the EI 
mass spectroscopic data with the literature (Table 11). 
 
Table 11: EI mass spectroscopic data of the trimethylsilyl ether derivatives of compounds 17, 35, 39 and 
46 identified in the C. cardunculus L. var. altilis (DC) dichloromethane extracts. 
No. 
Compound TMS 
derivative 
[𝐌]
+.  
(m/z) 
EI-MS product ions 
m/z (relative intensity %) 
Id. 
17 Inositol 612 367 (7), 318 (65), 305 [C3H2((CH3)SiO)3]
+
 (49), 265 
(17), 217 (49), 191 (24), 147 (30), 129 (14), 117 (12), 
103 (5), 75 [(CH3)2SiOH]
+
 (55), 73 [(CH3)3Si]
+
 (100), 45 
(7) 
63
 
35 2,3-Dihydroxypropyl 
hexadecanoate 
474 459 [M-CH3]
+
 (6), 371 [M-CH2OSi(CH3)3]
+
 (100), 313 
[C16H31O2Si(CH3)2]
+
 (7), 239 [C16H31O]
+
 (8), 218 [M-
C16H32O2]
+
 (5), 205 [M-C17O2H33]
+
 (17), 203 [M-
C16H32O2-CH3]
+
 (14), 191 [((CH3)3Si)2O2CH]
+
 (3), 147 
[C5H15Si2O]
+
 (35), 129 [(CH3)3SiOC3H4]
+
 (16), 103 
[(CH3)3SiOCH2]
+
 (9), 75 (19), 73 (39) 
64
 
39 E-Squalene 410 410 (1), 341 (3), 299 (1), 231 (2), 191 (3), 175 (4), 161 
(4), 149 (10), 137 [C10H17]
+
 (16), 121 (16), 109 (9), 95 
(20), 81 (70), 69 [C5H9]
+
 (100), 41 (11) 
Wiley 
NIST MS 
library 
46 α-Tocopherol 502 502 [M]
+.  (100), 277 
[C6(CH3)3CH2OSi(CH3)3OCCH2CH3]
+
 (8), 237 
[C6(CH3)3CH2OSi(CH3)3OH]
+
 (76), 221 (7), 193 (3), 75 
(4), 73 (35) 
65
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The EI mass spectrum of the inositol (17) TMS derivative ([M]
+.  at m/z 612) depicts the 
base peak at m/z 73 due to the formation of the [(CH3)3Si]
+
 ion. The peak at m/z 75, regarding 
the [(CH3)2SiOH]
+
 ion, also exhibited high relative abundance. The product ion at m/z 305 also 
revealed high relative abundance, resulting from cleavages on the C1-C2 and C4-C5 bonds.63 
The EI mass spectrum of 2,3-dihydroxypropyl hexadecanoate (35) (monoglyceride) 
TMS diether ([M]
+.  at m/z 612) displayed the base peak at m/z 371 arising from the loss of 
trimethylsilyloxymethyl radical (103 Da), which is characteristic of the EI fragmentation of 
monoglyceride TMS ethers. Other abundant product ion was found at m/z 205, generated by 
the loss of the hexadecanoyl radical.
45
 Characteristic product ions of the EI fragmentation of 
monoglyceride TMS ethers were also observed at m/z 313, 239, 218 and 203, in what 
concerns to product ions originated by the loss of hexadecanoyl derivates.
45
 
The EI mass spectrum of E-squalene (39) ([M]
+.  at m/z 410) demonstrated the base 
peak at m/z 69, due to the cleavage of C4-C5 bond. A product ion at m/z 137 resulted from the 
C8-C9 bond cleavage. 
 Finally, the EI fragmentation of α-tocopherol (46) TMS ether yielded the molecular ion 
at m/z 502, also being the base peak. An intense peak was observed at m/z 237 whose 
product ion arised from the loss of the side aliphatic chain and part of the epoxide. Moreover, 
a low relative abundance peak was detected at m/z 277 due to the loss of side aliphatic 
chain.65 
 
3.3 Quantitative analysis of the identified compounds in C. cardunculus L. var. 
altilis (DC) dichloromethane extracts 
The contents of the several families of lipophilic compounds identified in stalks (outer 
and inner parts), capitula (receptacles, bracts and florets) and leaves from C. cardunculus L. 
var. altilis (DC) are given in Figure 26. Sesquiterpene lactones and pentacyclic triterpenes 
were the main families of cultivated cardoon lipophilic components, whereas fatty acids, 
sterols, long chain aliphatic alcohols and aromatic compounds were present in smaller 
abundances. 
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Figure 26: Major families of lipophilic compounds identified in the dichloromethane extracts of C. 
cardunculus L. var. altilis (DC), before (BH) and after (AH) alkaline hydrolysis. Abbreviations: AC, 
aromatic compounds; FA, fatty acids; LCAA, long chain aliphatic alcohols; N.I. – non-identified 
compounds; PT, pentacyclic triterpenes; SL, sesquiterpene lactones; ST, sterols. 
 
The abundances of specific compounds were quite different between the different 
parts of C. cardunculus L. var. altilis (DC). The concentrations of the different families and 
individual compounds identified in the dichloromethane extracts of cultivated cardoon, before 
and after alkaline hydrolysis, are given in Table 12. The total content of identified compounds 
varied from 2985 mg/kg dw in stalks outer part to 182544 mg/kg dw in leaves. After alkaline 
hydrolysis, the total content of identified compounds decreased in leaves extracts, while it 
increased in the remaining cultivated cardoon extracts. 
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Table 12: Composition (mg of compound/kg dry weight) of dichloromethane extracts from different morphological parts of C. cardunculus L. var. altilis (DC) 
obtained before (BH) and after (AH) alkaline hydrolysis. 
No. Compound 
Content (mg/kg dw) 
Stalks Capitula 
Leaves 
Outer part Inner part 
Receptacles and 
bracts 
Florets 
BH AH BH AH BH AH BH AH BH AH 
 Aromatic compounds 114 
e
 112 
e
 223 
d
 248 
d
 373 
c
 460 
b
 487 
b
 477 
b
 516 
b
 2084 
a
 
1 Benzoic acid 16 
f
 13 
f
 32 
e
 31 
e
 53 
d
 63 
c,d
 63 
c,d
 66 
c
 254 
b
 282 
a
 
3 Vanillin 17 
d
 15 
d
 32 
c
 31 
c
 53 
b
 63 
b
 ‒ ‒ ‒ 279 a 
4 Syringaldehyde 16 
f
 16 
f
 32 
e
 31 
e
 54 
d
 64 
c,d
 83 
b
 76 
b,c
 ‒ 277 a 
5 2,6-Dimethoxyhydroquinone 16 
d
 ‒ 32 c 30 c 52 b ‒ 63 a ‒ ‒ ‒ 
7 Vanillic acid 16 
e
 13 
e
 32 
d
 31 
d
 53 
c
 63 
b,c
 63
 b,c
 66 
b
 ‒ 278 a 
8 3-Vanillylpropanol ‒ 13 d ‒ ‒ ‒ ‒ ‒ 66 c 262 b 360 a 
10 Vanillylpropanoic acid ‒ ‒ ‒ ‒ ‒ ‒ 64 a 67 a ‒ ‒ 
11 Syringic acid 16 
d
 13 
d
 32 
c
 31 
c
 52 
b
 64 
a
 65 
a
 68 
a
 ‒ ‒ 
12 Z-Ferulic acid ‒ 13 d ‒ 31 c ‒ 63 b ‒ ‒ ‒ 281 a 
19 E-Ferulic acid 16 
e
 16 
e
 32 
d,e
 34 
d
 56 
c
 79 
b
 ‒ 69 b,c ‒ 328 a 
48 Scopolin ‒ ‒ ‒ ‒ ‒ ‒ 87 ‒ ‒ ‒ 
 Fatty acids 712 
g
 1499 
f
 1200 
e
 2391 
d
 1354 
e,f
 2748 
c
 2164 
d
 3542 
b
 3721 
b
 16220 
a
 
 Saturated 340 
f
 913 
d,e
 559 
e,f
 1244 
d
 960 
d
 1852 
c
 1186 
d
 2153 
c
 2753 
b
 8489 
a
 
9 Tetradecanoic acid 16 
f
 18 
e,f
 27 
e
 31 
e
 101 
c
 63 
d
 54 
d
 64 
d
 210 
b
 306 
a
 
13 Pentadecanoic acid 15 
e
 28 
d,e
 30 
d
 44 
c,d
 44 
c
 61 
b
 55 
b,c
 65 
b
 ‒ 311 a 
18 Hexadecanoic acid 174 
f
 604 
d,e
 266 
f
 765 
c,e
 490 
d,e
 1038 
b
 545 
d,e 
1009 
b,c
 638 
d,e
 4011 
a
 
21 Heptadecanoic acid 15 
f
 23 
e,f
 26 
e,f
 32 
d,e,f
 44 
d,e
 88 
c
 52 
d
 79 
c
 203 
b
 290 
a
 
27 Octadecanoic acid 31 
g
 67 
e,f
 47 
f
 92 
e,f
 90 
d,f
 179 
b,c
 98 
d,e
 162 
c
 222 
b
 765 
a
 
28 Nonadecanoic acid 13 
d
 11 
d
 24 
c
 24 
c
 ‒ 49 b 48 b 53 b ‒ 237 a 
31 Eicosanoic acid 21
 f
 39 
e,f
 29 
e,f
 41 
e,f
 50 
d,e
 72 
d
 72 
d
 101 
c
 224 
b
 544 
a
 
33 Heneicosanoic acid 13 
e
 18 
d,e
 25 
d
 25 
d
 41 
c
 51 
b
 52 
b
 56 
b
 ‒ 238 a 
  
No. Compound 
Content (mg/kg dw) 
Stalks Capitula 
Leaves 
Outer part Inner part 
Receptacles and 
bracts 
Florets 
BH AH BH AH BH AH BH AH BH AH 
36 Docosanoic acid 14 
f
 23 
e,f
 27 
e,f
 34 
e,f
 48 
d,e
 69 
c,d
 91 
c
 191 
b
 221 
b
 408 
a
 
37 Tricosanoic acid 14 
f
 16 
f
 29 
e
 28 
e
 ‒ 57 d 54 d 67 c 209 b 255 a 
40 Tetracosanoic acid 15 
g
 21 
f,g
 28 
f,g
 34 
f
 51 
e
 72 
d
 65 
d,e
 104 
c
 251 
b
 347 
a
 
42 Pentacosanoic acid ‒ 13 c ‒ 25 b ‒ 53 a ‒ 57 a ‒ ‒ 
44 Hexacosanoic acid ‒ 17 c ‒ 38 c ‒ ‒ ‒ 71 c 345 b 430 a 
51 Octacosanoic acid ‒ 17 c ‒ 31 c ‒ ‒ ‒ 76 c 230 b 347 a 
 Unsaturated 360 
e
 573 
e
 616 
e
 1122 
c
 394 
e
 896 
c
 917 
c
 1389 
b
 968 
c
 7731 
a
 
15 (9Z)-Hexadec-9-enoic acid 13 
e
 11 
e
 25 
d
 25 
d
 41 
c
 52 
b
 48 
b,c
 52 
b
 ‒ 220 a 
16 (9E)-Hexadec-9-enoic acid 13 
d 
(16+17) 
12 
d
 26 
c
 
(16+17) 
25 
c
 ‒ 51 b 49 b 
(16+17) 
54 
b ‒ 233 a 
23 (9Z,12Z)-Octadeca-9,12-dienoic acid 181 
g,h
 349 
d,g,h
 374 
d,h
 749 
c
 163 
f,g
 420 
d,e
 511 
d
 887 
b 
233 
e,f,h
 1358 
a
 
24 (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid 47 
c,f
 64 
e,f
 108 
c,d,f
 169 
b,c,d
 81 
d,e
 190 
b,c
 175 
b
 214 
b
 260 
b
 4878 
a
 
25 (9Z)-Octadec-9-enoic acid 88 
c
 121 
c
 53 
d
 112 
c
 63 
c
 121 
c
 71 
c
 106 
c
 232 
b
 683 
a
 
26 (9E)-Octadec-9-enoic acid 17 
e
 17 
e
 30 
d,e
 41 
c,d,e
 45 
c,d
 62 
c,d
 62 
c,d
 76 
c
 243 
b
 359 
a
 
 Hydroxyfatty acids 13 
c
 13 
c
 25 
b
 26 
b
 ‒ ‒ 61 a ‒ ‒ ‒ 
2 2-Hydroxyheptanoic acid 13 
b
 13 
b
 25 
a
 26 
a
 ‒ ‒ ‒ ‒ ‒ ‒ 
6 2-Hydroxyundecanoic acid ‒ ‒ ‒ ‒ ‒ ‒ 61 ‒ ‒ ‒ 
 Long chain aliphatic alcohols 181 
e,f,g
 182 
e,f,g
 146 
g
 305 
d,f
 332 
d,e
 977 
c
 385 
d
 866 
c
 1764 
b
 3170 
a
 
14 Hexadecan-1-ol 26 
e
 23 
e
 49 
d,e
 51 
d,e
 ‒ 190 c 96 d 154 c 391 b 470 a 
20 (9Z)-Octadec-9-en-1-ol 28 
b
 24 
b
 ‒ ‒ ‒ 238 a ‒ ‒ ‒ ‒ 
22 Octadecan-1-ol 25 
e
 22 
e
 49 
d,e
 49 
d,e
 81 
c,d
 147 
b
 96 
c
 143 
b
 ‒ 456 a 
30 Eicosan-1-ol ‒ 21 c ‒ 48 b ‒ 98 a ‒ 104 a ‒ ‒ 
34 Docosan-1-ol 26 
e
 23 
e
 ‒ 48 d 83 c 99 b,c 96 b,c 107 b ‒ 494 a 
38 Tetracosan-1-ol 25 
f
 21 
f
 48 
e
 51 
e
 85 
d
 103 
c
 97 
c,d
 111 
c
 442 
b
 550 
a
 
43 Hexacosan-1-ol 26 
d
 24 
d
 ‒ ‒ 83 c 102 c ‒ 124 c 509 b 588 a 
47 Octocosan-1-ol 25 
d
 24 
d
 ‒ 58 d ‒ ‒ ‒ 123 c 422 b 612 a 
  
No. Compound 
Content (mg/kg dw) 
Stalks Capitula 
Leaves 
Outer part Inner part 
Receptacles and 
bracts 
Florets 
BH AH BH AH BH AH BH AH BH AH 
 Sesquiterpene lactones 301 
b
 244 
b
 184 
b
 397 
b
 16 
b
 46 
b
 ‒ 9 
b
 94571 
a
 103028 
a
 
29 Grosheimin 13 
b
 ‒ 20 b ‒ ‒ ‒ ‒ ‒ 6248 a 819 b 
32 Deacylcynaropicrin 9 
b
 244 
b
 10 
b
 397 
b
 ‒ 46 b ‒ 9 b 841 b 102208 a 
41 Cynaropicrin 279 
b
 ‒ 154 b ‒ 16 b ‒ ‒ ‒ 87482 a ‒ 
 Sterols 320 
e
 591 
e
 470 
e
 694 
d,e
 1102 
c,d
 1295 
b,c
 1441 
b,c
 1727 
b
 1328 
b,c
 3346 
a
 
45 Cholesterol 10 
c
 13 
c
 ‒ ‒ ‒ ‒ ‒ 63 b ‒ 276 a 
49 24-Methylenecholesterol ‒ 7 c ‒ 17 c ‒ ‒ 54 b 65 b ‒ 193 a 
50 Campesterol 26 
f
 46 
e,f
 41 
e,f
 56 
e,f
 81 
c,e
 117 
c,d
 150 
b
 190 
b
 151 
b,d
 248 
a
 
52 Stigmasterol 129 
e
 221 
d
 252 
d
 324 
b,d
 523 
b,c
 542 
b,c
 459 
b,c
 461 
b,c
 338 
b,d
 588 
a,c
 
54 β-Sitosterol 131 d 275 c,d 140 d 257 c,d 392 b,d 637 b 498 b,c 708 b 639 b 1716 a 
55 β-Sitostanol 25 c 30 b,c 38 b,c 40 b 106 a ‒ ‒ ‒ ‒ ‒ 
56 Δ5-Avenasterol ‒ ‒ ‒ ‒ ‒ ‒ 280 b,c 239 b,d 200 d 325 a,c 
 Pentacyclic triterpenes 933 
d
 937 
d
 7934 
c
 7941 
c
 22107 
a
 22114 
a
 27556 
a
 27558 
a
 13851 
b
 13857 
b
 
53 β-Amyrin 33 f 100 f 81 f 1090 e 2348 c 3520 b 1197 e 6041 a 290 f 1828 d 
57 α-Amyrin 41 f 81 e,f 63 d,f 1144 c 1886 b 2796 a 757 c,d,e 3030 a 80 e,f 300 e,f 
58 Lupeol 62 
e,g
 136 
e,g
 48 
d,g
 774 
d,f,g
 1397 
c,f
 2265 
b,a
 372 
d,e
 1892 
b,c
 524 
e,g
 2853 
a
 
59 β-Amyrin acetate 63 c traces 1003 b traces 1164 b traces 4844 a traces 1538 b traces 
60 α-Amyrin acetate 40 c traces 1081 b traces 910 b traces 2271 a traces 214 c traces 
61 Lupenyl acetate 74 
d
 traces 727 
c,d
 traces 868 
b,c
 traces 1521 
b
 traces 2330 
a
 traces 
62 ψ-Taraxasterol 46 e 105 e 143 e 1331 d 2530 c 3962 b 1351 d 6014 a 705 d,e 2925 c 
63 Taraxasterol 178 
d
 515 
d
 146 
d
 3601 
c
 5306 
b,c
 9571 
a
 1638 
d
 10581 
a
 1144 
d 
5950 
b
 
64 ψ -Taraxasteryl acetate 59 d traces 1188 c traces 1432 c,b traces 4663 a traces 2221 b traces 
65 Taraxasteryl acetate 336 
c
 traces 3455 
b
 traces 4265 
b
 traces 8942 
a
 traces 4806 
b
 traces 
            
            
  
No. Compound 
Content (mg/kg dw) 
Stalks Capitula 
Leaves 
Outer part Inner part 
Receptacles and 
bracts 
Florets 
BH AH BH AH BH AH BH AH BH AH 
 Others 4 
c
 ‒ 11 
c
 2 
c
 8 
c
 ‒ 12 
c
 ‒ 1221 
a
 528 
b
 
17 Inositol (16+17) ‒ (16+17) ‒ ‒ ‒ (16+17) ‒ 34 ‒ 
35 2,3-Dihydroxypropyl hexadecanoate 4 
c,d
 ‒ 11 b 2 d 8 b,c ‒ 12 b ‒ 23 a ‒ 
39 E-Squalene ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 158 a 130 a 
46 α-Tocopherol ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 1007 a 399 b 
 Non-identified compounds 419 
c
 714 
c
 609 
c
 515 
c
 825 
c
 643 
c
 1648 
c
 1152 
c
 65572 
a
 17773 
b
 
 Total detected compounds 2985 
d
 4280 
c,d
 10776 
d,e
 12492 
b,d,e
 26116 
b,c,e
 28283 
b,e
 33692 
b,e
 35331 
b
 182544 
a
 160007 
a
 
Results represent the means estimated from the analysis of two extracts injected in duplicate (standard deviation less than 5%). Means with different letters within 
the same row are significantly different (p < 0.05). Numbers in parenthesis correspond to compounds whose peaks were overlapped. 
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3.3.1 Sesquiterpene lactones 
Leaves demonstrated the highest sesquiterpene lactones content (Table 12), 
accounting for 94571 mg/kg dw which represented 52% of the total detected compounds 
content. The remaining morphological parts of cultivated cardoon contained considerably 
lower sesquiterpene lactone contents, ranging from 16 mg/kg dw in receptacles and bracts, to 
301 mg/kg dw in stalks outer part. These compounds were absent in capitula florets. 
Cultivated cardoon leaves exhibited the highest amount of cynaropicrin (41), 
contributing for 87482 mg/kg dw (Table 12). Cynaropicrin was present at much lower contents 
in stalks (154-279 mg/kg dw), and in receptacles and bracts (16 mg/kg dw). Previously, 
Schneider and Thiele
66
 demonstrated that the artichoke bitter principle, quantified as 
cynaropicrin, was mainly retained in leaf laminas (0.5-4.5% dw), and absent in the roots and 
developed capitula. Menin, et al.
67
 also noticed much higher cynaropicrin content in mature 
and old leaves than in receptacles of artichoke (23- and 33-fold, respectively). It is worthy to 
refer that cultivated cardoon cynaropicrin content, shown in this study, was 3.9-fold higher 
relatively to the commercial artichoke leaves extracts, available in the European market.
6
 
Grosheimin (29) and deacylcynaropicrin (32) represented respectively 4-11% and 1-
5% of the total sesquiterpene lactones contents (Table 12). Grosheimin was detected in 
considerable quantities in the leaves (6248 mg/kg dw), and at minor amounts in both parts of 
stalks. Deacylcynaropicrin was also concentrated in cultivated cardoon leaves (841 mg/kg 
dw). 
After alkaline hydrolysis, slightly higher amounts of sesquiterpene lactones were 
observed (Table 12). This may be related to the deacylcynaropicrin concentration in the 
hydrolyzed extracts, which was much higher than the sum of cynaropicrin and 
deacylcynaropicrin contents in the dichloromethane extracts. Deacylcynaropicrin or 
cynaropicrin may be esterified to high molecular weight compounds. On the contrary, the 
grosheimin abundance decreased 7.6-fold after alkaline hydrolysis (Table 12), probably being 
retained in the aqueous phase. 
 
3.3.2 Pentacyclic triterpenes 
Capitula exhibited the highest contents of pentacyclic triterpenes, accounting for 27556 
mg/kg dw in florets and 22107 mg/kg dw in receptacles and bracts (Table 12). These 
compounds were also found in the other morphological parts of cultivated caroon, varying 
between 933 mg/kg dw in stalks outer part and 13851 mg/kg dw in leaves. This family of 
lipophilic compounds ranged from 8% in the leaves to 84% in the receptacles and bracts, 
regarding the total amount of detected compounds. 
Taraxastanes (62-65) revealed the highest abundance, among pentacyclic triterpenes, 
representing 60-66% of the total pentacyclic triterpene content. Florets presented the highest 
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amount of taraxasteryl acetate (65) (8942 mg/kg dw), while receptacles and bracts showed the 
highest taraxasterol (63) content (5306 mg/kg dw). Oleananes, such as β-amyrin (53) and its 
acetate derivative (59), were noted at considerable amounts (10-22% of the total pentacyclic 
triterpenic content), followed by lupanes, like lupeol (58) and lupenyl acetate (61) (7-21% of 
total pentacyclic triterpene contents), and ursanes, such as α-amyrin (57) and its acetate 
derivative (60) (2-14% of the total pentacyclic triterpenic content). 
The content of pentacyclic triterpene alcohols slightly increased in all hydrolyzed 
extracts of cultivated cardoon. This variation can be related to alkaline hydrolysis of either the 
corresponding acetates or of the triterpenyl fatty acid esters. 
 
3.3.3 Fatty acids 
Fatty acids (Table 12) were mainly concentrated in leaves (3721 mg/kg dw). In the 
remaining parts of cultivated cardoon, the contents of these compounds varied from 712 
mg/kg dw in stalks outer part to 2164 mg/kg dw in florets. Moreover, this group represented 
12-24% of total amount of detected compounds, in the inner and outer parts of stalks, 
respectively. Both saturated and unsaturated fatty acids were identified in C. cardunculus L. 
var. altilis (DC) at appreciable amounts, accounting respectively for 44-70% and 25-49% of the 
total fatty acids content. 
Saturated fatty acids were predominantly observed in leaves (2753 mg/kg dw), while 
unsaturated fatty acids were mainly found in leaves and florets (968 and 917 mg/kg dw, 
respectively). Hexadecanoic acid (18) and 9Z,12Z-octadeca-9,12-dienoic acid (23) were 
respectively the predominant saturated and unsaturated fatty acid (638 mg/kg dw in leaves 
and 511 mg/kg dw in florets, respectively). After alkaline hydrolysis, fatty acids contents 
increased in all extracts, particularly in what regards to leaves (4-fold). 9Z,12Z,15Z-Octadeca-
9,12,15-trienoic acid (24) was the major fatty acid present in hydrolyzed extracts of leaves 
(4878 mg/kg dw), followed by hexadecanoic acid (4011 mg/kg dw). Furthermore, higher 
contents of odd-numbered saturated fatty acids were found in the hydrolyzed extracts. 
 
3.3.4 Long chain aliphatic alcohols 
Long chain aliphatic alcohols (Table 12) were present at quite low amounts, varying 
from 146 mg/kg dw in stalks inner part to 1764 mg/kg dw in leaves. These compounds ranged 
from 1% in leaves to 6% in stalks outer part, relatively to the total detected compounds 
content. Hexacosan-1-ol (14) was the major compound present in leaves (509 mg/kg dw), 
before alkaline hydrolysis. After alkaline hydrolysis, long chain aliphatic alcohols contents 
increased in cultivated cardoon extracts (with the exception of stalks outer part), principally in 
those of receptacles and bracts (2.9-fold). Moreover, eicosan-1-ol (30) was only detected after 
alkaline hydrolysis in all morphological parts, with the exception of leaves. 
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3.3.5 Sterols 
Sterols were detected in all morphological parts of cultivated cardoon at low 
abundance (Table 12), ranging from 320 mg/kg dw in stalks outer part to 1441 mg/kg dw in 
florets. This family of compounds represented between 1% in leaves and 11% in stalks outer 
part, regarding the total detected compounds content. Stigmastanes (52, 54-56) were the main 
sterol class (86-93% of the total sterols content). β-Sitosterol (54) was mainly found in leaves 
(639 mg/kg dw), florets (498 mg/kg dw) and in receptacles and bracts (392 mg/kg dw). 
Stigmasterol (52) was also found in the same content order. Campesterol (50) was found at 
lower content (26-151 mg/kg dw). 24-methylenecholesterol (49) and cholesterol (45) were 
observed in very low contents in florets and in stalks outer part, respectively. 
After alkaline hydrolysis, the sterol content increased in leaves hydrolyzed extracts 
(2.5-fold). This is in agreement with the presence of esterified sterols structures in the GC-MS 
chromatograms obtained with a short length column. It is also worth mentioning that the sterol 
content variation with hydrolysis is not related to the presence of steryl glycosides.
68
 
 
3.3.6 Aromatic and other compounds 
Aromatic compounds (Table 12) varied from 114 mg/kg dw in stalks outer part to 516 
mg/kg dw in leaves. This group corresponded to 0.3% in leaves and 4% in stalks outer part, 
relatively to total detected compounds content. 3-Vanillylpropanol (8) was mainly found in 
leaves (262 mg/kg dw). Scopolin (48) was only detected in capitula florets (87 mg/kg dw). 
Hydrolyzed extracts of receptacles and bracts, and leaves demonstrated higher 
contents of aromatic compounds (1.2- and 4-fold, respectively). Z-ferulic acid (12) was only 
noted in hydrolyzed extracts, with the exception of florets, which can be related with the fact 
that hydroxycinnamic acids tend to be esterified with lignin- and polysaccharides-like 
components.
27,68,69
 
Finally, 2,3-dihydroxypropyl hexadecanoate and E-squalene were also found in C. 
cardunculus L. var. altilis (DC) in reduced amounts; α-tocopherol was only detected in leaves 
(1007 mg/kg dw). 
 
4. Conclusions 
This chapter reflects one of the first detailed studies about the lipophilic composition of 
stalks (outer and inner parts), capitula (receptacles, bracts and florets) and leaves of C. 
cardunculus L. var. altilis (DC) from the south of Portugal. Sixty five compounds were 
identified in the dichloromethane extracts of cultivated cardoon, before and after alkaline 
hydrolysis, by GC-MS analysis. 
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Sesquiterpene lactones were the main lipophilic compounds of cultivated cardoon 
leaves, accounting for ≈94.5 g/kg dw. Cynaropicrin (41) was the most abundant sesquiterpene 
lactone in cultivated cardoon leaves, accounting for ≈87.4 g/kg dw. Recently, Eljournadi, et 
al.
70
 quantified cynaropicrin in artichoke tissues, at different developmental stages. They 
observed that cynaropicrin was mainly retained in leaves (9.6 g/kg dw), at the earliest stage of 
plant development (6 weeks old). They also reported that wild cardoon leaves contained 
approximately 7 g/kg dw of cynaropicrin. In this manner, the studied cultivated cardoon leaves 
revealed much higher cynaropicrin content, regarding artichoke (9.1-fold) and wild cardoon 
(≈12.5-fold).70 According to Eljournadi, et al.,70 the cynaropicrin content decreased 87.5% in 
the receptacles during its development, until it reached the commercial stage. Cynaropicrin 
content of the studied cultivated cardoon receptacles and bracts, collected in the florescence 
stage, was 3.1-fold lower relatively to artichoke edible capitula (0.05 g/kg dw).
70
 Moreover, 
deacylcynaropicrin (32) was identified for the first time in the C. cardunculus L. var. altilis (DC) 
lipophilic fraction. Meanwhile, Rial, et al.
71
 isolated grosheimin and cynaropicrin from wild 
cardoon leaves. 
Pentacyclic triterpenes were the main lipophilic components of stalks and capitula, 
accounting for ≈27.5 g/kg dw of florets. Taraxasteryl acetate (65) was the main compound of 
this family (≈8.9 g/kg dw in florets), followed by taraxasterol (63) (≈5.3 g/kg dw in receptacles 
and bracts), particularly concentrated in the capitula parts. Receptacles, bracts and florets of 
cultivated cardoon showed considerable taraxasterol and ψ-taraxasterol contents (≈7.8 and 
≈2.9 g/kg dw, respectively), being comparable to other Asteraceae plants, for instance flowers 
of Calendula officinalis (≈2.1-4.1 g/kg dw).72 Lupenyl acetate (61) was detected here for the 
first time in C. cardunculus L. species. Besides this pentacyclic triterpene, two more were 
identified in this work, for the first time, as cultivated cardoon components, namely β-amyrin 
acetate (59), α-amyrin acetate (60) and ψ-taraxasteryl acetate (64). 
 Low contents of other families of lipophilic compounds were also noted in the 
morphological parts of cultivated cardoon, namely fatty acids (≈3.7 g/kg dw in leaves), long 
chain aliphatic alcohols (≈1.7 g/kg dw in leaves), sterols (≈1.4 g/kg dw in florets) and aromatic 
compounds (≈0.5 g/kg dw in leaves). Meanwhile, Farag, et al.73 identified 9Z,12Z,15Z-
octadeca-9,12,15-trienoic acid and two isomers of hydroxyoctadecadienoic and 
hydroxyoctadecatrienoic acids in artichoke leaves. 
Since sesquiterpene lactones and pentacyclic triterpenes, namely cynaropicrin and 
taraxasteryl acetate, are known, respectively, for tumor antiproliferative
30
 and anti-
inflammatory
24
 properties,
 
this study is an important contribution for C. cardunculus L. var. 
altilis (DC) valorization as a promising source of bioactive compounds. Finally, the extraction 
of high-value bioactive compounds can be perfectly integrated within the potential large-scale 
Chapter III – Chemical characterization of C. cardunculus L. var. altilis (DC) lipophilic fraction 
 
153 
applications of cultivated cardoon, as raw material for energy conversion and for pulp fibers 
production. 
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Abstract 
The phenolic composition of Cynara cardunculus L. var. altilis (DC) from the south of 
Portugal was determined by analyzing the methanol/water/acetic acid (49.5:49.5:1) extracts of 
the different morphological parts of the plant, through high temperature-ultra high pressure 
liquid chromatography-tandem mass spectrometry. Among the 28 phenolic compounds 
identified, eriodictyol hexoside was described for the first time in C. cardunculus L., and 1,4-di-
O-caffeoylquinic acid, naringenin 7-O-glucoside, naringenin rutinoside, naringenin, luteolin 
acetylhexoside and apigenin acetylhexoside as cultivated cardoon components. Phenolic 
compounds were essentially retained in the capitula florets, accounting for ≈12.6 g/kg dw. 
Both outer and inner parts of stalks showed the highest hydroxycinnamic acids content (≈10.3 
g/kg dw and ≈9.9 g/kg dw, respectively), and capitula florets demonstrated the major 
flavonoids concentration (≈10.3 g/kg dw). Receptacles and bracts also evidenced considerably 
high hydroxycinnamic acids contents, while flavonoids were the main phenolic compounds 
found in leaves. The 5-O-caffeoylquinic and 1,5-di-O-caffeoylquinic acids represented the 
main mono and dicaffeoylquinic acids, whereas apigenin glucuronide, 7-O-glucoside and 7-O-
rutinoside were the major flavonoids of cultivated cardoon. 
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1. Introduction 
Cynara cardunculus L. (Asteraceae) is a Mediterranean species that includes the 
ancestor wild cardoon (var. sylvestris (Lamk) Fiori) and its two cultivated forms, named as 
globe artichoke (var. scolymus (L.) Fiori) and cultivated cardoon (var. altilis (DC)).
1
 Wild 
cardoon grows naturally in the Iberian Peninsula, north Africa, west Turkey and Macaronesia 
(Madeira and Canary Islands), while artichoke is produced all over the world, with special 
relevance in Italy, Spain, France and Turkey, owing to the edible immature capitula.
2
 The 
production of cultivated cardoon is located in Spain, Italy and France,
3
 once the blanched 
fleshy stems and leaf petioles are much enjoyed in the regional plates. Cultivated cardoon is 
very resistant to the hot summers and dry soils of the Mediterranean countries, yielding 
biomass productivity which ranges from 15.2 to 24.2 t/ha/year.
4
 Given this productivity and the 
high contents in cellulose and hemicelluloses, this plant has been also regarded as a 
multipurpose crop for several industrial applications, namely pulp fibers production and as 
solid biofuel.
4
 
Traditionally, water extracts of wild cardoon capitula are utilized in the Iberian 
Peninsula for manufacturing of protected designation of origin cheeses, once aspartic 
proteinases (cardosins A and B) are implicated in the milk clotting.
5
 Since the ancient times, 
infusions of artichoke and cardoon leaves have been used in the folk medicine, owing to their 
hepatoprotective,
6
 choleretic and anticholestatic actions.
7
 These physiological effects have 
been mostly attributed to phenolic compounds, in particular to caffeoylquinic acids and 
flavones, such as 5-O-caffeoylquinic and 1,3-di-O-caffeoylquinic acids,
6
 luteolin and luteolin 7-
O-glucoside.
7
 Moreover, several studies also proved other biological activities of artichoke and 
cardoon extracts, containing phenolic compounds, namely antioxidant,
8–10
 antimicrobial,
8,11,12
 
anti-inflammatory,
13
 and antitumor
9,14
 properties. 
Several studies have been carried out on the phenolic composition of both varieties of 
cardoon.
8,15–18
 Nevertheless, there is still missing a systematic detailed chemical 
characterization of the phenolic compounds, regarding all morphological parts of cultivated 
cardoon. The knowledge about the chemical composition of cultivated cardoon is essential to 
increase its economic value, and consequently to host its production in the Mediterranean 
countries. After the chemical characterization of the lipophilic fraction,
19
 the objective of this 
work is to determine the phenolic composition of stalks (outer and inner parts), capitula 
(receptacles, bracts and florets) and leaves of C. cardunculus L. var. altilis (DC) from Baixo 
Alentejo region (south of Portugal), by analyzing the chemical composition of their 
methanol/water/acetic acid (49.5:49.5:1) extracts, through high temperature-ultra high-
performance liquid chromatography (HT-UHPLC) coupled to diode array detector (DAD) and 
tandem mass spectrometry analysis (MS
n
). Moreover, the total phenolic contents of cultivated 
cardoon extracts are also determined by the Folin Ciocalteu assay. 
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2. Materials and Methods 
2.1 Chemicals 
Dichloromethane (p.a., ≥99% purity), methanol (p.a., ≥99.8% purity), HPLC-grade 
methanol, water and acetonitrile were supplied by Fisher Scientific (Pittsburgh, Pennsylvania, 
USA). Glacial acetic acid (p.a., ≥99.7% purity) was purchased from Panreac (Castellar del 
Vallès, Spain). Sodium carbonate (p.a., ≥99.9% purity) was obtained from Pronalab (Lisbon, 
Portugal). Gallic acid (≥97.5% purity), Folin Ciocalteu’s phenol reagent (2N), 3- and 5-O-
caffeoylquinic acids (≥98% and ≥95% purity, respectively) and luteolin 7-O-glucoside (≥98% 
purity) were supplied from Sigma Chemicals Co. (Madrid, Spain). Formic acid (≥98% purity) 
was purchased from Fluka Chemie (Madrid, Spain). 1,5-Di-O-caffeoylquinic acid (≥98 purity) 
was obtained from Biopurify (Chengdu Biopurify Phytochemicals Ltd., Chengdu, China). 
Scopoletin (≥95% purity), naringenin 7-O-glucoside (≥99% purity), apigenin 7-O-glucoside 
(≥99% purity) and apigenin 7-O-rutinoside (≥98.5% purity) were supplied by Extrasynthese 
(Lyon, France). Solvents were filtered using a Solvent Filtration Apparatus 58061 from 
Supelco (Bellefonte, Pennsylvania, USA). 
 
2.2 Samples preparation 
C. cardunculus L. var. altilis (DC) was collected at the flowering stage, in June 2010, at 
the Experimental Center of the Agriculture School from Instituto Politécnico de Beja, south of 
Portugal. Plants were separated in stalks, capitula and leaves, and preserved at -20 ºC until 
analysis. Before extraction, samples were freeze-dried. Then, stalks were separated in outer 
and inner parts and capitula in receptacles, bracts and florets. 
 
2.3 Extraction 
All plant fractions were grounded to a granulometry of 40‒60 mesh prior to extraction. 
Each sample (6 g dw) was submitted to Soxhlet extraction with dichloromethane (150 mL) for 
7 h to remove the lipophilic fraction, as explained elsewhere.
19
 Then, the extraction of phenolic 
compounds was carried out as previously cited.
20
 Briefly, 2 g of the dry leftover solid residue 
was extracted with 200 mL of methanol/water/acetic acid (49.5:49.5:1) under constant stirring, 
protected from the light, for 24 h at room temperature. The suspensions were then filtered; 
methanol and acetic acid were removed by low pressure evaporation (37-40 ºC) and water by 
freeze-drying. The dried extracts were weighted, and the extraction yield determined as the 
percentage of dry biomass material (w/w, %). The extracts were kept at room temperature 
protected from light until analysis. Two extracts were prepared for each morphological part of 
cultivated cardoon. 
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2.4 Total phenolic content 
The total phenolic content (TPC) was determined using the Folin Ciocalteu assay, 
according to the procedure employed by Dewanto, et al.
21
 Dry extracts were firstly dissolved in 
methanol/water (1:1), with concentrations ranging from 2 to 3 mg/mL. Then, 0.125 mL of each 
extract was mixed with 0.625 mL of Folin Ciocalteu’s reagent, previously diluted with water 
(1:5, v/v). After 6 min, 1.25 mL of 7% sodium carbonate aqueous solution and 1 mL of water 
were added. The reaction mixtures were allowed to stand in the dark for 60 min at room 
temperature. The absorbance was then read against a blank at 760 nm, using a UV/Vis V-530 
spectrophotometer (Jasco, Tokyo, Japan). The TPC was calculated as gallic acid equivalents 
(GAE) from the gallic acid standard curve (40-180 μg/mL), and expressed as mg GAE/g dry 
extract and as mg GAE/kg dw. The analyses were carried out in triplicate for each extract and 
the average value from the two extracts was calculated for each morphological part. 
 
2.5 HT-UHPLC-UV analysis 
The extracts of cultivated cardoon were previously dissolved in HPLC grade 
methanol/water mixture (1:1) at 10 mg/mL, and then filtered through a 0.2 μm 
polytetrafluoroethylene syringe filter. Methanol/water extracts (5 μL) were injected in the HPLC 
system equipped with an Accela 600 LC pump, an Accela autosampler (set at 16 ºC) and an 
Accela 80 Hz photo DAD. The separation of compounds was carried out on a Hypersil Gold 
RP C18 column (100 x 2.1 mm; 1.9 μm particle size) supplied by Thermo Fisher Scientific 
(San Jose, California, USA), maintained at 45 ºC. The mobile phase was constituted by (A) 
water:acetonitrile (99:1, v/v) and (B) acetonitrile, both with 0.1% of formic acid. A gradient 
elution program was applied at a flow rate of 0.48 mL/min during a 38 min period. The 
percentage of B was kept at 3% from 0 to 5 min, and then reached 12.0% from 5 to 14 min, 
12.8% from 14 to 14.50 min, 13.3% from 14.5 to 18.5 min, 14.5% from 18.5 to 24 min, 30% 
from 24 to 34 min and, finally 100% from 34 to 38 min. Before the next run, the percentage of 
B decreased from 100% to 3% during 4.5 min and it was maintained at 3% for 4.5 min. The 
chromatograms were recorded at 280, 330 and 350 nm and UV-Vis spectra recorded from 210 
to 600 nm. 
 
2.6 HT-UHPLC-MSn analysis 
The HT-UHPLC-MS
n
 analysis was performed following previously optimized 
conditions.
20
 The HPLC system was coupled to a LCQ Fleet ion trap mass spectrometer 
(ThermoFinnigan, San Jose, California, USA), equipped with an electrospray ionization (ESI) 
source. The ESI-MS was operated under the negative ionization mode with a spray voltage of 
5 kV and capillary temperature of 360 ºC. The flow rate of nitrogen sheath and auxiliary gas 
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were 50 and 10 (arbitrary units), respectively. The capillary and tube lens voltages were set at 
-28 V and -115 V, respectively. CID‒MSn experiments were performed on mass-selected 
precursor ions in the range of m/z 100‒2000. The isolation width of precursor ions was 1.0 
mass units. The scan time was equal to 100 ms and the collision energy was 35%, using 
helium as collision gas. The data acquisition was carried out by using Xcalibur
®
 data system 
(ThermoFinnigan, San Jose, California, USA). 
 
2.7 Quantification of phenolic compounds by HT-UHPLC-UV 
Standard curves were obtained by HPLC injection of 5-O-caffeoylquinic and 1,5-di-O-
caffeoylquinic acids, scopoletin, naringenin 7-O-glucoside, luteolin 7-O-glucoside and apigenin 
7-O-glucoside standard solutions in HPLC grade methanol/water (1:1), with six different 
concentrations ranging from 0.1 to 350 μg/mL. The quantification of individual compounds was 
done by using the linear equation (Table 1), obtained with the most similar standard 
compound. Accordingly, monocaffeoylquinic acids were quantified by using the 5-O-
caffeoylquinic acid standard curve, while dicaffeoylquinic and dicaffeoylsuccinoylquinic acids 
were quantified with the 1,5-di-O-caffeoylquinic acid standard curve. The scopoletin standard 
curve was used for the quantification of coumarins. The concentrations of naringenin, luteolin 
and apigenin derivatives were determined by using, respectively, the standard curve of 
naringenin 7-O-glucoside, luteolin 7-O-glucoside and apigenin 7-O-glucoside. Concentrations 
were assessed in triplicate for each extract, and the mean value of two extracts was calculated 
for each morphological part. 
 
Table 1: Standard data used for the HT-UHPLC-UV quantification of phenolic compounds of 
methanol/water/acetic acid extracts from C. cardunculus L. var. altilis (DC). 
Standard compound  (I) 
(nm) 
Conc. 
range 
(μg/mL) 
Linear equation 
(II)
 r
2
 
LOD 
(III)
 
(μg/mL) 
LOQ 
(IV) 
(μg/mL) 
5-O-Caffeoylquinic acid 330 0.5-350 y = 115495x + 316815 0.9992 13.26 44.18 
1,5-Di-O-caffeoylquinic 
acid 
330 0.5-350 y = 118780x + 330317 0.9992 13.20 43.99 
Scopoletin 330 0.5-20 y = 188470x ‒ 25906 0.9991 0.76 2.54 
Naringenin 7-O-glucoside 280 0.5-100 y = 100708x + 108220 0.9988 4.42 14.72 
Luteolin 7-O-glucoside 350 0.1-40 y = 193015x ‒ 50750 0.9998 0.71 2.38 
Apigenin 7-O-glucoside 330 0.5-100 y = 95591x + 14374 0.9987 4.66 15.52 
(I)
 Detection wavelength. 
(II)
 y = peak area, x = concentration in μg/mL. (III) LOD, limit of detection. (IV) 
LOQ, limit of quantification. 
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2.8 Statistical analysis 
The quantitative analysis data were analyzed using the MIXED procedure option of 
SAS (SAS Institute Inc., Cary, North Carolina, USA), considering morphological parts of C. 
cardunculus L. var. altilis (DC) and extracts as fixed and random effects, respectively. Where 
differences existed, the source of the differences at p < 0.05 of significance level was identified 
by all pairwise multiple comparison procedure. The Tukey’s test was used for pairwise 
comparisons. 
 
3. Results and Discussion 
3.1 Extractives yield and total phenolic content 
The extractives yields for the different parts of C. cardunculus L. var. altilis (DC), using 
methanol/water/acetic acid (49.5:49.5:1), as well as the corresponding TPC, determined 
through the Folin Ciocalteu assay, are shown in Table 2. 
The highest extractives yield was obtained from the capitula florets, being almost the 
double of the one provided by stalks outer part (Table 2). Comparing with the literature data, 
the extractives yields obtained in this work with both parts of capitula were higher than those 
previously indicated for methanol extracts of artichoke capitula (13.2%).
22
 Nonetheless, the 
extractives yield of cultivated cardoon leaves was slightly lower than the one earlier reported 
for methanol extracts of wild cardoon leaves (34.72%).
8
 These differences can be related to 
the geographical location, life cycle phase, agricultural methodologies, collection year, as well 
as extraction methodologies. 
 
Table 2: Extractives yield and total phenolic content of several morphological parts of C. cardunculus L. 
var. altilis (DC) by using methanol/water/acetic acid (49.5:49.5:1). 
C. cardunculus L. var. altilis (DC) 
Extractives 
yield (% w/w) 
Total phenolic content
 
 
mg GAE/kg DW mg GAE/g extract  
Stalks 
Outer part 17.5 ± 0.4 9243 ± 277 
b
 52.9 ± 1.1 
b
 
Inner part 20.2 ± 0.1 7503 ± 704 
c
 37.4 ± 3.5 
c
 
Capitula 
Receptacles and bracts 18.7 ± 1.8 11116 ± 707 
a
 59.4 ± 2.5 
a
 
Florets 33.9 ± 0.7 8499 ± 194 
b
 25.1 ± 1.0 
d
 
Leaves  28.0 ± 0.1 6310 ± 461 
d
 22.6 ± 1.7 
d
 
Results correspond to the means±standard deviation estimated from three aliquots of two extracts. 
Means with different superscript letters within the same column are statistically different (p < 0.05). 
 
The TPCs varied from 6310 mg/kg dw (22.6 mg/g extract) in leaves to 11116 mg/kg dw 
(59.4 mg/g extract) in receptacles and bracts (Table 2). When compared to literature data, 
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TPCs of both parts of capitula were higher than those previously cited for capitula of cultivated 
and wild cardoon,
8,9
 but lower than those noted for artichoke capitula.
22
 Moreover, TPCs of 
both parts of stalks were much higher relatively to those earlier noticed for cultivated and wild 
varieties of cardoon from south of Portugal.
9
 Additionally, the TPC of cultivated cardoon leaves 
was lower relatively to those published for artichoke,
10
 cultivated cardoon and wild cardoon.
8,9
 
These differences in TPC can be due to the different factors explained above. 
 
3.2 HT-UHPLC-UV-MSn analysis of methanol/water/acetic acid (49.5:49.5:1) 
extracts of C. cardunculus L. var. altilis (DC) 
Figure 1 highlights the HT-UHPLC-UV chromatograms of methanol/water/acetic acid 
extracts derived from stalks outer part and capitula florets of C. cardunculus L. var. altilis (DC), 
recorded at 330 nm. Phenolic compounds were identified by comparing the UV spectra and 
the MS
n
 fragmentation with those of standards or, when these were not available, with 
literature, as discussed below. 
 
 
Figure 1: HT-UHPLC-UV chromatograms of methanol/water/acetic acid (49.5:49.5:1) extracts of 
different morphological parts of C. cardunculus L. var. altilis (DC), recorded at 330 nm: (A) stalks inner 
part and (B) capitula florets. 
 
Twenty eight phenolic compounds were identified in the methanol/water/acetic acid 
extracts of C. cardunculus L. var. altilis (DC) (Table 3). Eriodictyol hexoside (6) was 
evidenced, for the first time, as a C. cardunculus L. component, with the exception of 
eriodictyol hexoside (6), scopolin (4) and dicaffeoyldisuccinoylquinic acid isomer (26), the 
remaining phenolic compounds noticed in this work were earlier described in stalks,
18,22,23
 
capitula, including receptacles and bracts,
17,22–27
 leaves,
10,11,18,23,26,28–30
 commercial 
supplements
30
 and by-products of artichoke.
30–33
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Table 3: Retention time (RT) of the compounds detected by HT-UHPLC-UV-MS
n
 analysis in the 
metanol/water/acetic acid (49.5:49.5:1) extracts of C. cardunculus L. var. altilis (DC). 
No. 
RT 
(min) 
Compound Presence in C. cardunculus L. 
1 1.70 1-O-Caffeoylquinic acid WC,
16
 Art,
10,18,22,24,25,28,31
 CC
16
 
2 2.34 3-O-Caffeoylquinic acid WC,
15,18
 Art,
18,24,25,28–31
 CC
18
 
3 4.90 5-O-Caffeoylquinic acid WC,
15,16,18,26
 Art,
10,18,22,24–26,28–33
 CC
16,18
 
4 6.33 Scopolin isomer C
34
 
5 10.52 1,3-Di-O-caffeoylquinic acid WC,
15
 Art,
10,11,24–26,28,30,31
 CC
26
 
6 14.97 Eriodictyol hexoside RFCC 
7 15.47 Luteolin glucuronide WC,
16,18
 Art,
17,22–25,30,31,33
 CC
16,18
 
8 15.76 Luteolin 7-O-glucoside WC,
15,16,18,22
 Art,
10,11,17,18,22–24,28,29,31,33
 
CC
16,18
 
9 16.02 Luteolin rutinoside WC,
16,18,22
 Art,
10,11,17,18,22–25,33
 CC
16
 
10 16.52 1,4-Di-O-caffeoylquinic acid Art
32
 
11 16.93 Non-identified compound  
12 17.40 1,5-Di-O-caffeoylquinic acid WC,
15,17,18
 Art,
17,18,22,24,25,28–32
 CC
18
 
13 17.73 Naringenin 7-O-glucoside Art
24,31,33
 
14 17.88 Naringenin rutinoside Art
10,27,31
 
15 18.33 Apigenin glucuronide WC,
16,18
 Art,
17,18,22–25,30,31,33
 CC
16–18
 
16 18.44 Apigenin 7-O-glucoside WC,
18
 Art,
11,18,22,24,25,28,30,31
 CC
18
 
17 18.55 Apigenin 7-O-rutinoside WC,
16–18
 Art,
10,11,18,22,24,25,31,33
 CC
16–18
 
18 19.15 1,5-Di-O-caffeoylsuccinoylquinic acid isomer WC,
16,18
 Art,
18
 CC
16,18
 
19 20.11 4-Acyl-di-O-caffeoylsuccinoylquinic acid 
isomer 
WC,
16,18
 Art,
18
 CC
16,18
 
20 20.12 Chrysoeriol hexoside isomer  
21 20.79 Luteolin acetylhexoside Art
30
 
22 20.89 4-Acyl-di-O-caffeoylquinic acid isomer Art
24,29–32
 
23 23.79 Dicaffeoylsuccinoylquinic acid isomer WC,
16,18
 Art,
18
 CC
16,18
 
24 25.36 Luteolin WC,
16–18
 Art,
17,18,22,23,25,26,28,29,33
 
CC
16,18,26
 
25 26.23 Apigenin acetylhexoside Art
27
 
26 26.86 Dicaffeoyldisuccinoylquinic acid isomer WC
16
 
27 27.43 Non-identified compound  
28 28.40 Naringenin Art
24,33
 
29 29.68 Apigenin WC,
8,16–18
 Art,
17,18,22,25,26,28,33
 CC
16–18
 
30 30.71 Chrysoeriol isomer Art
33
 
31 31.31 Non-identified compound  
Abbreviations: Art, artichoke; C, cardoon, without reference in literature regarding the variety; CC, 
cultivated cardoon; RFCC, reported for the first time in C. cardunculus L.; WC, wild cardoon. 
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Six phenolic compounds were here reported, for the first time, as cultivated cardoon 
components (Table 3), namely 1,4-di-O-caffeoylquinic acid (10), naringenin 7-O-glucoside 
(13), naringenin rutinoside (14), luteolin acetylhexoside (21), apigenin acetylhexoside (25) and 
naringenin (28). Isomers of 4-acyl-di-O-caffeoylquinic acid (22), dicaffeoyldisuccinoylquinic 
acid (26) and chrysoeriol (30) were also detected for the first time as cultivated cardoon 
components. An isomer of scopolin (4) was previously isolated from cardoon, but the variety 
was not indicated.
34
 
Although the remaining phenolic compounds were previously reported in cultivated and 
wild varieties of cardoon,
16–18
 four of them were proven here, for the first time, to be cultivated 
cardoon stalks components, such as: 1-O-caffeoylquinic (1) and 1,3-di-O-caffeoylquinic acids 
(5), apigenin glucuronide (15) and apigenin 7-O-glucoside (16). Moreover, five phenolic 
compounds were referred, for the first time, in capitula receptacles and bracts of cultivated 
cardoon, namely 1-O-caffeoylquinic (1), 3-O-caffeoylquinic (2) and 1,5-di-O-caffeoylquinic 
acids (12), luteolin glucuronide (7) and luteolin 7-O-glucoside (8). Finally, 1,5-di-O-
caffeoylquinic acid (12) was found for the first time in cultivated cardoon leaves. 
 
3.2.1 Hydroxycinnamic acids and coumarins 
The hydroxycinnamic acids identified in the C. cardunculus L. var. altilis (DC) extracts 
were grouped into caffeoylquinic (1-3, 5, 10, 12 and 22) and dicaffeoylsuccinoylquinic acids 
(18, 19, 23 and 26). A coumarin isomer (4) was also found in these extracts. 
 
3.2.1.1 Caffeoylquinic acids 
Compounds 1-3 were recognized as monocaffeoylquinic acids and compounds 5, 10, 
12 and 22 as dicaffeoylquinic acids (Figure 2). Their identification relies on the UV spectra, the 
detection of [M-H]
-
 and respective MS
n
 fragmentation (Table 4). 
 
 
Figure 2: Structures of caffeoylquinic acids identified in the methanol/water/acetic acid extracts of C. 
cardunculus L. var. altilis (DC). Abbreviation: caf, caffeoyl. 
  
Table 4: HT-UHPLC-UV-MS
n
 data of hydroxycinnamic acids and coumarins identified in the methanol/water/acetic acid extracts of C. cardunculus L. var. altilis 
(DC). 
No. Compound UV λmax (nm) 
[M-H]
-
 
(m/z) 
(I)
 
ESI-MS
n
 product ions 
m/z (% base peak) 
(II)
 
Id. 
(III)
 
1 1-O-Caffeoylquinic acid 247, 298, 328 353 MS
2
: 191 (100), 179 (5), 173 (1), 135 (1) 
MS
3
: 127 (100) 
35,36
 
2 3-O-Caffeoylquinic acid 242, 296, 324 353 MS
2
: 191 (100), 179 (5), 135 (1) 
MS
3
: 127 (100), 93 (49) 
Co 
3 5-O-Caffeoylquinic acid 244, 299, 324 353 MS
2
: 191 (100), 179 (4), 135 (1) 
MS
3
: 173 (50), 127 (100), 111 (29), 93 (46), 85 (77) 
Co 
4 Scopolin isomer 234, 250sh, 288, 
339 
399 MS
2
: 353 (18), 191 (100), 176 (2) 
37
 
5 1,3-Di-O-caffeoylquinic acid 237, 296, 320 515 MS
2
: 353 (100), 335 (44), 191 (1), 179 (23) 
MS
3
: 191 (100), 179 (46), 135 (5) 
38
 
10 1,4-Di-O-caffeoylquinic acid 240, 296, 325 515 MS
2
: 353 (100), 335 (18), 317 (42), 299 (53), 255 (11), 203 (54), 191 (3), 179 (2), 173 (7) 
MS
3
: 191 (40), 179 (84), 173 (100), 135 (12) 
MS
4
: 93 (100) 
38
 
12 1,5-Di-O-caffeoylquinic acid 243, 298, 327 515 MS
2
: 353 (100), 335 (5), 191 (13), 179 (1) 
MS
3
: 191 (100), 179 (7), 173 (1), 135 (2) 
MS
4
: 173 (66), 127 (100), 93 (59), 85 (56) 
Co 
18 1,5-Di-O-caffeoylsuccinoylquinic acid 
isomer 
245, 298, 324 615 MS
2
: 515 (12), 453 (100), 435 (2), 353 (54), 191 (2) 
MS
3
: 353 (100), 191 (5) 
MS
4
: 191 (100), 179 (10), 173 (5) 
39
 
19 4-Acyl-di-O-caffeoylsuccinoylquinic acid 
isomer 
239, 300, 327 615 MS
2
: 515 (100), 453 (19), 435 (15), 353 (30), 335 (8), 317 (4), 255 (1) 
MS
3
: 353 (100), 299 (7), 255 (6), 203 (12), 191 (5), 179 (2), 173 (5) 
MS
4
: 191 (100), 179 (43), 173 (86) 
39
 
22 4-Acyl-di-O-caffeoylquinic acid isomer 235, 297, 326 515 MS
2
: 353 (100), 335 (5), 317 (5), 299 (11), 255 (6), 203 (17), 191 (2), 179 (4), 173 (2) 
MS
3
: 191 (48), 179 (59), 173 (100), 135 (10) 
38
 
      
      
  
No. Compound UV λmax (nm) 
[M-H]
-
 
(m/z) 
(I)
 
ESI-MS
n
 product ions 
m/z (% base peak) 
(II)
 
Id. 
(III)
 
23 Dicaffeoylsuccinoylquinic acid isomer 227, 245, 301, 325 615 MS
2
: 515 (29), 453 (100), 435 (6), 353 (58), 335 (6), 191 (5) 
MS
3
: 353 (100) 
16
 
26 Dicaffeoyldisuccinoylquinic acid isomer 236, 300, 328 715 MS
2
: 677 (100), 615 (4), 553 (42), 453 (36), 353 (16) 
MS
3
 [715→615]: 515 (100) 
MS
3
 [715→353]: 191 (100) 
16
 
(I)
 Exception of compound 4, which was detected as a formate adduct. 
(II)
 m/z in bold was subjected to MS
n
 analysis. 
(III)
 Abbreviations: Co, co-injection of authentic standard; 
Id, identification. 
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Figure 3 demonstrates the MS
2
 [353] and MS
3
 [353→191] mass spectra and the 
product ions originated by the fragmentation of 5-O-caffeoylquinic acid (3), under the negative 
ESI. The MS
2
 spectrum of the ion at m/z 353 (I) displayed the base peak at m/z 191 (II) 
([quinic acid-H]
-
) which resulted from the loss of cinnamate (-162 Da) (Table 4). A low intense 
peak was observed at m/z 179 ([caffeic acid-H]
-
).
35
 The MS
3
 spectrum of the ion at m/z 191 
revealed the characteristic product ions of the deprotonated quinic acid ion fragmentation, 
namely at m/z 173 (III) ([quinic acid-H-H2O]
-
),
 
127 (IV) ([quinic acid-H-H2O-HCOOH]
-
), 111 (V) 
and 93 ([phenoxide]
-
) (Figure 3).
35,36
 The identification of this compound was confirmed with 
the injection of the standard in the same chromatographic conditions. 
 
 
Figure 3: Negative ESI mass spectra and the main product ions arising from 5-O-caffeoylquinic acid (3) 
fragmentation. 
 
Compound 2 was further assigned as 3-O-caffeoylquinic acid, based on the injection of 
the standard in the same chromatographic conditions. In addition to the UV spectrum and the 
MS
n
 data (Table 4), compound 1 was tentatively identified as 1-O-caffeoylquinic acid, since it 
was eluted before 3-O-caffeoylquinic acid, as earlier indicated.
31
 The elution order of the 
monocaffeoylquinic acids indeed corroborated with the literature.
29
 By using a C18 reversed-
phase HPLC column, Adzet, et al.
29
 had shown that monocaffeoylquinic acids with axial 
caffeoyl moieties (1- and 3-O-caffeoylquinic acids) firstly eluted from the HPLC column, 
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followed by monocaffeoylquinic acids with equatorial caffeoyl moieities (4- and 5-O-
caffeoylquinic acids). 
Compounds 5, 10, 12 and 22 (Figure 2) were considered as dicaffeoylquinic acids, 
through the UV spectra and the MS data. The negative ESI of these compounds gave origin to 
the [M-H]
-
 at m/z 515 (Table 4). Additionally, the base peak of the respective MS
2
 [515] 
spectra was noted at m/z 353, due to the loss of a cinnamate (-162 Da).
38
 
Figure 4 reveals the MS
2
 and the MS
3
 spectra of 1,3-di-O-caffeoylquinic acid (5) 
(Figure 2), as well as the main fragmentation product ions. The MS
2
 [515] spectrum exhibited 
the base peak at m/z 353 (I), due to the loss of a cinnamate, and an intense peak (>30%) at 
m/z 335 (II) resulting from successive losses of cinnamate and water (-18 Da). Furthermore, 
the MS
3
 [515→353] spectrum exposed a base peak at m/z 191 (III) ([quinic acid-H]-) and an 
intense peak (≈50%) at m/z 179 ([caffeic acid-H]-).38 Moreover, this compound was eluted 
much earlier than the other dicaffeoylquinic acids, as previously evidenced;
31,38
 this may be 
related to the axial position of the two caffeoyl moieties.
29 
 
 
Figure 4: Negative ESI mass spectra and the main product ions arising from 1,3-di-O-caffeoylquinic acid 
(5) fragmentation. 
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Compound 10 was tentatively assigned as 1,4-di-O-caffeoylquinic acid (Figure 2). The 
MS
2
 [515] spectrum of this compound evidenced three characteristic product ions from 4-acyl 
dicaffeoylquinic acids, namely at m/z 317 ([M-H-H2O-caffeoyl]
-
), 299 ([M-H-2H2O-caffeoyl]
-
) 
and 255 ([M-H-2H2O-caffeoyl-CO2]
-
) (Table 4), due to the successive loss of water (-18 Da), 
caffeic acid (-180 Da) and carboxylic acid (-44 Da).
38
 Furthermore, the base peak of the MS
3
 
[515→353] spectrum was noticed at m/z 173, due to the loss of water and cinnamate 
molecules.
38
 Additionally, the MS
4
 [515→353→173] spectrum exhibited the base peak at m/z 
93. Those base peaks are characteristic of the MS
n
 fragmentation of 4-O-acyl dicaffeoylquinic 
acids.
38
 In fact, the product ions at m/z 173 and m/z 93 were previously reported in literature 
as the base peaks of respectively MS
2
 [353] and MS
3
 [353→173] spectra of 4-O-caffeoylquinic 
acid.
35
 Three structures were hypothesized for compound 10, namely 1,4-; 3,4- or 4,5-di-O-
caffeoylquinic acid. Nevertheless, it might not be the last one, since the MS
2
 fragmentation of 
[M-H]
-
 yielded a product ion at m/z 335, which was not detected before in the MS
2
 spectrum of 
the 4,5-di-O-caffeoylquinic acid.
38
 Since two intense peaks at m/z 299 and 203 (>50% base 
peak) were observed in the MS
2
 [515]
-
 spectrum (Table 4), it was suggested that compound 
10 was 1,4-di-O-caffeoylquinic acid.
38
 
Compound 12 was identified as 1,5-di-O-caffeoylquinic acid (Figure 2), since the MS
2
 
[515] and the MS
3
 [515→353] spectra revealed low intense peaks at m/z 335 (<10%) and m/z 
179 (<10%), respectively.
38
 In addition to the mass spectroscopic data, the identification of 
compound 12 with the injection of the standard in the same chromatographic conditions. 
The MS
2
 [515] spectrum of compound 22 also revealed three product ions, at m/z 335, 
299 and 255 which are unique of 4-acyl dicaffeoylquinic acids MS
n
 fragmentation.
38
 Moreover, 
the MS
3
 [515→353] spectrum displayed a base peak at m/z 173. In this way, this compound 
might be either 3,4- or 4,5-di-O-caffeoylquinic acid. Compound 22 could be assigned as 3,4-di-
O-caffeoylquinic acid, since the MS
2
 spectrum demonstrated the product ion at m/z 335, as 
cited before.
38
 However, it is not possible to elucidate the chemical structure of compound 22 
as 3,4-di-O-caffeoylquinic acid, since a product ion at m/z 317 was noted in the MS
2
 spectrum, 
which was not referenced in previous data.
31,38
 
 
3.2.1.2 Dicaffeoylsuccinoylquinic acids 
Compounds 18, 19 (Figure 5) and 23 were considered as dicaffeoylsuccinoylquinic 
acids, based on the UV spectra, as well as on the detection of [M-H]
-
 ion at m/z 615 and the 
MS
n
 fragmentation under negative ionization (Table 4). 
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Figure 5: Structures of dicaffeoylsuccinoylquinic acids identified in the methanol/water/acetic acid 
extracts of C. cardunculus L. var. altilis (DC). Abbreviations: caf, caffeoyl; suc, succinoyl. 
 
The MS
2 
[615] spectrum of compound 18 exhibited a base peak at m/z 453 due to the 
loss of a cinnamate (Table 4). Moreover, a weak peak at m/z 515 was evidenced in the MS
2
 
[615] spectrum, caused by the loss of succinoyl moiety (-100 Da). Additionally, an intense 
peak at m/z 353 was originated by the successive loss of the succinoyl moiety and a 
cinnamate. Furthermore, the MS
3
 [615→453] spectrum displayed a base peak at m/z 353, due 
to the loss of succinoyl moiety.
16
 The MS
4
 spectrum of the ion at m/z 353 exposed a base 
peak at m/z 191 ([quinic acid]
-
) and a weak peak at m/z 179, which is similar to the MS
3
 
spectrum [515→353] of 1,5-di-O-caffeoylquinic acid (12), as described before.38 In this way, 
we proposed that compound 18 might be 1,5-di-O-caffeoyl-3-O-succinoylquinic acid or 1,5-di-
O-caffeoyl-4-O-succinoylquinic acid
39
 (Figure 5). Only based on the MS fragmentation, it was 
not possible to determine the position of succinoyl moiety in the structure. 
Regarding compound 19, the MS
2
 spectrum of the [M-H]
-
 ion at m/z 615 demonstrated 
a base peak at m/z 515, as well as an intense peak at m/z 353 and a weak peak at m/z 453 
(Table 4). Additionally, the base peak at m/z 353 was noticed in the MS
3
 spectrum of the ion at 
m/z 515, as well as two weak peaks at m/z 299 and 255 which are characteristic of the 
negative ESI fragmentation pathway of 4-acyl-dicaffeoylquinic acids.
38
 Thus, compound 19 
can be one of the following compounds: 1,4-di-O-caffeoyl-3-O-succinoylquinic, 1,4-di-O-
caffeoyl-5-O-succinoylquinic, 3,4-di-O-caffeoyl-1-O-succinoylquinic, 3,4-di-O-caffeoyl-5-O-
succinoylquinic, 4,5-di-O-caffeoyl-1-O-succinoylquinic or 4,5-di-O-caffeoyl-3-O-succinoylquinic 
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acids
39
 (Figure 5). Nonetheless, it was not possible to determine the linkage positions of 
caffeoyl and succinoyl moieties in the quinic acid, only based on the MS data. 
Finally, compound 23 was also noticied as a dicaffeoylsuccinoylquinic acid isomer, 
owing to the detection of the [M-H]
-
 ion at m/z 615, as well as of the characteristic product ions 
of MS
2
 [615] fragmentation, namely at m/z 515, 453, 353 and 191 (Table 4).
16,39
 Moreover, the 
MS
3
 spectrum of the ion at m/z 453 revealed a base peak at m/z 353. Nevertheless, it was not 
possible to identify unambiguously the substitution pattern of this compound with the MS data. 
Compound 26 was considered as a dicaffeoyldisuccinoylquinic acid isomer, based on 
the [M-H]
-
 at m/z 715 and on the respective MS
2
 product ions, namely at m/z 615 ([M-H-
succinoyl]
-
), 553 ([M-H-cinnamate]
-
), 453 ([M-H-cinnamate-succinoyl]
-
) and 353 ([M-H-
cinnamate-2succinoyl]
-
) (Table 4).
16
 Furthermore, the MS
3
 fragmentation of the ion at m/z 615 
yielded a product ion at m/z 515, due to the loss of a succinoyl moiety, while the MS
3
 
fragmentation of the ion at m/z 353 gave a product ion at m/z 191 ([quinic acid]
-
). However, it 
was not possible to distinguish the substitution pattern of caffeoyl and succinoyl moieties in the 
quinic acid through the MS data. So far, only one dicaffeoylsuccinoylquinic acid was detected 
in Asteraceae plants (Arctium lappa L.), named as 1,5-di-O-caffeoyl-3,4-di-O-succinoylquinic 
acid.
39
 
 
3.2.1.3 Coumarins 
Compound 4 was assigned as a scopolin isomer, which means that it can be either 
scopolin or isoscopolin (Figure 6) whose structures only differ in the methoxyl position in the 
aromatic ring (C6 and C7, respectively). 
 
 
Figure 6: Structures of scopolin isomers, namely scopolin and isoscopolin. One of these compounds 
may be assigned to the identification of compound (4), detected in the methanol/water/acetic acid 
(49.5:49.5:1) extracts of C. cardunculus L. var. altilis (DC). Abbreviation: Glc, glucosyl. 
 
Compound 4 proved to have similar UV spectrum to the standard of scopoletin. It was 
detected as formate adduct ([M+HCOO]
-
) at m/z 399. The MS
2 
[399] spectrum and the main 
fragmentation product ions of scopolin are given in Figure 7. The MS
2
 [M+HCOO]
-
 spectrum 
displayed a weak peak at m/z 353 ([M-H]
-
) and a base peak at m/z 191, due to the loss of a 
glucosyl unit (-162 Da) from the [M-H]
-
 ion. Nonetheless, it was not possible to identify 
unambiguously the position of the glucosyl moiety in the structure. 
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Figure 7: (A) Negative ESI MS
2
 [399] spectrum and (B) the main fragmentation product ions of scopolin. 
 
3.2.2 Flavonoids 
Sixteen flavonoids were found in the methanol/water/acetic acid extracts of C. 
cardunculus L. var. altilis (DC), namely four flavanones (6, 13, 14 and 28) and twelve flavones 
(7-9, 15-17, 20, 21, 24, 25, 29 and 30), based on the UV and mass spectroscopic data (Table 
5), as depicted bellow. 
 
  
Table 5: HT-UHPLC-UV-MS
n
 data of the flavonoids identified in the methanol/water/acetic acid extracts of C. cardunculus L. var. altilis (DC). 
No. Compound UV λmax (nm) 
[M-H]
-
  
(m/z) 
ESI-MS
n
 product ions 
m/z (% base peak) 
(I)
 
Identification 
6 Eriodictyol hexoside 234, 283, 328 449 MS
2
: 431 (25), 413 (5), 404 (5), 381 (21), 287 (100), 175 (4) 
MS
3
: 259 (22), 201 (19), 151 (100), 135 (17) 
40
 
7 Luteolin glucuronide 236, 253, 266, 343 461 MS
2
: 415 (2), 393 (3), 381 (6), 357 (5), 355 (4), 327 (6), 285 (100) 
MS
3
: 268 (100), 257 (94), 173 (82) 
31
 
8 Luteolin 7-O-glucoside 237, 253, 267, 346 447 MS
2
: 379 (7), 357 (1), 327 (1), 311 (4), 285 (100) 
MS
3
: 267 (62), 241 (92), 239 (39), 213 (62), 211 (22), 199 (100), 175 (86) 
Co 
(II)
 
9 Luteolin rutinoside 235, 252, 267, 345 593 MS
2
: 525 (1), 285 (100), 213 (1), 199 (1), 175 (1) 
MS
3
: 267 (11), 243 (41), 241 (37), 217 (69), 199 (100), 175 (27), 151 (18) 
41
 
13 Naringenin 7-O-glucoside 233, 282, 326 433 MS
2
: 379 (1), 365 (2), 348 (1), 271 (100), 268 (1) 
MS
3
: 177 (77), 151 (100), 125 (26) 
Co 
(II)
 
14 Naringenin rutinoside 234, 282, 329 579 MS
2
: 271 (100), 177 (1) 
MS
3
: 227 (5), 177 (36), 151 (100) 
41
 
15 Apigenin glucuronide 238, 266, 334 445 MS
2
: 377 (14), 269 (100), 175 (7) 
MS
3
: 225 (100) 
31
 
16 Apigenin 7-O-glucoside 237, 267, 335 431 MS
2
: 431 (100), 362 (1), 311 (1), 269 (27) 
MS
3
: 269 (30), 227 (25), 225 (100), 201 (72), 183 (13), 149 (29) 
Co 
(II)
 
17 Apigenin 7-O-rutinoside 239, 267, 335 577 MS
2
: 440 (1), 269 (100), 169 (1) 
MS
3
: 225 (100), 201 (40), 181 (37), 151 (57) 
Co 
(II)
 
20 Chrysoeriol hexoside 
isomer 
235, 251sh, 266, 
342 
461 MS
2
: 446 (100), 415 (2), 393 (2), 341 (5), 313 (14), 299 (87), 298 (14), 
297 (5), 284 (28), 283 (7), 269 (1), 255 (1) 
MS
3
: 285 (1), 284 (100), 256 (1) 
MS
4
: 257 (33), 256 (100) 
42
 
21 Luteolin acetylhexoside 236, 252, 266, 346 489 MS
2
: 447 (1), 285 (100), 284 (3), 241 (1) 
MS
3
: 257 (40), 241 (67), 217 (100), 213 (48), 175 (56), 151 (55) 
43
 
24 Luteolin 236, 251, 265, 347 285 MS
2
: 285 (2), 267 (13), 257 (17), 243 (60), 241 (100), 217 (74), 213 (18), 
199 (79), 197 (23), 175 (81), 151 (23), 133 (5) 
44
 
      
  
No. Compound UV λmax (nm) 
[M-H]
-
  
(m/z) 
ESI-MS
n
 product ions 
m/z (% base peak) 
(I)
 
Identification 
25 Apigenin acetylhexoside 234, 266, 333 473 MS
2
: 413 (4), 405 (4), 335 (1), 311 (3), 283 (2), 269 (100), 268 (56), 238 
(2), 237 (1) 
MS
3
: 225 (100), 181 (67) 
45
 
28 Naringenin 234, 288, 327 271 MS
2
: 253 (2), 227 (3), 177 (27), 151 (100), 119 (3), 107 (6) 
44
 
29 Apigenin 237, 267, 335 269 MS
2
: 269 (9), 241 (4), 227 (17), 225 (100), 201 (29), 183 (16), 181 (15), 
159 (6), 151 (21), 149 (33), 117 (3), 107 (2) 
44
 
30 Chrysoeriol isomer 234, 265, 287sh, 
338 
299 MS
2
: 285 (2) 284 (100), 255 (<1), 243 (<1), 133 (<1) 
MS
3
: 256 (100), 255 (1), 228 (1), 125 (1) 
46
 
(I)
 m/z in bold was subjected to MS
n
 analysis. 
(II)
 Co, co-injection of authentic standard. 
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3.2.2.1 Flavanones 
Four flavanones were reported in the methanol/water/acetic acid extracts of cultivated 
cardoon (Figure 8), namely eriodictyol hexoside (6), naringenin 7-O-glucoside (13), naringenin 
rutinoside (14) and naringenin (28). 
 
 
Figure 8: Structures of flavanones identified in the methanol/water/acetic acid extracts of C. cardunculus 
L. var. altilis (DC). The glycosyl substituent is attached to the common position of the aglycone. 
Abbreviations: Glc, glucosyl and Rha, rhamnosyl. 
 
Compound 6 (Figure 8) was proposed to correspond to eriodictyol hexoside, since it 
was observed the [M-H]
-
 ion at m/z 449 and its MS
2
 spectrum exhibited a base peak at m/z 
287 (Table 5), resulting from the loss of one hexosyl unit (-162 Da).
40
 Furthermore, the MS
3
 
spectrum of the ion at m/z 287 displayed the characteristic product ions of eriodictyol, namely 
at m/z 259 ([aglycone-CO]
-
), 201 ([aglycone-C2H2O-CO2]
-
), 151 ([
1,3
A]
-
) and 135 ([
1,3
B]
-
)
44
 (the 
nomenclature follows the one that was explained before
47
). 
Compounds 13 and 14 were considered as respectively naringenin 7-O-glucoside and 
naringenin rutinoside (Figure 8), based on the UV spectra and on the characteristic MS
3
 
product ions of naringenin at m/z 271 (Table 5). 
Figure 9 indicates the MS
2
 and MS
3
 spectra, as well as the main product ions derived 
from the negative ESI of naringenin 7-O-glucoside (13), under negative ionization. This 
compound evidenced the [M-H]
-
 ion at m/z 433 and the base peak of the MS
2
 [433] spectrum 
at m/z 271 (I), due to the loss of glucosyl moiety. Additionally, the MS
3
 fragmentation of the ion 
at m/z 271 yielded two product ions at m/z 177 (II) and m/z 151 (III), which is concordant with 
the one of naringenin, as discussed thereafter. The identification of this compound was thus 
confirmed with the injection of the standard in the same chromatographic conditions. 
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Figure 9: Negative ESI spectra and the main product ions arising from naringenin 7-O-glucoside (13) 
fragmentation. 
 
The negative ESI of naringenin rutinoside (14) gave rise to the [M-H]
-
 ion at m/z 579 
(Table 5). The MS
2
 [579] spectrum showed the base peak at m/z 271, resulting from 
successive losses of rhamnosyl (-146 Da) and hexosyl (-162 Da) moieties.
41
 Moreover, the 
MS
3
 fragmentation of the ion at m/z 271 originated characteristic product ions of naringenin, 
namely at m/z 227 ([aglycone-H-CO2]
-
), 177 ([aglycone-H-ring B]
-
) and 151 ([
1,3
A]
-
); the last 
product ion was formed through the retro Diels-Alder fragmentation pathway.
44
 
Compound 28 was assigned as naringenin (Figure 8), since the [M-H]
-
 ion was found 
at m/z 271 (Table 5). In addition to the product ions referred before, the MS
2
 [271] spectrum 
exposed other product ions at m/z 119 ([
1,3
B]
-
) and 107 ([
1,3
A-CO2]
-
), as explained in 
literature.
44
 
 
3.2.2.2 Flavones 
Five luteolin derivatives (7-9, 21 and 24), five apigenin derivatives (15-17, 25 and 29) 
and two isomers of chrysoeriol derivatives (20 and 30) (Figure 10) were found in the 
methanol/water/acetic acid extracts of cultivated cardoon, based on the UV spectra and on the 
MS
n
 fragmentation data (Table 5). 
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Figure 10: Structures of flavones identified in the methanol/water/acetic acid extracts of C. cardunculus 
L. var. altilis (DC). The glycosyl substituent is attached to the common position of the aglycone. 
Abbreviations: GlcAc, acetylglucosyl; Glc, glucosyl; GlcUA, glucuronyl; Rha, rhamnosyl. 
 
In addition to the UV spectra, compounds 7 and 21 were indicated as respectively 
luteolin glucuronide and luteolin acetylhexoside, regarding the detection of the corresponding 
[M-H]
-
 ions at m/z 461
31
 and 489 and the respective MS
n
 fragmentation.
43
 The MS
2
 [461] 
spectrum of luteolin glucuronide (7) exhibited a base peak at m/z 285, arising from the loss of 
the glucuronyl moiety (-176 Da), while the MS
2
 [489] spectrum of luteolin acetylhexoside (21) 
revealed a weak peak at m/z 447 and a base peak at m/z 285, due to successive losses of 
acetyl (-42 Da) and hexosyl (-162 Da) moieties. Moreover, the MS
3
 spectrum of the ion at m/z 
285 of both compounds 7 and 21 exhibited a characteristic product ion of luteolin negative ESI 
fragmentation, namely at m/z 257 ([aglycone-H-CO]
-
).
44
 
The identity of compound 8 was elucidated as luteolin 7-O-glucoside, based on the UV 
spectra, the detection of [M-H]
-
 ion at m/z 447 and the MS
n
 fragmentation. Figure 11 displays 
the MS
2
 and MS
3
 spectra of luteolin 7-O-glucoside, as well as the main fragmentation product 
ions, under the negative ESI. The base peak of the MS
2
 [447] spectrum was observed at m/z 
285 (I), arising from the loss of the glucosyl moiety. Three product ions were noted at m/z 267 
([aglycone-H-H2O]
-
), 241 (II) ([aglycone-H-CO2]
-
) and 213 (III) ([aglycone-H-CO2-CO]
-
) (Figure 
11). Additionally, several other characteristic product ions of luteolin were detected in the MS
3
 
spectrum of the ion at m/z 285, namely at: (i) m/z 199 (IV), due to the C-ring fragmentation 
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and cyclization involving the B-ring, leading to the loss of the C2H2O unit (-42 Da), followed by 
the loss of CO2 group and the formation of the contracted A-ring; and (ii) m/z 175 (V) resulting 
from the loss of C3O2 unit (-68 Da) from A-ring fragmentation, followed by the loss of C2H2O 
unit due to the C-ring fragmentation and cyclization involving the B-ring (Figure 11).
44
 The 
identification of this compound was confirmed with the injection of the standard in the same 
experimental conditions. 
 
 
Figure 11: Negative ESI spectra and the main product ions resulting from luteolin 7-O-glucoside (8) 
fragmentation. 
 
Compound 9 was tentatively assigned as luteolin rutinoside (Figure 10), due to the 
detection of the [M-H]
-
 at m/z 593 and its MS
2
 base peak at m/z 285 which resulted from 
successive losses of rhamnosyl (-146 Da) and glucosyl (-162 Da) moieties.
31
 Furthermore, the 
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MS
3
 fragmentation of the ion at m/z 285 yielded characteristic product ions of luteolin, namely 
at m/z 243 ([aglycone-H-C2H2O]
-
), 217 ([aglycone-H-C3O2]
-
)) and 151 ([
1,3
A]
-
).
44
 
Compound 24 was assigned as luteolin (Figure 10), due to the UV spectrum, as well 
as the detection of the [M-H]
-
 ion at m/z 285 (Table 5) and its MS
2
 product ions, at m/z 267, 
241, 213, 199, 197 ([aglycone-H-2CO2]
-
), 175 and 133 ([
1,3
B]
-
).
44
 
Compounds 15 and 25 were ascribed as apigenin glucuronide and apigenin 
acetylhexoside (Figure 10), respectively, based on the detection of [M-H]
-
 ions at m/z 445 (15) 
and m/z 473 (25). The MS
2
 spectra of both compounds exposed a base peak at m/z 269, 
resulting from the loss of the glucuronyl moiety for compound 15
31
 and the acetylhexosyl 
moiety for compound 25.
45
 Moreover, the MS
3
 spectrum of the ion at m/z 269 exhibited 
characteristic product ions of apigenin, namely at m/z 225 ([aglycone-H-CO2]
-
) and 181 
([aglycone-H-2CO2]
-
).
44
 
Compounds 16 and 17 were identified respectively as apigenin 7-O-glucoside and 
apigenin 7-O-rutinoside (Figure 10), since their retention time, UV spectra, [M-H]
-
 ions (m/z 
431 and 577, respectively) and MS
n
 product ions (Table 5) were the same as the pure 
compounds injected in the same conditions. 
The chemical structure of compound 29 was elucidated as apigenin (Figure 10), due to 
the UV spectrum and the detection of the [M-H]
-
 ion at m/z 269 (Table 5). Furthermore, the 
MS
2
 [269] spectrum highlighted characteristic product ions of apigenin, under negative ESI, 
namely at m/z 241 ([M-H-CO]
-
), 227 ([aglycone-H-C2H2O]
-
), 201 ([aglycone-H-C3O2]
-
), 183 
([aglycone-H-C2H2O-CO2]
-
), 181 ([aglycone-H-2CO2]
-
), 151 ([
1,3
A]
-
), 159 ([M-H-C3O2-C2H2O]
-
), 
151 ([
1,3
A]
-
), 149 ([
1,4
B+2H]
-
), 117 ([
1,3
B]
-
) and 107 ([
1,3
A-CO2]
-
).
44
 
Compound 30 yielded the [M-H]
-
 at m/z 299 and the base peak of MS
2
 [299] spectrum 
was observed at m/z 284 (Table 5), due to the loss of a methyl group. Furthermore, a base 
peak at m/z 256 ([M-H-CH3-CO]
-
) and a weak peak at m/z 228 ([M-H-CH3-2CO]
-
) were 
detected in the MS
3
 [299] spectrum. On the basis of the UV spectrum
48
 and the MS
n
 
fragmentation,
46
 this compound 30 was tentatively noticed as a chrysoeriol isomer (Figure 10), 
which means that this compound may be chrysoeriol or diosmetin, whose structures only differ 
in the methoxyl position in the B-ring (C3´ and C4´, respectively). 
Compound 20 had similar UV spectrum to compound 30, and the respective [M-H]
-
 ion 
was observed at m/z 461 (Table 5). The MS
2
 spectrum of this ion showed a product ion at m/z 
446 as the base peak, due to the loss of a methyl, and an intense peak at m/z 299, 
corresponding to the loss of a hexosyl moiety. Additionally, the MS
3
 [446→299] spectrum 
displayed the base peak at m/z 284 (loss of a methyl), while the MS
4
 [446→299→284] 
spectrum demonstrated the base peak at m/z 256 (loss of a carbonyl group), similar to MS
n
 
fragmentation of compound 30. The aglycone moiety of compound 20 can be a chrysoeriol 
isomer, and it was therefore tentatively assigned as a chrysoeriol hexoside isomer (Figure 10). 
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3.2.3 Unidentified compounds 
The structure elucidation of compounds 11, 27 and 31 could not be achieved only 
based on the MS
n
 data (Table 6). 
 
Table 6: HT-UHPLC-UV-MS
n
 data of non-identified compounds in the methanol/water/acetic acid 
(49.5:49.5:1) extracts of C. cardunculus L. var. altilis (DC) 
No. UV λmax (nm) [M-H]
-
 (m/z) ESI-MS
n
 product ions m/z (% base peak) 
(I)
 
11 236, 300, 320, 337 483 MS
2
: 415 (24), 263 (100), 253 (5) 
27 236, 302, 329 793 MS
2
: 725 (73), 631 (100) 
MS
3
: 469 (100) 
31 235 553 MS
2
: 503 (2), 459 (23), 433 (4), 415 (8), 401 (2), 391 
(100), 349 (2) 
MS
3
: 347 (100), 319 (80), 304 (89), 151 (90) 
(I)
 m/z in bold was subjected to MS
n
 analysis. 
 
Compound 11 demonstrated the [M-H]
-
 ion at m/z 483 and the MS
2
 [483] spectrum had 
the base peak at m/z 263. However, the MS data did not allow the identification of this 
compound. 
Compound 27 can be a caffeic acid derivative, since it presented similar UV spectrum 
to caffeoylquinic acid isomers. Moreover, the MS
2
 spectrum of the [M-H]
-
 ion at m/z 793 
evidenced a base peak at m/z 731, resulting from the loss of 162 Da, which may be attributed 
to a cinnamate or an hexosyl unit. Furthermore, the ion at m/z 731, during the MS
3
 
fragmentation, also suffered the loss of 162 Da, which may be attributed to the loss of a 
second cinnamate or hexosyl unit. Nevertheless, the MS data were not sufficient to elucidate 
the structure of this compound. 
Compound 31 exhibited the [M-H]
-
 ion at m/z 553 and its MS
2
 spectrum displayed the 
base peak at m/z 391 (loss of 162 Da), probably due to the loss of a hexosyl unit. Moreover, a 
low intense peak was observed at m/z 349 (loss of 204 Da) in the MS
2
 spectrum of the ion at 
m/z 553, probably due to the loss of an acetylhexosyl unit. Furthermore, the MS
3
 spectrum of 
the ion at m/z 391 exposed the base peak at m/z 347 (loss of 44 Da), probably due to the loss 
of one acetaldehydyl (CH3COH) or carboxyl (CO2) groups. Despite these data, it was not 
possible to indicate the chemical structure of this compound. 
 
3.3 Quantitative analysis of phenolic compounds identified in C. cardunculus L. 
var. altilis (DC) methanol/water/acetic acid extracts 
Phenolic compounds were quantified through the HT-UHPLC-UV standard curves of 
representative compounds from each family (Table 1). This study characterized, for the first 
time, the phenolic composition of stalks (outer and inner parts), capitula (receptacles, bracts 
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and florets) and leaves derived from C. cardunculus L. var. altilis (DC) (Figure 12 and Table 
7). 
The total contents of phenolic compounds in cultivated cardoon biomass varied 
between 2846 mg/kg dw in leaves and 12697 mg/kg dw in florets (Figure 12). Regarding the 
composition of methanol/water/acetic acid extracts, the phenolic concentrations ranged from 
10.4 mg/g extract in leaves to 63.5 mg/g extract in stalks outer part. 
The identified phenolic contents of both stalks parts and florets, when expressed either 
as mg/kg dw or mg/g extract, were higher than the corresponding total phenolic contents 
determined by the Folin Ciocalteu assay (Table 2) (from 17% in stalks outer part to 33% in 
florets). On the other hand, it was observed that the total identified phenolic contents of leaves 
were 54% lower relatively to those determined by the Folin-Ciocalteu assay. Despite the 
identified phenolic contents corresponded to the major phenolic compounds detected by HT-
UHPLC-UV, the increment of total phenolic contents of leaves determined with the colorimetric 
assay (Table 2) may be related with a series of interfering compounds which also react with 
the Folin-Ciocalteu’s reagent, and may be in those extracts, for instance sugars, ascorbic acid, 
organic acids, among others.
49 
 
Figure 12: Phenolic composition of C. cardunculus L. var. altilis (DC) morphological parts. 
Abbreviations: C, coumarins; F, flavonoids and HA, hydroxycinnamic acids. 
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Table 7: HT-UHPLC-UV quantification of phenolic compounds identified in methanol/water/acetic acid (49.5:49.5:1) extracts of C. cardunculus L. var. altilis (DC). 
(I)
 
No. Compound 
Phenolic content (mg/kg dw) Phenolic content (mg/g extract) 
Stalks Capitula 
Leaves 
Stalks Capitula 
Leaves 
Outer Inner 
Receptacles 
and bracts 
Florets Outer Inner 
Receptacles 
and bracts 
Florets 
 Total hydroxycinnamic acids 
(V)
 10323 
a
 9969 
a
 8786 
b
 1930 
c
 71 
d
 59.1 
a
 49.5
 b
 50.2 
b
 5.7 
c
 0.3 
c
 
 Total monocaffeoylquinic acids 3347 
b
 3345 
b
 3749 
a
 291 
c
 30 
c
 19.1 
b
 16.6 
c
 21.4 
a
 0.9 
d
 0.1 
d
 
1 1-O-Caffeoylquinic acid 112 
b
 216 
a
 56 
c
 ‒ ‒ 0.6 b 1.1 a 0.3 c ‒ ‒ 
2 3-O-Caffeoylquinic acid 159 
a
 44 
c
 94 
b
 ‒ ‒ 0.9 a 0.2 c 0.5 b ‒ ‒ 
3 5-O-Caffeoylquinic acid 3075 
b
 3085 
b
 3599 
a
 291 
c
 30 
c
 17.6 
b
 15.3 
c
 20.6 
a
 0.9 
d
 0.1 
d
 
 Total dicaffeoylquinic acids 
(V)
 3742 
b 
3381
 b 
5036 
a
 1640 
d
 41 
e
 21.4
 b 
16.8
 c 
28.8 
a
 4.8 
d
 0.1 
e
 
5 1,3-Di-O-caffeoylquinic acid 211 
b
 316 
a
 181 
b
 ‒ ‒ 1.2 b 1.6 a 1.0 c ‒ ‒ 
10 1,4-Di-O-caffeoylquinic acid 258 
b
 190 
c
 466 
a
 ‒ ‒ 1.5 b 0.9 c 2.7 a ‒ ‒ 
12 1,5-Di-O-caffeoylquinic acid 3273 
b
 2876 
c
 4292 
a
 1640 
d
 41 
e
 18.8 
b
 14.3 
c
 24.5 
a
 4.8 
d
 0.1 
e
 
22 4-Acyl-di-O-caffeoylquinic acid isomer
 
124 
a 
(21+22) 
135
 a
 
(21+22) 
97 
b
 ‒ ‒ 0.7 a 
(21+22) 
0.7
 a
 
(21+22) 
0.6 
a
 ‒ ‒ 
 Total dicaffeoylsuccinoylquinic acids 3235 
a
 3242 
a
 ‒ ‒ ‒ 18.5 a 16.1 a ‒ ‒ ‒ 
18 1,5-Di-O-caffeoylsuccinoylquinic acid isomer 2168 
a
 2151 
a
 ‒ ‒ ‒ 12.4 a 10.7 b ‒ ‒ ‒ 
19 4-Acyl-di-O-caffeoylsuccinoylquinic acid 
isomer 
479 
a
 557 
a
 ‒ ‒ ‒ 2.7 a 2.8 a ‒ ‒ ‒ 
23 Dicaffeoylsuccinoylquinic acid isomer 262 
a
 215 
b
 ‒ ‒ ‒ 1.5 a 1.1 b ‒ ‒ ‒ 
26 Dicaffeoyldisuccinoylquinic acid isomer 326 
a
 318 
a
 ‒ ‒ ‒ 1.9 a 1.6 a ‒ ‒ ‒ 
 Total coumarins ‒ ‒ ‒ 421 ‒ ‒ ‒ ‒ 1.2 ‒ 
4 Scopolin isomer ‒ ‒ ‒ 421 ‒ ‒ ‒ ‒ 1.2 ‒ 
            
  
No. Compound 
Phenolic content (mg/kg dw) Phenolic content (mg/g extract) 
Stalks Capitula 
Leaves 
Stalks Capitula 
Leaves 
Outer Inner 
Receptacles 
and bracts 
Florets Outer Inner 
Receptacles 
and bracts 
Florets 
 Total flavonoids 638 
d
 478 
d
 1740 
c
 10345 
a
 2775 
b
 3.7 
c
 2.4 
c
 9.9 
b
 30.6 
a
 10.2 
b
 
 Total flavanones ‒ ‒ ‒ 2703 ‒ ‒ ‒ ‒ 8.0 ‒ 
6 Eriodictyol hexoside 
(II)
 ‒ ‒ ‒ 40 ‒ ‒ ‒ ‒ 0.1 ‒ 
 Total naringenin derivatives ‒ ‒ ‒ 2663 ‒ ‒ ‒ ‒ 8.0 ‒ 
13 Naringenin 7-O-glucoside ‒ ‒ ‒ 812 ‒ ‒ ‒ ‒ 2.4 ‒ 
14 Naringenin rutinoside ‒ ‒ ‒ 1770 ‒ ‒ ‒ ‒ 5.4 ‒ 
28 Naringenin ‒ ‒ ‒ 81 ‒ ‒ ‒ ‒ 0.2 ‒ 
 Total flavones 638 
d
 478 
d
 1740 
c
 7642 
a
 2775 
b
 3.7 
c
 2.4 
c
 9.9 
b
 22.7 
a
 10.2 
b
 
 Total luteolin derivatives 379 
c
 169 
d
 211 
c,d
 1035 
b
 1607 
a
 2.2 
c
 0.8 
d
 1.2 
d
 3.1 
b
 5.7 
a
 
7 Luteolin glucuronide 171 
b,d
 101 
c
 146 
c,d
 208 
b
 388 
a
 1.0 
b
 0.5 
c
 0.8 
b
 0.6 
c
 1.4 
a
 
8 Luteolin 7-O-glucoside 208 
b
 68 
c
 65 
c
 205
 b
 841 
a
 1.2 
b
 0.3 
c
 0.4 
c
 0.6 
c
 3.0 
a
 
9 Luteolin rutinoside ‒ ‒ ‒ 109 a 31 b ‒ ‒ ‒ 0.3 a 0.1 a 
21 Luteolin acetylhexoside 
(IV)
 (21+22) (21+22) ‒ 114 b 207 a (21+22) (21+22) ‒ 0.3 a 0.7 b 
24 Luteolin ‒ ‒ ‒ 399 a 139 b ‒ ‒ ‒ 1.2 a 0.5 b 
 Total apigenin derivatives 259 
c
 309 
c
 1529 
b
 6545 
a
 1085
 b
 1.5 
d
 1.5 
d
 8.7 
b
 19.3 
a
 3.9 
c
 
15 Apigenin glucuronide 203 
d 
(15+16) 
281 
d 
(15+16) 
1423 
b 
4676
 a
 
(15+16+17) 
804 
c 
(15+16+17) 
1.2
 d
 
(15+16) 
1.4 
d 
(15+16) 
8.1 
b
 13.8
 a
 
(15+16+17) 
2.9
 c
 
(15+16+17) 
16 Apigenin 7-O-glucoside (15+16) (15+16) ‒ (15+16+17) (15+16+17) (15+16) (15+16) ‒ (15+16+17) (15+16+17) 
17 Apigenin 7-O-rutinoside ‒ ‒ ‒ (15+16+17) (15+16+17) ‒ ‒ ‒ (15+16+17) (15+16+17) 
25 Apigenin acetylhexoside 55 
c
 27 
d
 106 
b
 231 
a
 128 
b
 0.3 
c
 0.1 
d
 0.6 
b
 0.7 
a,b
 0.5 
b
 
29 Apigenin ‒ ‒ ‒ 1638 a 154 b ‒ ‒ ‒ 4.8 a 0.5 b 
            
  
No. Compound 
Phenolic content (mg/kg dw) Phenolic content (mg/g extract) 
Stalks Capitula 
Leaves 
Stalks Capitula 
Leaves 
Outer Inner 
Receptacles 
and bracts 
Florets Outer Inner 
Receptacles 
and bracts 
Florets 
 Total chrysoeriol derivatives ‒ ‒ ‒ 63 b 83 a ‒ ‒ ‒ 0.3 b 0.5 a 
20 Chrysoeriol hexoside isomer 
(III)
 ‒ ‒ ‒ 30 b 83 a ‒ ‒ ‒ 0.2 b 0.5 a 
30 Chrysoeriol isomer 
(III) 
‒ ‒ ‒ 33 ‒ ‒ ‒ ‒ 0.1 ‒ 
 Total identified phenolics 11085 
b
 10581 
b
 10525 
b
 12697 
a
 2846 
c
 63.5 
a
 52.5 
b
 60.2 
a
 37.6 
c
 10.4 
d
 
(I)
 Results represent the means estimated from the analysis of two extracts analyzed in triplicate (standard deviation less than 5%). Means with different superscript 
letters within the same row, among the phenolic content expressed in mg/kg dw and among the phenolic content expressed in mg/g extract, are statistically 
different (p < 0.05). Numbers in parenthesis correspond to compounds whose chromatographic peaks were overlapped. 
Standard curves used: 
(II)
 naringenin 7-O-glucoside and 
(III)
 luteolin 7-O-glucoside. 
(IV)
 Standard curve of 1,5-di-O-caffeoylquinic acid was chosen, because the overlapped peaks (compounds 21 and 22) was higher at 330 nm compared to 350 nm. 
(V)
 In the case of stalks outer and inner parts, the total contents did not include the content of 4-acyl-di-O-caffeoylquinic acid isomer (22), due to the co-elution with 
luteolin acetylhexoside (21). 
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The phenolic contents in both parts of stalks (10581-11085 mg/kg dw) were enclosed 
within the published concentration range for floral stem of artichoke,
18,22,24
 wild cardoon and 
cultivated cardoon.
18
 Receptacles and bracts also contained considerably high amount of 
hydroxycinnamic acids (10525 mg/kg dw), being in the same order as those earlier reported 
for the same parts of artichoke by Pandino, et al.,
50
 but lower than those shown by Negro, et 
al.
25
 The analyzed leaves contained lower phenolic compounds concentrations, relatively to 
those formerly indicated for cultivated cardoon
16,18
 and wild cardoon. Valentão
51
 earlier 
investigated the phenolic composition of wild cardoon leaves, collected in North Portugal, at 
the florescence stage. The presented total identified phenolic content of cultivated cardoon 
leaves was much lower (up to 10.2-fold) comparatively with Valentão’s results.51 This could be 
associated not only with the edapho-climatic conditions, but also with the variety, age and life 
stage of plant, and extraction methodology. 
 
3.3.1 Hydroxycinnamic acids and coumarins 
Hydroxycinnamic acids were mainly retained in stalks outer and inner parts (Figure 12 
and Table 7), accounting for 10323 and 9969 mg/kg dw, respectively. These compounds are 
commonly detected in stalks and capitula of C. cardunculus L.,
18,25,50
 due to their integrity and 
structural roles in plant cell wall.
52
 The hydroxycinnamic acids contents of stalks was in the 
same order as the content range previously referenced for floral stems of wild cardoon, 
artichoke,
18,22,24
 and cultivated cardoon.
18
 Stalks outer part extract revealed the highest 
hydroxycinnamic acids concentration (59.1 mg/g extract). 
Receptacles and bracts demonstrated the highest dicaffeoylquinic acids content, 
accounting for 5036 mg/kg dw and 28.8 mg/g extract (Figure 12 and Table 7). These values 
were higher than those cited for receptacles and bracts of wild cardoon
17
 and artichoke.
22,24,50
 
Monocaffeoylquinic acids were also found at considerable amounts, contributing for 3749 
mg/kg dw and 21.4 mg/g extract in receptacles and bracts, which was within the concentration 
range cited for artichoke receptacles and bracts.
22,24,25,50
 Dicaffeoylsuccinoylquinic acids were 
only noted in inner and outer parts of stalks, accounting for respectively 3242 and 3235 mg/kg 
dw (16.1 and 18.5 mg/g extract, respectively). Pandino, et al.
18
 had proven that these 
compounds were present in floral stems of cultivated cardoon, whose concentration was 2.3-
fold lower than the results obtained in this work. 
The 1,5-di-O-caffeoylquinic acid (12) was the most common hydroxycinnamic acid 
identified in cultivated cardoon, representing 4292 mg/kg dw and 24.5 mg/g extract of 
receptacles and bracts. The content of this compound was much higher than that previously 
indicated for wild cardoon capitula (21 mg/kg dw).
17
 Moreover, it was in the same order as the 
published concentration for receptacles and bracts of artichoke.
22,24,50
 5-O-caffeoylquinic acid 
(3) was the most abundant monocaffeoylquinic acid identified in cultivated cardoon, specially 
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in receptacles and bracts (3599 mg/kg dw and 20.6 mg/g extract). This was in the same order 
as that of artichoke receptacles and bracts.
24,50
 This compound was not previously detected in 
capitula of wild cardoon and cultivated cardoon.
17
 1,5-di-O-caffeoylsuccinoylquinic acid isomer 
(18) was the major dicaffeoylsuccinoylquinic acid of cultivated cardoon, accounting for 2168 
mg/kg dw (12.4 mg/g extract) and 2151 mg/kg dw (10.7 mg/g extract) in outer and inner parts 
of stalks, respectively. These concentrations were in the same order than those isomers found 
in cultivated cardoon floral stem.
18
 
Coumarins (4) were only noted in the florets (421 mg/kg dw and 1.2 mg/g extract) 
(Table 7). This phenolic subclass was for the first time quantified in C. cardunculus L. varieties 
by LC-UV analysis. 
 
3.3.2 Flavonoids 
Capitula florets presented the highest amount of flavonoids (10345 mg/kg dw and 30.6 
mg/g extract) (Table 7 and Figure 12), which may be linked with their role in plant 
reproduction.
53
 The concentration of this phenolic subclass was in the same order of artichoke 
capitula,
17,25
 and higher than those published regarding capitula of cultivated cardoon and wild 
cardoon.
17
 Furthermore, flavonoids were also in leaves (2775 mg/kg dw and 10.2 mg/g 
extract), probably due to their important protective function against the ultraviolet radiation.
18
 
Leaves flavonoids concentration was lower than those referenced for artichoke and wild 
cardoon.
16,18
 Nonetheless, it was included in the flavonoids concentration range, relatively to 
cultivated cardoon leaves.
16,18,51
 
Flavones were the most abundant flavonoids (Table 7 and Figure 12), particularly in 
florets (7642 mg/kg dw and 22.7 mg/g extract), mainly represented by apigenin derivatives 
(6545 mg/kg dw and 19.3 mg/g extract). The apigenin derivatives concentration was in the 
same concentration order as those that were earlier noticed for capitula of artichoke,
17,31
 wild 
cardoon and cultivated cardoon.
17
 In fact, apigenin glucuronide (15), apigenin 7-O-glucoside 
(16) and apigenin 7-O-rutinoside (17) were the most abundant flavonoids in cultivated cardoon 
florets (4676 mg/kg dw and 13.8 mg/g extract). Moreover, leaves extracts exhibited the 
highest content of total luteolin derivatives (1607 mg/kg dw and 5.7 mg/g extract), being 
comparable with those earlier studied from wild cardoon leaves
18,51
 and cultivated 
cardoon,
16,18
 but lower than those from artichoke leaves.
16,18
 Flavanones were only found in 
florets (2703 g/kg dw and 8.0 mg/g extract). This concentration was much higher than that 
indicated by Schutz, et al.
31
 for artichoke capitula. 
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4. Conclusions 
This work highlighted a detailed chemical characterization of phenolic compounds in 
stalks, capitula and leaves of C. cardunculus L. var. altilis (DC) from the south of Portugal, by 
HT-UHPLC-DAD-MS
n
 analysis. Among the 28 phenolic compounds identified in cultivated 
cardoon, eriodictyol hexoside was referred for the first time in C. cardunculus L., and six as 
cultivated cardoon components, namely 1,4-di-O-caffeoylquinic acid, naringenin 7-O-
glucoside, naringenin rutinoside, naringenin, luteolin acetylhexoside and apigenin 
acetylhexoside. Stalks contained the highest hydroxycinnamic acids abundances (≈9.9-10.3 
g/kg dw), while capitula florets demonstrated the highest flavonoids content (≈10.3 g/kg dw). 
Mono and dicaffeoylquinic acids were specially retained in receptacles and bracts (≈3.7 and 
≈4.9 g/kg dw, respectively). Furthermore, florets and leaves revealed the highest contents of 
apigenin (≈6.5 g/kg dw) and luteolin (≈1.6 g/kg dw) derivatives, respectively. 
In sum, the present work suggests that cultivated cardoon is promising in what 
concerns to phenolic composition, being comparable to other Asteraceae plants, like endemic 
Helichrysum species of Madeira Archipelago (Macaronesia).
54
 The pre-extraction of phenolic 
compounds from cultivated cardoon can be integrated in a future industrial value chain, 
comprehending energy, pulp fibers production and nutraceutics, in order to contribute for the 
economic development of Mediterranean countries. 
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Abstract 
Given the presence of phenolic compounds, the antioxidant activity of 
methanol/water/acetic acid (49.5:49.5:1) extracts, derived from stalks, capitula and leaves of 
Cynara cardunculus L. var. altilis (DC) was approached through the 2,2-diphenyl-1-
picrylhydrazyl (DPPH) free radical scavenging assay. For comparison reasons, ascorbic acid 
and 3,5-di-tert-4-butylhydroxytoluene (BHT) were used as, respectively, natural and synthetic 
reference antioxidants. Extracts of stalks outer part (IC50 = 34.35 µg/mL), and receptacles and 
bracts (IC50 = 35.25 µg/mL) exhibited the strongest DPPH scavenging effects. Nevertheless, 
cultivated cardoon extracts were less active to scavenge DPPH free radicals, comparatively to 
ascorbic acid (IC50 = 2.29 µg/mL) and BHT (IC50 = 16.02 µg/mL). The DPPH scavenging effect 
was linearly correlated with the total identified phenolic contents, assessed by HPLC-UV (r = -
0.899), in particular with the total monocaffeoylquinic acids content (r = -0.996). Novel 
antioxidant formulations, containing cultivated cardoon phenolic-rich fractions, may potentially 
be considered for food applications. 
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1. Introduction 
Cynara cardunculus L. (Asteraceae) comprises three varieties, namely wild cardoon 
(var. sylvestris (Lamk) Fiori), globe artichoke (var. scolymus (L.) Fiori) and cultivated cardoon 
(var. altilis (DC)).
1
 This species is well-adapted to the Mediterranean habitat conditions, 
namely clay soils and dry and hot summers.
2
 Cultivated cardoon has been produced in Spain, 
Italy, France and south of Portugal, given its potential to be transformed into 
biocombustibles.
3,4
 
Since the Roman times, C. cardunculus L. leaves infusions have been consumed, due 
to their hepatoprotective
5
 and anticholestatic properties.
6
 These biological actions have been 
ascribed to phenolic compounds, specially to hydroxycinnamic acids (e.g., 5-O-caffeoylquinic 
and 1,3-di-O-caffeoylquinic acids)
5
 and flavones (e.g., luteolin and luteolin 7-O-glucoside).
6
 
Moreover, C. cardunculus L. extracts, containing phenolic compounds, have also exhibited 
antimicrobial,
7–9
 anti-inflammatory,
10
 and antitumor
11,12
 effects. 
Artichoke phenolic-containing extracts have also evidenced antioxidant activity, by 
preventing oxidation of Cu
2+
-mediated low density lipoprotein,
13
 as well as by scavenging 2,2-
diphenyl-1-picrylhydrazyl (DPPH) free radicals
14
 and reactive oxygen species (ROS).
15
 
Methanol extracts and infusions of wild cardoon leaves have also demonstrated scavenging 
effect on DPPH,
7
 superoxide radical anion
7,16
 and hydroxyl radical,
16
 mainly due to the 
presence of phenolic compounds. It has also evidenced the ferric reducing antioxidant power 
of methanol aqueous extract derived from cultivated cardoon floral stems.
17 
Our group
12
 
previously observed the DPPH scavenging effect of methanol extracts, derived from several 
morphological parts of wild and cultivated cardoon, but a detailed chemical composition of 
these extracts was not determined, particularly in what regards phenolic compounds. 
After the chemical characterization of cultivated cardoon lipophilic fraction,
18
 our 
group
19
 found that phenolic compounds were mainly in methanol/water/acetic acid 
(49.5:49.5:1) extracts, derived from stalks outer part (63.5 mg/g), and receptacles and bracts 
(60.2 mg/g). Furthermore, we noticed that stalks outer and florets extracts displayed the 
highest content of hydroxycinnamic acids (59.1 mg/g) and flavonoids (30.6 mg/g), 
respectively.
19
 Considering our interest for seeking plant antioxidants, this study intends to 
examine the DPPH scavenging ability of methanol/water/acetic acid extracts, derived from 
several morphological parts of C. cardunculus L. var. altilis (DC), given the phenolic 
composition. 
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2. Materials and Methods 
2.1 Chemicals 
Methanol (p.a., ≥99.8% purity) and water were supplied by Fisher Scientific (Pittsburgh, 
Pennsylvania, USA). Glacial acetic acid (p.a., ≥99.7% purity) was purchased from Panreac 
(Castellar del Vallès, Spain). DPPH and 3,5-di-tert-4-butylhydroxytoluene (BHT) (≥99% purity) 
were obtained from Sigma Chemicals Co. (Madrid, Spain). Ascorbic acid (≥99.5% purity) was 
supplied from Fluka Chemie (Madrid, Spain). 
 
2.2 Preparation of C. cardunculus L. var. altilis (DC) methanol/water/acetic acid 
extracts 
C. cardunculus L. var. altilis (DC) was collected at the flowering stage, in June 2010, at 
the Experimental Center of the Agriculture School from Instituto Politécnico de Beja, south of 
Portugal. Plants were separated in stalks, capitula and leaves, and preserved at -20 ºC until 
their use. Before extraction, samples were freeze-dried. Then, stalks were separated in outer 
and inner parts and capitula in receptacles, bracts and florets. 
Methanol/water/acetic acid (49.5:49.5:1) extracts were prepared, after the lipophilic 
components removal, through solid-liquid extraction, and quantified by high performance liquid 
chromatography-ultraviolet detection (HPLC-UV), as discussed before.
19
 For comparison 
reasons, the total phenolic contents were also determined through the Folin-Ciocalteu assay.
19
 
The detailed chemical composition of cultivated cardoon extracts may be consulted in Chapter 
IV. 
 
2.3 DPPH scavenging effect assay 
The antioxidant activity of methanol/water/acetic acid extracts was evaluated through 
the DPPH free radical scavenging assay, according to a procedure explained before.
20
 
Ascorbic acid and BHT were used as reference antioxidants from natural and synthetic origin, 
respectively. 
Stock solutions of dry extracts, ascorbic acid and BHT were previously prepared in 
methanol/water (1:1). Sample aliquots (1 mL) were mixed with 0.25 mL of 0.95 mM DPPH 
methanolic solution and 2.75 mL of methanol. The ranges of final concentrations were 7.5-
400.0 µg/mL for methanol/water extracts, 2.3-25.0 µM for ascorbic acid and 9.1-363.1 µM for 
BHT. The mixtures were vortexed and left to stand in the dark for 30 min. The absorbance of 
DPPH free radical was measured at 517 nm against a blank (methanol), and compared to a 
control without sample, using a UV/Vis V-530 spectrophotometer (Jasco, Tokyo, Japan). 
DPPH scavenging effect was calculated as the percentage of DPPH discoloration, using the 
following equation: % DPPH free radical scavenging effect = [(ADPPH-AS)/ADPPH] x 100, where 
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ADPPH is the control absorbance and AS is the sample absorbance. The inhibitory concentration 
providing 50% DPPH scavenging effect (IC50) was determined from the graph of scavenging 
effect percentage in function of concentration logarithm (GraphPad Prism 5, LaJolla, 
California, USA). Two extracts of each cultivated cardoon morphological part were analyzed in 
triplicate. 
The antioxidant activity index (AAI) was calculated based on the following equation:
21
 
AAI = initial concentration of DPPH in the reaction mixture (μg/mL)/IC50 (extract) (μg/mL), 
where the initial DPPH concentration was 23.41 μg/mL. 
 
2.4 Statistical analysis 
The DPPH scavenging effect IC50 values were analyzed using the MIXED procedure 
option of SAS (SAS Institute Inc., Cary, North Carolina, USA), considering morphological parts 
of cultivated cardoon and extracts as fixed and random effects, respectively. Where 
differences existed, the source of the differences at p < 0.05 of significance level was identified 
by all pairwise multiple comparison procedure. The Tukey’s test was used for pairwise 
comparisons. The Pearson correlation coefficients between phenolic compounds 
concentrations and DPPH scavenging effect were determined by using the CORR procedure 
option of SAS. 
 
3. Results and Discussion 
Antioxidant activity of methanol/water/acetic acid (49.5:49.5:1) extracts, derived from 
several morphological parts of C. cardunculus L. var. altilis (DC), was examined through 
DPPH scavenging effect. For comparison reasons, the ability of reference antioxidants, 
namely ascorbic acid and BHT, to scavenge DPPH was also evaluated (Table 1). 
Extracts of stalks outer part, as well as of receptacles and bracts represented the most 
effective cultivated cardoon extracts to scavenge DPPH free radicals (p > 0.05), with IC50 
values of 34.35 and 35.25 μg/mL, respectively (Table 1). The IC50 value of stalks inner part 
extracts was 1.7-fold higher than the former extracts (p < 0.05). Finally, florets and leaves 
extracts presented the highest IC50 values (163.92 and 164.90 μg/mL, respectively) (p > 0.05). 
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Table 1: IC50 and AAI values of methanol/water/acetic acid (49.5:49.5:1) extracts of C. cardunculus L. 
var. altilis (DC) and reference compounds, regarding the DPPH scavenging assay. 
Cultivated cardoon extract/reference compound IC50 (μg/mL)
 (I)
 IC50 (μM) 
(I)
 AAI 
Stalks 
Outer part 34.35 ± 2.27 
c
 ‒ 0.68 
Inner part 58.65 ± 4.99 
b
 ‒ 0.40 
Capitula 
Receptacles and bracts 35.25 ± 2.59 
c
 ‒ 0.66 
Florets 163.92 ± 17.26 
a
 ‒ 0.14 
Leaves  164.90 ± 8.66 
a
 ‒ 0.14 
Ascorbic acid  2.29 ± 0.11 
e
 12.99 ± 0.61 
b
 10.22 
BHT  16.02 ± 3.59 
d
 72.69 ± 16.28 
a
 1.46 
(I)
 Results correspond to the means ± standard deviation estimated from the analysis from two extracts 
analyzed in triplicate. Means with different superscript letters within the same column are statistically 
different (p < 0.05). 
 
Nevertheless, cultivated cardoon extracts displayed higher DPPH scavenging effect 
IC50 values, compared to those of antioxidant standards (Table 1), namely ascorbic acid (IC50 
= 2.29 μg/mL) and BHT (IC50 = 16.02 μg/mL). Synthetic antioxidants, like butylated 
hydroxyanisole and BHT, are vastly used for preventing food lipid oxidation, due to their high 
performance, low cost and wide availability. However, there is a great search for plants 
phenolic compounds, as an alternative to potentially toxic and carcinogenic synthetic 
antioxidants.
22
 Despite their lower DPPH scavenging effect compared to BHT, future research 
may be performed, in an effort to discover the potential of cultivated cardoon phenolic-
enriched extracts to be included in novel food antioxidant formulations. 
The antioxidant activity of artichoke,
14,23,24
 wild cardoon
7,8,12
 and cultivated cardoon
12
 
extracts have been assessed through the DPPH scavenging effect assay, but several 
methods have been performed, differently in terms of: (i) initial concentration of DPPH 
solution; (ii) reaction time; and (iii) way of presenting data. Therefore, the antioxidant activity 
index (AAI) was determined according to the equation suggested by Scherer and Godoy
21 
(Table 1), in order to compare the DPPH scavenging effect of the tested cultivated cardoon 
extracts with the published results (Table 2). The tested capitula receptacles and bracts 
extracts were stronger (AAI = 0.66) than than several organic and hydroalcoholic extracts and 
fractions of wild cardoon capitula described in literature (AAI = 0.13
7
 and AAI range of 0.23-
0.31 
8
). Nonetheless, the analyzed capitula florets extract was as active (AAI = 0.14) as the 
methanol extract of wild cardoon capitula, earlier reported.
7
 Cultivated cardoon leaves extract 
(AAI = 0.14) was much more active than infusions of artichoke leaves and dietary supplements 
(AAI = 0.01 and 0.002, respectively24), but it was less effective than the methanol extract of 
wild cardoon leaves, published in literature (AAI = 0.30).
7 
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Table 2: AAI values regarding the DPPH scavenging effect of C. cardunculus L. extracts published in 
literature. 
C. cardunculus L. extracts AAI Source 
Artichoke Leaves infusion 0.01 
21
 
Dietary supplement infusion 0.002 
21
 
Wild cardoon Capitula methanol extract 0.13 
5
 
Capitula extracts 0.23-0.31 
6
 
Leaves methanol extract 0.30 
5
 
 
The DPPH scavenging effect of the tested cultivated cardoon extracts were 
comparable with phenolic-containing extracts of other Asteraceae plants, tested at the same 
reaction time.
25,26
 For example, the methanol/water/acetic acid extracts, derived from stalks 
outer part, and receptacles and bracts, were stronger relatively to Centaurea gigantea 
methanol extract (AAI = 0.56), containing chlorogenic acid, among other phenolic 
compounds.
25
 Valentova, et al.
26
 had noted that two ethyl acetate fractions, derived from 
Smallanthus sonchifolius leaves, exhibited DPPH scavenging effect (AAI = 0.55-0.83), 
containing 1.7-9.9 mg/g extract in terms of chlorogenic acid content.  
Table 3 reveals the Pearson correlation coefficients between the total contents of 
phenolic compounds and the DPPH scavenging effect. 
 
Table 3: Pearson correlation coefficients between phenolic compounds contents and DPPH scavenging 
effect of cultivated cardoon methanol/water/acetic acid (49.5:49.5:1) extracts. 
Total contents Pearson correlation coefficient 
Phenolic compounds (Folin-Ciocalteu assay) -0.929* 
Identified phenolic compounds (HPLC-UV) -0.899* 
Hydroxycinnamic acids -0.990** 
Monocaffeoylquinic acids -0.996** 
Dicaffeoylquinic acids -0.953* 
Flavonoids 0.696 
Apigenin derivatives 0.527 
Luteolin derivatives 0.808 
*Correlation is significant at p < 0.05. 
** Correlation is significant at p < 0.01. 
 
The DPPH scavenging effect of cultivated cardoon methanol/water/acetic acid extracts 
was linearly correlated with the phenolic compounds contents (Table 3), determined either by 
the Folin Ciocalteu assay (r = -0.929) or by the HPLC-UV quantification (r = -0.899). 
Furthermore, the DPPH scavenging effect of cultivated cardoon extracts was linearly 
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correlated with the total hydroxycinnamic acids content (r = -0.990), the total 
monocaffeoylquinic acids content (r = -0.996), and the total dicaffeoylquinic acids content (r = -
0.953) (Table 3). These findings may be related with the resonance stabilization of o- or p-
quinones originated by caffeoyl moieties.
27
 Regarding flavonoids, the IC50 values of cultivated 
cardoon extracts increased with the total contents of flavonoids, luteolin and apigenin 
derivatives. In this manner, the DPPH scavenging effect of cultivated cardoon extracts was not 
correlated with the flavonoids, apigenin and luteolin derivatives contents. Wang, et al.
14
 had 
showed that flavonoids, namely naringenin 7-O-rutinoside, luteolin 7-O-rutinoside and 
apigenin 7-O-glucoside, were less active to scavenge DPPH free radicals, compared to 1,3-di-
O-caffeoylquinic acid. 
Bioactivity-guided fractionation should be performed to clarify if phenolic compounds, 
or particularly hydroxycinnamic acids, were the main responsible for the DPPH scavenging 
effect of cultivated cardoon methanol/water/acetic acid extracts. 
The preparation of cultivated cardoon enriched fractions, either in phenolic compounds 
or in hydroxycinnamic acids, may potentiate their antioxidant activity. For example, our group
28
 
recently indicated that the nanofiltration technology was useful to increment the contents of 
phenolic compounds (1.8-fold) and 5-O-caffeoylquinic acid (1.6-fold), in cultivated cardoon 
methanol/water leaves extracts. Brás, et al.
28
 also indicated an 1.8-fold increment in the DPPH 
scavenging effect of cultivated cardoon phenolic-concentrated extracts, being correlated with 
the 5-O-caffeoylquinic acid content. Moreover, Kukic, et al.
8
 reported a 7.3-fold enhancement 
in the DPPH scavenging effect of ethyl acetate fraction, after a 4.1-fold increase in the total 
phenolic contents, from the wild cardoon bracts 96% ethanol extract. Additionally, it was 
previously shown that 5-O-caffeoylquinic acid was 3.1-fold more active in neutralizing the 
DPPH free radicals, compared to the C. gigantea methanol extract, from which it was 
isolated.
25
 In this manner, the preparation of cultivated cardoon enriched fractions in phenolic 
compounds, principally in hydroxycinnamic acids, derived from methanol/water/acetic acid 
extracts of stalks outer part and capitula receptacles and bracts, would probably enhance their 
DPPH scavenging effect. 
Future work should also be carried out to investigate the antioxidant activity of the 
cultivated cardoon phenolic-rich extracts, as well as of their bioactive-enriched fractions, 
against ROS which are associated with the initiation, progression and promotion of cancer and 
cardiovascular diseases. Actually, Valentão, et al.
16
 had noticed that wild cardoon leaves 
infusion was able to scavenge hydroxyl radicals. Besides the ROS scavenging effect,
15,16
 the 
antioxidant activity of cultivated cardoon phenolic-enriched fractions can be further studied in 
immortalized human cell lines, through their influencing role upon ROS formation,
29
 lipid 
peroxidation,
30
 mitochondrial membrane potential,
11
 and important antioxidant defense 
enzymes, namely superoxide dismutase, glutathione peroxidase and catalase.
31 
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4. Conclusions 
This study highlights the antioxidant activity of methanol/water/acetic acid (49.5:49.5:1) 
extracts derived from stalks, capitula and leaves of C. cardunculus L. var. altilis (DC), by using 
the DPPH free radical scavenging assay. Extracts of stalks outer part, and receptacles and 
bracts were the most active to scavenge DPPH free radicals, with IC50 values of 34.35 and 
35.25 µg/mL, respectively (p > 0.05). The antioxidant capacity of cultivated cardoon extracts, 
by using the DPPH assay, demonstrated linear correlation with the total phenolic contents, 
determined either by the Folin-Ciocalteu assay (r = -0.929) or by the HPLC-UV quantification (r 
= -0.899). The DPPH scavenging effect of cultivated cardoon extracts were also linearly 
correlated with the total contents of monocaffeoylquinic acids (r = -0.996), hydroxycinnamic 
acids (r = -0.990) and dicaffeoylquinic acids (r = -0.953). Despite the weaker DPPH 
scavenging effect compared to ascorbic acid and BHT, the phenolic-rich fraction of cultivated 
cardoon may have potential to be investigated, in the scope of new food antioxidant 
formulations. 
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Abstract 
This study reports, for the first time, the antiproliferative activity of sequential lipophilic 
and phenolic-rich extracts from Cynara cardunculus L. var. altilis (DC), against the human 
triple-negative breast cancer MDA-MB-231 cell line. Leaves lipophilic extract was the most 
active cultivated cardoon extract (IC50 = 10.39 µg/mL), in inhibiting MDA-MB-231 cellular 
viability (48 h). Cynaropicrin also prevented MDA-MB-231 cell growth (IC50 = 17.86 µM), within 
the same time period. Moreover, leaves lipophilic extract and cynaropicrin were efficient in 
preventing colony formation, although leaves lipophilic extract effect was seen in a greater 
extension. Furthermore, leaves lipophilic extract and cynaropicrin blocked cell cycle at G2 
phase, by upregulating p21
Waf1/Cip1
 and, consequently, inducing accumulation of inactive 
phospho-Tyr15-CDK1 and cyclin B1. The leaves lipophilic extract effect upon MDA-MB-231 
cell cycle, at G2 phase, was more evident compared to cynaropicrin. Suppressive activity of 
leaves lipophilic extract and cynaropicrin on MDA-MB-231 cell proliferation may also be 
related with decrease expression of phospho-Ser473-Akt. Present at considerably high 
content (455.2 mg/g extract), cynaropicrin may have greatly contributed for the antiproliferative 
effect of leaves lipophilic extract on MDA-MB-231 cells. These results showed the promising 
potential of cultivated cardoon leaves lipophilic extract and cynaropicrin to be researched, as a 
complementary approach to therapy of human triple-negative breast cancer. 
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1. Introduction 
Breast cancer (BC) has been reported as the second most common form of cancer, 
and the most incident cancer among women, being the major cause of female cancer death.
1
 
European countries are among those with the highest incidence rate of breast cancer in 
women (Figure 1), ranging from 38.7 (Republic of Moldova) to 111.9 (Belgium) per 100,000 
persons. Portugal also exhibits a considerable incidence rate of breast cancer among women 
(67.6 per 100,000 persons). Western Africa countries present the highest mortality rate (20 per 
100,000 persons).
1
 
 
Figure 1: Estimated breast cancer worldwide incidence among women in 2012. The values correspond 
to estimated age-standardized rates per 100,000 persons (adapted from 
1
). 
 
Modern BC classification already includes the triple-negative subtype (TNBC) which is 
estrogen and progesterone receptors negative, and lack HER2 overexpression.
2
 TNBC falls 
into basal-like BC subtype, based on gene profiling, but it also includes other molecular 
features. This subgroup shows different clinical behaviors, accounting for 10-20% of all 
invasive BC.
2
 The main risk factors of TNBC in women include: (i) younger age; (ii) African 
origin; and (iii) BC susceptibility gene 1 mutation.
3
 Currently, TNBC has not a targeted 
treatment; the most common chemotherapy approach is based on primary anthracycline and 
anthracycline/taxane derivatives therapies, as first line treatment, being in general not efficient, 
with high relapse risk, during the first three years after treatment,
4
 and high incidence of 
visceral metastases, namely liver, central nervous system and lung.
3
 The combination of 
cellular and molecular knowledge for new therapeutic strategies development, either as 
preventive or treatment, seems of high importance, especially in a scenario of so limited 
therapeutic options, with several side effects, and short survival rates. Several epidemiological 
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studies have indicated that the consumption of vegetables, fruits, fish and olive oil is inversely 
associated with BC risk.
5–7
 The presence of secondary metabolites, namely -3 fatty acids, 
tetraterpenes (e.g., β-carotene and lycopene), phytosterols5–7 and phenolic compounds,8,9 
may contribute for the reduction of BC incidence. Phytochemicals can be therefore considered 
for chemoprevention, as well as for new therapy strategies or as a complementary approach 
to BC chemotherapy, due to their promising reduced toxicity, desired range of efficacy and 
ability to influence simultaneously multiple pathways.
10
 
Cynara cardunculus L. (Asteraceae) is a Mediterranean species which comprehends 
three varieties, namely wild cardoon (var. sylvestris (Lamk) Fiori), artichoke (var. scolymus (L.) 
Fiori) and cultivated cardoon (var. altilis (DC)). Since the Roman times, C. cardunculus L. 
leaves infusions have been traditionally consumed against hepatobiliary disorders, due to 
hypocholesterolemic,
11
 choleretic and anticholestatic effects of phenolic compounds, such as 
caffeoylquinic acids and luteolin derivatives.
12
 Moreover, artichoke lipophilic extracts 
evidenced anti-hyperlipidemic
13
 and anti-inflammatory properties,
14
 mainly due to the presence 
of sesquiterpene lactones
13
 and pentacyclic triterpenes,
14
 respectively. Some studies have 
reported the antiproliferative action of artichoke methanol extracts, by regulating apoptosis 
pathway, upon human hepatocarcinoma (Hep G2 cell line)
15
 and TNBC cells (MDA-MB-231 
cell line),
16
 probably attributed to phenolic composition. Moreover, our group demonstrated the 
suppressive action of a methanol aqueous extract of cultivated cardoon leaves, on 48 h-cell 
growth of MDA-MB-231, but it was missing a detailed chemical composition.
17
 Regarding C. 
cardunculus L. lipophilic extracts, their antitumoral potential has been less explored. At the 
current knowledge, only one study explained the in vivo inhibitory effect of artichoke capitula 
extract (composed by taraxasterol derivatives, among other pentacyclic triterpenes), on the 
12-O-tetradecanoylphorbol-13-acetate tumor promotion of skin papilloma, in 7,12-
dimethylbenz[a]anthracene-initiated mouse model.
14
 
Recently, our group revealed that leaves and capitula florets of cultivated cardoon 
contained high abundances of sesquiterpene lactones and pentacyclic triterpenes 
respectively. Cynaropicrin (≈87.4 g/kg dw) and taraxasteryl acetate (≈8.9 g/kg dw) (Figure 2) 
represented the major sesquiterpene lactone and pentacyclic triterpene, respectively.
18
 Few 
researchers have described that cynaropicrin prevented the cellular viability of several human 
tumor cell lines,
19,20
 including the BC MCF-7 (estrogen receptor-positive) cell line.
19
 
Furthermore, the taraxasteryl acetate ingestion incremented the survival ratio of C3H/OuJ 
mammary tumor bearing mice to 66.6%, compared to control group, after 70 weeks. The 
taraxasterol treatment was even stronger than that with its acetate derivative, increasing the 
survival ratio to 80%.
21
 Regarding the phenolic fraction, our group also published a study 
describing the high contents of hydroxycinnamic acids and flavonoids in stalks outer part and 
capitula florets, respectively. The 1,5-di-O-caffeoylquinic acid (Figure 2) was one of the main 
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hydroxycinnamic acid found in cultivated cardoon (≈4.2 g/kg dw).22 Mileo, et al. (2012) 
reported the antiproliferative activity of 5-O-caffeoylquinic acid on TNBC MDA-MB-231 cell 
line, by increasing the percentage of apoptotic cells in a dose-dependent manner (200-1200 
µM), for 24 h.
16
 
 
Figure 2: Structures of cynaropicrin, taraxasteryl acetate and 1,5-di-O-caffeoylquinic acid. 
 
Following our research of new target bioactive-based TNBC treatment, this work aims 
to study the cell growth inhibitory action of lipophilic leaves and capitula florets, as well as of 
phenolic-rich extracts of stalks outer part and capitula florets, derived from cultivated cardoon 
on a TNBC cell line model (MDA-MB-231). The inhibitory effect of pure cynaropicrin, 
taraxasteryl acetate and 1,5-di-O-caffeoylquinic acid (Figure 2) on MDA-MB-231 cell growth 
was also assessed. The most effective antiproliferative extract and the related pure compound 
were further evaluated in terms of: (i) colony formation in an anchorage-independent growth 
assay; (ii) apoptosis assessment through caspase-3 activity; (iii) cell cycle analysis; (iv) protein 
expression of key cell cycle checkpoints; and (v) evaluation of Akt molecular cell signaling. 
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2. Materials and Methods 
2.1 Chemicals 
Dichloromethane (p.a. ≥99% purity) was supplied by Fischer Scientific (Pittsburgh, 
Pennsylvania, USA). p-Iodonitrotetrazolium violet, bovine serum albumin (BSA) (≥96% purity) 
and RNase were obtained from Sigma Chemicals Co. (Madrid, Spain). Cynaropicrin (≥97.5% 
purity) was purchased from Extrasynthese (Genay Cedex, France). Taraxasteryl acetate 
(≥99.2% purity) was provided by Avachem Scientific (San Antonio, Texas, USA). 1,5-di-O-
caffeoylquinic acid (≥98% purity) was supplied by Biopurify (Chengdu Biopurify 
Phytochemicals Ltd., Chengdu, China). Dulbecco’s modified Eagle’s medium (DMEM) 4.5 g/L 
glucose and L-glutamine, fetal bovine serum (FBS) and trypsin (5 g/L)/EDTA (2 g/L) were 
obtained from Lonza (Verviers, Belgium). Penicillin (10000 units/mL)-streptomycin (10 mg/mL) 
mixture was provided by BioWest (Nuaillé, France). Dimethyl sulfoxide (DMSO) cell culture 
grade was supplied from Applichem (Gatersleben, Germany). 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and propidium iodide was purchased from Calbiochem 
(San Diego, California, USA). Caspase-3/CPP32 colorimetric protease assay was provided by 
Invitrogen (Camarillo, California, USA). Anti-mouse horseradish peroxidase-conjugated 
secondary, cyclin-dependent kinase (CDK) inhibitory p21
Waf1/Cip1
 (hereafter referred as p21), 
cyclin B1 and phospho(Ser473)-Akt antibodies (hereafter referred as p-Ser473-Akt) were 
supplied by Cell Signaling Technology (Danvers, Massachusetts, USA). Donkey anti-goat 
horseradish peroxidase-conjugated secondary, Akt1 and β-actin antibodies were obtained 
from Santa Cruz Biotechnology (Dallas, Texas, USA), and phospho(Tyr15)-CDK1 (hereafter 
referred as p-Tyr15-CDK1) antibody was purchased from BD Biosciences (San Jose, 
California, USA). ECL reagents were provided by GE Healthcare Life Sciences 
(Buckinghamshire, U.K.). 
 
2.2 Preparation of C. cardunculus L. var. altilis (DC) extracts 
C. cardunculus L. var. altilis (DC) (cultivated cardoon) was collected at the flowering 
stage, in June 2010, at the Experimental Center of the School of Agriculture from Instituto 
Politécnico de Beja, Baixo Alentejo region, south Portugal. Stalks, capitula and leaves were 
separated and preserved at -20 ºC until analysis. 
Lipophilic extracts, derived from cultivated cardoon leaves and capitula florets, were 
prepared and analyzed by gas chromatography-mass spectrometry, as indicated elsewhere.
18
 
The phenolic-rich extracts were prepared, after the removal of lipophilic components, from the 
stalks outer part and capitula florets, and thereafter analyzed by liquid chromatography-mass 
spectrometry, as earlier explained.
22
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Lipophilic extracts of capitula florets and leaves contained respectively: 320.6 and 38.5 
mg/g extract of pentacyclic triterpenes; 8.8 and 3.4 mg/g extract of sterols; and 14.4 and 2.4 
mg/g extract of fatty acids. Sesquiterpene lactones were only present in leaves lipophilic 
extract, accounting for 484.9 mg/g extract, mainly represented by cynaropicrin (455.2 mg/g 
extract). Phenolic-rich extracts of stalks outer part and capitula florets contained respectively: 
53.9 and 0.7 mg/g extract of hydroxycinnamic acids, and 3.6 and 22.5 mg/g extract of 
flavonoids. The detailed chemical composition of lipophilic and phenolic-rich extracts of 
cultivated cardoon may be consulted in Appendix. 
 
2.3 Cell culture 
The human TNBC MDA-MB-231 cell line was purchased from American Type Cell 
Culture (ATCC, Manassas, Virginia, USA). Cells were grown in DMEM supplemented with 
10% (v/v) heat-inactivated FBS and 1% (v/v) penicillin–streptomycin mixture, at 37 ºC in a 5% 
CO2 humidified atmosphere (C150, Binder GmbH, Tuttlingen, Germany). Before confluence, 
cells were washed with phosphate buffered saline (PBS), collected following trypsinization with 
trypsin (0.5 g/L)/EDTA (0.2 g/L) solution and suspended in fresh growth medium before 
platting. 
 
2.4 Cell viability 
Stock solutions of cultivated cardoon lipophilic extracts, as well as of pure cynaropicrin 
and taraxasteryl acetate were prepared in DMSO. Phenolic-rich extracts and pure 1,5-di-O-
caffeoylquinic acid were prepared in 24% ethanol solution. Cells were seeded in 96-well plates 
at 2 × 10
5
 cells/mL density, and incubated for 24 h, at 37 ºC. Then, cells were treated with 
capitula florets and leaves lipophilic extracts (1-500 µg/mL), stalks outer part and capitula 
florets phenolic-rich extracts (2000-4500 µg/mL), cynaropicrin (0.1-150.0 µM), taraxasteryl 
acetate (0.1-5.0 µM) and 1,5-di-O-caffeoylquinic acid (1000-2500 µM) for 48 h. The respective 
vehicle solvent controls received DMSO and ethanol (<1% (v/v)). Cell viability was determined 
through MTT assay. This method lies on the reduction of tetrazolium salt MTT, by 
dehydrogenases in active mitochondria, to formazan derivative which is monitored through 
ultraviolet-visible spectroscopy.
23
 Cells were thus incubated with 20 μL, per well, of MTT stock 
solution (final concentration 0.5 mg/mL) in PBS, followed by 4 h of incubation, at  37 ºC. The 
medium was then discarded, and formazan crystals were solubilized in 100 µL of 
DMSO/ethanol (1:1) solution. The absorbance was read against a blank (ethanol/DMSO (1:1)) 
at 570 nm, by using Multiskan
TM
 FC microplate UV/Vis photometer (Thermo Scientific, 
Waltham, Massachusetts, USA). Results were expressed as the percentage of cell viability 
relative to that of the respective solvent control. The IC50, defined as the sample concentration 
necessary to cause 50% inhibition of cell viability, was calculated by plotting the percentage of 
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cell viability in function of sample concentration logarithm. Triplicates were performed in three 
independent experiments for each treatment. 
 
2.5 Soft agar colony formation assay 
MDA-MB-231 cells (9200 cells per well) were seeded in 0.336% agar on top of 0.5% 
pre-solidified agar, in a 12-well plate. Each treatment was performed in triplicate. After 24 h of 
incubation at 37 ºC, cells were treated with the IC50 values of leaves lipophilic extract      
(10.39 µg/mL) and cynaropicrin (17.86 µM). Vehicle solvent control cells received DMSO 
(0.09% (v/v)). Every other day, agar layers were supplemented according to the above 
mentioned concentrations. After 14 consecutive days, cells were overnight incubated with 
0.1% p-iodonitrotetrazolium violet, at 37 ºC. Colonies were thereafter observed by using an 
inverted microscope (Motic, Xiamen, P. R. China), at the 40 x magnification, and four fields of 
each well were photographed using Moticam 2500 camera (Motic, Xiamen, P. R. China). The 
images were processed using Motic Images Plus 2.0 program (Motic, Xiamen, P. R. China). 
 
2.6 Assessment of caspase-3 activity 
Caspase-3 activity was assessed according to manufacturer’s protocol (Caspase-
3/CPP32 colorimetric protease assay, Invitrogen, Camarillo, California, USA). DEVD-pNA, 
composed by the synthetic tetrapeptide substrate Asp-Glue-Val-Asp (the upstream amino acid 
sequence of the caspase-3 cleavage site in poly(adenosine diphosphate-ribose) polymerase); 
and tailed with p-nitroanilide (p-NA) chromophore. MDA-MB-231 cells were seeded at 
5x10
5
cells/mL, and after 24 h-incubation, cells were treated with IC50 values of leaves 
lipophilic extract (10.39 µg/mL) and cynaropicrin (17.86 µM). Vehicle solvent control cells were 
exposed to DMSO (0.09% (v/v)). After 48 h, cells were collected and centrifuged at 769 x g for 
5 min. The cell pellet (5 x 10
6
 cells) was resuspended in 50 µL of chilled cell lysis buffer and 
incubated on ice for 10 min. After centrifugation at 10,000 x g for 1 min at 4 ºC, supernatant 
(cytosol) was collected to examine caspase-3 activity. Total protein concentration was 
assayed according to Lowry method
24
 and BSA was used as protein standard. Cytosol 
samples (150 µg protein) were mixed with 50 µL of 2 x reaction buffer (10 mM dithiothreitol), 
and 5 µL of 4 mM DEVD-pNA. After 2 h-incubation, at 37 ºC in the dark, the absorbance of p-
NA was read at 405 nm against a blank (without sample), by using Multiskan
TM
 FC microplate 
UV/Vis photometer (Thermo Scientific, Waltham, Massachusetts, USA). Three independent 
experiments were carried out. 
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2.7 Cell cycle analysis 
MDA-MB-231 cells were cultured in six-well plates at a density of 4 x 10
5
 cells/mL for 
24 h at 37 ºC. Then, cells were exposed to the IC50 values of leaves lipophilic extract (10.39 
µg/mL) and cynaropicrin (17.86 µM). Vehicle solvent control cells received DMSO (0.09% 
(v/v)). After 48 h-incubation, cells were collected, PBS washed and fixed with 85% cold 
ethanol. Cell pellets were collected after centrifugation at 300 x g for 5 min at 4 °C, and 
resuspended in PBS. Then, cells were incubated with 50 µg/mL RNase and 50 µg/mL 
propidium iodide staining solution for 20 min at room temperature in dark. Propidium iodide-
stained cells were analyzed in the Beckman-Coulter
®
 EPICS-XL (Beckman-Coulter
®
, Brea, 
California, USA) flow cytometer equipped with an air-cooled argon-ion laser (15 mW, 488 nm). 
Results were obtained using the SYSTEM II software (version 3.0 Beckman-Coulter
®, 
Brea, 
California, USA), in which at least 5000 nuclei per sample were acquired. Analysis of cell cycle 
distribution was performed by using the FlowJo software (Tree Star, Ashland, Oregan, USA). 
Four replicates were performed for each treatment. 
 
2.8 Western blotting 
MDA-MB-231 cells were plated at 5 x 10
5
 cells/mL, and incubated for 24 h at 37 ºC. 
Medium was thereafter changed to medium containing IC50 values of leaves lipophilic extract 
(10.39 µg/mL) or cynaropicrin (17.86 µM). Vehicle solvent control cells were incubated with 
DMSO (0.09% (v/v)). After 48 h-incubation, cells were scraped, washed in cold PBS and 
centrifuged at 492 x g for 3 min, at 4 ºC. This procedure was repeated two more times. Cells 
were then lysed with RIPA buffer (1% NP-40 in 150 mM NaCl, 50 mM Tris-HCl (pH 8), 2 mM 
EDTA), containing 1 mM phenylmethylsulfonylfluoride, phosphatase inhibitors (20 mM NaF, 20 
mM Na2V3O4), and protease inhibitor cocktail (Roche, Mannheim, Germany), for 10 min, at 4 
ºC. Cell lysates were centrifuged at 24104 x g for 10 min, at 4 ºC. Supernatants were 
collected, and total protein concentrations were quantified according to the Lowry method,
24
 
using BSA as the protein standard. Cell lysates (25-40 µg protein) were electrophoresed on 
sodium dodecyl sulfate 10% polyacrylamide gel, and then transferred onto poly(vinylidene 
difluoride) (PVDF) membranes (Amersham Biosciences, Buckinghamshire, UK). PVDF 
membranes were blocked with 5% (w/v) of nonfat dry milk at room temperature for 1 h, and 
incubated overnight at 4°C with a primary antibody against p21 (1:2000); cyclin B1 (1:1000);  
p-Tyr15-CDK1 (1:250); Akt1 (1:200); p-Ser473-Akt (1:1000); and β-actin (1:300). Bands were 
visualized by chemiluminescence using appropriate horseradish peroxidase-conjugated 
secondary antibodies, and developed with ECL reagents (Amersham Biosciences, 
Buckinghamshire, UK), according to manufacturer’s instructions. Three independent 
experiments were performed for each treatment. 
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2.9 Statistical analysis 
All parameters measured were analyzed using the PROC GLM option of SAS (SAS 
Institute Inc., Cary, North Carolina, USA). In the case of the statistical analysis of cell cycle 
data, the pairwise multiple comparisons were performed between treatments for each phase 
(G0/G1, S and G2). Where differences existed, the source of the differences at p < 0.05 of 
significance level was identified by all pairwise multiple comparison procedure, through the 
Duncan’s test. 
 
3. Results and Discussion 
3.1 Inhibitory effects of cultivated cardoon lipophilic and phenolic-rich extracts 
on MDA-MB-231 cell growth 
After the chemical characterization of cultivated cardoon (Chapters III and IV), two 
lipophilic and two phenolic-rich extracts were chosen to assess their MDA-MB-231 cell growth 
inhibition effects, during 48 h. In this manner, lipophilic extracts of capitula florets and leaves 
were evaluated, since they presented the highest content of pentacyclic triterpenes and 
sesquiterpene lactones, respectively (Chapter III). Moreover, phenolic-rich extracts of stalks 
outer part and capitula florets were also examined, as they displayed the highest 
concentration of hydroxycinnamic acids and flavonoids, respectively (Chapter IV). In order to 
evaluate the 48 h-inhibitory potential of cultivated cardoon extracts, on MDA-MB-231 cell 
viability, their IC50 values were determined through the MTT assay, as listed in Table 1. For 
comparison reasons, the inhibitory actions of pure compounds of cynaropicrin and 1,5-di-O-
caffeoylquinic acid were also examinated, at the same experimental conditions (Table 1). 
 
Table 1: IC50 values regarding the 48 h-cell growth inhibition of cultivated cardoon lipophilic and 
phenolic-rich extracts on the MDA-MB-231cell line, determined through MTT assay. 
Cultivated cardoon extract/reference compound 
IC50 upon MDA-MB-231 cell line 
μg/mL μM 
Capitula florets lipophilic extract 315.22 ± 67.88 
c
 ‒ 
Leaves lipophilic extract 10.39 ± 0.41 
d
 ‒ 
Stalks outer part phenolic-rich extract 3341.20 ± 246.85 
a
 ‒ 
Cynaropicrin 6.19 ± 0.57 
d
 17.86 ± 1.65 
b
 
1,5-Di-O-caffeoylquinic acid 899.50 ± 21.33 
b
 1741.69 ± 41.29 
a
 
Results correspond to mean±standard deviation. Three independent experiments with triplicates were 
performed. Means with different superscript letters within the same column are statistically different (p < 
0.05). 
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The IC50 value of leaves lipophilic extract against MDA-MB-231 cell proliferation, was 
30-fold lower compared to that of capitula florets lipophilic extract (10.39 and 315.22 μg/mL, 
respectively) (p < 0.0087) (Table 1). The pure compound of cynaropicrin showed an IC50 value 
of 17.86 µM on MDA-MB-231 cell growth (Table 1). It was previously described that 
cynaropicrin suppressed the MCF-7 cell growth (human estrogen receptor-positive BC cell 
line), with an IC50 value of 3.18 µM.
19
 Regarding the pure compound of taraxasteryl acetate, 
the IC50 value may be higher than 5.00 µM (2.34 µg/mL), but it was not determined due to 
solubility issues. It had earlier demonstrated that taraxasteryl acetate (42.67 µM) did not 
suppress the cellular viability of a BC cell line.
25
 
The α-methylene-γ-lactone moiety present in sesquiterpene lactones is known to play 
a key role in cytotoxicity, as alkylating reactivity center.
26,27
 The α,β-unsaturated ketone    
(O=C-C=CH2), either in lactone, cyclopentenone ring or in an ester side chain, reacts with 
biological nucleophiles, namely thiol groups present in cysteine residues of proteins, through 
Michael addition reaction.
26,28
 Cho, et al.
29
 proposed that cynaropicrin may have reacted with 
thiol group of target protein(s), preventing therefore TNF-α production. Additionally, there are 
other structural moieties in sesquiterpene lactones that have been recognized to enhance their 
cytotoxicity in vitro, namely the presence of a side chain and its lipophilicity, as well as the 
molecular geometry and electronic features.
26
 Bruno, et al.
30
 noticed that the absence of 
unsaturated ester side chain, at C8 in germacranes, greatly decreased the cytotoxicity action, 
against several human tumor cells in vitro, including MDA-MB-231 cell line. Furthermore, 
Scotti, et al.
31
 previously noted that the presence of a methylene group, at C10 in 
guaianolides, increased the inhibitory effect against human KB cells, nasopharynx tumor cell 
line. The unsaturated ester side chain at C8 and the methylene group at C10 are two 
structural features present in cynaropicrin (Figure 2), in addition to α-methylene-γ-lactone 
moiety, which may have contributed to the suppressive effect on MDA-MB-231 cell growth. 
Cynaropicrin was identified as the major identified component of leaves lipophilic 
extract (455.2 mg/g extract). Therefore, this sesquiterpene lactone was, most probably, the 
main responsible for the inhibitory action of leaves lipophilic extract, upon MDA-MB-231 cell 
growth. In fact, leaves lipophilic extract and cynaropicrin IC50 values, when expressed as 
µg/mL, were not statistically different (p > 0.05). Nonetheless, it cannot be discarded the 
hypothesis that the suppressive effect of lipophilic leaves extract might also have resulted from 
synergistic or cumulative actions of cynaropicrin, together with other extract component(s), 
which needs to be further researched. 
The IC50 value of stalks outer part phenolic-rich extract (3341.20 µg/mL) (Table 1) was 
much higher than those of lipophilic extracts from florets (11-fold) and leaves (322-fold). 
Moreover, the IC50 of florets phenolic-rich extract may be higher than 4500 µg/mL. MDA-MB-
231 cells were thus more sensitive to lipophilic extracts than to phenolic-rich extracts. In what 
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concerns to the inhibitory effect of 1,5-di-O-caffeoylquinic acid, the respective IC50 value was 
97.5-fold higher (1741.69 µM) (Table 1) compared to cynaropicrin (p < 0.0001), reflecting that 
MDA-MB-231 cells were much less resistant to cynaropicrin than to 1,5-di-O-caffeoylquinic 
acid. 
The underlying biochemical mechanisms of cultivated cardoon leaves lipophilic extract, 
and its major compound cynaropicrin, on MDA-MB-231 cells were thereafter investigated. 
 
3.2 Effect of cultivated cardoon leaves lipophilic extract and cynaropicrin on the 
formation of MDA-MB-231 cell colony 
Soft agar has proven to be a powerful technique for screening active agents against the 
growth of several types of tumor cells, in a three-dimensional environment.
32 Following the 
strong effect upon cellular viability, in the two-dimensional monolayer assay, more insights 
were sought to know whether the leaves lipophilic extract and cynaropicrin, at the respective 
IC50 values, could also suppress the formation of MDA-MB-231 cell colonies, in a three-
dimensional environment, using an anchorage-independent growth assay. 
Treatments with 10.39 µg/mL leaves lipophilic extract and 17.86 µM cynaropicrin 
changed the size of MDA-MB-231 colonies, relatively to DMSO control (Figure 3A). 
Additionally, leaves lipophilic extract strongly prevented MDA-MB-231 cells to form colonies 
(Figure 3B), up to 19.8-fold regarding DMSO control cells (p < 0.0002). Similarly, MDA-MB-
231 cells lost their ability to form colonies, after being exposed to 17.86 µM cynaropicrin 
(Figure 3B); however, this effect was much less marked (up to 2.4-fold regarding to DMSO 
control cells (p < 0.0030)). Once again, cynaropicrin probably contributed for the inhibitory 
effect of leaves lipophilic extract, upon the formation of MDA-MB-231 colonies, but other 
extract component(s) may also be involved. 
At the current knowledge, this is the first time that inhibitory effects of cultivated 
cardoon leaves lipophilic extract and cynaropicrin, upon BC colony formation, are evidenced. 
Rao, et al.
33
 previously demonstrated that antrocin, a sesquiterpene lactone isolated from the 
medicinal mushroom Antrodia camphorata (Polyporaceae), was able to prevent the formation 
of TNBC MDA-MB-231 colonies, after 10-14 days in an anchorage-independent growth assay, 
at dose-dependent manner (1-10 µM). 
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Figure 3: Effect of 10.39 µg/mL cultivated cardoon leaves lipophilic extract and 17.86 µM cynaropicrin 
upon formation of MDA-MB-231 colonies in soft agar, after 14 days: (A) representative photographs of 
colonies (40 x magnification); (B) number of colonies. Each column and bar represents respectively the 
mean and the standard deviation. Triplicates were carried out. Columns with different letters are 
statistically different (p < 0.05). 
 
3.3 Measurement of caspase-3 activity in MDA-MB-231 cells, after treatment with 
cultivated cardoon leaves lipophilic extract and cynaropicrin 
Regarding the antiproliferative effects of cultivated cardoon leaves lipophilic extract 
and cynaropicrin, the hypothesis of apoptosis was studied by assessing caspase-3 activity 
through a commercial colorimetric kit (Figure 4). Caspase-3 is considered as the most 
important caspase within the execution phase of apoptosis, because its active form specifically 
induces the Caspase Activated DNAse, causing chromosomal DNA degradation and 
chromatin condensation.
34
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After 48 h-incubation, leaves lipophilic extract increased the caspase-3 activity of 
MDA-MB-231 cells (1.3-fold vs DMSO control (p < 0.0013)) (Figure 4). On the other hand, 
MDA-MB-231 cells treated with 17.86 µM cynaropicrin did not significantly affect the caspase-
3 activity, in relation to DMSO-treated control cells (p > 0.05). Contrarily, it was previously 
reported that cynaropicrin induced apoptosis in human gastric adenocarcinoma AGS cells, in 
dose (1-5 µM) and time (24 and 48 h) dependent ways.
35
 Moreover, another study showed 
cynaropicrin (10 µM) as an apoptosis inducer, in human leukocyte U937 cells, being 
associated with reactive oxygen species generation and the proteolytic cleavage of protein 
kinase C.
36
 More investigation should be carried out to know whether leaves lipophilic extract 
and cynaropicrin caused apoptosis in MDA-MB-231 cells. 
 
 
Figure 4: Caspase-3 activity assessment in the MDA-MB-231 cells, after 48 h-treatment with 10.39 
µg/mL cultivated cardoon leaves lipophilic extract and 17.86 µM cynaropicrin. Each column and bar 
represents respectively the mean and the standard deviation. Three independent experiments were 
carried out. Columns with different letters are statistically different (p < 0.05). 
 
3.4 Effect of cultivated cardoon leaves lipophilic extract and cynaropicrin on the 
MDA-MB-231 cell cycle 
Flow cytometry was applied to gain further insights about the suppressive actions of 
cultivated cardoon leaves lipophilic extract and cynaropicrin, upon the MDA-MB-231 cells 
distribution through the different cell cycle phases (G0/G1, S and G2 phases) (Figure 5). 
The 48 h-treatment with 10.39 μg/mL leaves lipophilic extract led to a significantly 
accumulation of 59.5% of MDA-MB-231 cells at G2 phase (Figure 5), representing a 4.7-fold 
cell percentage increase, regarding to DMSO control cells (p < 0.0001). Thereafter, there was 
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a corresponding decrease of cell percentage at G0/G1 and S phases (2.7- and 1.8-fold 
relatively to DMSO control cells, respectively). Leaves lipophilic extract thus induced cell cycle 
arrest at G2 phase. Similarly, cynaropicrin tested at 17.86 µM, for 48 h, also prevented MDA-
MB-231 cells to enter into mitosis (37.8%), by blocking cell cycle progression at G2 phase 
(Figure 5), but in a less extension (3-fold increase of cell percentage compared to DMSO 
control cells (p < 0.0001)). Additionally, the cynaropicrin treatment reduced 2.1-fold the S 
phase cell percentage (p < 0.0001), but it did not change G0/G1 phase cell percentage, 
compared to DMSO control cells (p > 0.05). This finding corroborated with the G2 cell cycle 
arrest of human gastric AGS cells, caused by cynaropicrin at dose (1-5 µM) and time (24 and 
48 h) dependent ways.
35
 On the other hand, another study revealed that the incubation of 
human leukocyte U937 cells with cynaropicrin (10 µM), for 12 and 24 h, led to G1 phase cell 
accumulation.
36
 
 
 
Figure 5: Cell cycle phase distribution of MDA-MB-231 cells, treated with 10.39 µg/mL cultivated 
cardoon leaves lipophilic extract and 17.86 µM cynaropicrin, after 48 h-incubation. DMSO was the 
solvent control. Each column and bar represents respectively the mean and the standard deviation. Four 
replicates were performed. Columns within each cell cycle phase presenting different letters are 
statistically different (P < 0.05). 
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3.5 Effect of cultivated cardoon leaves lipophilic extract and cynaropicrin on the 
p21Waf1/Cip1, p-Tyr15-CDK1 and cyclin B1 protein expression in MDA-MB-231 
cells 
The protein expressions of three G2/M checkpoint regulators, namely p21, p-Tyr-15-
CDK1 and cyclin B1, were examined (Figure 6), in order to understand the molecular 
mechanisms underlying the G2 cell cycle arrest in MDA-MB-231 cells, caused by cultivated 
cardoon leaves lipophilic extract and cynaropicrin. 
 
 
Figure 6: Western blot analysis of cyclin B1, phospho-Tyr 15-Cdk1, p21 and β-actin protein expressions 
in MDA-MB-231 cells, after 48 h-treatment with 10.39 μg/mL cultivated cardoon leaves lipophilic extract 
and 17.86 μM cynaropicrin. The blots shown are representative of three independent experiments. 
 
Belonging to the class of kinase inhibitor proteins, p21 inhibits the kinase activity of 
CDK2 bonded to cyclin E and cyclin A during G1/S transition, as well as the CDK1-2/cyclin A 
and CDK1/cyclin B complexes activity required for G2/M cell cycle progression.
37,38
 Moreover, 
it was proven that p21 mediates the nuclear retention of mitosis promoting factor (MPF), 
formed by CDK1/cyclin B1, thereby impeding its activation, through CDK1 dephosphorylation 
at Thr14 and Tyr15 by Cdc25 fosfatase.
39
 Besides the periodic accumulation and degradation 
of cyclin B1, MPF activity is controlled by the phosphorylation and dephosphorylation of CDK1. 
The activation of MPF is truly decisive for the transition of mammalian cells from G2 to mitosis. 
According to Figure 6, p21 protein expression increased in the 48 h-treated MDA-MB-
231 cells with 10.39 µg/mL leaves lipophilic extract and 17.86 µM cynaropicrin, regarding to 
DMSO control cells. Furthermore, cyclin B1 and p-Tyr15-CDK1 protein expressions also 
increased in MDA-MB-231 cells after both treatments, compared to DMSO control cells 
(Figure 6). In this manner, cultivated cardoon leaves lipophilic extract and cynaropicrin 
induced p21 expression in MDA-MB-231 cells, which may be associated with the 
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accumulation of inactive p-Tyr15-CDK1 and cyclin B1, and consequently with the G2 cell cycle 
arrest. 
So far, the regulating effects of cultivated cardoon leaves lipophilic extract and 
cynaropicrin on G2/M cell cycle checkpoint, in human tumor cells, was herein described for the 
first time. A previous report noticed that p21, p-Tyr15-Thr14-CDK1 and cyclin B1 protein 
expressions increased in G2/M arrested SK-28 human melanoma cells, after treatment (up to 
4 h) with two sesquiterpene lactones isolated from Inula viscosa (Asteraceae), namely 
tomentosin and inuviscolide (18-54 µM).
40
 Future investigation should be performed to know 
more about the regulating role of leaves lipophilic extract and cynaropicrin, upon key players in 
G2/M checkpoint. 
 
3.6 Effect of cultivated cardoon leaves lipophilic extract and cynaropicrin on the 
p-Ser473-Akt and Akt1 protein expression in MDA-MB-231 cells 
Akt has an important role in the glucose metabolism, survival, cell proliferation and 
programmed cell death.
41,42
 Active Akt indeed occurs frequently in human cancer cells.
42
 In 
this study, Akt1 and active p-Ser-473-Akt protein expressions, in MDA-MB-231 cells, were 
thus evaluated after 48 h-incubation with cultivated cardoon lipophilic extract and cynaropicrin, 
at the respective IC50 values (Figure 7). 
 
 
Figure 7: Western blot analysis of total Akt1, phospho-Ser-473-Akt and β-actin protein expressions in 
MDA-MB-231 cells after 48 h-treatment with 10.39 μg/mL cultivated cardoon leaves lipophilic extract and 
17.86 μM cynaropicrin. The blots shown are representative of three independent experiments. 
 
Notably, treatments with leaves lipophilic extract and cynaropicrin greatly decreased 
active p-Ser473-Akt protein expression in MDA-MB-231 cells, relatively to DMSO control 
(Figure 7). Nevertheless, total Akt1 protein expression in treated MDA-MB-231 cells remained 
unchanged (Figure 7). Therefore, decreased p-Ser473-Akt protein levels, caused by leaves 
lipophilic extract and cynaropicrin, were not influenced by variations in Akt1 protein 
expression. In this way, these data suggest that Akt signaling downregulation may be involved 
within the overall inhibitory effects of leaves lipophilic extract and cynaropicrin, upon TNBC 
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MDA-MB-231 cellular growth. At the present knowledge, few studies revealed the inhibitory 
actions of sesquiterpene lactones in the Akt signaling pathway. Rao, et al.
33
 explained that 
antrocin (10 µM) caused downregulation of p-Ser473-Akt protein expression in MDA-MB-231 
cells, in time dependent way (6-48 h), with no changes in total Akt protein level. These results 
indicate that it is necessary to gain more insights about the underlying mechanisms of leaves 
lipophilic extract and cynaropicrin, within the PI3K/Akt/mTOR pathway. 
4. Conclusions 
This work opens new perspectives for C. cardunculus L. var. altilis (DC) valorization, 
through the study of the antiproliferative effect of cultivated cardoon extracts and pure 
secondary metabolites, upon MDA-MB-231 cell line, in an effort to contribute for a potentially 
natural-based TNBC therapeutics. MDA-MB-231 cells were less resistant to cultivated cardoon 
lipophilic extracts, presenting sesquiterpene lactones and pentacyclic triterpenes, 
comparatively to phenolic-rich extracts. Cultivated cardoon leaves lipophilic extract and pure 
compound of cynaropicrin, representative of the main identified extract compound, inhibited 
strongly the TNBC MDA-MB-231 cell growth (IC50 = 10.39 µg/mL and 17.86 µM, respectively), 
for 48 h. Moreover, leaves lipophilic extract also suppressed the anchorage-independent 
growth of MDA-MB-231 cells, in soft agar, being even more active than cynaropicrin. 
Although leaves lipophilic extract slightly increased the caspase-3 activity, more details 
are required to understand whether lipophilic components of leaves extract stimulated the 
MDA-MB-231 cell death, through apoptosis. Furthermore, leaves lipophilic extract caused G2 
cell cycle arrest of MDA-MB-231 cells, in a more extension than cynaropicrin. The treatment of 
MDA-MB-231 cells with leaves lipophilic extract and cynaropicrin upregulated the CDK-
inhibitor p21, consequently causing accumulation of p-Tyr15-CDK1 and cyclin B1. These 
findings may be associated with the G2 cell cycle arrest of MDA-MB-231 cells. Leaves 
lipophilic extract and cynaropicrin also affected the Akt upstream pathway, in MDA-MB-231 
cells, by downregulating the active p-Ser473-Akt, without changing the total Akt1 expression. 
Despite the fact that cynaropicrin being the most abundant identified compound in 
leaves lipophilic extract (455.2 mg/g extract), further research should be performed to 
understand if synergistic or cumulative effects of cynaropicrin with other extract component(s) 
were implicated in the inhibitory action, upon TNBC MDA-MB-231 cellular viability. Other task 
to be addressed is related with potentiating the inhibitory action of cytostatic drugs, upon 
MDA-MB-231 cell growth, through supplementation with cynaropicrin. 
Taken all together, this study revealed that cultivated cardoon leaves lipophilic fraction 
and/or cynaropicrin may be promising agents for a complementary therapy of human TNBC. 
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Abstract 
The present work highlighted, for the first time, the antibacterial activity of lipophilic and 
phenolic-rich extracts, derived from Cynara cardunculus L. var. altilis (DC), against two 
multidrug-resistant bacteria, known to be key players in healthcare-associated infections: the 
Gram-negative Pseudomonas aeruginosa and the Gram-positive methicillin-resistant 
Staphylococcus aureus (MRSA). Capitula florets lipophilic and phenolic-rich extracts did not 
have inhibitory effects against P. aeruginosa or MRSA. Leaves lipophilic extract also did not 
demonstrate antibacterial effect on P. aeruginosa, but cynaropicrin showed a slightly 
antimicrobial effect (MIC = 2048 µg/mL). Leaves lipophilic extract (MIC = 1024 µg/mL) and 
cynaropicrin (MIC = 256 µg/mL) prevented the growth of MRSA. Globally, these findings 
suggest that lipophilic extract of C. cardunculus L. var. altilis (DC) leaves and cynaropicrin 
have potential to be investigated as MRSA therapeutic agents. Cynaropicrin may be 
considered as a potential lead for the development of an antibacterial drug against P. 
aeruginosa. 
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1. Introduction 
The multidrug-resistant (MDR) bacteria represent a severe threat to public health 
worldwide in the 21
st
 century, with financial burden on health care systems and elevated risk of 
morbidity and mortality. This situation was favored from the constant selection pressure 
caused by the misuse of antibiotics, in both humans and food-producing animals, the 
increased disease transmission, and a decay in the development of new antibacterial drugs 
since the 1980s.
1–3
 According to European Centre for Disease Prevention and Control, the 
MDR bacterial infections can cause 25000 deaths per year in Europe, in addition to the extra 
healthcare costs and productivity losses of at least € 1.5 billion.4 Due to the less effective 
action of antibiotics, the MDR bacteria have emerged as the major health care-associated 
infections (HCAI), formerly known as “nosocomial” or “hospital” infections. The Gram-negative 
Pseudomonas aeruginosa and the Gram-positive methicillin-resistant Staphylococcus aureus 
(MRSA) are two of the main MDR bacteria responsible for HCAI.
2,4
 
Among the Gram-negative HCAI bacteria, P. aeruginosa is the second most frequent 
pathogen responsible for pneumonia, and the third and fourth most frequent pathogen that 
contributes for septicemia, urinary tract infections, and surgical wound infections. 
Immunocompromised individuals are the most susceptible to P. aeruginosa infection.
5
 Being 
commonly disseminated in aquatic environments, P. aeruginosa can be transmitted by 
inadvertent contamination via water from household taps
6
 and sinks within intensive care 
units.
5
 P. aeruginosa has shown to selectively block several antimicrobial drugs, like 
fluoroquinolones, aminoglycosides and carbapenems, to penetrate its outer membrane. 
Regarding to the last European antimicrobial resistance surveillance, Portugal exhibited, in 
2013, higher percentage of fluoroquinolones-resistant P. aeruginosa (23.9%) compared to the 
European Union mean (20.0%).
4
 
S. aureus colonizes the skin of about 30% of healthy humans, which can afford several 
infections, namely in skin and in soft tissue, pneumonia, meningitis, endocarditis and toxic 
shock syndrome.
7
 The MRSA appeared just after three years of the methicillin introduction, 
being considered as the major HCAI.
2
 Based on the 2013 data of MRSA isolates in Europe, 
the percentages were generally lower in northern Europe and higher in southern and south-
eastern countries (Figure 1). Portugal ranks at third position relatively to the percentage of 
MRSA isolates (46.8%) in Europe, with Romania (64.5%) and Malta (51.8%) at first and 
second positions, respectively.
4
 MRSA causes a greater morbidity and mortality (up to 2-fold), 
compared to methicillin-susceptible S. aureus, which is mostly due to a delay in the 
administration of appropriate therapy and poor efficacy of the existing antibiotics.
8
 Risk factors 
of MRSA infection comprise recent hospitalization or surgery, dialysis, residence in a long-
term care facility, and the presence of percutaneous devices and catheters.
7
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Figure 1: Percentage of MRSA invasive isolates in European Union/European Economic Area 
countries, in 2013 (adapted from 
4
). 
 
After a stagnation on the antibiotic discovery field during the last years,
1
 natural 
products have gained renewed interest as sources of new or coadjutant therapeutic agents for 
combating the MDR bacterial infections, namely terpenes
9–11
 and phenolic compounds.
12–14
 
Sesquiterpene lactones isolated from two Asteraceae plants, namely Xanthium sibiricum 
Patrer Widd and Centratherum punctatum Cass. ssp. punctatum, inhibited the growth of P. 
aeruginosa
10
 and MRSA.
9
 Taraxasterol, a pentacyclic triterpene isolated from Chrysanthemum 
macrocarpum (Asteraceae), demonstrated antibacterial effect on P. aeruginosa (MIC = 16 
µg/mL).
15
 Other pentacyclic triterpenes, like ursolic and oleanolic acids, could prevent MRSA 
growth (MICs of 8 and 16 µg/mL, respectively), but not the growth of P. aeruginosa PAO1 
(MIC > 128 µg/mL),
11
 a chloroamphenicol-resistant mutant of the original Australian PAO 
isolate.
16
 In what concerns to phenolic compounds, ferulic acid
12
 and apigenin 7-O-glucoside
17
 
inhibited the MRSA growth (MICs of 500 µg/mL and 216 µg/mL, respectively). Moreover, it 
was proven that apigenin and luteolin were able to inhibit the growth of P. aeuruginosa PAO1 
strain.
18
 
The Mediterranean species of Cynara cardunculus L. (Asteraceae) comprises wild 
cardoon (var. sylvestris (Lamk) Fiori), artichoke (var. scolymus (L.) Fiori) and cultivated 
cardoon (var. altilis (DC)). Besides the consumption of artichoke capitula as vegetable and the 
use of cardoon capitula for producing Iberian ewe’s cheese, leaf infusions have been 
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traditionally used for therapeutic purposes, given to their hypocholesterolemic,
19
 choleretic and 
anticholestatic properties.
20
 These biological activities have been attributed to phenolic 
composition, namely caffeoylquinic acids and luteolin derivatives.
20
 Furthermore, artichoke 
and cardoon methanol extracts have also displayed anti-hyperlipidemic
21
 and anti-
inflammatory properties,
22
 mainly ascribed to sesquiterpene lactones
21
 and pentacyclic 
triterpenes,
22
 respectively. 
Some reports have shown the antibacterial action of C. cardunculus L. extracts.
23–25
 
Artichoke leaves n-butanol fraction presented antibacterial effect on P. aeruginosa and S. 
aureus, being comparable to kanamycin sulfate and streptomycin. Luteolin 7-O-glucoside, 
isolated from artichoke n-butanol fraction, was the most active phenolic compound against 
bacteria growth.
23
 Furthermore, wild cardoon leaves methanol extract also demonstrated to be 
active against the growth of P. aeruginosa and S. aureus, probably due to the presence of 
phenolic compounds.
24
 Lipophilic compounds isolated from wild cardoon capitula, like β-
sitosterol, have also exhibited antibacterial effect against for instance E. coli and S. aureus.
25
 
Our group previously revealed that high proportions of pentacyclic triterpenes (≈27.5 
g/kg dw) and sesquiterpene lactones (≈94.5 g/kg dw) were found in C. cardunculus L. var. 
altilis (DC) capitula florets and leaves, respectively.
26
 Moreover, our group also denoted that 
flavonoids were mainly detected in capitula florets (≈13.3 g/kg dw).27 At the current knowledge, 
the antibacterial activity of C. cardunculus L. var. altilis (DC) lipophilic and phenolic-rich 
extracts has not been already studied. The present work, in the scope of finding novel natural 
antibacterial substances, adresses to determine the minimum inhibitory concentration (MIC) of 
lipophilic and phenolic-rich extracts, derived from florets and leaves of cultivated cardoon, on 
P. aeruginosa and MRSA, the main bacteria of HCAI life-threatening infections. 
 
2. Materials and Methods 
2.1 Chemicals 
Dichloromethane (p.a. ≥99% purity) was supplied by Fischer Scientific (Pittsburgh, 
Pennsylvania, USA). Cynaropicrin (≥97.5% purity) was purchased from Extrasynthese (Genay 
Cedex, France). Dimethyl sulfoxide (DMSO) cell culture grade was obtained from Applichem 
(Gatersleben, Germany). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
was purchased to Calbiochem (San Diego, California, USA). Glycerol, Mueller Hinton agar 
and broth, Pseudomonas (cetrimide) agar, mannitol salt agar and buffered peptone water 
were obtained from Liofilchem (Roseto degli Abruzzi, Italy). Brucella Broth, gentamicin and 
trimethoprim were provided by Sigma Chemicals Co. (Madrid, Spain). 
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2.2 Bacterial strains 
P. aeruginosa PAO1 strain was donated by Professor Arsénio Fialho (Instituto 
Superior Técnico), being previously characterized.
28
 MRSA was kindly donated and 
characterized by Professor Manuela Pintado (Escola Superior de Biotecnologia, Universidade 
Católica Portuguesa Porto (ESB/UCP)).
12
 Bacterial strains were grown on Mueller Hinton Agar 
or Mueller Hinton Broth at 37 ºC. Selective media towards each bacterial strain was used to 
sustain the purity of the bacterial cultures. Bacteria were kept at -80 ºC, in Brucella Broth with 
20% (v/v)) glycerol until further need. 
The purity of P. aeruginosa and MRSA strains was evaluated by examination of the 
colony morphology in Pseudomonas (cetrimide) agar and mannitol salt agar plates, 
respectively, after overnight incubation at 37 ºC. 
 
2.3 Preparation of C. cardunculus L. var. altilis (DC) extracts 
C. cardunculus L. var. altilis (DC) (cultivated cardoon) was collected at the flowering 
stage, in June 2010, at the Experimental Center of the School of Agriculture from Instituto 
Politécnico de Beja, Baixo Alentejo region, south Portugal. Capitula and leaves were 
separated and preserved at -20 ºC until analysis was performed. 
Lipophilic extracts, derived from cultivated cardoon capitula florets and leaves, were 
prepared and analyzed by gas chromatography-mass spectrometry, as referred elsewhere.
26
 
The phenolic-rich extract of capitula florets was prepared after the removal of lipophilic 
components, and their chemical composition was investigated by liquid chromatography-mass 
spectrometry, as earlier explained.
27
 
Lipophilic extracts of capitula florets and leaves contained respectively: 320.6 and 38.5 
mg/g extract of pentacyclic triterpenes; 8.8 and 3.4 mg/g extract of sterols; and 14.4 and 2.4 
mg/g extract of fatty acids. Sesquiterpene lactones were only present in leaves lipophilic 
extract, accounting for 484.9 mg/g extract, mainly represented by cynaropicrin (455.2 mg/g 
extract). Phenolic-rich extracts of capitula florets contained 0.7 mg/g extract of 
hydroxycinnamic acids and 22.5 mg/g extract of flavonoids. The detailed chemical composition 
of lipophilic and phenolic-rich extracts of cultivated cardoon may be consulted in Appendix. 
 The antimicrobial effect of cultivated cardoon extracts and pure compound of 
cynaropicrin, representative of the major identified component of leaves lipophilic extract, was 
examined against Gram-negative P. aeruginosa and Gram-positive MRSA. For comparison 
reasons, gentamicin and trimethoprim were included as control antibiotics. Lipophilic extracts 
of florets and leaves, pure compound of cynaropicrin and trimethoprim were dissolved in 
DMSO. Florets phenolic-rich extract and gentamicin were prepared in buffered peptone water. 
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2.4 MIC determination 
Bacteria were grown in Mueller Hinton plates, overnight at 37 ºC. Colonies were then 
dissolved in Mueller Hinton Broth, followed by dilution in the same medium broth to obtain an 
inoculum of 1 x 10
5
 cfu/mL, as recommended by Clinical and Laboratory Standards Institute.
29
 
Culture suspensions were grown at 37 ºC, 200 rpm, until exponential phase. Afterwards, 
bacterial suspensions were then diluted to 1 x 10
5
 cfu/mL and added to 96-well plates. Stock 
solutions were dissolved with the bacterial inoculum in two-fold serial dilutions, from 2048 
µg/mL until 8 µg/mL. The solvent vehicle control for lipophilic extracts, cynaropicrin and 
trimethoprim received DMSO (4% (v/v)). The positive control was prepared with inoculum in 
Mueller Hinton Broth. Two negative controls were performed: one with Mueller Hinton Broth, 
and the other with the sample in Mueller Hinton Broth. 
MIC values were determined after overnight incubation at 37 ºC, by using the MTT 
assay adapted from Eloff, et al.,
30
 due to the color conferred by cultivated cardoon extracts to 
medium broth. MIC values were detected afte Briefly, 40 µL of MTT solution (200 µg/mL in 
peptone water) was added to each well, followed by incubation at 37 ºC for 45 min. MIC was 
considered as the minimum concentration of tested sample at which the yellow color of 
tetrazolium MTT salt did not change to the purple color of the formazan product. Three 
independent experiments were performed for each treatment, each in triplicate. 
 
3. Results and Discussion 
Lipophilic extracts of cultivated cardoon capitula florets and leaves demonstrated the 
highest contents of pentacyclic triterpenes and sesquiterpene lactones, respectively (Chapter 
III), whereas phenolic rich-extract of capitula florets displayed the highest flavonoids content 
(Chapter IV). In this manner, these extracts were selected to determine their MIC values on P. 
aeruginosa PAO1 and MRSA growth, through the MTT assay, as outlined in Table 1. 
Additionally, the MIC value of cynaropicrin pure compound, representative of the most 
abundant compound identified in leaves lipophilic extract, was also evaluated (Table 1). MIC 
values of two antibiotics, namely gentamicin and trimethoprim, were also assessed (Table 1). 
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Table 1: MIC values of lipophilic and phenolic-rich extracts of C. cardunculus L. var. altilis (DC) on P. 
aeruginosa PAO1 and MRSA growth, determined through MTT assay. 
Cultivated cardoon extract/reference compound 
MIC (µg/mL) 
P. aeruginosa PAO1 MRSA 
Capitula florets lipophilic extract > 2048 > 2048 
Leaves lipophilic extract > 2048 1024 
Capitula florets phenolic-rich extract > 2048 > 2048 
Cynaropicrin 2048 256 
Gentamicin 8 128 
Trimethoprim nt 32 
Abbreviation: nt, not tested. 
 
Lipophilic extracts of cultivated cardoon capitula florets and leaves showed the highest 
Despite the considerably high concentrations of pentacyclic triterpenes and sesquiterpene 
lactones, lipophilic extracts of cultivated cardoon florets and leaves did not prevent the P. 
aeruginosa PAO1 growth (Table 1), at range 8-2048 µg/mL. The pure compound of 
cynaropicrin presented a slightly inhibitory effect on P. aeruginosa PAO1 growth (MIC = 2048 
µg/mL). An earlier report revealed that cynaropicrin could inhibit irreversibly the enzymatic 
activity of MurA (uridine-N-acetyl-D-glucosamine (UDP-NAG) enolpyruvyl transferase), 
isolated from P. aeruginosa,
31
 which is implicated within the biosynthesis of cell wall 
peptidoglycan. Phenolic-rich extract of florets did not show anti-P. aeruginosa PAO1 effect, at 
the tested concentrations, which may be related with the low concentration of flavonoids and 
other phenolic compounds. 
Lipophilic and phenolic-rich extracts of cultivated cardoon florets did not inhibit MRSA 
growth, at range 8-2048 µg/mL (Table 1). Cultivated cardoon leaves lipophilic extract (45.5% 
of cynaropicrin) displayed anti-MRSA effect, with MIC of 1024 µg/mL. This antibacterial effect 
was comparable to the anti-S. aureus action of wild cardoon capitula fractions (MIC range 
1000-1500 µg/mL).
25
 It is worthy to notice that the MRSA, used in this work, was described to 
be resistant to oxacillin and to fluoroquinolones, like ciprofloxacin and levofloxacin.
12
 
Nonetheless, the anti-MRSA effect of lipophilic leaves extract was much weaker compared to 
gentamicin and trimethoprim (Table 1). The pure compound of cynaropicrin also inhibited 
MRSA growth (MIC = 256 µg/mL). This effect was stronger than the antibacterial action of 
cynaropicrin, shown by Schinor, et al.,
32
 on two strains of S. aureus, namely a penicillinase 
producer (MIC = 500 µg/mL) and a non-penicillinase producer (MIC = 2500 µg/mL). In addition 
to the different S. aureus strain, Schinor, et al.
32
 used the agar diffusion method. Further 
research will be needed to clarify if the anti-MRSA effect of leaves lipophilic extract resulted 
from inhibitory action of cynaropicrin, the most abundant compound identified in that extract. 
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These findings also reflected that P. aeruginosa PAO1 was more resistant towards the 
inhibitory actions of leaves lipophilic extract and cynaropicrin, compared to MRSA, probably 
due to the protective role of outer membrane. 
In sum, these results suggested that lipophilic extract of C. cardunculus L. var. altilis 
(DC) leaves and cynaropicrin may have potential for the development of anti-MRSA 
therapeutics. Moreover, it was also evidenced that cynaropicrin could probably be part of an 
antibacterial formulation against P. aeruginosa PAO1. 
 
4. Conclusions 
The present work demonstrated the antibacterial activity of lipophilic and phenolic-rich 
extracts of C. cardunculus L. var. altilis (DC). Cultivated cardoon leaves lipophilic extract did 
not prevent the P. aeruginosa growth, but inhibited the MRSA growth (MIC = 1024 µg/mL). In 
fact, cynaropicrin presented a considerably anti-MRSA effect (MIC = 256 µg/mL). Furthermore, 
cynaropicrin was also able to prevent the P. aeruginosa PAO1 growth (MIC = 2048 µg/mL). 
Considering these findings, novel biocidal formulations may contain cultivated cardoon leaves 
lipophilic extract or cynaropicrin, in the scope of potentiating the inhibitory action of antibiotics, 
against two main MDR bacteria responsible for HCAI, namely P. aeruginosa and MRSA. 
The pre-extraction of antibacterial compounds from cultivated cardoon can be a 
prospective task for its valorization and, simultaneously, to fulfill the urgency in finding novel 
therapeutic compounds against MDR bacteria. 
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1. Concluding remarks 
The cultivation of Cynara cardunculus L. var. altilis (DC) in the Mediterranean 
countries has gained increasing attention in the last decade. A vast search in literature (Part 
A) highlighted that this biomass can be converted, in a sustainable manner, into energy, pulp 
fibers, which perfectly fits with the biorefinary concept. The pre-extraction of terpenic and 
phenolic compounds would be an additional valorization pathway of cultivated cardoon, given 
the diversity of biological activities reported for these families. In fact, there has been a 
growing interest of pharmaceutical industry on natural bioactive compounds, in order to find 
new molecular entities, as well as to produce effective herbal products, which are more and 
more sought by the modern society. This thesis aimed to contribute to the increase of 
knowledge about the chemical composition of stalks, capitula and leaves of cultivated 
cardoon, planted in the south of Portugal (Baixo Alentejo region), regarding to lipophilic and 
phenolic compounds (Part B). Some relevant biological activities of cultivated cardoon 
extracts were also investigated, such as antioxidant, triple-negative breast cancer (TNBC) 
antiproliferative and anti-multidrug resistant (MDR) bacterial effects (Part C). 
The lipophilic fraction of C. cardunculus L. var. altilis (DC) was analyzed by gas 
chromatography coupled with mass spectrometry (Chapter III). This technique allowed the 
identification of 65 lipophilic compounds, from which 33 and 41 were described in this thesis, 
for the first time, as C. cardunculus L. and cultivated cardoon components, respectively. In 
what concerns the terpenic composition, 1 sesquiterpene lactone and 4 pentacyclic triterpenes 
were indicated as cultivated cardoon components, for the first time: deacylcynaropicrin, and 
the acetates of β- and α-amyrin, lupenyl acetate and ψ-taraxasteryl acetate. Sesquiterpene 
lactones consisted in the most abundant lipophilic compunds found in leaves (≈94.5 g/kg dw), 
mainly represented by cynaropicrin (≈87.4 g/kg dw). Pentacyclic triterpenes were the most 
common lipophilic components of stalks and capitula, reaching at maximum ≈27.5 g/kg dw in 
florets. Taraxasteryl acetate was the most abundant triterpene in florets (≈8.9 g/kg dw), while 
taraxasterol was mainly retained in receptacles and bracts (≈5.3 g/kg dw). Leaves and florets 
lipophilic extracts were thus chosen to be studied in terms of biological activity, since these 
revealed the highest concentrations of sesquiterpene lactones (484.9 mg/g extract) and 
pentacyclic triterpenes (320.6 mg/g extract), respectively. 
The phenolic composition of C. cardunculus L. var. altilis (DC) was thereafter studied 
by high performance liquid chromatography-ultraviolet detection-mass spectrometry (Chapter 
IV). The findings of this chapter indicated that 28 phenolic compounds were identified in stalks, 
capitula and leaves. Among these, eriodictyol hexoside was detected for the first time in C. 
cardunculus L., and 6 as cultivated cardoon components, namely 1,4-di-O-caffeoylquinic acid, 
naringenin 7-O-glucoside, naringenin rutinoside, naringenin, luteolin acetylhexoside and 
apigenin acetylhexoside. Florets exhibited the highest total concentration of the identified 
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phenolic compounds, accounting for ~12.7 g/kg dw. Stalks contained the highest the highest 
amounts of hydroxycinnamic acids, accounting for ≈10.3 g/kg dw and ≈9.9 g/kg dw in 
respectively outer and inner parts. Receptacles and bracts revealed the highest 
dicaffeoylquinic acids content (≈5.0 g/kg dw), mainly represented by 1,5-di-O-caffeoylquinic 
acid (≈4.2 g/kg dw). Flavonoids were the predominant phenolic compounds in capitula florets, 
accounting for ≈10.3 g/kg dw, mainly constituted by flavones (≈7.6 g/kg dw), such as apigenin 
glucuronide, apigenin 7-O-glucoside and apigenin 7-O-rutinoside (≈4.6 g/kg dw). Flavanones 
were only found in the florets (≈2.7 g/kg dw). Phenolic-rich extracts derived from stalks outer 
part and florets were selected to be assayed in terms of their biological effects, due to the 
highest contents in hydroxycinnamic acids and flavonoids, respectively. 
The antioxidant activity of C. cardunculus L. var. altilis (DC) phenolic-rich extracts was 
tested through the 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging effect (Chapter V). 
Phenolic-rich extracts of stalks outer part and receptacles and bracts were the most active in 
neutralizing DPPH free radicals (IC50 values of 34.35 and 35.25 µg/mL, respectively). 
Moreover, the DPPH scavenging effect of phenolic-rich extracts was linearly correlated 
specially with the total contents of monocaffeoylquinic acids (r = -0.996) and hydroxycinnamic 
acids (r = -0.990). Despite the weaker DPPH scavenging effects relatively to 3,5-di-tert-4-
butylhydroxytoluene (BHT), cultivated cardoon phenolic-rich extracts could be possibly utilized 
in food industry, as an alternative to synthetic antioxidants. 
Lipophilic and phenolic-rich extracts, derived from C. cardunculus L. var. altilis (DC), 
were screened in terms of the in vitro inhibitory action upon the cellular viability of TNBC MDA-
MB-231 cell line (Chapter VI). Leaves and florets lipophilic extracts presented much more 
inhibitory action (IC50 values of 10.39 and 315.22 µg/mL, respectively), on the MDA-MB-231 
cell growth, compared to the phenolic-rich extract of stalks outer part (IC50 = 3341.20 µg/mL) 
and florets (IC50 > 4500 µg/mL). MDA-MB-231 cells were also less resistant to cynaropicrin 
(IC50 = 17.86 µM) than to 1,5-di-O-caffeoylquinic acid (IC50 = 1741.69 µM). Considering the 
high concentration of cynaropicrin (455.2 mg/g extract), this sesquiterpene lactone may be 
mostly implicated in the suppressive effect of lipophilic leaves extract. Moreover, leaves 
lipophilic extract and cynaropicrin upregulated the p21
Waf1/Cip1
 expression, which may have led 
to accumulation of phospho-Tyr15-CDK1 and cyclin B1. These findings may be involved in the 
G2 cell cycle arrest of MDA-MB-231 cells. Furthermore, leaves lipophilic extract and 
cynaropicrin largely downregulated the phospho-Ser473-Akt protein expression, without 
affecting Akt1 total protein level. The results of this chapter pointed out that leaves lipophilic 
extract or cynaropicrin may have potential to be explored in terms of therapy of TNBC, one of 
the most refractory human cancers. 
The antimicrobial activities of lipophilic and phenolic-rich extracts, derived from 
cultivated cardoon, were evaluated, for the first time, against two MDR bacteria (Chapter VII), 
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main responsible for health care-associated infections (HCAI), namely Gram-negative 
Pseudomonas aeruginosa and Gram-positive methicillin-resistant Staphylococcus aureus 
(MRSA). Lipophilic and phenolic-rich extracts of florets, in the range 8-2048 µg/mL, were not 
efficient in preventing the growth of P. aeruginosa PAO1 and MRSA. Furthermore, lipophilic 
leaves extract did not exhibit antibacterial effect on P. aeruginosa PAO1 (MIC > 2048 µg/mL), 
contrarily to cynaropicrin (MIC = 2048 µg/mL). Nonetheless, lipophilic leaves extract was 
effective to suppress the MRSA growth (MIC = 1024 µg/mL). Cynaropicrin also inhibited the 
MRSA growth (MIC = 256 µg/mL). These data revealed the potential of cultivated cardoon 
leaves lipophilic extract and/or cynaropicrin to be investigated in the scope of MRSA 
therapeutics. 
This thesis contributes for the valorization of C. cardunculus L. var. altilis (DC) 
biomass. Stalks, capitula and leaves present lipophilic and phenolic compounds with 
promising antioxidant, human TNBC (MDA-MB-231 cell line) antiproliferative and anti-MDR 
bacterial effects. The acquired scientific knowledge reflects that cultivated cardoon can be 
potentially exploited as a source of bioactive compounds, in concilliation with other added 
value perspectives, namely production of energy and pulp fibers, and Portuguese traditional 
cheeses manufacturing. 
 
2. Future perspectives 
The purpose of this thesis consisted of the chemical characterization of C. cardunculus 
L. var. altilis (DC) sequential extracts and the evaluation of some biological activities, namely 
antioxidant, human TNBC antiproliferative and anti-MDR bacterial effects. However, there are 
still some issues that need to be tackled before proceeding with the upgrade of bioactive 
compounds extraction from cultivated cardoon: 
(i) to perform the bioactivity-guided fractionation of lipophilic and phenolic-containing 
extracts, in order to clarify the main responsible for the studied biological activities; 
(ii) to prepare cultivated cardoon bioactive-enriched fractions, by using environmentally 
friendly techniques, namely supercritical fluid extraction and membrane filtration 
technology; 
(iii) to assess the antioxidant action of cultivated cardoon extracts, containing phenolic 
compounds, in immortalized human cell lines, intending to understand their regulating role 
on scavenging and production of reactive oxygen species, as well as upon enzymes of 
cellular antioxidant system; 
(iv) to investigate the hypothesis of interaction between cynaropicrin and other 
compound(s)/enriched-fractions of leaves lipophilic extract, regarding the antiproliferative 
action upon TNBC MDA-MB-231 cells; 
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(v) to study the possibility of extracts or enriched fractions in phenolic compounds to be used 
in novel food antioxidant formulations; 
(vi) to evaluate the bioavailability of the most promising cultivated cardoon extracts/enriched 
fractions/pure compounds, through an in vitro simulated digestion model; 
(vii) to develop novel biocidal formulations, containing cultivated cardoon leaves lipophilic 
extract or cynaropicrin, in an effort to contribute for a decrease of health care-associated 
infections, caused by MDR bacteria; 
(viii) to explore the antitumoral potential of formulations, comprising cytostatic drugs and 
leaves lipophilic extract or cynaropicrin, to be applied in the development of a natural-
based TNBC therapeutics. 
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 Tables 1 and 2 of Appendix list the chemical composition of respectively lipophilic and 
phenolic-rich extracts, derived from Cynara cardunculus L. var. altilis (DC). 
 
Table 1: Chemical composition of lipophilic extracts derived from capitula florets and leaves of C. 
cardunculus L. var. altilis (DC). 
Compound 
Content (mg/g extract) 
Capitula florets Leaves 
Aromatic compounds 0.7 ± 0.1 
a
 0.1 ± 0.0 
b
 
Fatty acids 14.4 ± 0.4 
a
 2.5 ± 0.4 
b
 
Saturated 11.7 ± 0.3 
a
 1.6 ± 0.1 
b
 
Pentadecanoic acid 0.2 ± 0.1 ‒ 
Hexadecanoic acid 9.7 ± 0.1 
a
 1.0 ± 0.0 
b
 
Octadecanoic acid 0.5 ± 0.1 
a
 0.1 ± 0.0 
b
 
Eicosanoic acid 0.5 ± 0.1 
a
 0.2 ± 0.0 
b
 
Docosanoic acid 0.6 ± 0.1 ‒ 
Tetracosanoic acid 0.2 ± 0.1 
b
 0.4 ± 0.0 
a
 
Unsaturated 2.7 ± 0.1 
a
 0.8 ± 0.1 
b
 
9Z,12Z-Octadeca-9,12-dienoic acid 2.0 ± 0.1 
a
 0.2 ± 0.0 
b
 
9Z,12Z,15Z-Octadeca-9,12,15-trienoic acid 0.5 ± 0.0 
a
 0.3 ± 0.0 
a
 
9Z-Octadec-9-enoic acid 0.2 ± 0.0 
a
 0.3 ± 0.1 
a
 
Sesquiterpene lactones ‒ 484.9 ± 15.8 
Grosheimin ‒ 20.7 ± 1.1 
Deacylcynaropicrin ‒ 9.0 ± 0.2 
Cynaropicrin ‒ 455.2 ± 14.7 
Long chain aliphatic alcohols ‒ 1.1 ± 0.0 
Tetracosanol ‒ 0.4 ± 0.0 
Hexacosanol ‒ 0.7 ± 0.0 
Sterols 8.8 ± 4.4 
a
 3.4 ± 0.2 
a
 
Stigmaterol 2.2 ± 0.9 
a
 1.0 ± 0.0 
b
 
β-Sitosterol 4.2 ± 2.2 a 2.4 ± 0.2 a 
Δ5-Avenasterol 2.4 ± 1.1 ‒ 
Pentacyclic triterpenes 320.6 ± 80.7 
a
 38.5 ± 0.3 
b
 
β-Amyrin 33.1 ± 8.7 a 3.9 ± 0.3 b 
α-Amyrin 17.9 ± 4.8 a 0.8 ± 0.0 b 
Lupeol 10.6 ± 3.3 
a
 4.9 ± 0.2 
b
 
β-Amyrin acetate 32.8 ± 8.4 a 1.7 ± 0.0 b 
α-Amyrin acetate 13.9 ± 6.3 a 0.2 ± 0.1 b 
Lupeoyl acetate 12.0 ± 3.7 
a
 1.5 ± 0.1 
b
 
ψ-Taraxasterol 25.8 ± 3.4 a 5.7 ± 0.3 b 
Taraxasterol 49.4 ± 13.0 
a
 12.1 ± 0.3 
b
 
ψ-Taraxasteryl acetate 31.6 ± 14.9 a 2.0 ± 0.4 b 
Taraxasteryl acetate 93.4 ± 14.1 
a
 5.7 ± 0.6 
b
 
Others/non-identified 12.9 ± 1.3 
b
 326.6 ± 6.0 
a
 
Total identified compounds 357.4 ± 84.2 
b
 856.9 ± 9.3 
a
 
Results correspond to mean±standard deviation. Two aliquots of each extract were injected in 
duplicated. Means with different letters within the same row are statistically different (Tukey’s test, p < 
0.05). 
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Table 2: Chemical composition of phenolic-rich extracts from stalks outer part and capitula florets of C. 
cardunculus L. var. altilis (DC). 
No. Compound 
Content (mg/g extract) 
(I)
 
Stalks outer part Capitula florets 
 Total hydroxycinnamic acids 54.7 ± 2.4 
a
 0.7 ± 0.1 
b
 
1 1-O-Caffeoylquinic acid 1.1 ± 0.1 ‒ 
2 3-O-Caffeoylquinic acid 0.9 ± 0.1 ‒ 
3 5-O-Caffeoylquinic acid 18.2 ± 0.4 
a
 0.1 ± 0.0 
b
 
5 1,3-Di-O-caffeoylquinic acid 1.2 ± 0.1 ‒ 
10 1,4-Di-O-caffeoylquinic acid 1.4 ± 0.1 ‒ 
12 1,5-Di-O-caffeoylquinic acid 15.8 ± 1.5 
a
 0.6 ± 0.1 
b
 
22 4-Acyl-di-O-caffeoylquinic acid 
(II)
 0.7 ± 0.0 
(21+22) 
‒ 
18 1,5-Di-O-caffeoylsuccinoylquinic acid isomer 11.1 ± 0.5 ‒ 
19 4-Acyl-di-O-caffeoylsuccinoylquinic acid isomer 2.5 ± 0.0
 ‒ 
23 Dicaffeoylsuccinoylquinic acid isomer 0.9 ± 0.1 ‒ 
26 Dicaffeoyldisuccinoylquinic acid isomer 1.7 ± 0.1 ‒ 
 Total coumarins ‒ 1.5 ± 0.2 
4 Scopolin isomer ‒ 1.5 ± 0.2 
 Total flavonoids 3.6 ± 0.2 
b
 22.5 ± 2.2 
a
 
 Total flavanones ‒ 8.5 ± 0.7 
6 Eriodictyol hexoside ‒ nq (III) 
13 Naringenin 7-O-glucoside ‒ 2.1 ± 0.4 
14 Naringenin rutinoside ‒ 5.0 ± 0.3 
28 Naringenin ‒ 1.4 ± 0.1 
 Total flavones 3.6 ± 0.2 
b
 13.9 ± 1.5 
a
 
7 Luteolin glucuronide 0.9 ± 0.0 
a
 0.3 ± 0.0 
b
 
8 Luteolin 7-O-glucoside 1.2 ± 0.1 
a
 0.2 ± 0.0 
b
 
9 Luteolin rutinoside ‒ 0.1 ± 0.0 
21 Luteolin acetylhexoside (21+22) <0.1 
24 Luteolin ‒ 0.6 ± 0.1 
15 Apigenin glucuronide 1.1 ± 0.0 
b
 
(15+16) 
8.4 ± 0.8 
a
 
(15+16+17) 
16 Apigenin 7-O-glucoside (15+16) (15+16+17) 
17 Apigenin 7-O-rutinoside ‒ (15+16+17) 
25 Apigenin acetylhexoside 0.4 ± 0.1 
a
 0.2 ± 0.0 
b
 
29 Apigenin ‒ 4.1 ± 0.5 
20 Chrysoeriol hexoside isomer ‒ <0.1 
30 Chrysoeriol isomer ‒ <0.1 
 Total identified phenolic compounds 59.0 ± 2.4 
a
 24.7 ± 2.4 
b
 
(I)
 Results represent mean±standard deviation. Three samples of each extract were analyzed. Means 
with different letters within the same row are statistically different (Tukey’s test, p < 0.05). Numbers in 
parenthesis correspond to compounds whose peaks were overlapped. 
(II)
 Total hydroxycinnamic acid content did not include the content of 4-acyl-di-O-caffeoylquinic acid (22), 
due to the sum with luteolin acetylhexoside (21) (overlapped peaks). 
(III)
 Abbreviation: nq, not quantified since it was below the limit of quantification. 
